drug_index,disease_index,drug_name,disease_name,path_type,original_relation,nodes,score,prefix
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ABCC2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ABCC2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14227,29078.0,Etodolac,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Etodolac']",0.5,"Question: Is rheumatoid arthritis an indication for Etodolac?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Etodolac. These connections suggest that Etodolac may be effective in treating rheumatoid arthritis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'NR1H4', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene NR1H4. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14167,83845.0,Ampicillin,viral meningitis,disease-protein-drug,indication,"['viral meningitis', 'ALB', 'Ampicillin']",0.5,"Question: Is viral meningitis an indication for Ampicillin?
Reasoning: The disease viral meningitis is associated with the gene ALB, which is targeted by the drug Ampicillin. These connections suggest that Ampicillin may be effective in treating viral meningitis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'NRP2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene NRP2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'FA2H', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene FA2H. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14945,28640.0,Sorafenib,nonpapillary renal cell carcinoma,disease-protein-drug,indication,"['nonpapillary renal cell carcinoma', 'FLT4', 'Sorafenib']",0.5,"Question: Is nonpapillary renal cell carcinoma an indication for Sorafenib?
Reasoning: The disease nonpapillary renal cell carcinoma is associated with the gene FLT4, which is targeted by the drug Sorafenib. These connections suggest that Sorafenib may be effective in treating nonpapillary renal cell carcinoma.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'ATG5', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene ATG5. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15462,32875.0,Esomeprazole,Zollinger-Ellison syndrome,disease-phenotype-protein-drug,indication,"['Zollinger-Ellison syndrome', 'Nausea', 'ABCB1', 'Esomeprazole']",0.5,"Question: Is Zollinger-Ellison syndrome an indication for Esomeprazole?
Reasoning: The disease Zollinger-Ellison syndrome is associated with the phenotype Nausea, which in turn affects the gene ABCB1. This gene is targeted by the drug Esomeprazole. These connections suggest that Esomeprazole may be effective in treating Zollinger-Ellison syndrome.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PIGP', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene PIGP. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15263,83859.0,Enasidenib,acute myeloid leukemia with t(9;11)(p22;q23),disease-protein-drug,indication,"['acute myeloid leukemia with t(9;11)(p22;q23)', 'IDH2', 'Enasidenib']",0.5,"Question: Is acute myeloid leukemia with t(9;11)(p22;q23) an indication for Enasidenib?
Reasoning: The disease acute myeloid leukemia with t(9;11)(p22;q23) is associated with the gene IDH2, which is targeted by the drug Enasidenib. These connections suggest that Enasidenib may be effective in treating acute myeloid leukemia with t(9;11)(p22;q23).
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'KAT8', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene KAT8. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'FUT8', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene FUT8. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15193,28801.0,Rotigotine,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DRD1', 'Rotigotine']",0.5,"Question: Is juvenile onset Parkinson disease 19A an indication for Rotigotine?
Reasoning: The disease juvenile onset Parkinson disease 19A is associated with the gene DRD1, which is targeted by the drug Rotigotine. These connections suggest that Rotigotine may be effective in treating juvenile onset Parkinson disease 19A.
Answer: YES"
14030,33534.0,Prednisolone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Prednisolone']",0.5,"Question: Is pediatric systemic lupus erythematosus an indication for Prednisolone?
Reasoning: The disease pediatric systemic lupus erythematosus is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Prednisolone. These connections suggest that Prednisolone may be effective in treating pediatric systemic lupus erythematosus.
Answer: YES"
14830,28974.0,Amantadine,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Seizure', 'CHRNA3', 'Amantadine']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Amantadine?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the phenotype Seizure, which in turn affects the gene CHRNA3. This gene is targeted by the drug Amantadine. These connections suggest that Amantadine may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
14269,27648.0,Methylprednisolone,familial glucocorticoid deficiency,disease-phenotype-protein-drug,indication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Methylprednisolone']",0.5,"Question: Is familial glucocorticoid deficiency an indication for Methylprednisolone?
Reasoning: The disease familial glucocorticoid deficiency is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Methylprednisolone. These connections suggest that Methylprednisolone may be effective in treating familial glucocorticoid deficiency.
Answer: YES"
14948,83769.0,Teniposide,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Teniposide']",0.5,"Question: Is precursor T-cell acute lymphoblastic leukemia an indication for Teniposide?
Reasoning: The disease precursor T-cell acute lymphoblastic leukemia is associated with the gene ABCG2, which is targeted by the drug Teniposide. These connections suggest that Teniposide may be effective in treating precursor T-cell acute lymphoblastic leukemia.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Infertility', 'TTC19', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Infertility, which in turn affects the gene TTC19. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CDKL5', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene CDKL5. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14906,37703.0,Toloxatone,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'MAOA', 'Toloxatone']",0.5,"Question: Is neurotic disorder an indication for Toloxatone?
Reasoning: The disease neurotic disorder is associated with the gene MAOA, which is targeted by the drug Toloxatone. These connections suggest that Toloxatone may be effective in treating neurotic disorder.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'HACE1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene HACE1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Short stature', 'IQSEC1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Short stature, which in turn affects the gene IQSEC1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'CYP1A2', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene CYP1A2. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hypotonia', 'KANSL1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hypotonia, which in turn affects the gene KANSL1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14792,83819.0,Paclitaxel,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant dysgerminomatous germ cell tumor of ovary', 'CYP1B1', 'Paclitaxel']",0.5,"Question: Is malignant dysgerminomatous germ cell tumor of ovary an indication for Paclitaxel?
Reasoning: The disease malignant dysgerminomatous germ cell tumor of ovary is associated with the gene CYP1B1, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating malignant dysgerminomatous germ cell tumor of ovary.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'GAMT', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene GAMT. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14685,35739.0,Progesterone,uterine corpus cancer,disease-protein-drug,indication,"['uterine corpus cancer', 'ESR2', 'Progesterone']",0.5,"Question: Is uterine corpus cancer an indication for Progesterone?
Reasoning: The disease uterine corpus cancer is associated with the gene ESR2, which is targeted by the drug Progesterone. These connections suggest that Progesterone may be effective in treating uterine corpus cancer.
Answer: YES"
14060,33296.0,Levothyroxine,familial papillary or follicular thyroid carcinoma,disease-phenotype-protein-drug,indication,"['familial papillary or follicular thyroid carcinoma', 'Pain', 'ALB', 'Levothyroxine']",0.5,"Question: Is familial papillary or follicular thyroid carcinoma an indication for Levothyroxine?
Reasoning: The disease familial papillary or follicular thyroid carcinoma is associated with the phenotype Pain, which in turn affects the gene ALB. This gene is targeted by the drug Levothyroxine. These connections suggest that Levothyroxine may be effective in treating familial papillary or follicular thyroid carcinoma.
Answer: YES"
14208,83765.0,Testosterone,hypogonadotropic hypogonadism-frontoparietal alopecia syndrome,disease-protein-drug,indication,"['hypogonadotropic hypogonadism-frontoparietal alopecia syndrome', 'CYP19A1', 'Testosterone']",0.5,"Question: Is hypogonadotropic hypogonadism-frontoparietal alopecia syndrome an indication for Testosterone?
Reasoning: The disease hypogonadotropic hypogonadism-frontoparietal alopecia syndrome is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating hypogonadotropic hypogonadism-frontoparietal alopecia syndrome.
Answer: YES"
14269,83791.0,Methylprednisolone,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Methylprednisolone']",0.5,"Question: Is vasomotor rhinitis an indication for Methylprednisolone?
Reasoning: The disease vasomotor rhinitis is associated with the gene ALB, which is targeted by the drug Methylprednisolone. These connections suggest that Methylprednisolone may be effective in treating vasomotor rhinitis.
Answer: YES"
14059,32622.0,Liothyronine,thyroid gland undifferentiated (anaplastic) carcinoma,disease-phenotype-protein-drug,indication,"['thyroid gland undifferentiated (anaplastic) carcinoma', 'Pain', 'ALB', 'Liothyronine']",0.5,"Question: Is thyroid gland undifferentiated (anaplastic) carcinoma an indication for Liothyronine?
Reasoning: The disease thyroid gland undifferentiated (anaplastic) carcinoma is associated with the phenotype Pain, which in turn affects the gene ALB. This gene is targeted by the drug Liothyronine. These connections suggest that Liothyronine may be effective in treating thyroid gland undifferentiated (anaplastic) carcinoma.
Answer: YES"
15984,29078.0,Oxaprozin,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Oxaprozin']",0.5,"Question: Is rheumatoid arthritis an indication for Oxaprozin?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Oxaprozin. These connections suggest that Oxaprozin may be effective in treating rheumatoid arthritis.
Answer: YES"
14603,28208.0,Chlorpropamide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'ABCC8', 'Chlorpropamide']",0.5,"Question: Is type 2 diabetes mellitus an indication for Chlorpropamide?
Reasoning: The disease type 2 diabetes mellitus is associated with the gene ABCC8, which is targeted by the drug Chlorpropamide. These connections suggest that Chlorpropamide may be effective in treating type 2 diabetes mellitus.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'ADGRV1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene ADGRV1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15012,83796.0,Temsirolimus,lymphosarcoma,disease-protein-drug,indication,"['lymphosarcoma', 'MTOR', 'Temsirolimus']",0.5,"Question: Is lymphosarcoma an indication for Temsirolimus?
Reasoning: The disease lymphosarcoma is associated with the gene MTOR, which is targeted by the drug Temsirolimus. These connections suggest that Temsirolimus may be effective in treating lymphosarcoma.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'FDFT1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene FDFT1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'ADCYAP1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene ADCYAP1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15295,33592.0,Triamterene,acidosis disorder,disease-phenotype-protein-drug,contraindication,"['acidosis disorder', 'Lactic acidosis', 'ATAD3A', 'Triamterene']",1.0,"Question: Is acidosis disorder an indication for Triamterene?
Reasoning: The disease acidosis disorder is associated with the phenotype Lactic acidosis, which in turn affects the gene ATAD3A. This gene is not targeted by the drug Triamterene. These connections suggest that Triamterene may not be effective in treating acidosis disorder.
Answer: NO"
14789,29863.0,Daunorubicin,monocytic leukemia,disease-protein-drug,indication,"['monocytic leukemia', 'TOP2B', 'Daunorubicin']",0.5,"Question: Is monocytic leukemia an indication for Daunorubicin?
Reasoning: The disease monocytic leukemia is associated with the gene TOP2B, which is targeted by the drug Daunorubicin. These connections suggest that Daunorubicin may be effective in treating monocytic leukemia.
Answer: YES"
15493,32759.0,Bromocriptine,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'HTR1A', 'Bromocriptine']",0.5,"Question: Is hemiparkinsonism-hemiatrophy syndrome an indication for Bromocriptine?
Reasoning: The disease hemiparkinsonism-hemiatrophy syndrome is associated with the phenotype Tremor, which in turn affects the gene HTR1A. This gene is targeted by the drug Bromocriptine. These connections suggest that Bromocriptine may be effective in treating hemiparkinsonism-hemiatrophy syndrome.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CACNA1E', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene CACNA1E. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14880,84229.0,Nicotine,nicotine dependence,disease-protein-drug,indication,"['nicotine dependence', 'CYP2A6', 'Nicotine']",0.5,"Question: Is nicotine dependence an indication for Nicotine?
Reasoning: The disease nicotine dependence is associated with the gene CYP2A6, which is targeted by the drug Nicotine. These connections suggest that Nicotine may be effective in treating nicotine dependence.
Answer: YES"
14030,28830.0,Prednisolone,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'ABCB1', 'Prednisolone']",0.5,"Question: Is leukemia, lymphocytic, susceptibility to an indication for Prednisolone?
Reasoning: The disease leukemia, lymphocytic, susceptibility to is associated with the gene ABCB1, which is targeted by the drug Prednisolone. These connections suggest that Prednisolone may be effective in treating leukemia, lymphocytic, susceptibility to.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'AFF3', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene AFF3. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14945,29646.0,Sorafenib,hepatocellular carcinoma,disease-phenotype-protein-drug,indication,"['hepatocellular carcinoma', 'Hepatomegaly', 'CYP1A2', 'Sorafenib']",0.5,"Question: Is hepatocellular carcinoma an indication for Sorafenib?
Reasoning: The disease hepatocellular carcinoma is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Sorafenib. These connections suggest that Sorafenib may be effective in treating hepatocellular carcinoma.
Answer: YES"
15087,38957.0,Venlafaxine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Venlafaxine']",0.5,"Question: Is major depressive disorder an indication for Venlafaxine?
Reasoning: The disease major depressive disorder is associated with the gene SLC6A4, which is targeted by the drug Venlafaxine. These connections suggest that Venlafaxine may be effective in treating major depressive disorder.
Answer: YES"
14034,37888.0,Budesonide,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Budesonide']",0.5,"Question: Is allergic rhinitis an indication for Budesonide?
Reasoning: The disease allergic rhinitis is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is targeted by the drug Budesonide. These connections suggest that Budesonide may be effective in treating allergic rhinitis.
Answer: YES"
15200,33618.0,Vernakalant,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'KCND3', 'Vernakalant']",0.5,"Question: Is atrial fibrillation (disease) an indication for Vernakalant?
Reasoning: The disease atrial fibrillation (disease) is associated with the gene KCND3, which is targeted by the drug Vernakalant. These connections suggest that Vernakalant may be effective in treating atrial fibrillation (disease).
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'GM2A', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene GM2A. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'OTOA', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene OTOA. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14275,83821.0,Doxorubicin,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,indication,"['malignant Sertoli-Leydig cell tumor of ovary', 'CYP1B1', 'Doxorubicin']",0.5,"Question: Is malignant Sertoli-Leydig cell tumor of ovary an indication for Doxorubicin?
Reasoning: The disease malignant Sertoli-Leydig cell tumor of ovary is associated with the gene CYP1B1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating malignant Sertoli-Leydig cell tumor of ovary.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PPP2CA', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene PPP2CA. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14792,37152.0,Paclitaxel,familial ovarian cancer,disease-protein-drug,indication,"['familial ovarian cancer', 'CYP1B1', 'Paclitaxel']",0.5,"Question: Is familial ovarian cancer an indication for Paclitaxel?
Reasoning: The disease familial ovarian cancer is associated with the gene CYP1B1, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating familial ovarian cancer.
Answer: YES"
14806,31408.0,Entacapone,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'CYP2D6', 'Entacapone']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Entacapone?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the gene CYP2D6, which is targeted by the drug Entacapone. These connections suggest that Entacapone may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'SYN2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene SYN2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CDK8', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CDK8. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'IMPA1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene IMPA1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'IL1B', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene IL1B. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14340,29078.0,Magnesium salicylate,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Magnesium salicylate']",0.5,"Question: Is rheumatoid arthritis an indication for Magnesium salicylate?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Magnesium salicylate. These connections suggest that Magnesium salicylate may be effective in treating rheumatoid arthritis.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CLPB', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CLPB. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14664,31918.0,Sapropterin,phenylketonuria,disease-protein-drug,indication,"['phenylketonuria', 'PAH', 'Sapropterin']",0.5,"Question: Is phenylketonuria an indication for Sapropterin?
Reasoning: The disease phenylketonuria is associated with the gene PAH, which is targeted by the drug Sapropterin. These connections suggest that Sapropterin may be effective in treating phenylketonuria.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Feeding difficulties', 'PPP2CA', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Feeding difficulties, which in turn affects the gene PPP2CA. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'WDR37', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene WDR37. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'PTGS2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene PTGS2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'PET100', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene PET100. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15077,32531.0,Bortezomib,mantle cell lymphoma,disease-phenotype-protein-drug,indication,"['mantle cell lymphoma', 'Splenomegaly', 'CYP1A2', 'Bortezomib']",0.5,"Question: Is mantle cell lymphoma an indication for Bortezomib?
Reasoning: The disease mantle cell lymphoma is associated with the phenotype Splenomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Bortezomib. These connections suggest that Bortezomib may be effective in treating mantle cell lymphoma.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'ETV6', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene ETV6. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14737,37466.0,Carboplatin,ovarian small cell carcinoma,disease-protein-drug,indication,"['ovarian small cell carcinoma', 'ATP7B', 'Carboplatin']",0.5,"Question: Is ovarian small cell carcinoma an indication for Carboplatin?
Reasoning: The disease ovarian small cell carcinoma is associated with the gene ATP7B, which is targeted by the drug Carboplatin. These connections suggest that Carboplatin may be effective in treating ovarian small cell carcinoma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'FOLR1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene FOLR1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Feeding difficulties', 'ZNF292', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Feeding difficulties, which in turn affects the gene ZNF292. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14201,32949.0,Oxytetracycline,relapsing fever,disease-phenotype-protein-drug,indication,"['relapsing fever', 'Thrombocytopenia', 'ALB', 'Oxytetracycline']",0.5,"Question: Is relapsing fever an indication for Oxytetracycline?
Reasoning: The disease relapsing fever is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Oxytetracycline. These connections suggest that Oxytetracycline may be effective in treating relapsing fever.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'PACS2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene PACS2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TRPM3', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TRPM3. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16532,33675.0,Pirbuterol,asthma,disease-protein-drug,indication,"['asthma', 'ADRB2', 'Pirbuterol']",0.5,"Question: Is asthma an indication for Pirbuterol?
Reasoning: The disease asthma is associated with the gene ADRB2, which is targeted by the drug Pirbuterol. These connections suggest that Pirbuterol may be effective in treating asthma.
Answer: YES"
14019,37770.0,Betamethasone,contact dermatitis,disease-protein-drug,indication,"['contact dermatitis', 'CYP1B1', 'Betamethasone']",0.5,"Question: Is contact dermatitis an indication for Betamethasone?
Reasoning: The disease contact dermatitis is associated with the gene CYP1B1, which is targeted by the drug Betamethasone. These connections suggest that Betamethasone may be effective in treating contact dermatitis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'PNPT1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene PNPT1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14913,28313.0,Trifluoperazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'ABCB1', 'Trifluoperazine']",0.5,"Question: Is schizophrenia an indication for Trifluoperazine?
Reasoning: The disease schizophrenia is associated with the gene ABCB1, which is targeted by the drug Trifluoperazine. These connections suggest that Trifluoperazine may be effective in treating schizophrenia.
Answer: YES"
14293,33575.0,Glipizide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'ABCC8', 'Glipizide']",0.5,"Question: Is diabetes mellitus (disease) an indication for Glipizide?
Reasoning: The disease diabetes mellitus (disease) is associated with the gene ABCC8, which is targeted by the drug Glipizide. These connections suggest that Glipizide may be effective in treating diabetes mellitus (disease).
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'GFAP', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene GFAP. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14208,84094.0,Testosterone,premature menopause,disease-protein-drug,indication,"['premature menopause', 'CYP2C19', 'Testosterone']",0.5,"Question: Is premature menopause an indication for Testosterone?
Reasoning: The disease premature menopause is associated with the gene CYP2C19, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating premature menopause.
Answer: YES"
14691,36432.0,Amiloride,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'SLC9A1', 'Amiloride']",0.5,"Question: Is congestive heart failure an indication for Amiloride?
Reasoning: The disease congestive heart failure is associated with the gene SLC9A1, which is targeted by the drug Amiloride. These connections suggest that Amiloride may be effective in treating congestive heart failure.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CCL3', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CCL3. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Neurodevelopmental delay', 'NSD2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Neurodevelopmental delay, which in turn affects the gene NSD2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CLEC4A', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CLEC4A. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'FAAH', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene FAAH. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'TKFC', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene TKFC. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15018,83853.0,Midostaurin,acute myeloblastic leukemia without maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia without maturation', 'KIT', 'Midostaurin']",0.5,"Question: Is acute myeloblastic leukemia without maturation an indication for Midostaurin?
Reasoning: The disease acute myeloblastic leukemia without maturation is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating acute myeloblastic leukemia without maturation.
Answer: YES"
14713,83859.0,Decitabine,acute myeloid leukemia with t(9;11)(p22;q23),disease-protein-drug,indication,"['acute myeloid leukemia with t(9;11)(p22;q23)', 'DNMT3A', 'Decitabine']",0.5,"Question: Is acute myeloid leukemia with t(9;11)(p22;q23) an indication for Decitabine?
Reasoning: The disease acute myeloid leukemia with t(9;11)(p22;q23) is associated with the gene DNMT3A, which is targeted by the drug Decitabine. These connections suggest that Decitabine may be effective in treating acute myeloid leukemia with t(9;11)(p22;q23).
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'MBOAT2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene MBOAT2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'NAGA', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene NAGA. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ALPL', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ALPL. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14955,83769.0,Vincristine,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Vincristine']",0.5,"Question: Is precursor T-cell acute lymphoblastic leukemia an indication for Vincristine?
Reasoning: The disease precursor T-cell acute lymphoblastic leukemia is associated with the gene ABCG2, which is targeted by the drug Vincristine. These connections suggest that Vincristine may be effective in treating precursor T-cell acute lymphoblastic leukemia.
Answer: YES"
14207,28414.0,Imatinib,idiopathic hypereosinophilic syndrome,disease-phenotype-protein-drug,indication,"['idiopathic hypereosinophilic syndrome', 'Hepatomegaly', 'ALB', 'Imatinib']",0.5,"Question: Is idiopathic hypereosinophilic syndrome an indication for Imatinib?
Reasoning: The disease idiopathic hypereosinophilic syndrome is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Imatinib. These connections suggest that Imatinib may be effective in treating idiopathic hypereosinophilic syndrome.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'INS', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene INS. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'TMIE', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene TMIE. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14313,29361.0,Arsenic trioxide,acute promyelocytic leukemia,disease-phenotype-protein-drug,indication,"['acute promyelocytic leukemia', 'Thrombocytopenia', 'ALB', 'Arsenic trioxide']",0.5,"Question: Is acute promyelocytic leukemia an indication for Arsenic trioxide?
Reasoning: The disease acute promyelocytic leukemia is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Arsenic trioxide. These connections suggest that Arsenic trioxide may be effective in treating acute promyelocytic leukemia.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'MYO1B', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene MYO1B. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SLC1A1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene SLC1A1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'CDKL5', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene CDKL5. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15326,32729.0,Ofloxacin,botulism,disease-phenotype-protein-drug,indication,"['botulism', 'Arrhythmia', 'SLC22A5', 'Ofloxacin']",0.5,"Question: Is botulism an indication for Ofloxacin?
Reasoning: The disease botulism is associated with the phenotype Arrhythmia, which in turn affects the gene SLC22A5. This gene is targeted by the drug Ofloxacin. These connections suggest that Ofloxacin may be effective in treating botulism.
Answer: YES"
15324,29078.0,Leflunomide,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'AHR', 'Leflunomide']",0.5,"Question: Is rheumatoid arthritis an indication for Leflunomide?
Reasoning: The disease rheumatoid arthritis is associated with the gene AHR, which is targeted by the drug Leflunomide. These connections suggest that Leflunomide may be effective in treating rheumatoid arthritis.
Answer: YES"
14320,29182.0,Dexamethasone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,indication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Dexamethasone']",0.5,"Question: Is systemic lupus erythematosus (disease) an indication for Dexamethasone?
Reasoning: The disease systemic lupus erythematosus (disease) is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating systemic lupus erythematosus (disease).
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'XIAP', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene XIAP. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14275,84158.0,Doxorubicin,T-cell/histiocyte rich large B cell lymphoma,disease-protein-drug,indication,"['T-cell/histiocyte rich large B cell lymphoma', 'ABCB1', 'Doxorubicin']",0.5,"Question: Is T-cell/histiocyte rich large B cell lymphoma an indication for Doxorubicin?
Reasoning: The disease T-cell/histiocyte rich large B cell lymphoma is associated with the gene ABCB1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating T-cell/histiocyte rich large B cell lymphoma.
Answer: YES"
14206,33128.0,Chloroquine,malaria,disease-protein-drug,indication,"['malaria', 'TNF', 'Chloroquine']",0.5,"Question: Is malaria an indication for Chloroquine?
Reasoning: The disease malaria is associated with the gene TNF, which is targeted by the drug Chloroquine. These connections suggest that Chloroquine may be effective in treating malaria.
Answer: YES"
14242,29078.0,Meloxicam,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCC4', 'Meloxicam']",0.5,"Question: Is rheumatoid arthritis an indication for Meloxicam?
Reasoning: The disease rheumatoid arthritis is associated with the gene ABCC4, which is targeted by the drug Meloxicam. These connections suggest that Meloxicam may be effective in treating rheumatoid arthritis.
Answer: YES"
15018,84326.0,Midostaurin,obsolete classic mast cell leukemia,disease-protein-drug,indication,"['obsolete classic mast cell leukemia', 'KIT', 'Midostaurin']",0.5,"Question: Is obsolete classic mast cell leukemia an indication for Midostaurin?
Reasoning: The disease obsolete classic mast cell leukemia is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating obsolete classic mast cell leukemia.
Answer: YES"
15770,28208.0,Glimepiride,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'KCNJ11', 'Glimepiride']",0.5,"Question: Is type 2 diabetes mellitus an indication for Glimepiride?
Reasoning: The disease type 2 diabetes mellitus is associated with the phenotype Insulin resistance, which in turn affects the gene KCNJ11. This gene is targeted by the drug Glimepiride. These connections suggest that Glimepiride may be effective in treating type 2 diabetes mellitus.
Answer: YES"
15193,30093.0,Rotigotine,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'DRD1', 'Rotigotine']",0.5,"Question: Is parkinsonian-pyramidal syndrome an indication for Rotigotine?
Reasoning: The disease parkinsonian-pyramidal syndrome is associated with the gene DRD1, which is targeted by the drug Rotigotine. These connections suggest that Rotigotine may be effective in treating parkinsonian-pyramidal syndrome.
Answer: YES"
14175,36209.0,Nabumetone,arthropathy,disease-protein-drug,indication,"['arthropathy', 'AKR1C2', 'Nabumetone']",0.5,"Question: Is arthropathy an indication for Nabumetone?
Reasoning: The disease arthropathy is associated with the gene AKR1C2, which is targeted by the drug Nabumetone. These connections suggest that Nabumetone may be effective in treating arthropathy.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'LSS', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene LSS. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'LGALS3', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene LGALS3. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SMC1A', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene SMC1A. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14194,30075.0,Methotrexate,Burkitt lymphoma,disease-protein-drug,indication,"['Burkitt lymphoma', 'MTHFR', 'Methotrexate']",0.5,"Question: Is Burkitt lymphoma an indication for Methotrexate?
Reasoning: The disease Burkitt lymphoma is associated with the gene MTHFR, which is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating Burkitt lymphoma.
Answer: YES"
16532,39773.0,Pirbuterol,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Pirbuterol']",0.5,"Question: Is allergic asthma an indication for Pirbuterol?
Reasoning: The disease allergic asthma is associated with the gene ADRB2, which is targeted by the drug Pirbuterol. These connections suggest that Pirbuterol may be effective in treating allergic asthma.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'TUBA8', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene TUBA8. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14192,39815.0,Lamotrigine,visual epilepsy,disease-protein-drug,indication,"['visual epilepsy', 'DRD1', 'Lamotrigine']",0.5,"Question: Is visual epilepsy an indication for Lamotrigine?
Reasoning: The disease visual epilepsy is associated with the gene DRD1, which is targeted by the drug Lamotrigine. These connections suggest that Lamotrigine may be effective in treating visual epilepsy.
Answer: YES"
14463,83858.0,Gilteritinib,acute myeloid leukemia with t(6;9)(p23;q34),disease-protein-drug,indication,"['acute myeloid leukemia with t(6;9)(p23;q34)', 'FLT3', 'Gilteritinib']",0.5,"Question: Is acute myeloid leukemia with t(6;9)(p23;q34) an indication for Gilteritinib?
Reasoning: The disease acute myeloid leukemia with t(6;9)(p23;q34) is associated with the gene FLT3, which is targeted by the drug Gilteritinib. These connections suggest that Gilteritinib may be effective in treating acute myeloid leukemia with t(6;9)(p23;q34).
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'POMC', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene POMC. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'MYO15A', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene MYO15A. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ZNF292', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene ZNF292. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TUBA8', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TUBA8. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15193,28974.0,Rotigotine,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'CYP2D6', 'Rotigotine']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Rotigotine?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Rotigotine. These connections suggest that Rotigotine may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
14320,28830.0,Dexamethasone,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'CYP2E1', 'Dexamethasone']",0.5,"Question: Is leukemia, lymphocytic, susceptibility to an indication for Dexamethasone?
Reasoning: The disease leukemia, lymphocytic, susceptibility to is associated with the gene CYP2E1, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating leukemia, lymphocytic, susceptibility to.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'ALOX5', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene ALOX5. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15326,33474.0,Ofloxacin,typhoid fever,disease-phenotype-protein-drug,indication,"['typhoid fever', 'Hepatomegaly', 'CYP1A2', 'Ofloxacin']",0.5,"Question: Is typhoid fever an indication for Ofloxacin?
Reasoning: The disease typhoid fever is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Ofloxacin. These connections suggest that Ofloxacin may be effective in treating typhoid fever.
Answer: YES"
15222,38957.0,Levomilnacipran,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Levomilnacipran']",0.5,"Question: Is major depressive disorder an indication for Levomilnacipran?
Reasoning: The disease major depressive disorder is associated with the gene SLC6A4, which is targeted by the drug Levomilnacipran. These connections suggest that Levomilnacipran may be effective in treating major depressive disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'KCNA2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene KCNA2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14186,32617.0,Cisplatin,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'PTGS2', 'Cisplatin']",0.5,"Question: Is hereditary breast ovarian cancer syndrome an indication for Cisplatin?
Reasoning: The disease hereditary breast ovarian cancer syndrome is associated with the gene PTGS2, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating hereditary breast ovarian cancer syndrome.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CCR2', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CCR2. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PAM', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene PAM. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14204,29078.0,Sulindac,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Sulindac']",0.5,"Question: Is rheumatoid arthritis an indication for Sulindac?
Reasoning: The disease rheumatoid arthritis is associated with the gene PTGS1, which is targeted by the drug Sulindac. These connections suggest that Sulindac may be effective in treating rheumatoid arthritis.
Answer: YES"
14955,36425.0,Vincristine,primary central nervous system lymphoma,disease-protein-drug,indication,"['primary central nervous system lymphoma', 'ABCB1', 'Vincristine']",0.5,"Question: Is primary central nervous system lymphoma an indication for Vincristine?
Reasoning: The disease primary central nervous system lymphoma is associated with the gene ABCB1, which is targeted by the drug Vincristine. These connections suggest that Vincristine may be effective in treating primary central nervous system lymphoma.
Answer: YES"
14220,32974.0,Apomorphine,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'HTR1A', 'Apomorphine']",0.5,"Question: Is atypical juvenile parkinsonism an indication for Apomorphine?
Reasoning: The disease atypical juvenile parkinsonism is associated with the phenotype Resting tremor, which in turn affects the gene HTR1A. This gene is targeted by the drug Apomorphine. These connections suggest that Apomorphine may be effective in treating atypical juvenile parkinsonism.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'ALOX5AP', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene ALOX5AP. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'SLC17A7', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene SLC17A7. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'COMT', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene COMT. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'MSRB3', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene MSRB3. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'TBC1D20', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene TBC1D20. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GM2A', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene GM2A. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14028,83781.0,Hydrocortisone,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'HSD11B2', 'Hydrocortisone']",0.5,"Question: Is intrinsic asthma an indication for Hydrocortisone?
Reasoning: The disease intrinsic asthma is associated with the gene HSD11B2, which is targeted by the drug Hydrocortisone. These connections suggest that Hydrocortisone may be effective in treating intrinsic asthma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'FANCA', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene FANCA. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16758,29078.0,Alclofenac,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Alclofenac']",0.5,"Question: Is rheumatoid arthritis an indication for Alclofenac?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Alclofenac. These connections suggest that Alclofenac may be effective in treating rheumatoid arthritis.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'PTHLH', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene PTHLH. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14323,28313.0,Aripiprazole,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'HTR5A', 'Aripiprazole']",0.5,"Question: Is schizophrenia an indication for Aripiprazole?
Reasoning: The disease schizophrenia is associated with the gene HTR5A, which is targeted by the drug Aripiprazole. These connections suggest that Aripiprazole may be effective in treating schizophrenia.
Answer: YES"
15413,36794.0,Gemcitabine,ovarian adenocarcinoma,disease-protein-drug,indication,"['ovarian adenocarcinoma', 'TYMS', 'Gemcitabine']",0.5,"Question: Is ovarian adenocarcinoma an indication for Gemcitabine?
Reasoning: The disease ovarian adenocarcinoma is associated with the gene TYMS, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating ovarian adenocarcinoma.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'MTHFR', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene MTHFR. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
17437,35895.0,Metyrosine,small intestine cancer,disease-protein-drug,indication,"['small intestine cancer', 'TH', 'Metyrosine']",0.5,"Question: Is small intestine cancer an indication for Metyrosine?
Reasoning: The disease small intestine cancer is associated with the gene TH, which is targeted by the drug Metyrosine. These connections suggest that Metyrosine may be effective in treating small intestine cancer.
Answer: YES"
17232,37888.0,Triprolidine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Triprolidine']",0.5,"Question: Is allergic rhinitis an indication for Triprolidine?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Triprolidine. These connections suggest that Triprolidine may be effective in treating allergic rhinitis.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'GBA', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene GBA. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14139,28801.0,Benzatropine,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Seizure', 'SLC6A2', 'Benzatropine']",0.5,"Question: Is juvenile onset Parkinson disease 19A an indication for Benzatropine?
Reasoning: The disease juvenile onset Parkinson disease 19A is associated with the phenotype Seizure, which in turn affects the gene SLC6A2. This gene is targeted by the drug Benzatropine. These connections suggest that Benzatropine may be effective in treating juvenile onset Parkinson disease 19A.
Answer: YES"
15597,29118.0,Ruxolitinib,acquired polycythemia vera,disease-phenotype-protein-drug,indication,"['acquired polycythemia vera', 'Venous thrombosis', 'JAK2', 'Ruxolitinib']",0.5,"Question: Is acquired polycythemia vera an indication for Ruxolitinib?
Reasoning: The disease acquired polycythemia vera is associated with the phenotype Venous thrombosis, which in turn affects the gene JAK2. This gene is targeted by the drug Ruxolitinib. These connections suggest that Ruxolitinib may be effective in treating acquired polycythemia vera.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'DRD1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene DRD1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14806,28547.0,Entacapone,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'CYP2D6', 'Entacapone']",0.5,"Question: Is Parkinson disease an indication for Entacapone?
Reasoning: The disease Parkinson disease is associated with the gene CYP2D6, which is targeted by the drug Entacapone. These connections suggest that Entacapone may be effective in treating Parkinson disease.
Answer: YES"
15510,37764.0,Bezafibrate,familial hyperlipidemia,disease-protein-drug,indication,"['familial hyperlipidemia', 'PPARA', 'Bezafibrate']",0.5,"Question: Is familial hyperlipidemia an indication for Bezafibrate?
Reasoning: The disease familial hyperlipidemia is associated with the gene PPARA, which is targeted by the drug Bezafibrate. These connections suggest that Bezafibrate may be effective in treating familial hyperlipidemia.
Answer: YES"
16341,33589.0,Iron,hypochromic anemia,disease-protein-drug,indication,"['hypochromic anemia', 'TF', 'Iron']",0.5,"Question: Is hypochromic anemia an indication for Iron?
Reasoning: The disease hypochromic anemia is associated with the gene TF, which is targeted by the drug Iron. These connections suggest that Iron may be effective in treating hypochromic anemia.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'PAM', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene PAM. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14830,32974.0,Amantadine,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'MAOB', 'Amantadine']",0.5,"Question: Is atypical juvenile parkinsonism an indication for Amantadine?
Reasoning: The disease atypical juvenile parkinsonism is associated with the gene MAOB, which is targeted by the drug Amantadine. These connections suggest that Amantadine may be effective in treating atypical juvenile parkinsonism.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hypocalcemia', 'CASR', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hypocalcemia, which in turn affects the gene CASR. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
17545,83852.0,Gemtuzumab ozogamicin,acute myeloid leukemia with minimal differentiation,disease-protein-drug,indication,"['acute myeloid leukemia with minimal differentiation', 'CD33', 'Gemtuzumab ozogamicin']",0.5,"Question: Is acute myeloid leukemia with minimal differentiation an indication for Gemtuzumab ozogamicin?
Reasoning: The disease acute myeloid leukemia with minimal differentiation is associated with the gene CD33, which is targeted by the drug Gemtuzumab ozogamicin. These connections suggest that Gemtuzumab ozogamicin may be effective in treating acute myeloid leukemia with minimal differentiation.
Answer: YES"
15205,36935.0,Pazopanib,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'FLT1', 'Pazopanib']",0.5,"Question: Is renal cell adenocarcinoma an indication for Pazopanib?
Reasoning: The disease renal cell adenocarcinoma is associated with the gene FLT1, which is targeted by the drug Pazopanib. These connections suggest that Pazopanib may be effective in treating renal cell adenocarcinoma.
Answer: YES"
14893,37703.0,Iproniazid,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'MAOB', 'Iproniazid']",0.5,"Question: Is neurotic disorder an indication for Iproniazid?
Reasoning: The disease neurotic disorder is associated with the gene MAOB, which is targeted by the drug Iproniazid. These connections suggest that Iproniazid may be effective in treating neurotic disorder.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'ITGB4', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene ITGB4. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'CEACAM1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene CEACAM1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'IL16', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene IL16. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'CD40LG', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene CD40LG. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Respiratory insufficiency', 'TBCD', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Respiratory insufficiency, which in turn affects the gene TBCD. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14218,37805.0,Lamivudine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Lamivudine']",0.5,"Question: Is HIV infectious disease an indication for Lamivudine?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Lamivudine. These connections suggest that Lamivudine may be effective in treating HIV infectious disease.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CHRNA4', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CHRNA4. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'NQO2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene NQO2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
17601,29078.0,Golimumab,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'TNF', 'Golimumab']",0.5,"Question: Is rheumatoid arthritis an indication for Golimumab?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene TNF. This gene is targeted by the drug Golimumab. These connections suggest that Golimumab may be effective in treating rheumatoid arthritis.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'IL1RAP', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene IL1RAP. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CUL4B', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CUL4B. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14030,29854.0,Prednisolone,hereditary angioedema,disease-phenotype-protein-drug,indication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Prednisolone']",0.5,"Question: Is hereditary angioedema an indication for Prednisolone?
Reasoning: The disease hereditary angioedema is associated with the phenotype Nausea, which in turn affects the gene ABCB1. This gene is targeted by the drug Prednisolone. These connections suggest that Prednisolone may be effective in treating hereditary angioedema.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TMX2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TMX2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15240,30494.0,Ixazomib,plasma cell myeloma,disease-phenotype-protein-drug,indication,"['plasma cell myeloma', 'Splenomegaly', 'CYP1A2', 'Ixazomib']",0.5,"Question: Is plasma cell myeloma an indication for Ixazomib?
Reasoning: The disease plasma cell myeloma is associated with the phenotype Splenomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Ixazomib. These connections suggest that Ixazomib may be effective in treating plasma cell myeloma.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'NRP2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene NRP2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15457,32033.0,Flurazepam,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Flurazepam']",0.5,"Question: Is insomnia (disease) an indication for Flurazepam?
Reasoning: The disease insomnia (disease) is associated with the gene GABRB3, which is targeted by the drug Flurazepam. These connections suggest that Flurazepam may be effective in treating insomnia (disease).
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'CRISPLD2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene CRISPLD2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'CAMK2A', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene CAMK2A. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14830,31408.0,Amantadine,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'MAOB', 'Amantadine']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Amantadine?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the gene MAOB, which is targeted by the drug Amantadine. These connections suggest that Amantadine may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'TIMP3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene TIMP3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'FLT3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene FLT3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14139,32759.0,Benzatropine,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'SLC6A3', 'Benzatropine']",0.5,"Question: Is hemiparkinsonism-hemiatrophy syndrome an indication for Benzatropine?
Reasoning: The disease hemiparkinsonism-hemiatrophy syndrome is associated with the gene SLC6A3, which is targeted by the drug Benzatropine. These connections suggest that Benzatropine may be effective in treating hemiparkinsonism-hemiatrophy syndrome.
Answer: YES"
15282,28208.0,Insulin lispro,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'CYP1A2', 'Insulin lispro']",0.5,"Question: Is type 2 diabetes mellitus an indication for Insulin lispro?
Reasoning: The disease type 2 diabetes mellitus is associated with the gene CYP1A2, which is targeted by the drug Insulin lispro. These connections suggest that Insulin lispro may be effective in treating type 2 diabetes mellitus.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SAMHD1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SAMHD1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ADAMTSL2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene ADAMTSL2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'SMAD4', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene SMAD4. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'COL6A1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene COL6A1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
15107,33077.0,Vinblastine,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Pruritus', 'ABCB11', 'Vinblastine']",0.5,"Question: Is Hodgkins lymphoma an indication for Vinblastine?
Reasoning: The disease Hodgkins lymphoma is associated with the phenotype Pruritus, which in turn affects the gene ABCB11. This gene is targeted by the drug Vinblastine. These connections suggest that Vinblastine may be effective in treating Hodgkins lymphoma.
Answer: YES"
17174,38575.0,Rivastigmine,cerebellar degeneration,disease-protein-drug,indication,"['cerebellar degeneration', 'BCHE', 'Rivastigmine']",0.5,"Question: Is cerebellar degeneration an indication for Rivastigmine?
Reasoning: The disease cerebellar degeneration is associated with the gene BCHE, which is targeted by the drug Rivastigmine. These connections suggest that Rivastigmine may be effective in treating cerebellar degeneration.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'TCF4', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene TCF4. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14186,37967.0,Cisplatin,ovarian endometrioid adenocarcinoma,disease-protein-drug,indication,"['ovarian endometrioid adenocarcinoma', 'ATP7B', 'Cisplatin']",0.5,"Question: Is ovarian endometrioid adenocarcinoma an indication for Cisplatin?
Reasoning: The disease ovarian endometrioid adenocarcinoma is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating ovarian endometrioid adenocarcinoma.
Answer: YES"
14230,32932.0,Tetracycline,brucellosis,disease-phenotype-protein-drug,indication,"['brucellosis', 'Hepatomegaly', 'ALB', 'Tetracycline']",0.5,"Question: Is brucellosis an indication for Tetracycline?
Reasoning: The disease brucellosis is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Tetracycline. These connections suggest that Tetracycline may be effective in treating brucellosis.
Answer: YES"
14054,28900.0,Vitamin E,familial isolated deficiency of vitamin E,disease-protein-drug,indication,"['familial isolated deficiency of vitamin E', 'TTPA', 'Vitamin E']",0.5,"Question: Is familial isolated deficiency of vitamin E an indication for Vitamin E?
Reasoning: The disease familial isolated deficiency of vitamin E is associated with the gene TTPA, which is targeted by the drug Vitamin E. These connections suggest that Vitamin E may be effective in treating familial isolated deficiency of vitamin E.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GNB3', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene GNB3. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
17245,37888.0,Phenindamine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Phenindamine']",0.5,"Question: Is allergic rhinitis an indication for Phenindamine?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Phenindamine. These connections suggest that Phenindamine may be effective in treating allergic rhinitis.
Answer: YES"
14186,83819.0,Cisplatin,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ATP7B', 'Cisplatin']",0.5,"Question: Is malignant dysgerminomatous germ cell tumor of ovary an indication for Cisplatin?
Reasoning: The disease malignant dysgerminomatous germ cell tumor of ovary is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating malignant dysgerminomatous germ cell tumor of ovary.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'ABHD5', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene ABHD5. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'CD7', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene CD7. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
17174,28473.0,Rivastigmine,Pick disease,disease-protein-drug,indication,"['Pick disease', 'BCHE', 'Rivastigmine']",0.5,"Question: Is Pick disease an indication for Rivastigmine?
Reasoning: The disease Pick disease is associated with the gene BCHE, which is targeted by the drug Rivastigmine. These connections suggest that Rivastigmine may be effective in treating Pick disease.
Answer: YES"
14175,29273.0,Nabumetone,osteoarthritis susceptibility,disease-protein-drug,indication,"['osteoarthritis susceptibility', 'AKR1C2', 'Nabumetone']",0.5,"Question: Is osteoarthritis susceptibility an indication for Nabumetone?
Reasoning: The disease osteoarthritis susceptibility is associated with the gene AKR1C2, which is targeted by the drug Nabumetone. These connections suggest that Nabumetone may be effective in treating osteoarthritis susceptibility.
Answer: YES"
14785,32875.0,Omeprazole,Zollinger-Ellison syndrome,disease-phenotype-protein-drug,indication,"['Zollinger-Ellison syndrome', 'Nausea', 'ABCB1', 'Omeprazole']",0.5,"Question: Is Zollinger-Ellison syndrome an indication for Omeprazole?
Reasoning: The disease Zollinger-Ellison syndrome is associated with the phenotype Nausea, which in turn affects the gene ABCB1. This gene is targeted by the drug Omeprazole. These connections suggest that Omeprazole may be effective in treating Zollinger-Ellison syndrome.
Answer: YES"
14955,35884.0,Vincristine,diffuse large B-cell lymphoma,disease-protein-drug,indication,"['diffuse large B-cell lymphoma', 'ABCB1', 'Vincristine']",0.5,"Question: Is diffuse large B-cell lymphoma an indication for Vincristine?
Reasoning: The disease diffuse large B-cell lymphoma is associated with the gene ABCB1, which is targeted by the drug Vincristine. These connections suggest that Vincristine may be effective in treating diffuse large B-cell lymphoma.
Answer: YES"
15294,83960.0,Tacrine,Alzheimer disease without neurofibrillary tangles,disease-protein-drug,indication,"['Alzheimer disease without neurofibrillary tangles', 'BCHE', 'Tacrine']",0.5,"Question: Is Alzheimer disease without neurofibrillary tangles an indication for Tacrine?
Reasoning: The disease Alzheimer disease without neurofibrillary tangles is associated with the gene BCHE, which is targeted by the drug Tacrine. These connections suggest that Tacrine may be effective in treating Alzheimer disease without neurofibrillary tangles.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'CLN6', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene CLN6. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'NOS2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene NOS2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'MBOAT2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene MBOAT2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15116,38957.0,Paroxetine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'HTR1B', 'Paroxetine']",0.5,"Question: Is major depressive disorder an indication for Paroxetine?
Reasoning: The disease major depressive disorder is associated with the gene HTR1B, which is targeted by the drug Paroxetine. These connections suggest that Paroxetine may be effective in treating major depressive disorder.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'IL1B', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene IL1B. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14320,83791.0,Dexamethasone,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Dexamethasone']",0.5,"Question: Is vasomotor rhinitis an indication for Dexamethasone?
Reasoning: The disease vasomotor rhinitis is associated with the gene ALB, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating vasomotor rhinitis.
Answer: YES"
14266,37888.0,Fexofenadine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Fexofenadine']",0.5,"Question: Is allergic rhinitis an indication for Fexofenadine?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Fexofenadine. These connections suggest that Fexofenadine may be effective in treating allergic rhinitis.
Answer: YES"
17258,83791.0,Acrivastine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Acrivastine']",0.5,"Question: Is vasomotor rhinitis an indication for Acrivastine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Acrivastine. These connections suggest that Acrivastine may be effective in treating vasomotor rhinitis.
Answer: YES"
15613,33688.0,Ceritinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Ceritinib']",0.5,"Question: Is non-small cell lung carcinoma (disease) an indication for Ceritinib?
Reasoning: The disease non-small cell lung carcinoma (disease) is associated with the gene ABCB1, which is targeted by the drug Ceritinib. These connections suggest that Ceritinib may be effective in treating non-small cell lung carcinoma (disease).
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'ECM1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene ECM1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'LAMA4', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene LAMA4. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
17230,37888.0,Doxylamine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Doxylamine']",0.5,"Question: Is allergic rhinitis an indication for Doxylamine?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Doxylamine. These connections suggest that Doxylamine may be effective in treating allergic rhinitis.
Answer: YES"
14413,33688.0,Nintedanib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Nintedanib']",0.5,"Question: Is non-small cell lung carcinoma (disease) an indication for Nintedanib?
Reasoning: The disease non-small cell lung carcinoma (disease) is associated with the gene ABCB1, which is targeted by the drug Nintedanib. These connections suggest that Nintedanib may be effective in treating non-small cell lung carcinoma (disease).
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'SH3PXD2B', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene SH3PXD2B. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14956,38242.0,Carbamazepine,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'SCN2A', 'Carbamazepine']",0.5,"Question: Is bipolar disorder an indication for Carbamazepine?
Reasoning: The disease bipolar disorder is associated with the gene SCN2A, which is targeted by the drug Carbamazepine. These connections suggest that Carbamazepine may be effective in treating bipolar disorder.
Answer: YES"
14983,83791.0,Azelastine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Azelastine']",0.5,"Question: Is vasomotor rhinitis an indication for Azelastine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Azelastine. These connections suggest that Azelastine may be effective in treating vasomotor rhinitis.
Answer: YES"
15655,37743.0,Velpatasvir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Velpatasvir']",0.5,"Question: Is hepatitis C virus infection an indication for Velpatasvir?
Reasoning: The disease hepatitis C virus infection is associated with the gene CYP3A4, which is targeted by the drug Velpatasvir. These connections suggest that Velpatasvir may be effective in treating hepatitis C virus infection.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Delayed puberty', 'LHB', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Delayed puberty, which in turn affects the gene LHB. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Short stature', 'AMMECR1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Short stature, which in turn affects the gene AMMECR1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Short stature', 'KDM3B', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Short stature, which in turn affects the gene KDM3B. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14060,32719.0,Levothyroxine,congenital hypothyroidism,disease-phenotype-protein-drug,indication,"['congenital hypothyroidism', 'Growth delay', 'THRA', 'Levothyroxine']",0.5,"Question: Is congenital hypothyroidism an indication for Levothyroxine?
Reasoning: The disease congenital hypothyroidism is associated with the phenotype Growth delay, which in turn affects the gene THRA. This gene is targeted by the drug Levothyroxine. These connections suggest that Levothyroxine may be effective in treating congenital hypothyroidism.
Answer: YES"
14190,36223.0,Fluorouracil,malignant colon neoplasm,disease-protein-drug,indication,"['malignant colon neoplasm', 'TYMP', 'Fluorouracil']",0.5,"Question: Is malignant colon neoplasm an indication for Fluorouracil?
Reasoning: The disease malignant colon neoplasm is associated with the gene TYMP, which is targeted by the drug Fluorouracil. These connections suggest that Fluorouracil may be effective in treating malignant colon neoplasm.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'GNB1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene GNB1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15424,28375.0,Cabergoline,familial hyperprolactinemia,disease-protein-drug,indication,"['familial hyperprolactinemia', 'DRD2', 'Cabergoline']",0.5,"Question: Is familial hyperprolactinemia an indication for Cabergoline?
Reasoning: The disease familial hyperprolactinemia is associated with the gene DRD2, which is targeted by the drug Cabergoline. These connections suggest that Cabergoline may be effective in treating familial hyperprolactinemia.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TSC1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TSC1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14279,32999.0,Sulfamethoxazole,shigellosis,disease-phenotype-protein-drug,indication,"['shigellosis', 'Thrombocytopenia', 'ALB', 'Sulfamethoxazole']",0.5,"Question: Is shigellosis an indication for Sulfamethoxazole?
Reasoning: The disease shigellosis is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Sulfamethoxazole. These connections suggest that Sulfamethoxazole may be effective in treating shigellosis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'A1BG', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene A1BG. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'KNG1', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene KNG1. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ABCC2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ABCC2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14737,37082.0,Carboplatin,malignant germ cell tumor of ovary,disease-protein-drug,indication,"['malignant germ cell tumor of ovary', 'ATP7B', 'Carboplatin']",0.5,"Question: Is malignant germ cell tumor of ovary an indication for Carboplatin?
Reasoning: The disease malignant germ cell tumor of ovary is associated with the gene ATP7B, which is targeted by the drug Carboplatin. These connections suggest that Carboplatin may be effective in treating malignant germ cell tumor of ovary.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OXT', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene OXT. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15001,35915.0,Paliperidone,mental disorder,disease-protein-drug,indication,"['mental disorder', 'HTR2A', 'Paliperidone']",0.5,"Question: Is mental disorder an indication for Paliperidone?
Reasoning: The disease mental disorder is associated with the gene HTR2A, which is targeted by the drug Paliperidone. These connections suggest that Paliperidone may be effective in treating mental disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SCAMP5', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SCAMP5. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14258,33618.0,Quinidine,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'SCN5A', 'Quinidine']",0.5,"Question: Is atrial fibrillation (disease) an indication for Quinidine?
Reasoning: The disease atrial fibrillation (disease) is associated with the gene SCN5A, which is targeted by the drug Quinidine. These connections suggest that Quinidine may be effective in treating atrial fibrillation (disease).
Answer: YES"
15138,30093.0,Selegiline,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'MAOB', 'Selegiline']",0.5,"Question: Is parkinsonian-pyramidal syndrome an indication for Selegiline?
Reasoning: The disease parkinsonian-pyramidal syndrome is associated with the gene MAOB, which is targeted by the drug Selegiline. These connections suggest that Selegiline may be effective in treating parkinsonian-pyramidal syndrome.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Feeding difficulties', 'GOT2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Feeding difficulties, which in turn affects the gene GOT2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14186,83820.0,Cisplatin,maligant granulosa cell tumor of ovary,disease-protein-drug,indication,"['maligant granulosa cell tumor of ovary', 'ATP7B', 'Cisplatin']",0.5,"Question: Is maligant granulosa cell tumor of ovary an indication for Cisplatin?
Reasoning: The disease maligant granulosa cell tumor of ovary is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating maligant granulosa cell tumor of ovary.
Answer: YES"
15322,33314.0,Norfloxacin,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'CYP1A1', 'Norfloxacin']",0.5,"Question: Is leptospirosis an indication for Norfloxacin?
Reasoning: The disease leptospirosis is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A1. This gene is targeted by the drug Norfloxacin. These connections suggest that Norfloxacin may be effective in treating leptospirosis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Respiratory insufficiency', 'MECP2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Respiratory insufficiency, which in turn affects the gene MECP2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15822,29955.0,Ursodeoxycholic acid,Reynolds syndrome,disease-phenotype-protein-drug,indication,"['Reynolds syndrome', 'Hepatomegaly', 'NR1H4', 'Ursodeoxycholic acid']",0.5,"Question: Is Reynolds syndrome an indication for Ursodeoxycholic acid?
Reasoning: The disease Reynolds syndrome is associated with the phenotype Hepatomegaly, which in turn affects the gene NR1H4. This gene is targeted by the drug Ursodeoxycholic acid. These connections suggest that Ursodeoxycholic acid may be effective in treating Reynolds syndrome.
Answer: YES"
14713,83853.0,Decitabine,acute myeloblastic leukemia without maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia without maturation', 'DNMT3A', 'Decitabine']",0.5,"Question: Is acute myeloblastic leukemia without maturation an indication for Decitabine?
Reasoning: The disease acute myeloblastic leukemia without maturation is associated with the gene DNMT3A, which is targeted by the drug Decitabine. These connections suggest that Decitabine may be effective in treating acute myeloblastic leukemia without maturation.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'RARS1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene RARS1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
17414,28547.0,Piribedil,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DRD2', 'Piribedil']",0.5,"Question: Is Parkinson disease an indication for Piribedil?
Reasoning: The disease Parkinson disease is associated with the gene DRD2, which is targeted by the drug Piribedil. These connections suggest that Piribedil may be effective in treating Parkinson disease.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'SESN2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene SESN2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'SCAMP5', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene SCAMP5. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15558,28456.0,Tolvaptan,nephrogenic syndrome of inappropriate antidiuresis,disease-protein-drug,indication,"['nephrogenic syndrome of inappropriate antidiuresis', 'AVPR2', 'Tolvaptan']",0.5,"Question: Is nephrogenic syndrome of inappropriate antidiuresis an indication for Tolvaptan?
Reasoning: The disease nephrogenic syndrome of inappropriate antidiuresis is associated with the gene AVPR2, which is targeted by the drug Tolvaptan. These connections suggest that Tolvaptan may be effective in treating nephrogenic syndrome of inappropriate antidiuresis.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'RARS1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene RARS1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14223,37717.0,Risperidone,autism spectrum disorder,disease-protein-drug,indication,"['autism spectrum disorder', 'HTR1D', 'Risperidone']",0.5,"Question: Is autism spectrum disorder an indication for Risperidone?
Reasoning: The disease autism spectrum disorder is associated with the gene HTR1D, which is targeted by the drug Risperidone. These connections suggest that Risperidone may be effective in treating autism spectrum disorder.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'PJVK', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene PJVK. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'OXR1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene OXR1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14793,36050.0,Docetaxel,head and neck cancer,disease-protein-drug,indication,"['head and neck cancer', 'BCL2', 'Docetaxel']",0.5,"Question: Is head and neck cancer an indication for Docetaxel?
Reasoning: The disease head and neck cancer is associated with the gene BCL2, which is targeted by the drug Docetaxel. These connections suggest that Docetaxel may be effective in treating head and neck cancer.
Answer: YES"
14904,33241.0,Safinamide,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'CYP2D6', 'Safinamide']",0.5,"Question: Is hereditary late onset Parkinson disease an indication for Safinamide?
Reasoning: The disease hereditary late onset Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Safinamide. These connections suggest that Safinamide may be effective in treating hereditary late onset Parkinson disease.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'BCHE', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene BCHE. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Short stature', 'FBXL3', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Short stature, which in turn affects the gene FBXL3. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
15739,28520.0,Ivosidenib,myeloid leukemia,disease-protein-drug,indication,"['myeloid leukemia', 'IDH1', 'Ivosidenib']",0.5,"Question: Is myeloid leukemia an indication for Ivosidenib?
Reasoning: The disease myeloid leukemia is associated with the gene IDH1, which is targeted by the drug Ivosidenib. These connections suggest that Ivosidenib may be effective in treating myeloid leukemia.
Answer: YES"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Joint laxity', 'COMP', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Joint laxity, which in turn affects the gene COMP. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
15018,39171.0,Midostaurin,mast cell leukemia,disease-protein-drug,indication,"['mast cell leukemia', 'KIT', 'Midostaurin']",0.5,"Question: Is mast cell leukemia an indication for Midostaurin?
Reasoning: The disease mast cell leukemia is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating mast cell leukemia.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SLC6A2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene SLC6A2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'HNRNPR', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene HNRNPR. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'DHPS', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene DHPS. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16210,36035.0,Eprosartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Eprosartan']",0.5,"Question: Is hypertension an indication for Eprosartan?
Reasoning: The disease hypertension is associated with the gene AGTR1, which is targeted by the drug Eprosartan. These connections suggest that Eprosartan may be effective in treating hypertension.
Answer: YES"
15460,83791.0,Azatadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Azatadine']",0.5,"Question: Is vasomotor rhinitis an indication for Azatadine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Azatadine. These connections suggest that Azatadine may be effective in treating vasomotor rhinitis.
Answer: YES"
16842,28801.0,Pramipexole,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'HTR1A', 'Pramipexole']",0.5,"Question: Is juvenile onset Parkinson disease 19A an indication for Pramipexole?
Reasoning: The disease juvenile onset Parkinson disease 19A is associated with the phenotype Tremor, which in turn affects the gene HTR1A. This gene is targeted by the drug Pramipexole. These connections suggest that Pramipexole may be effective in treating juvenile onset Parkinson disease 19A.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'RHOBTB2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene RHOBTB2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'ADGRV1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene ADGRV1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SLC2A1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene SLC2A1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14186,37423.0,Cisplatin,ovarian clear cell adenocarcinoma,disease-protein-drug,indication,"['ovarian clear cell adenocarcinoma', 'ATP7B', 'Cisplatin']",0.5,"Question: Is ovarian clear cell adenocarcinoma an indication for Cisplatin?
Reasoning: The disease ovarian clear cell adenocarcinoma is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating ovarian clear cell adenocarcinoma.
Answer: YES"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'IGFBP2', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene IGFBP2. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'FAS', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene FAS. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'LEP', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene LEP. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
17023,33591.0,Tafamidis,amyloidosis (disease),disease-protein-drug,indication,"['amyloidosis (disease)', 'TTR', 'Tafamidis']",0.5,"Question: Is amyloidosis (disease) an indication for Tafamidis?
Reasoning: The disease amyloidosis (disease) is associated with the gene TTR, which is targeted by the drug Tafamidis. These connections suggest that Tafamidis may be effective in treating amyloidosis (disease).
Answer: YES"
14141,32456.0,Phenytoin,cutis verticis gyrata,disease-protein-drug,indication,"['cutis verticis gyrata', 'SCN1A', 'Phenytoin']",0.5,"Question: Is cutis verticis gyrata an indication for Phenytoin?
Reasoning: The disease cutis verticis gyrata is associated with the gene SCN1A, which is targeted by the drug Phenytoin. These connections suggest that Phenytoin may be effective in treating cutis verticis gyrata.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'HLA-DQB1', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene HLA-DQB1. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
16495,83860.0,Quizartinib,acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2),disease-protein-drug,indication,"['acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)', 'FLT3', 'Quizartinib']",0.5,"Question: Is acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) an indication for Quizartinib?
Reasoning: The disease acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) is associated with the gene FLT3, which is targeted by the drug Quizartinib. These connections suggest that Quizartinib may be effective in treating acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2).
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'IL1B', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene IL1B. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'AP3D1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene AP3D1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14269,28158.0,Methylprednisolone,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'ABCB1', 'Methylprednisolone']",0.5,"Question: Is inflammatory bowel disease an indication for Methylprednisolone?
Reasoning: The disease inflammatory bowel disease is associated with the gene ABCB1, which is targeted by the drug Methylprednisolone. These connections suggest that Methylprednisolone may be effective in treating inflammatory bowel disease.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'RNF13', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene RNF13. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'STAT1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene STAT1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14561,83776.0,Cholecalciferol,postmenopausal osteoporosis,disease-protein-drug,indication,"['postmenopausal osteoporosis', 'VDR', 'Cholecalciferol']",0.5,"Question: Is postmenopausal osteoporosis an indication for Cholecalciferol?
Reasoning: The disease postmenopausal osteoporosis is associated with the gene VDR, which is targeted by the drug Cholecalciferol. These connections suggest that Cholecalciferol may be effective in treating postmenopausal osteoporosis.
Answer: YES"
14952,83778.0,Haloperidol,schizophreniform disorder,disease-protein-drug,indication,"['schizophreniform disorder', 'HTR2A', 'Haloperidol']",0.5,"Question: Is schizophreniform disorder an indication for Haloperidol?
Reasoning: The disease schizophreniform disorder is associated with the gene HTR2A, which is targeted by the drug Haloperidol. These connections suggest that Haloperidol may be effective in treating schizophreniform disorder.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SOD2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene SOD2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15148,27933.0,Escitalopram,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOB', 'Escitalopram']",0.5,"Question: Is anxiety disorder an indication for Escitalopram?
Reasoning: The disease anxiety disorder is associated with the gene MAOB, which is targeted by the drug Escitalopram. These connections suggest that Escitalopram may be effective in treating anxiety disorder.
Answer: YES"
15490,37706.0,Pergolide,parkinsonian disorder,disease-protein-drug,indication,"['parkinsonian disorder', 'DRD2', 'Pergolide']",0.5,"Question: Is parkinsonian disorder an indication for Pergolide?
Reasoning: The disease parkinsonian disorder is associated with the gene DRD2, which is targeted by the drug Pergolide. These connections suggest that Pergolide may be effective in treating parkinsonian disorder.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'TNFSF13', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene TNFSF13. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'GRIK1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene GRIK1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'GRXCR1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene GRXCR1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CHRNA7', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene CHRNA7. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14792,37423.0,Paclitaxel,ovarian clear cell adenocarcinoma,disease-protein-drug,indication,"['ovarian clear cell adenocarcinoma', 'CYP1B1', 'Paclitaxel']",0.5,"Question: Is ovarian clear cell adenocarcinoma an indication for Paclitaxel?
Reasoning: The disease ovarian clear cell adenocarcinoma is associated with the gene CYP1B1, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating ovarian clear cell adenocarcinoma.
Answer: YES"
17724,84242.0,Methadyl acetate,morphine dependence,disease-protein-drug,indication,"['morphine dependence', 'OPRM1', 'Methadyl acetate']",0.5,"Question: Is morphine dependence an indication for Methadyl acetate?
Reasoning: The disease morphine dependence is associated with the gene OPRM1, which is targeted by the drug Methadyl acetate. These connections suggest that Methadyl acetate may be effective in treating morphine dependence.
Answer: YES"
14806,28801.0,Entacapone,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'CYP2D6', 'Entacapone']",0.5,"Question: Is juvenile onset Parkinson disease 19A an indication for Entacapone?
Reasoning: The disease juvenile onset Parkinson disease 19A is associated with the gene CYP2D6, which is targeted by the drug Entacapone. These connections suggest that Entacapone may be effective in treating juvenile onset Parkinson disease 19A.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CACNA1E', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CACNA1E. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CYP11A1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CYP11A1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16690,83823.0,Lisinopril,coronary thrombosis,disease-protein-drug,indication,"['coronary thrombosis', 'ACE', 'Lisinopril']",0.5,"Question: Is coronary thrombosis an indication for Lisinopril?
Reasoning: The disease coronary thrombosis is associated with the gene ACE, which is targeted by the drug Lisinopril. These connections suggest that Lisinopril may be effective in treating coronary thrombosis.
Answer: YES"
15055,33341.0,Deutetrabenazine,juvenile Huntington disease,disease-phenotype-protein-drug,indication,"['juvenile Huntington disease', 'Rigidity', 'CYP2D6', 'Deutetrabenazine']",0.5,"Question: Is juvenile Huntington disease an indication for Deutetrabenazine?
Reasoning: The disease juvenile Huntington disease is associated with the phenotype Rigidity, which in turn affects the gene CYP2D6. This gene is targeted by the drug Deutetrabenazine. These connections suggest that Deutetrabenazine may be effective in treating juvenile Huntington disease.
Answer: YES"
14203,30827.0,Medroxyprogesterone acetate,endometrial cancer,disease-protein-drug,indication,"['endometrial cancer', 'PGR', 'Medroxyprogesterone acetate']",0.5,"Question: Is endometrial cancer an indication for Medroxyprogesterone acetate?
Reasoning: The disease endometrial cancer is associated with the gene PGR, which is targeted by the drug Medroxyprogesterone acetate. These connections suggest that Medroxyprogesterone acetate may be effective in treating endometrial cancer.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TRAPPC4', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TRAPPC4. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'ATP6V1B1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene ATP6V1B1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14799,29113.0,Insulin human,diabetic ketoacidosis,disease-phenotype-protein-drug,indication,"['diabetic ketoacidosis', 'Insulin resistance', 'INSR', 'Insulin human']",0.5,"Question: Is diabetic ketoacidosis an indication for Insulin human?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene INSR. This gene is targeted by the drug Insulin human. These connections suggest that Insulin human may be effective in treating diabetic ketoacidosis.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'ARNT', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene ARNT. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Generalized hypotonia', 'ATN1', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Generalized hypotonia, which in turn affects the gene ATN1. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Ataxia', 'SNX14', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Ataxia, which in turn affects the gene SNX14. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16054,32759.0,Trihexyphenidyl,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'CHRM4', 'Trihexyphenidyl']",0.5,"Question: Is hemiparkinsonism-hemiatrophy syndrome an indication for Trihexyphenidyl?
Reasoning: The disease hemiparkinsonism-hemiatrophy syndrome is associated with the phenotype Tremor, which in turn affects the gene CHRM4. This gene is targeted by the drug Trihexyphenidyl. These connections suggest that Trihexyphenidyl may be effective in treating hemiparkinsonism-hemiatrophy syndrome.
Answer: YES"
14559,38682.0,Calcitriol,nephrocalcinosis,disease-protein-drug,indication,"['nephrocalcinosis', 'CYP24A1', 'Calcitriol']",0.5,"Question: Is nephrocalcinosis an indication for Calcitriol?
Reasoning: The disease nephrocalcinosis is associated with the gene CYP24A1, which is targeted by the drug Calcitriol. These connections suggest that Calcitriol may be effective in treating nephrocalcinosis.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'KIAA1109', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene KIAA1109. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'CHRNB4', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene CHRNB4. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CD40LG', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CD40LG. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14336,83791.0,Ephedrine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Ephedrine']",0.5,"Question: Is vasomotor rhinitis an indication for Ephedrine?
Reasoning: The disease vasomotor rhinitis is associated with the gene ALB, which is targeted by the drug Ephedrine. These connections suggest that Ephedrine may be effective in treating vasomotor rhinitis.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'GLUL', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene GLUL. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14924,38720.0,Diazoxide,hyperinsulinemic hypoglycemia,disease-protein-drug,indication,"['hyperinsulinemic hypoglycemia', 'KCNJ11', 'Diazoxide']",0.5,"Question: Is hyperinsulinemic hypoglycemia an indication for Diazoxide?
Reasoning: The disease hyperinsulinemic hypoglycemia is associated with the gene KCNJ11, which is targeted by the drug Diazoxide. These connections suggest that Diazoxide may be effective in treating hyperinsulinemic hypoglycemia.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'WDR1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene WDR1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'TSC22D3', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene TSC22D3. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'CHRNA7', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene CHRNA7. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'TET3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene TET3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15367,30494.0,Pomalidomide,plasma cell myeloma,disease-phenotype-protein-drug,indication,"['plasma cell myeloma', 'Splenomegaly', 'CYP1A2', 'Pomalidomide']",0.5,"Question: Is plasma cell myeloma an indication for Pomalidomide?
Reasoning: The disease plasma cell myeloma is associated with the phenotype Splenomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Pomalidomide. These connections suggest that Pomalidomide may be effective in treating plasma cell myeloma.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'RALA', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene RALA. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15288,33294.0,Interferon alfa-2b,follicular lymphoma,disease-phenotype-protein-drug,indication,"['follicular lymphoma', 'Splenomegaly', 'CYP1A2', 'Interferon alfa-2b']",0.5,"Question: Is follicular lymphoma an indication for Interferon alfa-2b?
Reasoning: The disease follicular lymphoma is associated with the phenotype Splenomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Interferon alfa-2b. These connections suggest that Interferon alfa-2b may be effective in treating follicular lymphoma.
Answer: YES"
14024,83777.0,Prednisone,occupational dermatitis,disease-protein-drug,indication,"['occupational dermatitis', 'CYP1B1', 'Prednisone']",0.5,"Question: Is occupational dermatitis an indication for Prednisone?
Reasoning: The disease occupational dermatitis is associated with the gene CYP1B1, which is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating occupational dermatitis.
Answer: YES"
14275,32617.0,Doxorubicin,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Doxorubicin']",0.5,"Question: Is hereditary breast ovarian cancer syndrome an indication for Doxorubicin?
Reasoning: The disease hereditary breast ovarian cancer syndrome is associated with the gene ABCB1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating hereditary breast ovarian cancer syndrome.
Answer: YES"
14188,33314.0,Ciprofloxacin,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'ALB', 'Ciprofloxacin']",0.5,"Question: Is leptospirosis an indication for Ciprofloxacin?
Reasoning: The disease leptospirosis is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Ciprofloxacin. These connections suggest that Ciprofloxacin may be effective in treating leptospirosis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'AFF3', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene AFF3. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16588,33575.0,Metformin,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'SLC22A3', 'Metformin']",0.5,"Question: Is diabetes mellitus (disease) an indication for Metformin?
Reasoning: The disease diabetes mellitus (disease) is associated with the gene SLC22A3, which is targeted by the drug Metformin. These connections suggest that Metformin may be effective in treating diabetes mellitus (disease).
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'LEP', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene LEP. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14476,31630.0,Testosterone cypionate,androgen insensitivity syndrome,disease-protein-drug,indication,"['androgen insensitivity syndrome', 'AR', 'Testosterone cypionate']",0.5,"Question: Is androgen insensitivity syndrome an indication for Testosterone cypionate?
Reasoning: The disease androgen insensitivity syndrome is associated with the gene AR, which is targeted by the drug Testosterone cypionate. These connections suggest that Testosterone cypionate may be effective in treating androgen insensitivity syndrome.
Answer: YES"
14685,33680.0,Progesterone,endometriosis (disease),disease-protein-drug,indication,"['endometriosis (disease)', 'NR3C2', 'Progesterone']",0.5,"Question: Is endometriosis (disease) an indication for Progesterone?
Reasoning: The disease endometriosis (disease) is associated with the gene NR3C2, which is targeted by the drug Progesterone. These connections suggest that Progesterone may be effective in treating endometriosis (disease).
Answer: YES"
14540,37703.0,Amoxapine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'HTR1B', 'Amoxapine']",0.5,"Question: Is neurotic disorder an indication for Amoxapine?
Reasoning: The disease neurotic disorder is associated with the gene HTR1B, which is targeted by the drug Amoxapine. These connections suggest that Amoxapine may be effective in treating neurotic disorder.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'APP', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene APP. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14019,83789.0,Betamethasone,serum sickness,disease-protein-drug,indication,"['serum sickness', 'ALB', 'Betamethasone']",0.5,"Question: Is serum sickness an indication for Betamethasone?
Reasoning: The disease serum sickness is associated with the gene ALB, which is targeted by the drug Betamethasone. These connections suggest that Betamethasone may be effective in treating serum sickness.
Answer: YES"
14154,28017.0,Acetaminophen,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Acetaminophen']",0.5,"Question: Is migraine with or without aura, susceptibility to an indication for Acetaminophen?
Reasoning: The disease migraine with or without aura, susceptibility to is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Acetaminophen. These connections suggest that Acetaminophen may be effective in treating migraine with or without aura, susceptibility to.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Confusion', 'TRPV4', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Confusion, which in turn affects the gene TRPV4. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14208,38508.0,Testosterone,non-acquired pituitary hormone deficiency,disease-protein-drug,indication,"['non-acquired pituitary hormone deficiency', 'CYP19A1', 'Testosterone']",0.5,"Question: Is non-acquired pituitary hormone deficiency an indication for Testosterone?
Reasoning: The disease non-acquired pituitary hormone deficiency is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating non-acquired pituitary hormone deficiency.
Answer: YES"
14161,83840.0,Olanzapine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Olanzapine']",0.5,"Question: Is unipolar depression an indication for Olanzapine?
Reasoning: The disease unipolar depression is associated with the gene ABCB1, which is targeted by the drug Olanzapine. These connections suggest that Olanzapine may be effective in treating unipolar depression.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'DSCAM', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene DSCAM. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'LETM1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene LETM1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'GABRA5', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene GABRA5. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14154,83791.0,Acetaminophen,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Acetaminophen']",0.5,"Question: Is vasomotor rhinitis an indication for Acetaminophen?
Reasoning: The disease vasomotor rhinitis is associated with the gene ALB, which is targeted by the drug Acetaminophen. These connections suggest that Acetaminophen may be effective in treating vasomotor rhinitis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'SOD1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene SOD1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16495,83853.0,Quizartinib,acute myeloblastic leukemia without maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia without maturation', 'FLT3', 'Quizartinib']",0.5,"Question: Is acute myeloblastic leukemia without maturation an indication for Quizartinib?
Reasoning: The disease acute myeloblastic leukemia without maturation is associated with the gene FLT3, which is targeted by the drug Quizartinib. These connections suggest that Quizartinib may be effective in treating acute myeloblastic leukemia without maturation.
Answer: YES"
15982,28158.0,Sulfasalazine,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'PPARG', 'Sulfasalazine']",0.5,"Question: Is inflammatory bowel disease an indication for Sulfasalazine?
Reasoning: The disease inflammatory bowel disease is associated with the gene PPARG, which is targeted by the drug Sulfasalazine. These connections suggest that Sulfasalazine may be effective in treating inflammatory bowel disease.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'FOS', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene FOS. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15662,29078.0,Sarilumab,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'IL6R', 'Sarilumab']",0.5,"Question: Is rheumatoid arthritis an indication for Sarilumab?
Reasoning: The disease rheumatoid arthritis is associated with the gene IL6R, which is targeted by the drug Sarilumab. These connections suggest that Sarilumab may be effective in treating rheumatoid arthritis.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'UGP2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene UGP2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TBCD', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TBCD. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14737,83822.0,Carboplatin,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,indication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ATP7B', 'Carboplatin']",0.5,"Question: Is theca steroid-producing cell malignant tumor of ovary, not further specified an indication for Carboplatin?
Reasoning: The disease theca steroid-producing cell malignant tumor of ovary, not further specified is associated with the gene ATP7B, which is targeted by the drug Carboplatin. These connections suggest that Carboplatin may be effective in treating theca steroid-producing cell malignant tumor of ovary, not further specified.
Answer: YES"
14139,32974.0,Benzatropine,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Seizure', 'SLC6A2', 'Benzatropine']",0.5,"Question: Is atypical juvenile parkinsonism an indication for Benzatropine?
Reasoning: The disease atypical juvenile parkinsonism is associated with the phenotype Seizure, which in turn affects the gene SLC6A2. This gene is targeted by the drug Benzatropine. These connections suggest that Benzatropine may be effective in treating atypical juvenile parkinsonism.
Answer: YES"
14463,38274.0,Gilteritinib,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'FLT3', 'Gilteritinib']",0.5,"Question: Is inherited acute myeloid leukemia an indication for Gilteritinib?
Reasoning: The disease inherited acute myeloid leukemia is associated with the gene FLT3, which is targeted by the drug Gilteritinib. These connections suggest that Gilteritinib may be effective in treating inherited acute myeloid leukemia.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'CHRNA4', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene CHRNA4. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'HTR1A', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Action tremor, which in turn affects the gene HTR1A. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14141,83928.0,Phenytoin,partial motor epilepsy,disease-protein-drug,indication,"['partial motor epilepsy', 'ABCC2', 'Phenytoin']",0.5,"Question: Is partial motor epilepsy an indication for Phenytoin?
Reasoning: The disease partial motor epilepsy is associated with the gene ABCC2, which is targeted by the drug Phenytoin. These connections suggest that Phenytoin may be effective in treating partial motor epilepsy.
Answer: YES"
15124,28974.0,Biperiden,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'CYP2D6', 'Biperiden']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Biperiden?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Biperiden. These connections suggest that Biperiden may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ACHE', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ACHE. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Photophobia', 'ATF6', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Photophobia, which in turn affects the gene ATF6. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'EMP1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene EMP1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'NOTCH1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene NOTCH1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14275,30494.0,Doxorubicin,plasma cell myeloma,disease-protein-drug,indication,"['plasma cell myeloma', 'NQO1', 'Doxorubicin']",0.5,"Question: Is plasma cell myeloma an indication for Doxorubicin?
Reasoning: The disease plasma cell myeloma is associated with the gene NQO1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating plasma cell myeloma.
Answer: YES"
14024,32967.0,Prednisone,sarcoidosis,disease-phenotype-protein-drug,indication,"['sarcoidosis', 'Hepatomegaly', 'ALB', 'Prednisone']",0.5,"Question: Is sarcoidosis an indication for Prednisone?
Reasoning: The disease sarcoidosis is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating sarcoidosis.
Answer: YES"
14189,37703.0,Nortriptyline,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'ADRB1', 'Nortriptyline']",0.5,"Question: Is neurotic disorder an indication for Nortriptyline?
Reasoning: The disease neurotic disorder is associated with the gene ADRB1, which is targeted by the drug Nortriptyline. These connections suggest that Nortriptyline may be effective in treating neurotic disorder.
Answer: YES"
17583,32325.0,Etanercept,juvenile idiopathic arthritis,disease-protein-drug,indication,"['juvenile idiopathic arthritis', 'FCGR1A', 'Etanercept']",0.5,"Question: Is juvenile idiopathic arthritis an indication for Etanercept?
Reasoning: The disease juvenile idiopathic arthritis is associated with the gene FCGR1A, which is targeted by the drug Etanercept. These connections suggest that Etanercept may be effective in treating juvenile idiopathic arthritis.
Answer: YES"
14262,29078.0,Salicylic acid,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Salicylic acid']",0.5,"Question: Is rheumatoid arthritis an indication for Salicylic acid?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Salicylic acid. These connections suggest that Salicylic acid may be effective in treating rheumatoid arthritis.
Answer: YES"
15098,83779.0,Promazine,schizoaffective disorder,disease-protein-drug,indication,"['schizoaffective disorder', 'HTR2A', 'Promazine']",0.5,"Question: Is schizoaffective disorder an indication for Promazine?
Reasoning: The disease schizoaffective disorder is associated with the gene HTR2A, which is targeted by the drug Promazine. These connections suggest that Promazine may be effective in treating schizoaffective disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'APP', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene APP. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15597,36825.0,Ruxolitinib,plasmacytoma,disease-protein-drug,indication,"['plasmacytoma', 'JAK1', 'Ruxolitinib']",0.5,"Question: Is plasmacytoma an indication for Ruxolitinib?
Reasoning: The disease plasmacytoma is associated with the gene JAK1, which is targeted by the drug Ruxolitinib. These connections suggest that Ruxolitinib may be effective in treating plasmacytoma.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'DAPK2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene DAPK2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
17229,83791.0,Cetirizine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Cetirizine']",0.5,"Question: Is vasomotor rhinitis an indication for Cetirizine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Cetirizine. These connections suggest that Cetirizine may be effective in treating vasomotor rhinitis.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'MMP9', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene MMP9. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Delayed puberty', 'LHB', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Delayed puberty, which in turn affects the gene LHB. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14789,29361.0,Daunorubicin,acute promyelocytic leukemia,disease-phenotype-protein-drug,indication,"['acute promyelocytic leukemia', 'Thrombocytopenia', 'XDH', 'Daunorubicin']",0.5,"Question: Is acute promyelocytic leukemia an indication for Daunorubicin?
Reasoning: The disease acute promyelocytic leukemia is associated with the phenotype Thrombocytopenia, which in turn affects the gene XDH. This gene is targeted by the drug Daunorubicin. These connections suggest that Daunorubicin may be effective in treating acute promyelocytic leukemia.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'AFP', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene AFP. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'SERPINB3', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene SERPINB3. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
18036,33575.0,Bacitracin,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'ADIPOQ', 'Bacitracin']",1.0,"Question: Is diabetes mellitus (disease) an indication for Bacitracin?
Reasoning: The disease diabetes mellitus (disease) is associated with the phenotype Maternal diabetes, which in turn affects the gene ADIPOQ. This gene is not targeted by the drug Bacitracin. These connections suggest that Bacitracin may not be effective in treating diabetes mellitus (disease).
Answer: NO"
14159,37888.0,Ipratropium,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Ipratropium']",0.5,"Question: Is allergic rhinitis an indication for Ipratropium?
Reasoning: The disease allergic rhinitis is associated with the gene ALB, which is targeted by the drug Ipratropium. These connections suggest that Ipratropium may be effective in treating allergic rhinitis.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Arthralgia', 'MVK', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Arthralgia, which in turn affects the gene MVK. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'GRIA2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene GRIA2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'IL1R1', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene IL1R1. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TBC1D20', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TBC1D20. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14831,30093.0,Droxidopa,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'ADRB2', 'Droxidopa']",0.5,"Question: Is parkinsonian-pyramidal syndrome an indication for Droxidopa?
Reasoning: The disease parkinsonian-pyramidal syndrome is associated with the phenotype Tremor, which in turn affects the gene ADRB2. This gene is targeted by the drug Droxidopa. These connections suggest that Droxidopa may be effective in treating parkinsonian-pyramidal syndrome.
Answer: YES"
14544,83760.0,Bupropion,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A2', 'Bupropion']",0.5,"Question: Is dysthymic disorder an indication for Bupropion?
Reasoning: The disease dysthymic disorder is associated with the gene SLC6A2, which is targeted by the drug Bupropion. These connections suggest that Bupropion may be effective in treating dysthymic disorder.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Back pain', 'PLAT', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Back pain, which in turn affects the gene PLAT. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'HTR1B', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene HTR1B. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14463,28520.0,Gilteritinib,myeloid leukemia,disease-protein-drug,indication,"['myeloid leukemia', 'FLT3', 'Gilteritinib']",0.5,"Question: Is myeloid leukemia an indication for Gilteritinib?
Reasoning: The disease myeloid leukemia is associated with the gene FLT3, which is targeted by the drug Gilteritinib. These connections suggest that Gilteritinib may be effective in treating myeloid leukemia.
Answer: YES"
20196,31181.0,Golodirsen,muscular dystrophy,disease-protein-drug,indication,"['muscular dystrophy', 'DMD', 'Golodirsen']",0.5,"Question: Is muscular dystrophy an indication for Golodirsen?
Reasoning: The disease muscular dystrophy is associated with the gene DMD, which is targeted by the drug Golodirsen. These connections suggest that Golodirsen may be effective in treating muscular dystrophy.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hypocalcemia', 'POMC', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hypocalcemia, which in turn affects the gene POMC. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14024,32563.0,Prednisone,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,indication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Prednisone']",0.5,"Question: Is heparin-induced thrombocytopenia (disease) an indication for Prednisone?
Reasoning: The disease heparin-induced thrombocytopenia (disease) is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating heparin-induced thrombocytopenia (disease).
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'CHRM4', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Action tremor, which in turn affects the gene CHRM4. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'TCN2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene TCN2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'NR1H2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene NR1H2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14623,33534.0,Prasterone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Proteinuria', 'PPARA', 'Prasterone']",0.5,"Question: Is pediatric systemic lupus erythematosus an indication for Prasterone?
Reasoning: The disease pediatric systemic lupus erythematosus is associated with the phenotype Proteinuria, which in turn affects the gene PPARA. This gene is targeted by the drug Prasterone. These connections suggest that Prasterone may be effective in treating pediatric systemic lupus erythematosus.
Answer: YES"
16495,83857.0,Quizartinib,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'FLT3', 'Quizartinib']",0.5,"Question: Is acute myeloid leukemia with t(8;16)(p11;p13) translocation an indication for Quizartinib?
Reasoning: The disease acute myeloid leukemia with t(8;16)(p11;p13) translocation is associated with the gene FLT3, which is targeted by the drug Quizartinib. These connections suggest that Quizartinib may be effective in treating acute myeloid leukemia with t(8;16)(p11;p13) translocation.
Answer: YES"
15739,83855.0,Ivosidenib,acute myeloid leukemia with t(8;21)(q22;q22) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;21)(q22;q22) translocation', 'IDH1', 'Ivosidenib']",0.5,"Question: Is acute myeloid leukemia with t(8;21)(q22;q22) translocation an indication for Ivosidenib?
Reasoning: The disease acute myeloid leukemia with t(8;21)(q22;q22) translocation is associated with the gene IDH1, which is targeted by the drug Ivosidenib. These connections suggest that Ivosidenib may be effective in treating acute myeloid leukemia with t(8;21)(q22;q22) translocation.
Answer: YES"
15594,29993.0,Brentuximab vedotin,classic Hodgkin lymphoma,disease-protein-drug,indication,"['classic Hodgkin lymphoma', 'TNFRSF8', 'Brentuximab vedotin']",0.5,"Question: Is classic Hodgkin lymphoma an indication for Brentuximab vedotin?
Reasoning: The disease classic Hodgkin lymphoma is associated with the gene TNFRSF8, which is targeted by the drug Brentuximab vedotin. These connections suggest that Brentuximab vedotin may be effective in treating classic Hodgkin lymphoma.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'DRD3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene DRD3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'WHRN', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene WHRN. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14024,32325.0,Prednisone,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Prednisone']",0.5,"Question: Is juvenile idiopathic arthritis an indication for Prednisone?
Reasoning: The disease juvenile idiopathic arthritis is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating juvenile idiopathic arthritis.
Answer: YES"
14792,37082.0,Paclitaxel,malignant germ cell tumor of ovary,disease-protein-drug,indication,"['malignant germ cell tumor of ovary', 'CYP1B1', 'Paclitaxel']",0.5,"Question: Is malignant germ cell tumor of ovary an indication for Paclitaxel?
Reasoning: The disease malignant germ cell tumor of ovary is associated with the gene CYP1B1, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating malignant germ cell tumor of ovary.
Answer: YES"
14320,27452.0,Dexamethasone,Diamond-Blackfan anemia,disease-phenotype-protein-drug,indication,"['Diamond-Blackfan anemia', 'Thrombocytopenia', 'ALB', 'Dexamethasone']",0.5,"Question: Is Diamond-Blackfan anemia an indication for Dexamethasone?
Reasoning: The disease Diamond-Blackfan anemia is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating Diamond-Blackfan anemia.
Answer: YES"
15413,33688.0,Gemcitabine,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Gemcitabine']",0.5,"Question: Is non-small cell lung carcinoma (disease) an indication for Gemcitabine?
Reasoning: The disease non-small cell lung carcinoma (disease) is associated with the gene ABCB1, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating non-small cell lung carcinoma (disease).
Answer: YES"
16179,32354.0,Turoctocog alfa,symptomatic form of hemophilia in female carriers,disease-protein-drug,indication,"['symptomatic form of hemophilia in female carriers', 'F9', 'Turoctocog alfa']",0.5,"Question: Is symptomatic form of hemophilia in female carriers an indication for Turoctocog alfa?
Reasoning: The disease symptomatic form of hemophilia in female carriers is associated with the gene F9, which is targeted by the drug Turoctocog alfa. These connections suggest that Turoctocog alfa may be effective in treating symptomatic form of hemophilia in female carriers.
Answer: YES"
14993,35641.0,Phenobarbital,epilepsy,disease-protein-drug,indication,"['epilepsy', 'ABCB1', 'Phenobarbital']",0.5,"Question: Is epilepsy an indication for Phenobarbital?
Reasoning: The disease epilepsy is associated with the gene ABCB1, which is targeted by the drug Phenobarbital. These connections suggest that Phenobarbital may be effective in treating epilepsy.
Answer: YES"
17112,33449.0,Filgrastim,severe congenital neutropenia,disease-protein-drug,indication,"['severe congenital neutropenia', 'ELANE', 'Filgrastim']",0.5,"Question: Is severe congenital neutropenia an indication for Filgrastim?
Reasoning: The disease severe congenital neutropenia is associated with the gene ELANE, which is targeted by the drug Filgrastim. These connections suggest that Filgrastim may be effective in treating severe congenital neutropenia.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Prolonged neonatal jaundice', 'NR1I2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Prolonged neonatal jaundice, which in turn affects the gene NR1I2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GABRA5', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene GABRA5. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14139,31408.0,Benzatropine,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Seizure', 'SLC6A2', 'Benzatropine']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Benzatropine?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the phenotype Seizure, which in turn affects the gene SLC6A2. This gene is targeted by the drug Benzatropine. These connections suggest that Benzatropine may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'MRC1', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene MRC1. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'ARG2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene ARG2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15982,29078.0,Sulfasalazine,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Sulfasalazine']",0.5,"Question: Is rheumatoid arthritis an indication for Sulfasalazine?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Sulfasalazine. These connections suggest that Sulfasalazine may be effective in treating rheumatoid arthritis.
Answer: YES"
15816,29078.0,Loxoprofen,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Loxoprofen']",0.5,"Question: Is rheumatoid arthritis an indication for Loxoprofen?
Reasoning: The disease rheumatoid arthritis is associated with the gene PTGS1, which is targeted by the drug Loxoprofen. These connections suggest that Loxoprofen may be effective in treating rheumatoid arthritis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Respiratory insufficiency', 'MAPT', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Respiratory insufficiency, which in turn affects the gene MAPT. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14196,28052.0,Propranolol,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,indication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'CYP1A1', 'Propranolol']",0.5,"Question: Is hypertrophic cardiomyopathy an indication for Propranolol?
Reasoning: The disease hypertrophic cardiomyopathy is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A1. This gene is targeted by the drug Propranolol. These connections suggest that Propranolol may be effective in treating hypertrophic cardiomyopathy.
Answer: YES"
15373,28208.0,Lobeglitazone,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'CYP1A2', 'Lobeglitazone']",0.5,"Question: Is type 2 diabetes mellitus an indication for Lobeglitazone?
Reasoning: The disease type 2 diabetes mellitus is associated with the gene CYP1A2, which is targeted by the drug Lobeglitazone. These connections suggest that Lobeglitazone may be effective in treating type 2 diabetes mellitus.
Answer: YES"
15295,33592.0,Triamterene,acidosis disorder,disease-phenotype-protein-drug,contraindication,"['acidosis disorder', 'Metabolic acidosis', 'SLC9A4', 'Triamterene']",1.0,"Question: Is acidosis disorder an indication for Triamterene?
Reasoning: The disease acidosis disorder is associated with the phenotype Metabolic acidosis, which in turn affects the gene SLC9A4. This gene is not targeted by the drug Triamterene. These connections suggest that Triamterene may not be effective in treating acidosis disorder.
Answer: NO"
16495,83855.0,Quizartinib,acute myeloid leukemia with t(8;21)(q22;q22) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;21)(q22;q22) translocation', 'FLT3', 'Quizartinib']",0.5,"Question: Is acute myeloid leukemia with t(8;21)(q22;q22) translocation an indication for Quizartinib?
Reasoning: The disease acute myeloid leukemia with t(8;21)(q22;q22) translocation is associated with the gene FLT3, which is targeted by the drug Quizartinib. These connections suggest that Quizartinib may be effective in treating acute myeloid leukemia with t(8;21)(q22;q22) translocation.
Answer: YES"
14427,28714.0,Lumacaftor,cystic fibrosis,disease-phenotype-protein-drug,indication,"['cystic fibrosis', 'Male infertility', 'CFTR', 'Lumacaftor']",0.5,"Question: Is cystic fibrosis an indication for Lumacaftor?
Reasoning: The disease cystic fibrosis is associated with the phenotype Male infertility, which in turn affects the gene CFTR. This gene is targeted by the drug Lumacaftor. These connections suggest that Lumacaftor may be effective in treating cystic fibrosis.
Answer: YES"
14987,83898.0,Fluvastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Fluvastatin']",0.5,"Question: Is obsolete familial combined hyperlipidemia an indication for Fluvastatin?
Reasoning: The disease obsolete familial combined hyperlipidemia is associated with the gene HMGCR, which is targeted by the drug Fluvastatin. These connections suggest that Fluvastatin may be effective in treating obsolete familial combined hyperlipidemia.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'TM4SF4', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene TM4SF4. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14792,37466.0,Paclitaxel,ovarian small cell carcinoma,disease-protein-drug,indication,"['ovarian small cell carcinoma', 'CYP1B1', 'Paclitaxel']",0.5,"Question: Is ovarian small cell carcinoma an indication for Paclitaxel?
Reasoning: The disease ovarian small cell carcinoma is associated with the gene CYP1B1, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating ovarian small cell carcinoma.
Answer: YES"
14207,84261.0,Imatinib,"blast phase chronic myelogenous leukemia, BCR-ABL1 positive",disease-protein-drug,indication,"['blast phase chronic myelogenous leukemia, BCR-ABL1 positive', 'BCR', 'Imatinib']",0.5,"Question: Is blast phase chronic myelogenous leukemia, BCR-ABL1 positive an indication for Imatinib?
Reasoning: The disease blast phase chronic myelogenous leukemia, BCR-ABL1 positive is associated with the gene BCR, which is targeted by the drug Imatinib. These connections suggest that Imatinib may be effective in treating blast phase chronic myelogenous leukemia, BCR-ABL1 positive.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'GABRR2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene GABRR2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14381,37888.0,Levocetirizine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Levocetirizine']",0.5,"Question: Is allergic rhinitis an indication for Levocetirizine?
Reasoning: The disease allergic rhinitis is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is targeted by the drug Levocetirizine. These connections suggest that Levocetirizine may be effective in treating allergic rhinitis.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'PCYT2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene PCYT2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Muscle weakness', 'CSF2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Muscle weakness, which in turn affects the gene CSF2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'TGFB1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene TGFB1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CHRM1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CHRM1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ATP1A1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ATP1A1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'HABP2', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene HABP2. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14884,37703.0,Phenelzine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'MAOB', 'Phenelzine']",0.5,"Question: Is neurotic disorder an indication for Phenelzine?
Reasoning: The disease neurotic disorder is associated with the gene MAOB, which is targeted by the drug Phenelzine. These connections suggest that Phenelzine may be effective in treating neurotic disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'PRPS1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene PRPS1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'APP', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene APP. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15603,35727.0,Dabrafenib,metastatic melanoma,disease-protein-drug,indication,"['metastatic melanoma', 'SIK1', 'Dabrafenib']",0.5,"Question: Is metastatic melanoma an indication for Dabrafenib?
Reasoning: The disease metastatic melanoma is associated with the gene SIK1, which is targeted by the drug Dabrafenib. These connections suggest that Dabrafenib may be effective in treating metastatic melanoma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PDYN', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene PDYN. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'DLL1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene DLL1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'FOXO1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene FOXO1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14955,84158.0,Vincristine,T-cell/histiocyte rich large B cell lymphoma,disease-protein-drug,indication,"['T-cell/histiocyte rich large B cell lymphoma', 'ABCB1', 'Vincristine']",0.5,"Question: Is T-cell/histiocyte rich large B cell lymphoma an indication for Vincristine?
Reasoning: The disease T-cell/histiocyte rich large B cell lymphoma is associated with the gene ABCB1, which is targeted by the drug Vincristine. These connections suggest that Vincristine may be effective in treating T-cell/histiocyte rich large B cell lymphoma.
Answer: YES"
15197,38957.0,Mianserin,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Mianserin']",0.5,"Question: Is major depressive disorder an indication for Mianserin?
Reasoning: The disease major depressive disorder is associated with the gene SLC6A4, which is targeted by the drug Mianserin. These connections suggest that Mianserin may be effective in treating major depressive disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'RBFOX1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene RBFOX1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14030,30813.0,Prednisolone,Addison disease,disease-phenotype-protein-drug,indication,"['Addison disease', 'Vomiting', 'ABCB1', 'Prednisolone']",0.5,"Question: Is Addison disease an indication for Prednisolone?
Reasoning: The disease Addison disease is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Prednisolone. These connections suggest that Prednisolone may be effective in treating Addison disease.
Answer: YES"
14207,84305.0,Imatinib,"chronic eosinophilic leukemia, not otherwise specified",disease-protein-drug,indication,"['chronic eosinophilic leukemia, not otherwise specified', 'PDGFRA', 'Imatinib']",0.5,"Question: Is chronic eosinophilic leukemia, not otherwise specified an indication for Imatinib?
Reasoning: The disease chronic eosinophilic leukemia, not otherwise specified is associated with the gene PDGFRA, which is targeted by the drug Imatinib. These connections suggest that Imatinib may be effective in treating chronic eosinophilic leukemia, not otherwise specified.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Mesenteric venous thrombosis', 'F2', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Mesenteric venous thrombosis, which in turn affects the gene F2. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14024,28830.0,Prednisone,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'ABCB1', 'Prednisone']",0.5,"Question: Is leukemia, lymphocytic, susceptibility to an indication for Prednisone?
Reasoning: The disease leukemia, lymphocytic, susceptibility to is associated with the gene ABCB1, which is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating leukemia, lymphocytic, susceptibility to.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Respiratory insufficiency', 'MGME1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Respiratory insufficiency, which in turn affects the gene MGME1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14186,83818.0,Cisplatin,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,indication,"['primary non-gestational choriocarcinoma of ovary', 'ATP7B', 'Cisplatin']",0.5,"Question: Is primary non-gestational choriocarcinoma of ovary an indication for Cisplatin?
Reasoning: The disease primary non-gestational choriocarcinoma of ovary is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating primary non-gestational choriocarcinoma of ovary.
Answer: YES"
16495,83861.0,Quizartinib,acute myeloid leukemia with NPM1 somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with NPM1 somatic mutations', 'FLT3', 'Quizartinib']",0.5,"Question: Is acute myeloid leukemia with NPM1 somatic mutations an indication for Quizartinib?
Reasoning: The disease acute myeloid leukemia with NPM1 somatic mutations is associated with the gene FLT3, which is targeted by the drug Quizartinib. These connections suggest that Quizartinib may be effective in treating acute myeloid leukemia with NPM1 somatic mutations.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'TRH', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene TRH. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14178,83763.0,Chlorpromazine,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'DRD5', 'Chlorpromazine']",0.5,"Question: Is manic bipolar affective disorder an indication for Chlorpromazine?
Reasoning: The disease manic bipolar affective disorder is associated with the gene DRD5, which is targeted by the drug Chlorpromazine. These connections suggest that Chlorpromazine may be effective in treating manic bipolar affective disorder.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'COL1A1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene COL1A1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
15458,28017.0,Ergotamine,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Ergotamine']",0.5,"Question: Is migraine with or without aura, susceptibility to an indication for Ergotamine?
Reasoning: The disease migraine with or without aura, susceptibility to is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Ergotamine. These connections suggest that Ergotamine may be effective in treating migraine with or without aura, susceptibility to.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'FOLR1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene FOLR1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15211,38957.0,Desvenlafaxine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Desvenlafaxine']",0.5,"Question: Is major depressive disorder an indication for Desvenlafaxine?
Reasoning: The disease major depressive disorder is associated with the gene SLC6A4, which is targeted by the drug Desvenlafaxine. These connections suggest that Desvenlafaxine may be effective in treating major depressive disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PLPPR1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene PLPPR1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Facial palsy', 'POMC', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Facial palsy, which in turn affects the gene POMC. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hypotonia', 'ABAT', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hypotonia, which in turn affects the gene ABAT. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14984,36035.0,Felodipine,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Felodipine']",0.5,"Question: Is hypertension an indication for Felodipine?
Reasoning: The disease hypertension is associated with the gene CYP3A5, which is targeted by the drug Felodipine. These connections suggest that Felodipine may be effective in treating hypertension.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PDYN', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene PDYN. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Abnormality of extrapyramidal motor function', 'NUS1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Abnormality of extrapyramidal motor function, which in turn affects the gene NUS1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14342,84094.0,Testosterone propionate,premature menopause,disease-protein-drug,indication,"['premature menopause', 'AR', 'Testosterone propionate']",0.5,"Question: Is premature menopause an indication for Testosterone propionate?
Reasoning: The disease premature menopause is associated with the gene AR, which is targeted by the drug Testosterone propionate. These connections suggest that Testosterone propionate may be effective in treating premature menopause.
Answer: YES"
14208,32337.0,Testosterone,"combined pituitary hormone deficiencies, genetic form",disease-phenotype-protein-drug,indication,"['combined pituitary hormone deficiencies, genetic form', 'Seizure', 'CYP11A1', 'Testosterone']",0.5,"Question: Is combined pituitary hormone deficiencies, genetic form an indication for Testosterone?
Reasoning: The disease combined pituitary hormone deficiencies, genetic form is associated with the phenotype Seizure, which in turn affects the gene CYP11A1. This gene is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating combined pituitary hormone deficiencies, genetic form.
Answer: YES"
14283,83790.0,Probenecid,gout,disease-protein-drug,indication,"['gout', 'SLC2A9', 'Probenecid']",0.5,"Question: Is gout an indication for Probenecid?
Reasoning: The disease gout is associated with the gene SLC2A9, which is targeted by the drug Probenecid. These connections suggest that Probenecid may be effective in treating gout.
Answer: YES"
14208,39203.0,Testosterone,pituitary deficiency,disease-protein-drug,indication,"['pituitary deficiency', 'CYP19A1', 'Testosterone']",0.5,"Question: Is pituitary deficiency an indication for Testosterone?
Reasoning: The disease pituitary deficiency is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating pituitary deficiency.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'CCDC50', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene CCDC50. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20133,27933.0,Ethyl loflazepate,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'GABRB3', 'Ethyl loflazepate']",0.5,"Question: Is anxiety disorder an indication for Ethyl loflazepate?
Reasoning: The disease anxiety disorder is associated with the gene GABRB3, which is targeted by the drug Ethyl loflazepate. These connections suggest that Ethyl loflazepate may be effective in treating anxiety disorder.
Answer: YES"
15333,33241.0,Rasagiline,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'MAOB', 'Rasagiline']",0.5,"Question: Is hereditary late onset Parkinson disease an indication for Rasagiline?
Reasoning: The disease hereditary late onset Parkinson disease is associated with the gene MAOB, which is targeted by the drug Rasagiline. These connections suggest that Rasagiline may be effective in treating hereditary late onset Parkinson disease.
Answer: YES"
14680,36924.0,Zinc acetate,dermatitis,disease-protein-drug,indication,"['dermatitis', 'PARP1', 'Zinc acetate']",0.5,"Question: Is dermatitis an indication for Zinc acetate?
Reasoning: The disease dermatitis is associated with the gene PARP1, which is targeted by the drug Zinc acetate. These connections suggest that Zinc acetate may be effective in treating dermatitis.
Answer: YES"
14263,39773.0,Salmeterol,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Salmeterol']",0.5,"Question: Is allergic asthma an indication for Salmeterol?
Reasoning: The disease allergic asthma is associated with the gene ADRB2, which is targeted by the drug Salmeterol. These connections suggest that Salmeterol may be effective in treating allergic asthma.
Answer: YES"
14993,28017.0,Phenobarbital,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Phenobarbital']",0.5,"Question: Is migraine with or without aura, susceptibility to an indication for Phenobarbital?
Reasoning: The disease migraine with or without aura, susceptibility to is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Phenobarbital. These connections suggest that Phenobarbital may be effective in treating migraine with or without aura, susceptibility to.
Answer: YES"
16855,30664.0,Methylphenidate,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,indication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'SLC6A3', 'Methylphenidate']",0.5,"Question: Is X-linked adrenoleukodystrophy an indication for Methylphenidate?
Reasoning: The disease X-linked adrenoleukodystrophy is associated with the phenotype Neurodegeneration, which in turn affects the gene SLC6A3. This gene is targeted by the drug Methylphenidate. These connections suggest that Methylphenidate may be effective in treating X-linked adrenoleukodystrophy.
Answer: YES"
14831,28547.0,Droxidopa,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DDC', 'Droxidopa']",0.5,"Question: Is Parkinson disease an indication for Droxidopa?
Reasoning: The disease Parkinson disease is associated with the gene DDC, which is targeted by the drug Droxidopa. These connections suggest that Droxidopa may be effective in treating Parkinson disease.
Answer: YES"
15110,83779.0,Fluphenazine,schizoaffective disorder,disease-protein-drug,indication,"['schizoaffective disorder', 'HTR2A', 'Fluphenazine']",0.5,"Question: Is schizoaffective disorder an indication for Fluphenazine?
Reasoning: The disease schizoaffective disorder is associated with the gene HTR2A, which is targeted by the drug Fluphenazine. These connections suggest that Fluphenazine may be effective in treating schizoaffective disorder.
Answer: YES"
15012,28640.0,Temsirolimus,nonpapillary renal cell carcinoma,disease-protein-drug,indication,"['nonpapillary renal cell carcinoma', 'MTOR', 'Temsirolimus']",0.5,"Question: Is nonpapillary renal cell carcinoma an indication for Temsirolimus?
Reasoning: The disease nonpapillary renal cell carcinoma is associated with the gene MTOR, which is targeted by the drug Temsirolimus. These connections suggest that Temsirolimus may be effective in treating nonpapillary renal cell carcinoma.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'MAPK14', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene MAPK14. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Vomiting', 'ABCB1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15413,39603.0,Gemcitabine,malignant sex cord stromal tumor of ovary,disease-protein-drug,indication,"['malignant sex cord stromal tumor of ovary', 'TYMS', 'Gemcitabine']",0.5,"Question: Is malignant sex cord stromal tumor of ovary an indication for Gemcitabine?
Reasoning: The disease malignant sex cord stromal tumor of ovary is associated with the gene TYMS, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating malignant sex cord stromal tumor of ovary.
Answer: YES"
14220,31408.0,Apomorphine,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'HTR1A', 'Apomorphine']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Apomorphine?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the phenotype Resting tremor, which in turn affects the gene HTR1A. This gene is targeted by the drug Apomorphine. These connections suggest that Apomorphine may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
16056,28547.0,Procyclidine,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'CHRM4', 'Procyclidine']",0.5,"Question: Is Parkinson disease an indication for Procyclidine?
Reasoning: The disease Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene CHRM4. This gene is targeted by the drug Procyclidine. These connections suggest that Procyclidine may be effective in treating Parkinson disease.
Answer: YES"
14806,33241.0,Entacapone,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'CYP2D6', 'Entacapone']",0.5,"Question: Is hereditary late onset Parkinson disease an indication for Entacapone?
Reasoning: The disease hereditary late onset Parkinson disease is associated with the gene CYP2D6, which is targeted by the drug Entacapone. These connections suggest that Entacapone may be effective in treating hereditary late onset Parkinson disease.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'OTOF', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene OTOF. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'ALPK1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene ALPK1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'FN1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene FN1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14042,30813.0,Hydrocortisone acetate,Addison disease,disease-phenotype-protein-drug,indication,"['Addison disease', 'Vomiting', 'ABCB1', 'Hydrocortisone acetate']",0.5,"Question: Is Addison disease an indication for Hydrocortisone acetate?
Reasoning: The disease Addison disease is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Hydrocortisone acetate. These connections suggest that Hydrocortisone acetate may be effective in treating Addison disease.
Answer: YES"
14945,33643.0,Sorafenib,renal cell carcinoma (disease),disease-protein-drug,indication,"['renal cell carcinoma (disease)', 'FLT4', 'Sorafenib']",0.5,"Question: Is renal cell carcinoma (disease) an indication for Sorafenib?
Reasoning: The disease renal cell carcinoma (disease) is associated with the gene FLT4, which is targeted by the drug Sorafenib. These connections suggest that Sorafenib may be effective in treating renal cell carcinoma (disease).
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hypotonia', 'INTS1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hypotonia, which in turn affects the gene INTS1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'ADPRS', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene ADPRS. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14768,32296.0,Dalteparin,acquired purpura fulminans,disease-protein-drug,indication,"['acquired purpura fulminans', 'SERPINC1', 'Dalteparin']",0.5,"Question: Is acquired purpura fulminans an indication for Dalteparin?
Reasoning: The disease acquired purpura fulminans is associated with the gene SERPINC1, which is targeted by the drug Dalteparin. These connections suggest that Dalteparin may be effective in treating acquired purpura fulminans.
Answer: YES"
15311,29865.0,Primidone,Lennox-Gastaut syndrome,disease-phenotype-protein-drug,indication,"['Lennox-Gastaut syndrome', 'Focal-onset seizure', 'GRIA2', 'Primidone']",0.5,"Question: Is Lennox-Gastaut syndrome an indication for Primidone?
Reasoning: The disease Lennox-Gastaut syndrome is associated with the phenotype Focal-onset seizure, which in turn affects the gene GRIA2. This gene is targeted by the drug Primidone. These connections suggest that Primidone may be effective in treating Lennox-Gastaut syndrome.
Answer: YES"
14504,36634.0,Floxuridine,liver cancer,disease-protein-drug,indication,"['liver cancer', 'TYMS', 'Floxuridine']",0.5,"Question: Is liver cancer an indication for Floxuridine?
Reasoning: The disease liver cancer is associated with the gene TYMS, which is targeted by the drug Floxuridine. These connections suggest that Floxuridine may be effective in treating liver cancer.
Answer: YES"
14220,32974.0,Apomorphine,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'DRD1', 'Apomorphine']",0.5,"Question: Is atypical juvenile parkinsonism an indication for Apomorphine?
Reasoning: The disease atypical juvenile parkinsonism is associated with the gene DRD1, which is targeted by the drug Apomorphine. These connections suggest that Apomorphine may be effective in treating atypical juvenile parkinsonism.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'CYBA', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene CYBA. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14196,32222.0,Propranolol,congenital hemangioma,disease-phenotype-protein-drug,indication,"['congenital hemangioma', 'Thrombocytopenia', 'ALB', 'Propranolol']",0.5,"Question: Is congenital hemangioma an indication for Propranolol?
Reasoning: The disease congenital hemangioma is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Propranolol. These connections suggest that Propranolol may be effective in treating congenital hemangioma.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'IL1R2', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene IL1R2. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
15430,83906.0,Pentobarbital,status epilepticus,disease-protein-drug,indication,"['status epilepticus', 'GRIA2', 'Pentobarbital']",0.5,"Question: Is status epilepticus an indication for Pentobarbital?
Reasoning: The disease status epilepticus is associated with the gene GRIA2, which is targeted by the drug Pentobarbital. These connections suggest that Pentobarbital may be effective in treating status epilepticus.
Answer: YES"
15956,83781.0,Dyphylline,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'PDE4D', 'Dyphylline']",0.5,"Question: Is intrinsic asthma an indication for Dyphylline?
Reasoning: The disease intrinsic asthma is associated with the gene PDE4D, which is targeted by the drug Dyphylline. These connections suggest that Dyphylline may be effective in treating intrinsic asthma.
Answer: YES"
14194,32531.0,Methotrexate,mantle cell lymphoma,disease-protein-drug,indication,"['mantle cell lymphoma', 'MTHFR', 'Methotrexate']",0.5,"Question: Is mantle cell lymphoma an indication for Methotrexate?
Reasoning: The disease mantle cell lymphoma is associated with the gene MTHFR, which is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating mantle cell lymphoma.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'SLC6A3', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene SLC6A3. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15761,84255.0,Oseltamivir,"influenza, severe, susceptibility to",disease-protein-drug,indication,"['influenza, severe, susceptibility to', 'SLC22A8', 'Oseltamivir']",0.5,"Question: Is influenza, severe, susceptibility to an indication for Oseltamivir?
Reasoning: The disease influenza, severe, susceptibility to is associated with the gene SLC22A8, which is targeted by the drug Oseltamivir. These connections suggest that Oseltamivir may be effective in treating influenza, severe, susceptibility to.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'PIGU', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene PIGU. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14141,83906.0,Phenytoin,status epilepticus,disease-protein-drug,indication,"['status epilepticus', 'SCN8A', 'Phenytoin']",0.5,"Question: Is status epilepticus an indication for Phenytoin?
Reasoning: The disease status epilepticus is associated with the gene SCN8A, which is targeted by the drug Phenytoin. These connections suggest that Phenytoin may be effective in treating status epilepticus.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ALKBH8', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ALKBH8. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
17270,28974.0,Pimavanserin,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'DRD2', 'Pimavanserin']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Pimavanserin?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the gene DRD2, which is targeted by the drug Pimavanserin. These connections suggest that Pimavanserin may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
16842,32759.0,Pramipexole,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'DRD2', 'Pramipexole']",0.5,"Question: Is hemiparkinsonism-hemiatrophy syndrome an indication for Pramipexole?
Reasoning: The disease hemiparkinsonism-hemiatrophy syndrome is associated with the gene DRD2, which is targeted by the drug Pramipexole. These connections suggest that Pramipexole may be effective in treating hemiparkinsonism-hemiatrophy syndrome.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'NR1H2', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene NR1H2. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CHAT', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CHAT. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'TYROBP', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene TYROBP. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CNNM2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CNNM2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14263,83781.0,Salmeterol,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ADRB2', 'Salmeterol']",0.5,"Question: Is intrinsic asthma an indication for Salmeterol?
Reasoning: The disease intrinsic asthma is associated with the gene ADRB2, which is targeted by the drug Salmeterol. These connections suggest that Salmeterol may be effective in treating intrinsic asthma.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SAMHD1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene SAMHD1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'ESRRB', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene ESRRB. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14249,83791.0,Pseudoephedrine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Pseudoephedrine']",0.5,"Question: Is vasomotor rhinitis an indication for Pseudoephedrine?
Reasoning: The disease vasomotor rhinitis is associated with the gene ALB, which is targeted by the drug Pseudoephedrine. These connections suggest that Pseudoephedrine may be effective in treating vasomotor rhinitis.
Answer: YES"
15146,83840.0,Nefazodone,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Nefazodone']",0.5,"Question: Is unipolar depression an indication for Nefazodone?
Reasoning: The disease unipolar depression is associated with the gene ABCB1, which is targeted by the drug Nefazodone. These connections suggest that Nefazodone may be effective in treating unipolar depression.
Answer: YES"
14201,32932.0,Oxytetracycline,brucellosis,disease-phenotype-protein-drug,indication,"['brucellosis', 'Hepatomegaly', 'ALB', 'Oxytetracycline']",0.5,"Question: Is brucellosis an indication for Oxytetracycline?
Reasoning: The disease brucellosis is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Oxytetracycline. These connections suggest that Oxytetracycline may be effective in treating brucellosis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CNNM2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CNNM2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CLU', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CLU. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Feeding difficulties', 'PIGP', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Feeding difficulties, which in turn affects the gene PIGP. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15242,33128.0,Artenimol,malaria,disease-phenotype-protein-drug,indication,"['malaria', 'Thrombocytopenia', 'CYCS', 'Artenimol']",0.5,"Question: Is malaria an indication for Artenimol?
Reasoning: The disease malaria is associated with the phenotype Thrombocytopenia, which in turn affects the gene CYCS. This gene is targeted by the drug Artenimol. These connections suggest that Artenimol may be effective in treating malaria.
Answer: YES"
14042,83790.0,Hydrocortisone acetate,gout,disease-protein-drug,indication,"['gout', 'ABCG2', 'Hydrocortisone acetate']",0.5,"Question: Is gout an indication for Hydrocortisone acetate?
Reasoning: The disease gout is associated with the gene ABCG2, which is targeted by the drug Hydrocortisone acetate. These connections suggest that Hydrocortisone acetate may be effective in treating gout.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'HLA-DPB1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene HLA-DPB1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'CRYGD', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene CRYGD. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'DSPP', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene DSPP. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14313,29361.0,Arsenic trioxide,acute promyelocytic leukemia,disease-protein-drug,indication,"['acute promyelocytic leukemia', 'PML', 'Arsenic trioxide']",0.5,"Question: Is acute promyelocytic leukemia an indication for Arsenic trioxide?
Reasoning: The disease acute promyelocytic leukemia is associated with the gene PML, which is targeted by the drug Arsenic trioxide. These connections suggest that Arsenic trioxide may be effective in treating acute promyelocytic leukemia.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'CACNA2D2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene CACNA2D2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14215,36035.0,Losartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Losartan']",0.5,"Question: Is hypertension an indication for Losartan?
Reasoning: The disease hypertension is associated with the gene AGTR1, which is targeted by the drug Losartan. These connections suggest that Losartan may be effective in treating hypertension.
Answer: YES"
14934,28764.0,Cyclosporine,Sjogren syndrome,disease-phenotype-protein-drug,indication,"['Sjogren syndrome', 'Seizure', 'ABCC2', 'Cyclosporine']",0.5,"Question: Is Sjogren syndrome an indication for Cyclosporine?
Reasoning: The disease Sjogren syndrome is associated with the phenotype Seizure, which in turn affects the gene ABCC2. This gene is targeted by the drug Cyclosporine. These connections suggest that Cyclosporine may be effective in treating Sjogren syndrome.
Answer: YES"
15612,32631.0,Siltuximab,Castleman disease,disease-protein-drug,indication,"['Castleman disease', 'IL6', 'Siltuximab']",0.5,"Question: Is Castleman disease an indication for Siltuximab?
Reasoning: The disease Castleman disease is associated with the gene IL6, which is targeted by the drug Siltuximab. These connections suggest that Siltuximab may be effective in treating Castleman disease.
Answer: YES"
14256,37805.0,Didanosine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Didanosine']",0.5,"Question: Is HIV infectious disease an indication for Didanosine?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Didanosine. These connections suggest that Didanosine may be effective in treating HIV infectious disease.
Answer: YES"
16215,36035.0,Fimasartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Fimasartan']",0.5,"Question: Is hypertension an indication for Fimasartan?
Reasoning: The disease hypertension is associated with the gene AGTR1, which is targeted by the drug Fimasartan. These connections suggest that Fimasartan may be effective in treating hypertension.
Answer: YES"
17376,83845.0,Cefotaxime,viral meningitis,disease-protein-drug,indication,"['viral meningitis', 'ALB', 'Cefotaxime']",0.5,"Question: Is viral meningitis an indication for Cefotaxime?
Reasoning: The disease viral meningitis is associated with the gene ALB, which is targeted by the drug Cefotaxime. These connections suggest that Cefotaxime may be effective in treating viral meningitis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CHRM1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CHRM1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'SLC8A3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene SLC8A3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'MTHFR', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene MTHFR. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15231,28005.0,Stiripentol,developmental and epileptic encephalopathy,disease-protein-drug,indication,"['developmental and epileptic encephalopathy', 'GABRG2', 'Stiripentol']",0.5,"Question: Is developmental and epileptic encephalopathy an indication for Stiripentol?
Reasoning: The disease developmental and epileptic encephalopathy is associated with the gene GABRG2, which is targeted by the drug Stiripentol. These connections suggest that Stiripentol may be effective in treating developmental and epileptic encephalopathy.
Answer: YES"
15979,32354.0,Coagulation Factor IX Human,symptomatic form of hemophilia in female carriers,disease-protein-drug,indication,"['symptomatic form of hemophilia in female carriers', 'F8', 'Coagulation Factor IX Human']",0.5,"Question: Is symptomatic form of hemophilia in female carriers an indication for Coagulation Factor IX Human?
Reasoning: The disease symptomatic form of hemophilia in female carriers is associated with the gene F8, which is targeted by the drug Coagulation Factor IX Human. These connections suggest that Coagulation Factor IX Human may be effective in treating symptomatic form of hemophilia in female carriers.
Answer: YES"
14861,31650.0,Neostigmine,myasthenia gravis,disease-phenotype-protein-drug,indication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Neostigmine']",0.5,"Question: Is myasthenia gravis an indication for Neostigmine?
Reasoning: The disease myasthenia gravis is associated with the phenotype Seizure, which in turn affects the gene BCHE. This gene is targeted by the drug Neostigmine. These connections suggest that Neostigmine may be effective in treating myasthenia gravis.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'HPGDS', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene HPGDS. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'GTPBP2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene GTPBP2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15914,37830.0,Minocycline,bronchitis,disease-protein-drug,indication,"['bronchitis', 'VEGFA', 'Minocycline']",0.5,"Question: Is bronchitis an indication for Minocycline?
Reasoning: The disease bronchitis is associated with the gene VEGFA, which is targeted by the drug Minocycline. These connections suggest that Minocycline may be effective in treating bronchitis.
Answer: YES"
14208,32518.0,Testosterone,trisomy 13,disease-phenotype-protein-drug,indication,"['trisomy 13', 'Seizure', 'CYP11A1', 'Testosterone']",0.5,"Question: Is trisomy 13 an indication for Testosterone?
Reasoning: The disease trisomy 13 is associated with the phenotype Seizure, which in turn affects the gene CYP11A1. This gene is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating trisomy 13.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'AHR', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene AHR. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
15173,84036.0,Dextroamphetamine,"attention deficit hyperactivity disorder, inattentive type",disease-protein-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'SLC6A3', 'Dextroamphetamine']",0.5,"Question: Is attention deficit hyperactivity disorder, inattentive type an indication for Dextroamphetamine?
Reasoning: The disease attention deficit hyperactivity disorder, inattentive type is associated with the gene SLC6A3, which is targeted by the drug Dextroamphetamine. These connections suggest that Dextroamphetamine may be effective in treating attention deficit hyperactivity disorder, inattentive type.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'MPDZ', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene MPDZ. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SIGMAR1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene SIGMAR1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'CSF3', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene CSF3. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'SAMHD1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene SAMHD1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
19222,38957.0,Isocarboxazid,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'MAOB', 'Isocarboxazid']",0.5,"Question: Is major depressive disorder an indication for Isocarboxazid?
Reasoning: The disease major depressive disorder is associated with the gene MAOB, which is targeted by the drug Isocarboxazid. These connections suggest that Isocarboxazid may be effective in treating major depressive disorder.
Answer: YES"
15018,83855.0,Midostaurin,acute myeloid leukemia with t(8;21)(q22;q22) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;21)(q22;q22) translocation', 'KIT', 'Midostaurin']",0.5,"Question: Is acute myeloid leukemia with t(8;21)(q22;q22) translocation an indication for Midostaurin?
Reasoning: The disease acute myeloid leukemia with t(8;21)(q22;q22) translocation is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating acute myeloid leukemia with t(8;21)(q22;q22) translocation.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PCYT2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene PCYT2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'ACTA2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene ACTA2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'APC', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene APC. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,28899.0,Fluoxetine,obsessive-compulsive disorder,disease-protein-drug,indication,"['obsessive-compulsive disorder', 'SLC6A4', 'Fluoxetine']",0.5,"Question: Is obsessive-compulsive disorder an indication for Fluoxetine?
Reasoning: The disease obsessive-compulsive disorder is associated with the gene SLC6A4, which is targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may be effective in treating obsessive-compulsive disorder.
Answer: YES"
14737,36794.0,Carboplatin,ovarian adenocarcinoma,disease-protein-drug,indication,"['ovarian adenocarcinoma', 'ATP7B', 'Carboplatin']",0.5,"Question: Is ovarian adenocarcinoma an indication for Carboplatin?
Reasoning: The disease ovarian adenocarcinoma is associated with the gene ATP7B, which is targeted by the drug Carboplatin. These connections suggest that Carboplatin may be effective in treating ovarian adenocarcinoma.
Answer: YES"
15517,32033.0,Prazepam,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Prazepam']",0.5,"Question: Is insomnia (disease) an indication for Prazepam?
Reasoning: The disease insomnia (disease) is associated with the gene GABRB3, which is targeted by the drug Prazepam. These connections suggest that Prazepam may be effective in treating insomnia (disease).
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'DSPP', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene DSPP. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14323,31912.0,Aripiprazole,autism susceptibility 1,disease-phenotype-protein-drug,indication,"['autism susceptibility 1', 'Seizure', 'HTR1B', 'Aripiprazole']",0.5,"Question: Is autism susceptibility 1 an indication for Aripiprazole?
Reasoning: The disease autism susceptibility 1 is associated with the phenotype Seizure, which in turn affects the gene HTR1B. This gene is targeted by the drug Aripiprazole. These connections suggest that Aripiprazole may be effective in treating autism susceptibility 1.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'GTPBP2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene GTPBP2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'NOTCH3', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene NOTCH3. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
18036,33575.0,Bacitracin,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Bacitracin']",1.0,"Question: Is diabetes mellitus (disease) an indication for Bacitracin?
Reasoning: The disease diabetes mellitus (disease) is associated with the phenotype Maternal diabetes, which in turn affects the gene CYP19A1. This gene is not targeted by the drug Bacitracin. These connections suggest that Bacitracin may not be effective in treating diabetes mellitus (disease).
Answer: NO"
14544,84229.0,Bupropion,nicotine dependence,disease-protein-drug,indication,"['nicotine dependence', 'CHRNA3', 'Bupropion']",0.5,"Question: Is nicotine dependence an indication for Bupropion?
Reasoning: The disease nicotine dependence is associated with the gene CHRNA3, which is targeted by the drug Bupropion. These connections suggest that Bupropion may be effective in treating nicotine dependence.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Lethargy', 'IL1B', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Lethargy, which in turn affects the gene IL1B. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14956,39815.0,Carbamazepine,visual epilepsy,disease-protein-drug,indication,"['visual epilepsy', 'ABCC2', 'Carbamazepine']",0.5,"Question: Is visual epilepsy an indication for Carbamazepine?
Reasoning: The disease visual epilepsy is associated with the gene ABCC2, which is targeted by the drug Carbamazepine. These connections suggest that Carbamazepine may be effective in treating visual epilepsy.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'GP9', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene GP9. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14320,31511.0,Dexamethasone,autoimmune thrombocytopenic,disease-phenotype-protein-drug,indication,"['autoimmune thrombocytopenic', 'Thrombocytopenia', 'ALB', 'Dexamethasone']",0.5,"Question: Is autoimmune thrombocytopenic an indication for Dexamethasone?
Reasoning: The disease autoimmune thrombocytopenic is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating autoimmune thrombocytopenic.
Answer: YES"
14962,83841.0,Trazodone,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Trazodone']",0.5,"Question: Is endogenous depression an indication for Trazodone?
Reasoning: The disease endogenous depression is associated with the gene SLC6A4, which is targeted by the drug Trazodone. These connections suggest that Trazodone may be effective in treating endogenous depression.
Answer: YES"
14906,83760.0,Toloxatone,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'MAOA', 'Toloxatone']",0.5,"Question: Is dysthymic disorder an indication for Toloxatone?
Reasoning: The disease dysthymic disorder is associated with the gene MAOA, which is targeted by the drug Toloxatone. These connections suggest that Toloxatone may be effective in treating dysthymic disorder.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'ERCC6', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene ERCC6. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'IFNA2', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Nausea, which in turn affects the gene IFNA2. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
17560,33675.0,Orciprenaline,asthma,disease-protein-drug,indication,"['asthma', 'ADRB2', 'Orciprenaline']",0.5,"Question: Is asthma an indication for Orciprenaline?
Reasoning: The disease asthma is associated with the gene ADRB2, which is targeted by the drug Orciprenaline. These connections suggest that Orciprenaline may be effective in treating asthma.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'AGT', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene AGT. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16698,36432.0,Enalaprilat,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'ACE', 'Enalaprilat']",0.5,"Question: Is congestive heart failure an indication for Enalaprilat?
Reasoning: The disease congestive heart failure is associated with the gene ACE, which is targeted by the drug Enalaprilat. These connections suggest that Enalaprilat may be effective in treating congestive heart failure.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CSNK2A1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CSNK2A1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'DHFR', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene DHFR. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TSEN15', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TSEN15. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'BDKRB1', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene BDKRB1. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
15511,39773.0,Pranlukast,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'RNASE3', 'Pranlukast']",0.5,"Question: Is allergic asthma an indication for Pranlukast?
Reasoning: The disease allergic asthma is associated with the gene RNASE3, which is targeted by the drug Pranlukast. These connections suggest that Pranlukast may be effective in treating allergic asthma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'MYO7A', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene MYO7A. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14797,36209.0,Imipenem,arthropathy,disease-protein-drug,indication,"['arthropathy', 'DPEP1', 'Imipenem']",0.5,"Question: Is arthropathy an indication for Imipenem?
Reasoning: The disease arthropathy is associated with the gene DPEP1, which is targeted by the drug Imipenem. These connections suggest that Imipenem may be effective in treating arthropathy.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ACAT1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ACAT1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CCR9', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CCR9. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'HP', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene HP. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'TPRN', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene TPRN. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'COMMD1', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene COMMD1. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'NOS1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene NOS1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14208,37285.0,Testosterone,thymus gland disease,disease-protein-drug,indication,"['thymus gland disease', 'CYP19A1', 'Testosterone']",0.5,"Question: Is thymus gland disease an indication for Testosterone?
Reasoning: The disease thymus gland disease is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating thymus gland disease.
Answer: YES"
14275,83769.0,Doxorubicin,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Doxorubicin']",0.5,"Question: Is precursor T-cell acute lymphoblastic leukemia an indication for Doxorubicin?
Reasoning: The disease precursor T-cell acute lymphoblastic leukemia is associated with the gene ABCG2, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating precursor T-cell acute lymphoblastic leukemia.
Answer: YES"
14554,30816.0,Mecasermin,Laron syndrome,disease-phenotype-protein-drug,indication,"['Laron syndrome', 'Delayed puberty', 'IGFALS', 'Mecasermin']",0.5,"Question: Is Laron syndrome an indication for Mecasermin?
Reasoning: The disease Laron syndrome is associated with the phenotype Delayed puberty, which in turn affects the gene IGFALS. This gene is targeted by the drug Mecasermin. These connections suggest that Mecasermin may be effective in treating Laron syndrome.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'IL4', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene IL4. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Postural tremor', 'ADRB2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Postural tremor, which in turn affects the gene ADRB2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14186,36527.0,Cisplatin,yolk sac tumor,disease-protein-drug,indication,"['yolk sac tumor', 'ATP7B', 'Cisplatin']",0.5,"Question: Is yolk sac tumor an indication for Cisplatin?
Reasoning: The disease yolk sac tumor is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating yolk sac tumor.
Answer: YES"
15493,28547.0,Bromocriptine,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'HTR1A', 'Bromocriptine']",0.5,"Question: Is Parkinson disease an indication for Bromocriptine?
Reasoning: The disease Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene HTR1A. This gene is targeted by the drug Bromocriptine. These connections suggest that Bromocriptine may be effective in treating Parkinson disease.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'RNR1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene RNR1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14275,32622.0,Doxorubicin,thyroid gland undifferentiated (anaplastic) carcinoma,disease-phenotype-protein-drug,indication,"['thyroid gland undifferentiated (anaplastic) carcinoma', 'Pain', 'ALB', 'Doxorubicin']",0.5,"Question: Is thyroid gland undifferentiated (anaplastic) carcinoma an indication for Doxorubicin?
Reasoning: The disease thyroid gland undifferentiated (anaplastic) carcinoma is associated with the phenotype Pain, which in turn affects the gene ALB. This gene is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating thyroid gland undifferentiated (anaplastic) carcinoma.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Postural tremor', 'ATP7A', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Postural tremor, which in turn affects the gene ATP7A. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'CAT', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene CAT. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'SLC1A1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene SLC1A1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14297,33598.0,Atorvastatin,stroke disorder,disease-protein-drug,indication,"['stroke disorder', 'ALB', 'Atorvastatin']",0.5,"Question: Is stroke disorder an indication for Atorvastatin?
Reasoning: The disease stroke disorder is associated with the gene ALB, which is targeted by the drug Atorvastatin. These connections suggest that Atorvastatin may be effective in treating stroke disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'BSND', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene BSND. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ZNF142', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene ZNF142. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15263,83852.0,Enasidenib,acute myeloid leukemia with minimal differentiation,disease-protein-drug,indication,"['acute myeloid leukemia with minimal differentiation', 'IDH2', 'Enasidenib']",0.5,"Question: Is acute myeloid leukemia with minimal differentiation an indication for Enasidenib?
Reasoning: The disease acute myeloid leukemia with minimal differentiation is associated with the gene IDH2, which is targeted by the drug Enasidenib. These connections suggest that Enasidenib may be effective in treating acute myeloid leukemia with minimal differentiation.
Answer: YES"
14135,83898.0,Lovastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Lovastatin']",0.5,"Question: Is obsolete familial combined hyperlipidemia an indication for Lovastatin?
Reasoning: The disease obsolete familial combined hyperlipidemia is associated with the gene HMGCR, which is targeted by the drug Lovastatin. These connections suggest that Lovastatin may be effective in treating obsolete familial combined hyperlipidemia.
Answer: YES"
14603,33575.0,Chlorpropamide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'ABCC8', 'Chlorpropamide']",0.5,"Question: Is diabetes mellitus (disease) an indication for Chlorpropamide?
Reasoning: The disease diabetes mellitus (disease) is associated with the gene ABCC8, which is targeted by the drug Chlorpropamide. These connections suggest that Chlorpropamide may be effective in treating diabetes mellitus (disease).
Answer: YES"
14189,83760.0,Nortriptyline,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'ADRB1', 'Nortriptyline']",0.5,"Question: Is dysthymic disorder an indication for Nortriptyline?
Reasoning: The disease dysthymic disorder is associated with the gene ADRB1, which is targeted by the drug Nortriptyline. These connections suggest that Nortriptyline may be effective in treating dysthymic disorder.
Answer: YES"
15124,38003.0,Biperiden,basal ganglia disease,disease-protein-drug,indication,"['basal ganglia disease', 'CYP2D6', 'Biperiden']",0.5,"Question: Is basal ganglia disease an indication for Biperiden?
Reasoning: The disease basal ganglia disease is associated with the gene CYP2D6, which is targeted by the drug Biperiden. These connections suggest that Biperiden may be effective in treating basal ganglia disease.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PHACTR1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene PHACTR1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CAMK2A', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene CAMK2A. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'MAP2', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene MAP2. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ACTL6B', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ACTL6B. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'GABRA5', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene GABRA5. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15333,32759.0,Rasagiline,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'MAOB', 'Rasagiline']",0.5,"Question: Is hemiparkinsonism-hemiatrophy syndrome an indication for Rasagiline?
Reasoning: The disease hemiparkinsonism-hemiatrophy syndrome is associated with the gene MAOB, which is targeted by the drug Rasagiline. These connections suggest that Rasagiline may be effective in treating hemiparkinsonism-hemiatrophy syndrome.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'ATN1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene ATN1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'MACF1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene MACF1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14024,84154.0,Prednisone,"primary cutaneous diffuse large B-cell lymphoma, Leg type",disease-protein-drug,indication,"['primary cutaneous diffuse large B-cell lymphoma, Leg type', 'ABCB1', 'Prednisone']",0.5,"Question: Is primary cutaneous diffuse large B-cell lymphoma, Leg type an indication for Prednisone?
Reasoning: The disease primary cutaneous diffuse large B-cell lymphoma, Leg type is associated with the gene ABCB1, which is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating primary cutaneous diffuse large B-cell lymphoma, Leg type.
Answer: YES"
14320,35884.0,Dexamethasone,diffuse large B-cell lymphoma,disease-protein-drug,indication,"['diffuse large B-cell lymphoma', 'CYP2E1', 'Dexamethasone']",0.5,"Question: Is diffuse large B-cell lymphoma an indication for Dexamethasone?
Reasoning: The disease diffuse large B-cell lymphoma is associated with the gene CYP2E1, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating diffuse large B-cell lymphoma.
Answer: YES"
14999,30318.0,Quetiapine,autosomal recessive severe congenital neutropenia due to JAGN1 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to JAGN1 deficiency', 'Short stature', 'SLC10A7', 'Quetiapine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to JAGN1 deficiency an indication for Quetiapine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to JAGN1 deficiency is associated with the phenotype Short stature, which in turn affects the gene SLC10A7. This gene is not targeted by the drug Quetiapine. These connections suggest that Quetiapine may not be effective in treating autosomal recessive severe congenital neutropenia due to JAGN1 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'MDK', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene MDK. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SLC2A1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene SLC2A1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Delayed puberty', 'KISS1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Delayed puberty, which in turn affects the gene KISS1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'PTGIS', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene PTGIS. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
15191,83995.0,Ospemifene,psychologic dyspareunia,disease-protein-drug,indication,"['psychologic dyspareunia', 'CYP2D6', 'Ospemifene']",0.5,"Question: Is psychologic dyspareunia an indication for Ospemifene?
Reasoning: The disease psychologic dyspareunia is associated with the gene CYP2D6, which is targeted by the drug Ospemifene. These connections suggest that Ospemifene may be effective in treating psychologic dyspareunia.
Answer: YES"
15083,38957.0,Reboxetine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'ABCB1', 'Reboxetine']",0.5,"Question: Is major depressive disorder an indication for Reboxetine?
Reasoning: The disease major depressive disorder is associated with the gene ABCB1, which is targeted by the drug Reboxetine. These connections suggest that Reboxetine may be effective in treating major depressive disorder.
Answer: YES"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'MC4R', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene MC4R. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CCL8', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CCL8. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14774,35849.0,Enoxaparin,disseminated intravascular coagulation,disease-protein-drug,indication,"['disseminated intravascular coagulation', 'SERPINC1', 'Enoxaparin']",0.5,"Question: Is disseminated intravascular coagulation an indication for Enoxaparin?
Reasoning: The disease disseminated intravascular coagulation is associated with the gene SERPINC1, which is targeted by the drug Enoxaparin. These connections suggest that Enoxaparin may be effective in treating disseminated intravascular coagulation.
Answer: YES"
14988,31283.0,Pimozide,Tourette syndrome,disease-protein-drug,indication,"['Tourette syndrome', 'DRD3', 'Pimozide']",0.5,"Question: Is Tourette syndrome an indication for Pimozide?
Reasoning: The disease Tourette syndrome is associated with the gene DRD3, which is targeted by the drug Pimozide. These connections suggest that Pimozide may be effective in treating Tourette syndrome.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SSTR2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SSTR2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'CLDN14', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene CLDN14. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'LEP', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene LEP. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'CACNA1D', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene CACNA1D. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15290,28536.0,Anagrelide,thrombocythemia,disease-phenotype-protein-drug,indication,"['thrombocythemia', 'Splenomegaly', 'CYP1A2', 'Anagrelide']",0.5,"Question: Is thrombocythemia an indication for Anagrelide?
Reasoning: The disease thrombocythemia is associated with the phenotype Splenomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Anagrelide. These connections suggest that Anagrelide may be effective in treating thrombocythemia.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'GJB2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene GJB2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15667,83760.0,Esketamine,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'CYP2C19', 'Esketamine']",0.5,"Question: Is dysthymic disorder an indication for Esketamine?
Reasoning: The disease dysthymic disorder is associated with the gene CYP2C19, which is targeted by the drug Esketamine. These connections suggest that Esketamine may be effective in treating dysthymic disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SLC6A2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SLC6A2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14030,37888.0,Prednisolone,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Prednisolone']",0.5,"Question: Is allergic rhinitis an indication for Prednisolone?
Reasoning: The disease allergic rhinitis is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is targeted by the drug Prednisolone. These connections suggest that Prednisolone may be effective in treating allergic rhinitis.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hypotonia', 'PAX7', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hypotonia, which in turn affects the gene PAX7. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16842,28801.0,Pramipexole,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DRD2', 'Pramipexole']",0.5,"Question: Is juvenile onset Parkinson disease 19A an indication for Pramipexole?
Reasoning: The disease juvenile onset Parkinson disease 19A is associated with the gene DRD2, which is targeted by the drug Pramipexole. These connections suggest that Pramipexole may be effective in treating juvenile onset Parkinson disease 19A.
Answer: YES"
14944,36035.0,Amlodipine,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Amlodipine']",0.5,"Question: Is hypertension an indication for Amlodipine?
Reasoning: The disease hypertension is associated with the gene CYP3A5, which is targeted by the drug Amlodipine. These connections suggest that Amlodipine may be effective in treating hypertension.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'AKAP5', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene AKAP5. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'KEAP1', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene KEAP1. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14737,83820.0,Carboplatin,maligant granulosa cell tumor of ovary,disease-protein-drug,indication,"['maligant granulosa cell tumor of ovary', 'ATP7B', 'Carboplatin']",0.5,"Question: Is maligant granulosa cell tumor of ovary an indication for Carboplatin?
Reasoning: The disease maligant granulosa cell tumor of ovary is associated with the gene ATP7B, which is targeted by the drug Carboplatin. These connections suggest that Carboplatin may be effective in treating maligant granulosa cell tumor of ovary.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'AHR', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene AHR. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ADAM3A', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene ADAM3A. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14249,37888.0,Pseudoephedrine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Pseudoephedrine']",0.5,"Question: Is allergic rhinitis an indication for Pseudoephedrine?
Reasoning: The disease allergic rhinitis is associated with the gene ALB, which is targeted by the drug Pseudoephedrine. These connections suggest that Pseudoephedrine may be effective in treating allergic rhinitis.
Answer: YES"
14768,35849.0,Dalteparin,disseminated intravascular coagulation,disease-protein-drug,indication,"['disseminated intravascular coagulation', 'SERPINC1', 'Dalteparin']",0.5,"Question: Is disseminated intravascular coagulation an indication for Dalteparin?
Reasoning: The disease disseminated intravascular coagulation is associated with the gene SERPINC1, which is targeted by the drug Dalteparin. These connections suggest that Dalteparin may be effective in treating disseminated intravascular coagulation.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'CHD7', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene CHD7. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'CCK', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene CCK. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'REL', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene REL. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14950,36091.0,Loratadine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'CYP1A1', 'Loratadine']",0.5,"Question: Is atopic conjunctivitis an indication for Loratadine?
Reasoning: The disease atopic conjunctivitis is associated with the phenotype Allergy, which in turn affects the gene CYP1A1. This gene is targeted by the drug Loratadine. These connections suggest that Loratadine may be effective in treating atopic conjunctivitis.
Answer: YES"
16690,83824.0,Lisinopril,myocardial infarction,disease-protein-drug,indication,"['myocardial infarction', 'ACE', 'Lisinopril']",0.5,"Question: Is myocardial infarction an indication for Lisinopril?
Reasoning: The disease myocardial infarction is associated with the gene ACE, which is targeted by the drug Lisinopril. These connections suggest that Lisinopril may be effective in treating myocardial infarction.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CCK', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CCK. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'RRM2B', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene RRM2B. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'BDNF', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene BDNF. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'CCL2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene CCL2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GTF3C3', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene GTF3C3. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CCL2', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CCL2. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ALAD', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene ALAD. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14275,33621.0,Doxorubicin,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'ABCB1', 'Doxorubicin']",0.5,"Question: Is acute lymphoblastic leukemia (disease) an indication for Doxorubicin?
Reasoning: The disease acute lymphoblastic leukemia (disease) is associated with the gene ABCB1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating acute lymphoblastic leukemia (disease).
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PLPPR1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene PLPPR1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'FOS', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene FOS. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14831,32759.0,Droxidopa,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'DDC', 'Droxidopa']",0.5,"Question: Is hemiparkinsonism-hemiatrophy syndrome an indication for Droxidopa?
Reasoning: The disease hemiparkinsonism-hemiatrophy syndrome is associated with the gene DDC, which is targeted by the drug Droxidopa. These connections suggest that Droxidopa may be effective in treating hemiparkinsonism-hemiatrophy syndrome.
Answer: YES"
14139,28547.0,Benzatropine,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'SLC6A3', 'Benzatropine']",0.5,"Question: Is Parkinson disease an indication for Benzatropine?
Reasoning: The disease Parkinson disease is associated with the gene SLC6A3, which is targeted by the drug Benzatropine. These connections suggest that Benzatropine may be effective in treating Parkinson disease.
Answer: YES"
14729,28542.0,Cimetidine,mastocytosis,disease-phenotype-protein-drug,indication,"['mastocytosis', 'Hepatomegaly', 'CYP1A2', 'Cimetidine']",0.5,"Question: Is mastocytosis an indication for Cimetidine?
Reasoning: The disease mastocytosis is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Cimetidine. These connections suggest that Cimetidine may be effective in treating mastocytosis.
Answer: YES"
14177,83841.0,Duloxetine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Duloxetine']",0.5,"Question: Is endogenous depression an indication for Duloxetine?
Reasoning: The disease endogenous depression is associated with the gene SLC6A4, which is targeted by the drug Duloxetine. These connections suggest that Duloxetine may be effective in treating endogenous depression.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'APEX1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene APEX1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14186,83821.0,Cisplatin,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,indication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ATP7B', 'Cisplatin']",0.5,"Question: Is malignant Sertoli-Leydig cell tumor of ovary an indication for Cisplatin?
Reasoning: The disease malignant Sertoli-Leydig cell tumor of ovary is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating malignant Sertoli-Leydig cell tumor of ovary.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'RNR1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene RNR1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CYP11A1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CYP11A1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15077,30494.0,Bortezomib,plasma cell myeloma,disease-phenotype-protein-drug,indication,"['plasma cell myeloma', 'Splenomegaly', 'CYP1A2', 'Bortezomib']",0.5,"Question: Is plasma cell myeloma an indication for Bortezomib?
Reasoning: The disease plasma cell myeloma is associated with the phenotype Splenomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Bortezomib. These connections suggest that Bortezomib may be effective in treating plasma cell myeloma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PRKCD', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene PRKCD. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
18230,38024.0,Ustekinumab,psoriasis,disease-protein-drug,indication,"['psoriasis', 'IL23A', 'Ustekinumab']",0.5,"Question: Is psoriasis an indication for Ustekinumab?
Reasoning: The disease psoriasis is associated with the gene IL23A, which is targeted by the drug Ustekinumab. These connections suggest that Ustekinumab may be effective in treating psoriasis.
Answer: YES"
16510,84243.0,Bevacizumab,squamous cell carcinoma of the corpus uteri,disease-protein-drug,indication,"['squamous cell carcinoma of the corpus uteri', 'C1QB', 'Bevacizumab']",0.5,"Question: Is squamous cell carcinoma of the corpus uteri an indication for Bevacizumab?
Reasoning: The disease squamous cell carcinoma of the corpus uteri is associated with the gene C1QB, which is targeted by the drug Bevacizumab. These connections suggest that Bevacizumab may be effective in treating squamous cell carcinoma of the corpus uteri.
Answer: YES"
15282,29113.0,Insulin lispro,diabetic ketoacidosis,disease-phenotype-protein-drug,indication,"['diabetic ketoacidosis', 'Insulin resistance', 'INSR', 'Insulin lispro']",0.5,"Question: Is diabetic ketoacidosis an indication for Insulin lispro?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene INSR. This gene is targeted by the drug Insulin lispro. These connections suggest that Insulin lispro may be effective in treating diabetic ketoacidosis.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'KLF11', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene KLF11. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14208,27741.0,Testosterone,pituitary deficiency due to empty sella turcica syndrome,disease-phenotype-protein-drug,indication,"['pituitary deficiency due to empty sella turcica syndrome', 'Seizure', 'CYP11A1', 'Testosterone']",0.5,"Question: Is pituitary deficiency due to empty sella turcica syndrome an indication for Testosterone?
Reasoning: The disease pituitary deficiency due to empty sella turcica syndrome is associated with the phenotype Seizure, which in turn affects the gene CYP11A1. This gene is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating pituitary deficiency due to empty sella turcica syndrome.
Answer: YES"
14729,28426.0,Cimetidine,multiple endocrine neoplasia,disease-phenotype-protein-drug,indication,"['multiple endocrine neoplasia', 'Vomiting', 'ABCB1', 'Cimetidine']",0.5,"Question: Is multiple endocrine neoplasia an indication for Cimetidine?
Reasoning: The disease multiple endocrine neoplasia is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Cimetidine. These connections suggest that Cimetidine may be effective in treating multiple endocrine neoplasia.
Answer: YES"
14266,83791.0,Fexofenadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Fexofenadine']",0.5,"Question: Is vasomotor rhinitis an indication for Fexofenadine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Fexofenadine. These connections suggest that Fexofenadine may be effective in treating vasomotor rhinitis.
Answer: YES"
14197,29273.0,Fenoprofen,osteoarthritis susceptibility,disease-protein-drug,indication,"['osteoarthritis susceptibility', 'PPARG', 'Fenoprofen']",0.5,"Question: Is osteoarthritis susceptibility an indication for Fenoprofen?
Reasoning: The disease osteoarthritis susceptibility is associated with the gene PPARG, which is targeted by the drug Fenoprofen. These connections suggest that Fenoprofen may be effective in treating osteoarthritis susceptibility.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'BCL2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene BCL2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15138,32974.0,Selegiline,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'CYP2D6', 'Selegiline']",0.5,"Question: Is atypical juvenile parkinsonism an indication for Selegiline?
Reasoning: The disease atypical juvenile parkinsonism is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Selegiline. These connections suggest that Selegiline may be effective in treating atypical juvenile parkinsonism.
Answer: YES"
14400,28714.0,Ivacaftor,cystic fibrosis,disease-protein-drug,indication,"['cystic fibrosis', 'CFTR', 'Ivacaftor']",0.5,"Question: Is cystic fibrosis an indication for Ivacaftor?
Reasoning: The disease cystic fibrosis is associated with the gene CFTR, which is targeted by the drug Ivacaftor. These connections suggest that Ivacaftor may be effective in treating cystic fibrosis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'CXCL8', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene CXCL8. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Abnormality of extrapyramidal motor function', 'NUS1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Abnormality of extrapyramidal motor function, which in turn affects the gene NUS1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'MSRB3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene MSRB3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
17561,33675.0,Bitolterol,asthma,disease-protein-drug,indication,"['asthma', 'ADRB2', 'Bitolterol']",0.5,"Question: Is asthma an indication for Bitolterol?
Reasoning: The disease asthma is associated with the gene ADRB2, which is targeted by the drug Bitolterol. These connections suggest that Bitolterol may be effective in treating asthma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'RSPH4A', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene RSPH4A. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'IFI6', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene IFI6. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'STAC3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene STAC3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CHRNA5', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene CHRNA5. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Headache', 'IFNA2', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Headache, which in turn affects the gene IFNA2. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'COPS3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene COPS3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DHPS', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene DHPS. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14275,84155.0,Doxorubicin,Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly,disease-protein-drug,indication,"['Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly', 'ABCB1', 'Doxorubicin']",0.5,"Question: Is Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly an indication for Doxorubicin?
Reasoning: The disease Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly is associated with the gene ABCB1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Answer: YES"
14561,27647.0,Cholecalciferol,hypoparathyroidism,disease-phenotype-protein-drug,indication,"['hypoparathyroidism', 'Seizure', 'CYP27A1', 'Cholecalciferol']",0.5,"Question: Is hypoparathyroidism an indication for Cholecalciferol?
Reasoning: The disease hypoparathyroidism is associated with the phenotype Seizure, which in turn affects the gene CYP27A1. This gene is targeted by the drug Cholecalciferol. These connections suggest that Cholecalciferol may be effective in treating hypoparathyroidism.
Answer: YES"
14696,32503.0,Pentamidine,human African trypanosomiasis,disease-phenotype-protein-drug,indication,"['human African trypanosomiasis', 'Tremor', 'CYP2D6', 'Pentamidine']",0.5,"Question: Is human African trypanosomiasis an indication for Pentamidine?
Reasoning: The disease human African trypanosomiasis is associated with the phenotype Tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Pentamidine. These connections suggest that Pentamidine may be effective in treating human African trypanosomiasis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'RELA', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene RELA. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'DEGS1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene DEGS1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'ASPG', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene ASPG. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14561,83952.0,Cholecalciferol,obsolete vitamin D deficiency,disease-protein-drug,indication,"['obsolete vitamin D deficiency', 'VDR', 'Cholecalciferol']",0.5,"Question: Is obsolete vitamin D deficiency an indication for Cholecalciferol?
Reasoning: The disease obsolete vitamin D deficiency is associated with the gene VDR, which is targeted by the drug Cholecalciferol. These connections suggest that Cholecalciferol may be effective in treating obsolete vitamin D deficiency.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'NPY', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene NPY. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14230,32949.0,Tetracycline,relapsing fever,disease-phenotype-protein-drug,indication,"['relapsing fever', 'Thrombocytopenia', 'ALB', 'Tetracycline']",0.5,"Question: Is relapsing fever an indication for Tetracycline?
Reasoning: The disease relapsing fever is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Tetracycline. These connections suggest that Tetracycline may be effective in treating relapsing fever.
Answer: YES"
14320,37608.0,Dexamethasone,ciliary body disease,disease-protein-drug,indication,"['ciliary body disease', 'ALB', 'Dexamethasone']",0.5,"Question: Is ciliary body disease an indication for Dexamethasone?
Reasoning: The disease ciliary body disease is associated with the gene ALB, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating ciliary body disease.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TCF4', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TCF4. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Generalized hypotonia', 'PIGB', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Generalized hypotonia, which in turn affects the gene PIGB. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
15421,32033.0,Temazepam,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Temazepam']",0.5,"Question: Is insomnia (disease) an indication for Temazepam?
Reasoning: The disease insomnia (disease) is associated with the gene GABRB3, which is targeted by the drug Temazepam. These connections suggest that Temazepam may be effective in treating insomnia (disease).
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'KDM3B', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene KDM3B. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
19207,32974.0,Carbidopa,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'DDC', 'Carbidopa']",0.5,"Question: Is atypical juvenile parkinsonism an indication for Carbidopa?
Reasoning: The disease atypical juvenile parkinsonism is associated with the gene DDC, which is targeted by the drug Carbidopa. These connections suggest that Carbidopa may be effective in treating atypical juvenile parkinsonism.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'MTHFR', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene MTHFR. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15599,36999.0,Regorafenib,adenocarcinoma of liver and intrahepatic biliary tract,disease-protein-drug,indication,"['adenocarcinoma of liver and intrahepatic biliary tract', 'ABCB1', 'Regorafenib']",0.5,"Question: Is adenocarcinoma of liver and intrahepatic biliary tract an indication for Regorafenib?
Reasoning: The disease adenocarcinoma of liver and intrahepatic biliary tract is associated with the gene ABCB1, which is targeted by the drug Regorafenib. These connections suggest that Regorafenib may be effective in treating adenocarcinoma of liver and intrahepatic biliary tract.
Answer: YES"
15822,31144.0,Ursodeoxycholic acid,primary biliary cholangitis,disease-protein-drug,indication,"['primary biliary cholangitis', 'ABCC2', 'Ursodeoxycholic acid']",0.5,"Question: Is primary biliary cholangitis an indication for Ursodeoxycholic acid?
Reasoning: The disease primary biliary cholangitis is associated with the gene ABCC2, which is targeted by the drug Ursodeoxycholic acid. These connections suggest that Ursodeoxycholic acid may be effective in treating primary biliary cholangitis.
Answer: YES"
15282,33575.0,Insulin lispro,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'CYP1A2', 'Insulin lispro']",0.5,"Question: Is diabetes mellitus (disease) an indication for Insulin lispro?
Reasoning: The disease diabetes mellitus (disease) is associated with the gene CYP1A2, which is targeted by the drug Insulin lispro. These connections suggest that Insulin lispro may be effective in treating diabetes mellitus (disease).
Answer: YES"
14269,37888.0,Methylprednisolone,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Methylprednisolone']",0.5,"Question: Is allergic rhinitis an indication for Methylprednisolone?
Reasoning: The disease allergic rhinitis is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is targeted by the drug Methylprednisolone. These connections suggest that Methylprednisolone may be effective in treating allergic rhinitis.
Answer: YES"
14019,33077.0,Betamethasone,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Hepatomegaly', 'ALB', 'Betamethasone']",0.5,"Question: Is Hodgkins lymphoma an indication for Betamethasone?
Reasoning: The disease Hodgkins lymphoma is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Betamethasone. These connections suggest that Betamethasone may be effective in treating Hodgkins lymphoma.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'CHRNA3', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene CHRNA3. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15242,33128.0,Artenimol,malaria,disease-protein-drug,indication,"['malaria', 'G6PD', 'Artenimol']",0.5,"Question: Is malaria an indication for Artenimol?
Reasoning: The disease malaria is associated with the gene G6PD, which is targeted by the drug Artenimol. These connections suggest that Artenimol may be effective in treating malaria.
Answer: YES"
15087,83840.0,Venlafaxine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Venlafaxine']",0.5,"Question: Is unipolar depression an indication for Venlafaxine?
Reasoning: The disease unipolar depression is associated with the gene ABCB1, which is targeted by the drug Venlafaxine. These connections suggest that Venlafaxine may be effective in treating unipolar depression.
Answer: YES"
14516,83899.0,Tegafur,gastric linitis plastica,disease-protein-drug,indication,"['gastric linitis plastica', 'CYP2A6', 'Tegafur']",0.5,"Question: Is gastric linitis plastica an indication for Tegafur?
Reasoning: The disease gastric linitis plastica is associated with the gene CYP2A6, which is targeted by the drug Tegafur. These connections suggest that Tegafur may be effective in treating gastric linitis plastica.
Answer: YES"
17232,83791.0,Triprolidine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Triprolidine']",0.5,"Question: Is vasomotor rhinitis an indication for Triprolidine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Triprolidine. These connections suggest that Triprolidine may be effective in treating vasomotor rhinitis.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'TRH', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene TRH. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15338,33434.0,Deferasirox,beta-thalassemia intermedia,disease-phenotype-protein-drug,indication,"['beta-thalassemia intermedia', 'Hepatomegaly', 'CYP1A2', 'Deferasirox']",0.5,"Question: Is beta-thalassemia intermedia an indication for Deferasirox?
Reasoning: The disease beta-thalassemia intermedia is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Deferasirox. These connections suggest that Deferasirox may be effective in treating beta-thalassemia intermedia.
Answer: YES"
14443,37743.0,Grazoprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Grazoprevir']",0.5,"Question: Is hepatitis C virus infection an indication for Grazoprevir?
Reasoning: The disease hepatitis C virus infection is associated with the gene CYP3A4, which is targeted by the drug Grazoprevir. These connections suggest that Grazoprevir may be effective in treating hepatitis C virus infection.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'HTR1B', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene HTR1B. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15113,83911.0,Galantamine,Reye syndrome,disease-protein-drug,indication,"['Reye syndrome', 'CHRNA7', 'Galantamine']",0.5,"Question: Is Reye syndrome an indication for Galantamine?
Reasoning: The disease Reye syndrome is associated with the gene CHRNA7, which is targeted by the drug Galantamine. These connections suggest that Galantamine may be effective in treating Reye syndrome.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'FKRP', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene FKRP. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
19217,36223.0,Tipiracil,malignant colon neoplasm,disease-protein-drug,indication,"['malignant colon neoplasm', 'TYMP', 'Tipiracil']",0.5,"Question: Is malignant colon neoplasm an indication for Tipiracil?
Reasoning: The disease malignant colon neoplasm is associated with the gene TYMP, which is targeted by the drug Tipiracil. These connections suggest that Tipiracil may be effective in treating malignant colon neoplasm.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'CCR2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene CCR2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'INS', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene INS. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14177,27933.0,Duloxetine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Duloxetine']",0.5,"Question: Is anxiety disorder an indication for Duloxetine?
Reasoning: The disease anxiety disorder is associated with the gene ABCB1, which is targeted by the drug Duloxetine. These connections suggest that Duloxetine may be effective in treating anxiety disorder.
Answer: YES"
15083,83840.0,Reboxetine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Reboxetine']",0.5,"Question: Is unipolar depression an indication for Reboxetine?
Reasoning: The disease unipolar depression is associated with the gene ABCB1, which is targeted by the drug Reboxetine. These connections suggest that Reboxetine may be effective in treating unipolar depression.
Answer: YES"
16511,33064.0,Ranibizumab,retinal artery occlusion,disease-protein-drug,indication,"['retinal artery occlusion', 'VEGFA', 'Ranibizumab']",0.5,"Question: Is retinal artery occlusion an indication for Ranibizumab?
Reasoning: The disease retinal artery occlusion is associated with the gene VEGFA, which is targeted by the drug Ranibizumab. These connections suggest that Ranibizumab may be effective in treating retinal artery occlusion.
Answer: YES"
14419,32325.0,Dexibuprofen,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Dexibuprofen']",0.5,"Question: Is juvenile idiopathic arthritis an indication for Dexibuprofen?
Reasoning: The disease juvenile idiopathic arthritis is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Dexibuprofen. These connections suggest that Dexibuprofen may be effective in treating juvenile idiopathic arthritis.
Answer: YES"
14221,29061.0,Norethisterone,endometriosis of uterus,disease-protein-drug,indication,"['endometriosis of uterus', 'SRD5A1', 'Norethisterone']",0.5,"Question: Is endometriosis of uterus an indication for Norethisterone?
Reasoning: The disease endometriosis of uterus is associated with the gene SRD5A1, which is targeted by the drug Norethisterone. These connections suggest that Norethisterone may be effective in treating endometriosis of uterus.
Answer: YES"
14194,33621.0,Methotrexate,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'MTHFR', 'Methotrexate']",0.5,"Question: Is acute lymphoblastic leukemia (disease) an indication for Methotrexate?
Reasoning: The disease acute lymphoblastic leukemia (disease) is associated with the gene MTHFR, which is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating acute lymphoblastic leukemia (disease).
Answer: YES"
14176,38957.0,Fluoxetine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Fluoxetine']",0.5,"Question: Is major depressive disorder an indication for Fluoxetine?
Reasoning: The disease major depressive disorder is associated with the gene SLC6A4, which is targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may be effective in treating major depressive disorder.
Answer: YES"
15185,31245.0,Tetrabenazine,Huntington disease,disease-phenotype-protein-drug,indication,"['Huntington disease', 'Rigidity', 'CYP2D6', 'Tetrabenazine']",0.5,"Question: Is Huntington disease an indication for Tetrabenazine?
Reasoning: The disease Huntington disease is associated with the phenotype Rigidity, which in turn affects the gene CYP2D6. This gene is targeted by the drug Tetrabenazine. These connections suggest that Tetrabenazine may be effective in treating Huntington disease.
Answer: YES"
14318,83845.0,Ceftriaxone,viral meningitis,disease-protein-drug,indication,"['viral meningitis', 'ALB', 'Ceftriaxone']",0.5,"Question: Is viral meningitis an indication for Ceftriaxone?
Reasoning: The disease viral meningitis is associated with the gene ALB, which is targeted by the drug Ceftriaxone. These connections suggest that Ceftriaxone may be effective in treating viral meningitis.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'FUT8', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene FUT8. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15116,37703.0,Paroxetine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'HTR1B', 'Paroxetine']",0.5,"Question: Is neurotic disorder an indication for Paroxetine?
Reasoning: The disease neurotic disorder is associated with the gene HTR1B, which is targeted by the drug Paroxetine. These connections suggest that Paroxetine may be effective in treating neurotic disorder.
Answer: YES"
14111,33452.0,Alitretinoin,granulomatous slack skin disease,disease-phenotype-protein-drug,contraindication,"['granulomatous slack skin disease', 'Erythema', 'COL2A1', 'Alitretinoin']",1.0,"Question: Is granulomatous slack skin disease an indication for Alitretinoin?
Reasoning: The disease granulomatous slack skin disease is associated with the phenotype Erythema, which in turn affects the gene COL2A1. This gene is not targeted by the drug Alitretinoin. These connections suggest that Alitretinoin may not be effective in treating granulomatous slack skin disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Ataxia', 'SCN8A', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Ataxia, which in turn affects the gene SCN8A. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15043,37743.0,Asunaprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP2A6', 'Asunaprevir']",0.5,"Question: Is hepatitis C virus infection an indication for Asunaprevir?
Reasoning: The disease hepatitis C virus infection is associated with the gene CYP2A6, which is targeted by the drug Asunaprevir. These connections suggest that Asunaprevir may be effective in treating hepatitis C virus infection.
Answer: YES"
14198,33577.0,Clonidine,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Clonidine']",0.5,"Question: Is hypertensive disorder an indication for Clonidine?
Reasoning: The disease hypertensive disorder is associated with the gene CYP3A5, which is targeted by the drug Clonidine. These connections suggest that Clonidine may be effective in treating hypertensive disorder.
Answer: YES"
15413,37423.0,Gemcitabine,ovarian clear cell adenocarcinoma,disease-protein-drug,indication,"['ovarian clear cell adenocarcinoma', 'TYMS', 'Gemcitabine']",0.5,"Question: Is ovarian clear cell adenocarcinoma an indication for Gemcitabine?
Reasoning: The disease ovarian clear cell adenocarcinoma is associated with the gene TYMS, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating ovarian clear cell adenocarcinoma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'TMTC2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene TMTC2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15100,28313.0,Prochlorperazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'HRH1', 'Prochlorperazine']",0.5,"Question: Is schizophrenia an indication for Prochlorperazine?
Reasoning: The disease schizophrenia is associated with the gene HRH1, which is targeted by the drug Prochlorperazine. These connections suggest that Prochlorperazine may be effective in treating schizophrenia.
Answer: YES"
15413,36527.0,Gemcitabine,yolk sac tumor,disease-protein-drug,indication,"['yolk sac tumor', 'TYMS', 'Gemcitabine']",0.5,"Question: Is yolk sac tumor an indication for Gemcitabine?
Reasoning: The disease yolk sac tumor is associated with the gene TYMS, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating yolk sac tumor.
Answer: YES"
15984,29078.0,Oxaprozin,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Oxaprozin']",0.5,"Question: Is rheumatoid arthritis an indication for Oxaprozin?
Reasoning: The disease rheumatoid arthritis is associated with the gene PTGS1, which is targeted by the drug Oxaprozin. These connections suggest that Oxaprozin may be effective in treating rheumatoid arthritis.
Answer: YES"
15042,37743.0,Elbasvir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Elbasvir']",0.5,"Question: Is hepatitis C virus infection an indication for Elbasvir?
Reasoning: The disease hepatitis C virus infection is associated with the gene CYP3A4, which is targeted by the drug Elbasvir. These connections suggest that Elbasvir may be effective in treating hepatitis C virus infection.
Answer: YES"
14139,28974.0,Benzatropine,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'SLC6A3', 'Benzatropine']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Benzatropine?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the gene SLC6A3, which is targeted by the drug Benzatropine. These connections suggest that Benzatropine may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
14955,84159.0,Vincristine,ALK-positive large B-cell lymphoma,disease-protein-drug,indication,"['ALK-positive large B-cell lymphoma', 'ABCB1', 'Vincristine']",0.5,"Question: Is ALK-positive large B-cell lymphoma an indication for Vincristine?
Reasoning: The disease ALK-positive large B-cell lymphoma is associated with the gene ABCB1, which is targeted by the drug Vincristine. These connections suggest that Vincristine may be effective in treating ALK-positive large B-cell lymphoma.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'FCGR2A', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene FCGR2A. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'IL12B', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene IL12B. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'NPY', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene NPY. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CYP27A1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CYP27A1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PACS2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene PACS2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15119,27933.0,Tranylcypromine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOB', 'Tranylcypromine']",0.5,"Question: Is anxiety disorder an indication for Tranylcypromine?
Reasoning: The disease anxiety disorder is associated with the gene MAOB, which is targeted by the drug Tranylcypromine. These connections suggest that Tranylcypromine may be effective in treating anxiety disorder.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'COL5A2', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene COL5A2. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14806,28547.0,Entacapone,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Entacapone']",0.5,"Question: Is Parkinson disease an indication for Entacapone?
Reasoning: The disease Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Entacapone. These connections suggest that Entacapone may be effective in treating Parkinson disease.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'PIGU', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene PIGU. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TRH', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TRH. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14282,36286.0,Irbesartan,diabetic nephropathy,disease-protein-drug,indication,"['diabetic nephropathy', 'ALB', 'Irbesartan']",0.5,"Question: Is diabetic nephropathy an indication for Irbesartan?
Reasoning: The disease diabetic nephropathy is associated with the gene ALB, which is targeted by the drug Irbesartan. These connections suggest that Irbesartan may be effective in treating diabetic nephropathy.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'MAPT', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene MAPT. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GAMT', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene GAMT. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14594,27361.0,Albutrepenonacog alfa,hemophilia,disease-protein-drug,indication,"['hemophilia', 'F8', 'Albutrepenonacog alfa']",0.5,"Question: Is hemophilia an indication for Albutrepenonacog alfa?
Reasoning: The disease hemophilia is associated with the gene F8, which is targeted by the drug Albutrepenonacog alfa. These connections suggest that Albutrepenonacog alfa may be effective in treating hemophilia.
Answer: YES"
15148,83840.0,Escitalopram,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'MAOB', 'Escitalopram']",0.5,"Question: Is unipolar depression an indication for Escitalopram?
Reasoning: The disease unipolar depression is associated with the gene MAOB, which is targeted by the drug Escitalopram. These connections suggest that Escitalopram may be effective in treating unipolar depression.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'LNPK', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene LNPK. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ZNF292', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ZNF292. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'HDC', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene HDC. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Short stature', 'EIF4A3', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Short stature, which in turn affects the gene EIF4A3. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'COL4A1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene COL4A1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15082,83841.0,Citalopram,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Citalopram']",0.5,"Question: Is endogenous depression an indication for Citalopram?
Reasoning: The disease endogenous depression is associated with the gene SLC6A4, which is targeted by the drug Citalopram. These connections suggest that Citalopram may be effective in treating endogenous depression.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CNR1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CNR1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
17270,31408.0,Pimavanserin,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'DRD2', 'Pimavanserin']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Pimavanserin?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the gene DRD2, which is targeted by the drug Pimavanserin. These connections suggest that Pimavanserin may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
15295,33592.0,Triamterene,acidosis disorder,disease-phenotype-protein-drug,contraindication,"['acidosis disorder', 'Lactic acidosis', 'RRM2B', 'Triamterene']",1.0,"Question: Is acidosis disorder an indication for Triamterene?
Reasoning: The disease acidosis disorder is associated with the phenotype Lactic acidosis, which in turn affects the gene RRM2B. This gene is not targeted by the drug Triamterene. These connections suggest that Triamterene may not be effective in treating acidosis disorder.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'GPR155', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene GPR155. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'KEAP1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene KEAP1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14806,28974.0,Entacapone,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'CYP2D6', 'Entacapone']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Entacapone?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the gene CYP2D6, which is targeted by the drug Entacapone. These connections suggest that Entacapone may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
15012,36935.0,Temsirolimus,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'MTOR', 'Temsirolimus']",0.5,"Question: Is renal cell adenocarcinoma an indication for Temsirolimus?
Reasoning: The disease renal cell adenocarcinoma is associated with the gene MTOR, which is targeted by the drug Temsirolimus. These connections suggest that Temsirolimus may be effective in treating renal cell adenocarcinoma.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'FGFR3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene FGFR3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'FBXL4', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene FBXL4. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15493,30093.0,Bromocriptine,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'ABCB1', 'Bromocriptine']",0.5,"Question: Is parkinsonian-pyramidal syndrome an indication for Bromocriptine?
Reasoning: The disease parkinsonian-pyramidal syndrome is associated with the gene ABCB1, which is targeted by the drug Bromocriptine. These connections suggest that Bromocriptine may be effective in treating parkinsonian-pyramidal syndrome.
Answer: YES"
14544,38957.0,Bupropion,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'CYP2C9', 'Bupropion']",0.5,"Question: Is major depressive disorder an indication for Bupropion?
Reasoning: The disease major depressive disorder is associated with the gene CYP2C9, which is targeted by the drug Bupropion. These connections suggest that Bupropion may be effective in treating major depressive disorder.
Answer: YES"
14463,83860.0,Gilteritinib,acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2),disease-protein-drug,indication,"['acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)', 'FLT3', 'Gilteritinib']",0.5,"Question: Is acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) an indication for Gilteritinib?
Reasoning: The disease acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) is associated with the gene FLT3, which is targeted by the drug Gilteritinib. These connections suggest that Gilteritinib may be effective in treating acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2).
Answer: YES"
15297,35641.0,Secobarbital,epilepsy,disease-protein-drug,indication,"['epilepsy', 'CHRNA7', 'Secobarbital']",0.5,"Question: Is epilepsy an indication for Secobarbital?
Reasoning: The disease epilepsy is associated with the gene CHRNA7, which is targeted by the drug Secobarbital. These connections suggest that Secobarbital may be effective in treating epilepsy.
Answer: YES"
14621,27361.0,Lonoctocog alfa,hemophilia,disease-protein-drug,indication,"['hemophilia', 'F9', 'Lonoctocog alfa']",0.5,"Question: Is hemophilia an indication for Lonoctocog alfa?
Reasoning: The disease hemophilia is associated with the gene F9, which is targeted by the drug Lonoctocog alfa. These connections suggest that Lonoctocog alfa may be effective in treating hemophilia.
Answer: YES"
15107,30990.0,Vinblastine,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Pruritus', 'ABCB11', 'Vinblastine']",0.5,"Question: Is mycosis fungoides and variants an indication for Vinblastine?
Reasoning: The disease mycosis fungoides and variants is associated with the phenotype Pruritus, which in turn affects the gene ABCB11. This gene is targeted by the drug Vinblastine. These connections suggest that Vinblastine may be effective in treating mycosis fungoides and variants.
Answer: YES"
15126,28780.0,Donepezil,Alzheimer disease,disease-protein-drug,indication,"['Alzheimer disease', 'BCHE', 'Donepezil']",0.5,"Question: Is Alzheimer disease an indication for Donepezil?
Reasoning: The disease Alzheimer disease is associated with the gene BCHE, which is targeted by the drug Donepezil. These connections suggest that Donepezil may be effective in treating Alzheimer disease.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hyperkalemia', 'CYP17A1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hyperkalemia, which in turn affects the gene CYP17A1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
17584,29078.0,Adalimumab,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'TNF', 'Adalimumab']",0.5,"Question: Is rheumatoid arthritis an indication for Adalimumab?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene TNF. This gene is targeted by the drug Adalimumab. These connections suggest that Adalimumab may be effective in treating rheumatoid arthritis.
Answer: YES"
14680,36214.0,Zinc acetate,iron metabolism disease,disease-protein-drug,indication,"['iron metabolism disease', 'A2M', 'Zinc acetate']",0.5,"Question: Is iron metabolism disease an indication for Zinc acetate?
Reasoning: The disease iron metabolism disease is associated with the gene A2M, which is targeted by the drug Zinc acetate. These connections suggest that Zinc acetate may be effective in treating iron metabolism disease.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'NGFR', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene NGFR. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14050,33654.0,Prednisolone acetate,uveitis,disease-protein-drug,indication,"['uveitis', 'ALB', 'Prednisolone acetate']",0.5,"Question: Is uveitis an indication for Prednisolone acetate?
Reasoning: The disease uveitis is associated with the gene ALB, which is targeted by the drug Prednisolone acetate. These connections suggest that Prednisolone acetate may be effective in treating uveitis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SLC30A1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SLC30A1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'MECP2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene MECP2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15458,37768.0,Ergotamine,migraine disorder,disease-protein-drug,indication,"['migraine disorder', 'HTR2A', 'Ergotamine']",0.5,"Question: Is migraine disorder an indication for Ergotamine?
Reasoning: The disease migraine disorder is associated with the gene HTR2A, which is targeted by the drug Ergotamine. These connections suggest that Ergotamine may be effective in treating migraine disorder.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'ADORA2A', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Action tremor, which in turn affects the gene ADORA2A. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14212,36035.0,Verapamil,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Verapamil']",0.5,"Question: Is hypertension an indication for Verapamil?
Reasoning: The disease hypertension is associated with the gene CYP3A5, which is targeted by the drug Verapamil. These connections suggest that Verapamil may be effective in treating hypertension.
Answer: YES"
14238,29078.0,Naproxen,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Naproxen']",0.5,"Question: Is rheumatoid arthritis an indication for Naproxen?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Naproxen. These connections suggest that Naproxen may be effective in treating rheumatoid arthritis.
Answer: YES"
14831,32974.0,Droxidopa,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'ADRB2', 'Droxidopa']",0.5,"Question: Is atypical juvenile parkinsonism an indication for Droxidopa?
Reasoning: The disease atypical juvenile parkinsonism is associated with the phenotype Resting tremor, which in turn affects the gene ADRB2. This gene is targeted by the drug Droxidopa. These connections suggest that Droxidopa may be effective in treating atypical juvenile parkinsonism.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'COL6A3', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene COL6A3. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hyponatremia', 'IFNG', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hyponatremia, which in turn affects the gene IFNG. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
17718,31116.0,Necitumumab,lung cancer,disease-protein-drug,indication,"['lung cancer', 'EGFR', 'Necitumumab']",0.5,"Question: Is lung cancer an indication for Necitumumab?
Reasoning: The disease lung cancer is associated with the gene EGFR, which is targeted by the drug Necitumumab. These connections suggest that Necitumumab may be effective in treating lung cancer.
Answer: YES"
14204,29078.0,Sulindac,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Sulindac']",0.5,"Question: Is rheumatoid arthritis an indication for Sulindac?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Sulindac. These connections suggest that Sulindac may be effective in treating rheumatoid arthritis.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CCL19', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CCL19. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
17545,83857.0,Gemtuzumab ozogamicin,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'CD33', 'Gemtuzumab ozogamicin']",0.5,"Question: Is acute myeloid leukemia with t(8;16)(p11;p13) translocation an indication for Gemtuzumab ozogamicin?
Reasoning: The disease acute myeloid leukemia with t(8;16)(p11;p13) translocation is associated with the gene CD33, which is targeted by the drug Gemtuzumab ozogamicin. These connections suggest that Gemtuzumab ozogamicin may be effective in treating acute myeloid leukemia with t(8;16)(p11;p13) translocation.
Answer: YES"
17585,37785.0,Infliximab,ulcerative colitis (disease),disease-protein-drug,indication,"['ulcerative colitis (disease)', 'TNF', 'Infliximab']",0.5,"Question: Is ulcerative colitis (disease) an indication for Infliximab?
Reasoning: The disease ulcerative colitis (disease) is associated with the gene TNF, which is targeted by the drug Infliximab. These connections suggest that Infliximab may be effective in treating ulcerative colitis (disease).
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'PJVK', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene PJVK. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14023,39245.0,Triamcinolone,panuveitis (disease),disease-protein-drug,indication,"['panuveitis (disease)', 'ALB', 'Triamcinolone']",0.5,"Question: Is panuveitis (disease) an indication for Triamcinolone?
Reasoning: The disease panuveitis (disease) is associated with the gene ALB, which is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating panuveitis (disease).
Answer: YES"
16268,37764.0,Fenofibric acid,familial hyperlipidemia,disease-protein-drug,indication,"['familial hyperlipidemia', 'PPARA', 'Fenofibric acid']",0.5,"Question: Is familial hyperlipidemia an indication for Fenofibric acid?
Reasoning: The disease familial hyperlipidemia is associated with the gene PPARA, which is targeted by the drug Fenofibric acid. These connections suggest that Fenofibric acid may be effective in treating familial hyperlipidemia.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ALAD', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ALAD. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14780,30654.0,Cytarabine,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'POLB', 'Cytarabine']",0.5,"Question: Is acute lymphoblastic/lymphocytic leukemia an indication for Cytarabine?
Reasoning: The disease acute lymphoblastic/lymphocytic leukemia is associated with the gene POLB, which is targeted by the drug Cytarabine. These connections suggest that Cytarabine may be effective in treating acute lymphoblastic/lymphocytic leukemia.
Answer: YES"
15671,30654.0,Duvelisib,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Duvelisib']",0.5,"Question: Is acute lymphoblastic/lymphocytic leukemia an indication for Duvelisib?
Reasoning: The disease acute lymphoblastic/lymphocytic leukemia is associated with the gene ABCG2, which is targeted by the drug Duvelisib. These connections suggest that Duvelisib may be effective in treating acute lymphoblastic/lymphocytic leukemia.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CHRNA5', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CHRNA5. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14170,28849.0,Trifluridine,colorectal cancer,disease-protein-drug,indication,"['colorectal cancer', 'TYMP', 'Trifluridine']",0.5,"Question: Is colorectal cancer an indication for Trifluridine?
Reasoning: The disease colorectal cancer is associated with the gene TYMP, which is targeted by the drug Trifluridine. These connections suggest that Trifluridine may be effective in treating colorectal cancer.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'IL6', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene IL6. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
16510,32617.0,Bevacizumab,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'C1QB', 'Bevacizumab']",0.5,"Question: Is hereditary breast ovarian cancer syndrome an indication for Bevacizumab?
Reasoning: The disease hereditary breast ovarian cancer syndrome is associated with the gene C1QB, which is targeted by the drug Bevacizumab. These connections suggest that Bevacizumab may be effective in treating hereditary breast ovarian cancer syndrome.
Answer: YES"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Generalized hypotonia', 'SNX27', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Generalized hypotonia, which in turn affects the gene SNX27. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DLL1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene DLL1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'FA2H', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene FA2H. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYGB', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene CYGB. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Fatigue', 'IFNA2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Fatigue, which in turn affects the gene IFNA2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'BMPR2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene BMPR2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'SLC5A6', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene SLC5A6. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14208,27219.0,Testosterone,hypogonadotropic hypogonadism with or without anosmia,disease-protein-drug,indication,"['hypogonadotropic hypogonadism with or without anosmia', 'CYP19A1', 'Testosterone']",0.5,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Testosterone?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'NR1I3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene NR1I3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14854,31650.0,Ambenonium,myasthenia gravis,disease-phenotype-protein-drug,indication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Ambenonium']",0.5,"Question: Is myasthenia gravis an indication for Ambenonium?
Reasoning: The disease myasthenia gravis is associated with the phenotype Seizure, which in turn affects the gene BCHE. This gene is targeted by the drug Ambenonium. These connections suggest that Ambenonium may be effective in treating myasthenia gravis.
Answer: YES"
17305,83760.0,Protriptyline,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A4', 'Protriptyline']",0.5,"Question: Is dysthymic disorder an indication for Protriptyline?
Reasoning: The disease dysthymic disorder is associated with the gene SLC6A4, which is targeted by the drug Protriptyline. These connections suggest that Protriptyline may be effective in treating dysthymic disorder.
Answer: YES"
14831,32759.0,Droxidopa,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'ADRB2', 'Droxidopa']",0.5,"Question: Is hemiparkinsonism-hemiatrophy syndrome an indication for Droxidopa?
Reasoning: The disease hemiparkinsonism-hemiatrophy syndrome is associated with the phenotype Tremor, which in turn affects the gene ADRB2. This gene is targeted by the drug Droxidopa. These connections suggest that Droxidopa may be effective in treating hemiparkinsonism-hemiatrophy syndrome.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Feeding difficulties', 'TRAPPC4', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Feeding difficulties, which in turn affects the gene TRAPPC4. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'NOS2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene NOS2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14542,37703.0,Maprotiline,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A2', 'Maprotiline']",0.5,"Question: Is neurotic disorder an indication for Maprotiline?
Reasoning: The disease neurotic disorder is associated with the gene SLC6A2, which is targeted by the drug Maprotiline. These connections suggest that Maprotiline may be effective in treating neurotic disorder.
Answer: YES"
14293,28208.0,Glipizide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'ABCC8', 'Glipizide']",0.5,"Question: Is type 2 diabetes mellitus an indication for Glipizide?
Reasoning: The disease type 2 diabetes mellitus is associated with the gene ABCC8, which is targeted by the drug Glipizide. These connections suggest that Glipizide may be effective in treating type 2 diabetes mellitus.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TRRAP', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TRRAP. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15418,33618.0,Dofetilide,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'KCNH2', 'Dofetilide']",0.5,"Question: Is atrial fibrillation (disease) an indication for Dofetilide?
Reasoning: The disease atrial fibrillation (disease) is associated with the gene KCNH2, which is targeted by the drug Dofetilide. These connections suggest that Dofetilide may be effective in treating atrial fibrillation (disease).
Answer: YES"
17310,27933.0,Amineptine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'SLC6A2', 'Amineptine']",0.5,"Question: Is anxiety disorder an indication for Amineptine?
Reasoning: The disease anxiety disorder is associated with the gene SLC6A2, which is targeted by the drug Amineptine. These connections suggest that Amineptine may be effective in treating anxiety disorder.
Answer: YES"
14463,83852.0,Gilteritinib,acute myeloid leukemia with minimal differentiation,disease-protein-drug,indication,"['acute myeloid leukemia with minimal differentiation', 'FLT3', 'Gilteritinib']",0.5,"Question: Is acute myeloid leukemia with minimal differentiation an indication for Gilteritinib?
Reasoning: The disease acute myeloid leukemia with minimal differentiation is associated with the gene FLT3, which is targeted by the drug Gilteritinib. These connections suggest that Gilteritinib may be effective in treating acute myeloid leukemia with minimal differentiation.
Answer: YES"
14924,32272.0,Diazoxide,pancreatic insulin-producing neuroendocrine tumor,disease-phenotype-protein-drug,indication,"['pancreatic insulin-producing neuroendocrine tumor', 'Increased body weight', 'KCNMA1', 'Diazoxide']",0.5,"Question: Is pancreatic insulin-producing neuroendocrine tumor an indication for Diazoxide?
Reasoning: The disease pancreatic insulin-producing neuroendocrine tumor is associated with the phenotype Increased body weight, which in turn affects the gene KCNMA1. This gene is targeted by the drug Diazoxide. These connections suggest that Diazoxide may be effective in treating pancreatic insulin-producing neuroendocrine tumor.
Answer: YES"
14042,33621.0,Hydrocortisone acetate,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'ABCB1', 'Hydrocortisone acetate']",0.5,"Question: Is acute lymphoblastic leukemia (disease) an indication for Hydrocortisone acetate?
Reasoning: The disease acute lymphoblastic leukemia (disease) is associated with the gene ABCB1, which is targeted by the drug Hydrocortisone acetate. These connections suggest that Hydrocortisone acetate may be effective in treating acute lymphoblastic leukemia (disease).
Answer: YES"
14297,35953.0,Atorvastatin,atherosclerosis,disease-protein-drug,indication,"['atherosclerosis', 'AHR', 'Atorvastatin']",0.5,"Question: Is atherosclerosis an indication for Atorvastatin?
Reasoning: The disease atherosclerosis is associated with the gene AHR, which is targeted by the drug Atorvastatin. These connections suggest that Atorvastatin may be effective in treating atherosclerosis.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'APEX1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene APEX1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14408,30826.0,Enzalutamide,familial prostate carcinoma,disease-protein-drug,indication,"['familial prostate carcinoma', 'CYP2C19', 'Enzalutamide']",0.5,"Question: Is familial prostate carcinoma an indication for Enzalutamide?
Reasoning: The disease familial prostate carcinoma is associated with the gene CYP2C19, which is targeted by the drug Enzalutamide. These connections suggest that Enzalutamide may be effective in treating familial prostate carcinoma.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'APC', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene APC. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14248,32469.0,Cysteamine,cystinosis,disease-phenotype-protein-drug,indication,"['cystinosis', 'Proteinuria', 'ALB', 'Cysteamine']",0.5,"Question: Is cystinosis an indication for Cysteamine?
Reasoning: The disease cystinosis is associated with the phenotype Proteinuria, which in turn affects the gene ALB. This gene is targeted by the drug Cysteamine. These connections suggest that Cysteamine may be effective in treating cystinosis.
Answer: YES"
14226,39773.0,Zileuton,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ALOX5', 'Zileuton']",0.5,"Question: Is allergic asthma an indication for Zileuton?
Reasoning: The disease allergic asthma is associated with the gene ALOX5, which is targeted by the drug Zileuton. These connections suggest that Zileuton may be effective in treating allergic asthma.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'CYP1A1', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A1. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14737,83819.0,Carboplatin,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ATP7B', 'Carboplatin']",0.5,"Question: Is malignant dysgerminomatous germ cell tumor of ovary an indication for Carboplatin?
Reasoning: The disease malignant dysgerminomatous germ cell tumor of ovary is associated with the gene ATP7B, which is targeted by the drug Carboplatin. These connections suggest that Carboplatin may be effective in treating malignant dysgerminomatous germ cell tumor of ovary.
Answer: YES"
15124,32759.0,Biperiden,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'CYP2D6', 'Biperiden']",0.5,"Question: Is hemiparkinsonism-hemiatrophy syndrome an indication for Biperiden?
Reasoning: The disease hemiparkinsonism-hemiatrophy syndrome is associated with the phenotype Tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Biperiden. These connections suggest that Biperiden may be effective in treating hemiparkinsonism-hemiatrophy syndrome.
Answer: YES"
14403,37805.0,Rilpivirine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Rilpivirine']",0.5,"Question: Is HIV infectious disease an indication for Rilpivirine?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Rilpivirine. These connections suggest that Rilpivirine may be effective in treating HIV infectious disease.
Answer: YES"
14560,83776.0,Ergocalciferol,postmenopausal osteoporosis,disease-protein-drug,indication,"['postmenopausal osteoporosis', 'CYP24A1', 'Ergocalciferol']",0.5,"Question: Is postmenopausal osteoporosis an indication for Ergocalciferol?
Reasoning: The disease postmenopausal osteoporosis is associated with the gene CYP24A1, which is targeted by the drug Ergocalciferol. These connections suggest that Ergocalciferol may be effective in treating postmenopausal osteoporosis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'TMPRSS3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene TMPRSS3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'CEACAM5', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene CEACAM5. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14141,83761.0,Phenytoin,epilepsy with generalized tonic-clonic seizures,disease-protein-drug,indication,"['epilepsy with generalized tonic-clonic seizures', 'CYP2D6', 'Phenytoin']",0.5,"Question: Is epilepsy with generalized tonic-clonic seizures an indication for Phenytoin?
Reasoning: The disease epilepsy with generalized tonic-clonic seizures is associated with the gene CYP2D6, which is targeted by the drug Phenytoin. These connections suggest that Phenytoin may be effective in treating epilepsy with generalized tonic-clonic seizures.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'ATP7B', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene ATP7B. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
17233,83791.0,Carbinoxamine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Carbinoxamine']",0.5,"Question: Is vasomotor rhinitis an indication for Carbinoxamine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Carbinoxamine. These connections suggest that Carbinoxamine may be effective in treating vasomotor rhinitis.
Answer: YES"
16341,84087.0,Iron,iron deficiency anemia,disease-protein-drug,indication,"['iron deficiency anemia', 'TFRC', 'Iron']",0.5,"Question: Is iron deficiency anemia an indication for Iron?
Reasoning: The disease iron deficiency anemia is associated with the gene TFRC, which is targeted by the drug Iron. These connections suggest that Iron may be effective in treating iron deficiency anemia.
Answer: YES"
14273,29078.0,Azathioprine,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Azathioprine']",0.5,"Question: Is rheumatoid arthritis an indication for Azathioprine?
Reasoning: The disease rheumatoid arthritis is associated with the gene ABCB1, which is targeted by the drug Azathioprine. These connections suggest that Azathioprine may be effective in treating rheumatoid arthritis.
Answer: YES"
15413,32617.0,Gemcitabine,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Gemcitabine']",0.5,"Question: Is hereditary breast ovarian cancer syndrome an indication for Gemcitabine?
Reasoning: The disease hereditary breast ovarian cancer syndrome is associated with the gene ABCB1, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating hereditary breast ovarian cancer syndrome.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'PNKP', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene PNKP. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hypotonia', 'LETM1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hypotonia, which in turn affects the gene LETM1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14269,37770.0,Methylprednisolone,contact dermatitis,disease-protein-drug,indication,"['contact dermatitis', 'CYP1B1', 'Methylprednisolone']",0.5,"Question: Is contact dermatitis an indication for Methylprednisolone?
Reasoning: The disease contact dermatitis is associated with the gene CYP1B1, which is targeted by the drug Methylprednisolone. These connections suggest that Methylprednisolone may be effective in treating contact dermatitis.
Answer: YES"
14310,29709.0,Doxepin,"dermatitis, atopic",disease-phenotype-protein-drug,indication,"['dermatitis, atopic', 'Pruritus', 'HRH1', 'Doxepin']",0.5,"Question: Is dermatitis, atopic an indication for Doxepin?
Reasoning: The disease dermatitis, atopic is associated with the phenotype Pruritus, which in turn affects the gene HRH1. This gene is targeted by the drug Doxepin. These connections suggest that Doxepin may be effective in treating dermatitis, atopic.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CYP11A1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene CYP11A1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
17724,37753.0,Methadyl acetate,opiate dependence,disease-protein-drug,indication,"['opiate dependence', 'OPRM1', 'Methadyl acetate']",0.5,"Question: Is opiate dependence an indication for Methadyl acetate?
Reasoning: The disease opiate dependence is associated with the gene OPRM1, which is targeted by the drug Methadyl acetate. These connections suggest that Methadyl acetate may be effective in treating opiate dependence.
Answer: YES"
15230,28640.0,Lenvatinib,nonpapillary renal cell carcinoma,disease-protein-drug,indication,"['nonpapillary renal cell carcinoma', 'FLT4', 'Lenvatinib']",0.5,"Question: Is nonpapillary renal cell carcinoma an indication for Lenvatinib?
Reasoning: The disease nonpapillary renal cell carcinoma is associated with the gene FLT4, which is targeted by the drug Lenvatinib. These connections suggest that Lenvatinib may be effective in treating nonpapillary renal cell carcinoma.
Answer: YES"
14527,27522.0,Fluoxymesterone,Noonan syndrome,disease-phenotype-protein-drug,indication,"['Noonan syndrome', 'Male infertility', 'AR', 'Fluoxymesterone']",0.5,"Question: Is Noonan syndrome an indication for Fluoxymesterone?
Reasoning: The disease Noonan syndrome is associated with the phenotype Male infertility, which in turn affects the gene AR. This gene is targeted by the drug Fluoxymesterone. These connections suggest that Fluoxymesterone may be effective in treating Noonan syndrome.
Answer: YES"
14111,33452.0,Alitretinoin,granulomatous slack skin disease,disease-phenotype-protein-drug,contraindication,"['granulomatous slack skin disease', 'Erythema', 'ALDH2', 'Alitretinoin']",1.0,"Question: Is granulomatous slack skin disease an indication for Alitretinoin?
Reasoning: The disease granulomatous slack skin disease is associated with the phenotype Erythema, which in turn affects the gene ALDH2. This gene is not targeted by the drug Alitretinoin. These connections suggest that Alitretinoin may not be effective in treating granulomatous slack skin disease.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'COL5A1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene COL5A1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
16825,35849.0,Ardeparin,disseminated intravascular coagulation,disease-protein-drug,indication,"['disseminated intravascular coagulation', 'SERPINC1', 'Ardeparin']",0.5,"Question: Is disseminated intravascular coagulation an indication for Ardeparin?
Reasoning: The disease disseminated intravascular coagulation is associated with the gene SERPINC1, which is targeted by the drug Ardeparin. These connections suggest that Ardeparin may be effective in treating disseminated intravascular coagulation.
Answer: YES"
14713,38274.0,Decitabine,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'DNMT3A', 'Decitabine']",0.5,"Question: Is inherited acute myeloid leukemia an indication for Decitabine?
Reasoning: The disease inherited acute myeloid leukemia is associated with the gene DNMT3A, which is targeted by the drug Decitabine. These connections suggest that Decitabine may be effective in treating inherited acute myeloid leukemia.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'COCH', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene COCH. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16056,28974.0,Procyclidine,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'CHRM4', 'Procyclidine']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Procyclidine?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the phenotype Resting tremor, which in turn affects the gene CHRM4. This gene is targeted by the drug Procyclidine. These connections suggest that Procyclidine may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'NBEA', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene NBEA. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14956,33352.0,Carbamazepine,glossopharyngeal neuralgia,disease-phenotype-protein-drug,indication,"['glossopharyngeal neuralgia', 'Seizure', 'ABCC2', 'Carbamazepine']",0.5,"Question: Is glossopharyngeal neuralgia an indication for Carbamazepine?
Reasoning: The disease glossopharyngeal neuralgia is associated with the phenotype Seizure, which in turn affects the gene ABCC2. This gene is targeted by the drug Carbamazepine. These connections suggest that Carbamazepine may be effective in treating glossopharyngeal neuralgia.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'CLDN14', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene CLDN14. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PIGP', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene PIGP. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'HLA-DRB5', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene HLA-DRB5. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14194,83769.0,Methotrexate,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Methotrexate']",0.5,"Question: Is precursor T-cell acute lymphoblastic leukemia an indication for Methotrexate?
Reasoning: The disease precursor T-cell acute lymphoblastic leukemia is associated with the gene ABCG2, which is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating precursor T-cell acute lymphoblastic leukemia.
Answer: YES"
14207,84304.0,Imatinib,chronic eosinophilic leukemia,disease-protein-drug,indication,"['chronic eosinophilic leukemia', 'PDGFRA', 'Imatinib']",0.5,"Question: Is chronic eosinophilic leukemia an indication for Imatinib?
Reasoning: The disease chronic eosinophilic leukemia is associated with the gene PDGFRA, which is targeted by the drug Imatinib. These connections suggest that Imatinib may be effective in treating chronic eosinophilic leukemia.
Answer: YES"
14387,31630.0,Methyltestosterone,androgen insensitivity syndrome,disease-protein-drug,indication,"['androgen insensitivity syndrome', 'AR', 'Methyltestosterone']",0.5,"Question: Is androgen insensitivity syndrome an indication for Methyltestosterone?
Reasoning: The disease androgen insensitivity syndrome is associated with the gene AR, which is targeted by the drug Methyltestosterone. These connections suggest that Methyltestosterone may be effective in treating androgen insensitivity syndrome.
Answer: YES"
14308,36035.0,Carvedilol,hypertension,disease-protein-drug,indication,"['hypertension', 'VEGFA', 'Carvedilol']",0.5,"Question: Is hypertension an indication for Carvedilol?
Reasoning: The disease hypertension is associated with the gene VEGFA, which is targeted by the drug Carvedilol. These connections suggest that Carvedilol may be effective in treating hypertension.
Answer: YES"
14028,37770.0,Hydrocortisone,contact dermatitis,disease-protein-drug,indication,"['contact dermatitis', 'CYP1B1', 'Hydrocortisone']",0.5,"Question: Is contact dermatitis an indication for Hydrocortisone?
Reasoning: The disease contact dermatitis is associated with the gene CYP1B1, which is targeted by the drug Hydrocortisone. These connections suggest that Hydrocortisone may be effective in treating contact dermatitis.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'TAC1', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene TAC1. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'USH1G', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene USH1G. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'OPRK1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene OPRK1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14111,33452.0,Alitretinoin,granulomatous slack skin disease,disease-phenotype-protein-drug,contraindication,"['granulomatous slack skin disease', 'Erythema', 'ACSL4', 'Alitretinoin']",1.0,"Question: Is granulomatous slack skin disease an indication for Alitretinoin?
Reasoning: The disease granulomatous slack skin disease is associated with the phenotype Erythema, which in turn affects the gene ACSL4. This gene is not targeted by the drug Alitretinoin. These connections suggest that Alitretinoin may not be effective in treating granulomatous slack skin disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'CYP1A1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14999,28249.0,Quetiapine,major affective disorder,disease-protein-drug,indication,"['major affective disorder', 'DRD5', 'Quetiapine']",0.5,"Question: Is major affective disorder an indication for Quetiapine?
Reasoning: The disease major affective disorder is associated with the gene DRD5, which is targeted by the drug Quetiapine. These connections suggest that Quetiapine may be effective in treating major affective disorder.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ZNF292', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ZNF292. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14184,37805.0,Ritonavir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Ritonavir']",0.5,"Question: Is HIV infectious disease an indication for Ritonavir?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Ritonavir. These connections suggest that Ritonavir may be effective in treating HIV infectious disease.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Postural tremor', 'ACHE', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Postural tremor, which in turn affects the gene ACHE. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14938,36035.0,Reserpine,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Reserpine']",0.5,"Question: Is hypertension an indication for Reserpine?
Reasoning: The disease hypertension is associated with the gene CYP3A5, which is targeted by the drug Reserpine. These connections suggest that Reserpine may be effective in treating hypertension.
Answer: YES"
15020,28640.0,Axitinib,nonpapillary renal cell carcinoma,disease-protein-drug,indication,"['nonpapillary renal cell carcinoma', 'FLT4', 'Axitinib']",0.5,"Question: Is nonpapillary renal cell carcinoma an indication for Axitinib?
Reasoning: The disease nonpapillary renal cell carcinoma is associated with the gene FLT4, which is targeted by the drug Axitinib. These connections suggest that Axitinib may be effective in treating nonpapillary renal cell carcinoma.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'RALA', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene RALA. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'RHOBTB2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene RHOBTB2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15596,36937.0,Cabozantinib,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'MET', 'Cabozantinib']",0.5,"Question: Is clear cell renal carcinoma an indication for Cabozantinib?
Reasoning: The disease clear cell renal carcinoma is associated with the gene MET, which is targeted by the drug Cabozantinib. These connections suggest that Cabozantinib may be effective in treating clear cell renal carcinoma.
Answer: YES"
16825,39484.0,Ardeparin,purpura fulminans,disease-protein-drug,indication,"['purpura fulminans', 'SERPINC1', 'Ardeparin']",0.5,"Question: Is purpura fulminans an indication for Ardeparin?
Reasoning: The disease purpura fulminans is associated with the gene SERPINC1, which is targeted by the drug Ardeparin. These connections suggest that Ardeparin may be effective in treating purpura fulminans.
Answer: YES"
14275,37967.0,Doxorubicin,ovarian endometrioid adenocarcinoma,disease-protein-drug,indication,"['ovarian endometrioid adenocarcinoma', 'CYP1B1', 'Doxorubicin']",0.5,"Question: Is ovarian endometrioid adenocarcinoma an indication for Doxorubicin?
Reasoning: The disease ovarian endometrioid adenocarcinoma is associated with the gene CYP1B1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating ovarian endometrioid adenocarcinoma.
Answer: YES"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'SIRT1', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene SIRT1. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
14792,83817.0,Paclitaxel,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary site-specific ovarian cancer syndrome', 'CYP1B1', 'Paclitaxel']",0.5,"Question: Is hereditary site-specific ovarian cancer syndrome an indication for Paclitaxel?
Reasoning: The disease hereditary site-specific ovarian cancer syndrome is associated with the gene CYP1B1, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating hereditary site-specific ovarian cancer syndrome.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'BDKRB1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene BDKRB1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14380,28313.0,Asenapine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'HTR5A', 'Asenapine']",0.5,"Question: Is schizophrenia an indication for Asenapine?
Reasoning: The disease schizophrenia is associated with the gene HTR5A, which is targeted by the drug Asenapine. These connections suggest that Asenapine may be effective in treating schizophrenia.
Answer: YES"
14955,33188.0,Vincristine,neuroblastoma,disease-protein-drug,indication,"['neuroblastoma', 'ABCB1', 'Vincristine']",0.5,"Question: Is neuroblastoma an indication for Vincristine?
Reasoning: The disease neuroblastoma is associated with the gene ABCB1, which is targeted by the drug Vincristine. These connections suggest that Vincristine may be effective in treating neuroblastoma.
Answer: YES"
15101,29078.0,Celecoxib,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Celecoxib']",0.5,"Question: Is rheumatoid arthritis an indication for Celecoxib?
Reasoning: The disease rheumatoid arthritis is associated with the gene ABCB1, which is targeted by the drug Celecoxib. These connections suggest that Celecoxib may be effective in treating rheumatoid arthritis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'UGP2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene UGP2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'CRISP3', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene CRISP3. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14192,35641.0,Lamotrigine,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GABRG2', 'Lamotrigine']",0.5,"Question: Is epilepsy an indication for Lamotrigine?
Reasoning: The disease epilepsy is associated with the gene GABRG2, which is targeted by the drug Lamotrigine. These connections suggest that Lamotrigine may be effective in treating epilepsy.
Answer: YES"
14232,36091.0,Olopatadine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'ALB', 'Olopatadine']",0.5,"Question: Is atopic conjunctivitis an indication for Olopatadine?
Reasoning: The disease atopic conjunctivitis is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is targeted by the drug Olopatadine. These connections suggest that Olopatadine may be effective in treating atopic conjunctivitis.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'TRIM37', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene TRIM37. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Generalized hypotonia', 'FCSK', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Generalized hypotonia, which in turn affects the gene FCSK. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
14238,28017.0,Naproxen,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Naproxen']",0.5,"Question: Is migraine with or without aura, susceptibility to an indication for Naproxen?
Reasoning: The disease migraine with or without aura, susceptibility to is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Naproxen. These connections suggest that Naproxen may be effective in treating migraine with or without aura, susceptibility to.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'IL1B', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene IL1B. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'TSFM', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene TSFM. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'TNR', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene TNR. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'PPARA', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene PPARA. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'IKZF5', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene IKZF5. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'AGT', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene AGT. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15012,36937.0,Temsirolimus,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'MTOR', 'Temsirolimus']",0.5,"Question: Is clear cell renal carcinoma an indication for Temsirolimus?
Reasoning: The disease clear cell renal carcinoma is associated with the gene MTOR, which is targeted by the drug Temsirolimus. These connections suggest that Temsirolimus may be effective in treating clear cell renal carcinoma.
Answer: YES"
15138,33241.0,Selegiline,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'CYP2D6', 'Selegiline']",0.5,"Question: Is hereditary late onset Parkinson disease an indication for Selegiline?
Reasoning: The disease hereditary late onset Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Selegiline. These connections suggest that Selegiline may be effective in treating hereditary late onset Parkinson disease.
Answer: YES"
14208,39202.0,Testosterone,non-acquired combined pituitary hormone deficiency,disease-protein-drug,indication,"['non-acquired combined pituitary hormone deficiency', 'CYP19A1', 'Testosterone']",0.5,"Question: Is non-acquired combined pituitary hormone deficiency an indication for Testosterone?
Reasoning: The disease non-acquired combined pituitary hormone deficiency is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating non-acquired combined pituitary hormone deficiency.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'NR1I2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene NR1I2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SST', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SST. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Delayed puberty', 'IGFALS', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Delayed puberty, which in turn affects the gene IGFALS. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'TMIE', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene TMIE. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CUX2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CUX2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15291,30093.0,Ropinirole,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'DRD2', 'Ropinirole']",0.5,"Question: Is parkinsonian-pyramidal syndrome an indication for Ropinirole?
Reasoning: The disease parkinsonian-pyramidal syndrome is associated with the gene DRD2, which is targeted by the drug Ropinirole. These connections suggest that Ropinirole may be effective in treating parkinsonian-pyramidal syndrome.
Answer: YES"
14325,28899.0,Clomipramine,obsessive-compulsive disorder,disease-protein-drug,indication,"['obsessive-compulsive disorder', 'HTR2A', 'Clomipramine']",0.5,"Question: Is obsessive-compulsive disorder an indication for Clomipramine?
Reasoning: The disease obsessive-compulsive disorder is associated with the gene HTR2A, which is targeted by the drug Clomipramine. These connections suggest that Clomipramine may be effective in treating obsessive-compulsive disorder.
Answer: YES"
15989,29078.0,Tiaprofenic acid,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Tiaprofenic acid']",0.5,"Question: Is rheumatoid arthritis an indication for Tiaprofenic acid?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Tiaprofenic acid. These connections suggest that Tiaprofenic acid may be effective in treating rheumatoid arthritis.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'LNPK', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene LNPK. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15018,83858.0,Midostaurin,acute myeloid leukemia with t(6;9)(p23;q34),disease-protein-drug,indication,"['acute myeloid leukemia with t(6;9)(p23;q34)', 'KIT', 'Midostaurin']",0.5,"Question: Is acute myeloid leukemia with t(6;9)(p23;q34) an indication for Midostaurin?
Reasoning: The disease acute myeloid leukemia with t(6;9)(p23;q34) is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating acute myeloid leukemia with t(6;9)(p23;q34).
Answer: YES"
14336,37888.0,Ephedrine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Ephedrine']",0.5,"Question: Is allergic rhinitis an indication for Ephedrine?
Reasoning: The disease allergic rhinitis is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is targeted by the drug Ephedrine. These connections suggest that Ephedrine may be effective in treating allergic rhinitis.
Answer: YES"
16344,84087.0,Ferrous gluconate,iron deficiency anemia,disease-protein-drug,indication,"['iron deficiency anemia', 'TFRC', 'Ferrous gluconate']",0.5,"Question: Is iron deficiency anemia an indication for Ferrous gluconate?
Reasoning: The disease iron deficiency anemia is associated with the gene TFRC, which is targeted by the drug Ferrous gluconate. These connections suggest that Ferrous gluconate may be effective in treating iron deficiency anemia.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'AKR7A3', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene AKR7A3. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CHRNA7', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CHRNA7. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'AHR', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene AHR. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Short stature', 'SLC2A2', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Short stature, which in turn affects the gene SLC2A2. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'POMC', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene POMC. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14170,37144.0,Trifluridine,squamous cell carcinoma of colon,disease-protein-drug,indication,"['squamous cell carcinoma of colon', 'TYMP', 'Trifluridine']",0.5,"Question: Is squamous cell carcinoma of colon an indication for Trifluridine?
Reasoning: The disease squamous cell carcinoma of colon is associated with the gene TYMP, which is targeted by the drug Trifluridine. These connections suggest that Trifluridine may be effective in treating squamous cell carcinoma of colon.
Answer: YES"
14184,37743.0,Ritonavir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Ritonavir']",0.5,"Question: Is hepatitis C virus infection an indication for Ritonavir?
Reasoning: The disease hepatitis C virus infection is associated with the gene CYP3A4, which is targeted by the drug Ritonavir. These connections suggest that Ritonavir may be effective in treating hepatitis C virus infection.
Answer: YES"
15887,39524.0,Certolizumab pegol,psoriatic arthritis,disease-protein-drug,indication,"['psoriatic arthritis', 'TNF', 'Certolizumab pegol']",0.5,"Question: Is psoriatic arthritis an indication for Certolizumab pegol?
Reasoning: The disease psoriatic arthritis is associated with the gene TNF, which is targeted by the drug Certolizumab pegol. These connections suggest that Certolizumab pegol may be effective in treating psoriatic arthritis.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'CD82', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene CD82. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14282,36035.0,Irbesartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Irbesartan']",0.5,"Question: Is hypertension an indication for Irbesartan?
Reasoning: The disease hypertension is associated with the gene AGTR1, which is targeted by the drug Irbesartan. These connections suggest that Irbesartan may be effective in treating hypertension.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'TSC2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene TSC2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ABCC2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene ABCC2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SLC8A3', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene SLC8A3. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14275,36527.0,Doxorubicin,yolk sac tumor,disease-protein-drug,indication,"['yolk sac tumor', 'CYP1B1', 'Doxorubicin']",0.5,"Question: Is yolk sac tumor an indication for Doxorubicin?
Reasoning: The disease yolk sac tumor is associated with the gene CYP1B1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating yolk sac tumor.
Answer: YES"
18036,33575.0,Bacitracin,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'SOD2', 'Bacitracin']",1.0,"Question: Is diabetes mellitus (disease) an indication for Bacitracin?
Reasoning: The disease diabetes mellitus (disease) is associated with the phenotype Maternal diabetes, which in turn affects the gene SOD2. This gene is not targeted by the drug Bacitracin. These connections suggest that Bacitracin may not be effective in treating diabetes mellitus (disease).
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'FCSK', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene FCSK. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ZMIZ1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene ZMIZ1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'MED12L', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene MED12L. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'ADRB2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Action tremor, which in turn affects the gene ADRB2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14560,33626.0,Ergocalciferol,rickets (disease),disease-protein-drug,indication,"['rickets (disease)', 'VDR', 'Ergocalciferol']",0.5,"Question: Is rickets (disease) an indication for Ergocalciferol?
Reasoning: The disease rickets (disease) is associated with the gene VDR, which is targeted by the drug Ergocalciferol. These connections suggest that Ergocalciferol may be effective in treating rickets (disease).
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'TGFBR1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene TGFBR1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'HBB', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene HBB. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14955,30654.0,Vincristine,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Vincristine']",0.5,"Question: Is acute lymphoblastic/lymphocytic leukemia an indication for Vincristine?
Reasoning: The disease acute lymphoblastic/lymphocytic leukemia is associated with the gene ABCG2, which is targeted by the drug Vincristine. These connections suggest that Vincristine may be effective in treating acute lymphoblastic/lymphocytic leukemia.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'ITGB6', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene ITGB6. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14144,29865.0,Topiramate,Lennox-Gastaut syndrome,disease-phenotype-protein-drug,indication,"['Lennox-Gastaut syndrome', 'Mental deterioration', 'CACNA1C', 'Topiramate']",0.5,"Question: Is Lennox-Gastaut syndrome an indication for Topiramate?
Reasoning: The disease Lennox-Gastaut syndrome is associated with the phenotype Mental deterioration, which in turn affects the gene CACNA1C. This gene is targeted by the drug Topiramate. These connections suggest that Topiramate may be effective in treating Lennox-Gastaut syndrome.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SNX27', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene SNX27. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'SMC1A', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene SMC1A. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CHRNA4', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CHRNA4. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15185,32740.0,Tetrabenazine,Huntington disease-like syndrome due to C9ORF72 expansions,disease-phenotype-protein-drug,indication,"['Huntington disease-like syndrome due to C9ORF72 expansions', 'Rigidity', 'CYP2D6', 'Tetrabenazine']",0.5,"Question: Is Huntington disease-like syndrome due to C9ORF72 expansions an indication for Tetrabenazine?
Reasoning: The disease Huntington disease-like syndrome due to C9ORF72 expansions is associated with the phenotype Rigidity, which in turn affects the gene CYP2D6. This gene is targeted by the drug Tetrabenazine. These connections suggest that Tetrabenazine may be effective in treating Huntington disease-like syndrome due to C9ORF72 expansions.
Answer: YES"
15222,27933.0,Levomilnacipran,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Levomilnacipran']",0.5,"Question: Is anxiety disorder an indication for Levomilnacipran?
Reasoning: The disease anxiety disorder is associated with the gene ABCB1, which is targeted by the drug Levomilnacipran. These connections suggest that Levomilnacipran may be effective in treating anxiety disorder.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'POU3F4', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene POU3F4. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14320,83789.0,Dexamethasone,serum sickness,disease-protein-drug,indication,"['serum sickness', 'ALB', 'Dexamethasone']",0.5,"Question: Is serum sickness an indication for Dexamethasone?
Reasoning: The disease serum sickness is associated with the gene ALB, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating serum sickness.
Answer: YES"
17174,28780.0,Rivastigmine,Alzheimer disease,disease-protein-drug,indication,"['Alzheimer disease', 'BCHE', 'Rivastigmine']",0.5,"Question: Is Alzheimer disease an indication for Rivastigmine?
Reasoning: The disease Alzheimer disease is associated with the gene BCHE, which is targeted by the drug Rivastigmine. These connections suggest that Rivastigmine may be effective in treating Alzheimer disease.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'DIABLO', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene DIABLO. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14163,33618.0,Diltiazem,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'CYP2C19', 'Diltiazem']",0.5,"Question: Is atrial fibrillation (disease) an indication for Diltiazem?
Reasoning: The disease atrial fibrillation (disease) is associated with the gene CYP2C19, which is targeted by the drug Diltiazem. These connections suggest that Diltiazem may be effective in treating atrial fibrillation (disease).
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'PACS2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene PACS2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'TFRC', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene TFRC. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14208,83766.0,Testosterone,short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,disease-protein-drug,indication,"['short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia', 'CYP19A1', 'Testosterone']",0.5,"Question: Is short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia an indication for Testosterone?
Reasoning: The disease short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia.
Answer: YES"
14787,35963.0,Flutamide,prostate carcinoma,disease-protein-drug,indication,"['prostate carcinoma', 'CYP2C19', 'Flutamide']",0.5,"Question: Is prostate carcinoma an indication for Flutamide?
Reasoning: The disease prostate carcinoma is associated with the gene CYP2C19, which is targeted by the drug Flutamide. These connections suggest that Flutamide may be effective in treating prostate carcinoma.
Answer: YES"
14227,29078.0,Etodolac,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Etodolac']",0.5,"Question: Is rheumatoid arthritis an indication for Etodolac?
Reasoning: The disease rheumatoid arthritis is associated with the gene PTGS1, which is targeted by the drug Etodolac. These connections suggest that Etodolac may be effective in treating rheumatoid arthritis.
Answer: YES"
14320,84160.0,Dexamethasone,primary mediastinal large B-cell lymphoma,disease-protein-drug,indication,"['primary mediastinal large B-cell lymphoma', 'ABCB1', 'Dexamethasone']",0.5,"Question: Is primary mediastinal large B-cell lymphoma an indication for Dexamethasone?
Reasoning: The disease primary mediastinal large B-cell lymphoma is associated with the gene ABCB1, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating primary mediastinal large B-cell lymphoma.
Answer: YES"
15987,29078.0,Choline magnesium trisalicylate,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Choline magnesium trisalicylate']",0.5,"Question: Is rheumatoid arthritis an indication for Choline magnesium trisalicylate?
Reasoning: The disease rheumatoid arthritis is associated with the gene PTGS1, which is targeted by the drug Choline magnesium trisalicylate. These connections suggest that Choline magnesium trisalicylate may be effective in treating rheumatoid arthritis.
Answer: YES"
14999,30318.0,Quetiapine,autosomal recessive severe congenital neutropenia due to JAGN1 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to JAGN1 deficiency', 'Short stature', 'IGFALS', 'Quetiapine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to JAGN1 deficiency an indication for Quetiapine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to JAGN1 deficiency is associated with the phenotype Short stature, which in turn affects the gene IGFALS. This gene is not targeted by the drug Quetiapine. These connections suggest that Quetiapine may not be effective in treating autosomal recessive severe congenital neutropenia due to JAGN1 deficiency.
Answer: NO"
15173,27921.0,Dextroamphetamine,attention deficit-hyperactivity disorder,disease-protein-drug,indication,"['attention deficit-hyperactivity disorder', 'SLC6A3', 'Dextroamphetamine']",0.5,"Question: Is attention deficit-hyperactivity disorder an indication for Dextroamphetamine?
Reasoning: The disease attention deficit-hyperactivity disorder is associated with the gene SLC6A3, which is targeted by the drug Dextroamphetamine. These connections suggest that Dextroamphetamine may be effective in treating attention deficit-hyperactivity disorder.
Answer: YES"
14275,35771.0,Doxorubicin,breast neoplasm,disease-protein-drug,indication,"['breast neoplasm', 'ABCB1', 'Doxorubicin']",0.5,"Question: Is breast neoplasm an indication for Doxorubicin?
Reasoning: The disease breast neoplasm is associated with the gene ABCB1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating breast neoplasm.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'IL11', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene IL11. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14707,36315.0,Ferrous sulfate anhydrous,deficiency anemia,disease-protein-drug,indication,"['deficiency anemia', 'TFRC', 'Ferrous sulfate anhydrous']",0.5,"Question: Is deficiency anemia an indication for Ferrous sulfate anhydrous?
Reasoning: The disease deficiency anemia is associated with the gene TFRC, which is targeted by the drug Ferrous sulfate anhydrous. These connections suggest that Ferrous sulfate anhydrous may be effective in treating deficiency anemia.
Answer: YES"
15122,37888.0,Tripelennamine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Tripelennamine']",0.5,"Question: Is allergic rhinitis an indication for Tripelennamine?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Tripelennamine. These connections suggest that Tripelennamine may be effective in treating allergic rhinitis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'DSCAM', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene DSCAM. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'IL6', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene IL6. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'KCNA2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene KCNA2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14275,31116.0,Doxorubicin,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Doxorubicin']",0.5,"Question: Is lung cancer an indication for Doxorubicin?
Reasoning: The disease lung cancer is associated with the gene ABCB1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating lung cancer.
Answer: YES"
14060,32622.0,Levothyroxine,thyroid gland undifferentiated (anaplastic) carcinoma,disease-phenotype-protein-drug,indication,"['thyroid gland undifferentiated (anaplastic) carcinoma', 'Pain', 'ALB', 'Levothyroxine']",0.5,"Question: Is thyroid gland undifferentiated (anaplastic) carcinoma an indication for Levothyroxine?
Reasoning: The disease thyroid gland undifferentiated (anaplastic) carcinoma is associated with the phenotype Pain, which in turn affects the gene ALB. This gene is targeted by the drug Levothyroxine. These connections suggest that Levothyroxine may be effective in treating thyroid gland undifferentiated (anaplastic) carcinoma.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'CABCOCO1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene CABCOCO1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
17583,30800.0,Etanercept,juvenile arthritis due to defect in LACC1,disease-protein-drug,indication,"['juvenile arthritis due to defect in LACC1', 'FCGR1A', 'Etanercept']",0.5,"Question: Is juvenile arthritis due to defect in LACC1 an indication for Etanercept?
Reasoning: The disease juvenile arthritis due to defect in LACC1 is associated with the gene FCGR1A, which is targeted by the drug Etanercept. These connections suggest that Etanercept may be effective in treating juvenile arthritis due to defect in LACC1.
Answer: YES"
15424,84023.0,Cabergoline,acquired hyperprolactinemia,disease-protein-drug,indication,"['acquired hyperprolactinemia', 'DRD2', 'Cabergoline']",0.5,"Question: Is acquired hyperprolactinemia an indication for Cabergoline?
Reasoning: The disease acquired hyperprolactinemia is associated with the gene DRD2, which is targeted by the drug Cabergoline. These connections suggest that Cabergoline may be effective in treating acquired hyperprolactinemia.
Answer: YES"
14600,32325.0,Rofecoxib,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'CYP1A2', 'Rofecoxib']",0.5,"Question: Is juvenile idiopathic arthritis an indication for Rofecoxib?
Reasoning: The disease juvenile idiopathic arthritis is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Rofecoxib. These connections suggest that Rofecoxib may be effective in treating juvenile idiopathic arthritis.
Answer: YES"
14792,37334.0,Paclitaxel,breast carcinoma,disease-protein-drug,indication,"['breast carcinoma', 'ABCB1', 'Paclitaxel']",0.5,"Question: Is breast carcinoma an indication for Paclitaxel?
Reasoning: The disease breast carcinoma is associated with the gene ABCB1, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating breast carcinoma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'MARVELD2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene MARVELD2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ACHE', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene ACHE. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14960,37888.0,Astemizole,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Astemizole']",0.5,"Question: Is allergic rhinitis an indication for Astemizole?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Astemizole. These connections suggest that Astemizole may be effective in treating allergic rhinitis.
Answer: YES"
14962,38957.0,Trazodone,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Trazodone']",0.5,"Question: Is major depressive disorder an indication for Trazodone?
Reasoning: The disease major depressive disorder is associated with the gene SLC6A4, which is targeted by the drug Trazodone. These connections suggest that Trazodone may be effective in treating major depressive disorder.
Answer: YES"
15112,32778.0,Dextropropoxyphene,familial visceral myopathy,disease-phenotype-protein-drug,contraindication,"['familial visceral myopathy', 'Aganglionic megacolon', 'SLC8A1', 'Dextropropoxyphene']",1.0,"Question: Is familial visceral myopathy an indication for Dextropropoxyphene?
Reasoning: The disease familial visceral myopathy is associated with the phenotype Aganglionic megacolon, which in turn affects the gene SLC8A1. This gene is not targeted by the drug Dextropropoxyphene. These connections suggest that Dextropropoxyphene may not be effective in treating familial visceral myopathy.
Answer: NO"
14731,36035.0,Mibefradil,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Mibefradil']",0.5,"Question: Is hypertension an indication for Mibefradil?
Reasoning: The disease hypertension is associated with the gene CYP3A5, which is targeted by the drug Mibefradil. These connections suggest that Mibefradil may be effective in treating hypertension.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'GJB6', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene GJB6. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14111,33452.0,Alitretinoin,granulomatous slack skin disease,disease-phenotype-protein-drug,contraindication,"['granulomatous slack skin disease', 'Erythema', 'OXT', 'Alitretinoin']",1.0,"Question: Is granulomatous slack skin disease an indication for Alitretinoin?
Reasoning: The disease granulomatous slack skin disease is associated with the phenotype Erythema, which in turn affects the gene OXT. This gene is not targeted by the drug Alitretinoin. These connections suggest that Alitretinoin may not be effective in treating granulomatous slack skin disease.
Answer: NO"
15122,83791.0,Tripelennamine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Tripelennamine']",0.5,"Question: Is vasomotor rhinitis an indication for Tripelennamine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Tripelennamine. These connections suggest that Tripelennamine may be effective in treating vasomotor rhinitis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SYN2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SYN2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14275,37150.0,Doxorubicin,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'CYP1B1', 'Doxorubicin']",0.5,"Question: Is malignant non-dysgerminomatous germ cell tumor of ovary an indication for Doxorubicin?
Reasoning: The disease malignant non-dysgerminomatous germ cell tumor of ovary is associated with the gene CYP1B1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating malignant non-dysgerminomatous germ cell tumor of ovary.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'DPM2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene DPM2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14220,33241.0,Apomorphine,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'DRD1', 'Apomorphine']",0.5,"Question: Is hereditary late onset Parkinson disease an indication for Apomorphine?
Reasoning: The disease hereditary late onset Parkinson disease is associated with the gene DRD1, which is targeted by the drug Apomorphine. These connections suggest that Apomorphine may be effective in treating hereditary late onset Parkinson disease.
Answer: YES"
15882,27366.0,Acemetacin,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Acemetacin']",0.5,"Question: Is spondyloarthropathy, susceptibility to an indication for Acemetacin?
Reasoning: The disease spondyloarthropathy, susceptibility to is associated with the phenotype Arrhythmia, which in turn affects the gene PTGS2. This gene is targeted by the drug Acemetacin. These connections suggest that Acemetacin may be effective in treating spondyloarthropathy, susceptibility to.
Answer: YES"
14731,33577.0,Mibefradil,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Mibefradil']",0.5,"Question: Is hypertensive disorder an indication for Mibefradil?
Reasoning: The disease hypertensive disorder is associated with the gene CYP3A5, which is targeted by the drug Mibefradil. These connections suggest that Mibefradil may be effective in treating hypertensive disorder.
Answer: YES"
14721,33593.0,Orlistat,obesity disorder,disease-protein-drug,indication,"['obesity disorder', 'FASN', 'Orlistat']",0.5,"Question: Is obesity disorder an indication for Orlistat?
Reasoning: The disease obesity disorder is associated with the gene FASN, which is targeted by the drug Orlistat. These connections suggest that Orlistat may be effective in treating obesity disorder.
Answer: YES"
14904,28974.0,Safinamide,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'MAOB', 'Safinamide']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Safinamide?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the gene MAOB, which is targeted by the drug Safinamide. These connections suggest that Safinamide may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
17112,29352.0,Filgrastim,cyclic hematopoiesis,disease-protein-drug,indication,"['cyclic hematopoiesis', 'ELANE', 'Filgrastim']",0.5,"Question: Is cyclic hematopoiesis an indication for Filgrastim?
Reasoning: The disease cyclic hematopoiesis is associated with the gene ELANE, which is targeted by the drug Filgrastim. These connections suggest that Filgrastim may be effective in treating cyclic hematopoiesis.
Answer: YES"
14269,31511.0,Methylprednisolone,autoimmune thrombocytopenic,disease-phenotype-protein-drug,indication,"['autoimmune thrombocytopenic', 'Thrombocytopenia', 'ALB', 'Methylprednisolone']",0.5,"Question: Is autoimmune thrombocytopenic an indication for Methylprednisolone?
Reasoning: The disease autoimmune thrombocytopenic is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Methylprednisolone. These connections suggest that Methylprednisolone may be effective in treating autoimmune thrombocytopenic.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hypocalcemia', 'PTH', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hypocalcemia, which in turn affects the gene PTH. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'INS', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene INS. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'BDNF', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene BDNF. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14934,29078.0,Cyclosporine,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Cyclosporine']",0.5,"Question: Is rheumatoid arthritis an indication for Cyclosporine?
Reasoning: The disease rheumatoid arthritis is associated with the gene ABCB1, which is targeted by the drug Cyclosporine. These connections suggest that Cyclosporine may be effective in treating rheumatoid arthritis.
Answer: YES"
15914,33193.0,Minocycline,plague,disease-phenotype-protein-drug,indication,"['plague', 'Hepatomegaly', 'MAPK14', 'Minocycline']",0.5,"Question: Is plague an indication for Minocycline?
Reasoning: The disease plague is associated with the phenotype Hepatomegaly, which in turn affects the gene MAPK14. This gene is targeted by the drug Minocycline. These connections suggest that Minocycline may be effective in treating plague.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ADORA2A', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ADORA2A. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'TMC1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene TMC1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15036,32617.0,Olaparib,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Olaparib']",0.5,"Question: Is hereditary breast ovarian cancer syndrome an indication for Olaparib?
Reasoning: The disease hereditary breast ovarian cancer syndrome is associated with the gene ABCB1, which is targeted by the drug Olaparib. These connections suggest that Olaparib may be effective in treating hereditary breast ovarian cancer syndrome.
Answer: YES"
14288,32228.0,Benzylpenicillin,foodborne botulism,disease-phenotype-protein-drug,indication,"['foodborne botulism', 'Arrhythmia', 'SLC22A5', 'Benzylpenicillin']",0.5,"Question: Is foodborne botulism an indication for Benzylpenicillin?
Reasoning: The disease foodborne botulism is associated with the phenotype Arrhythmia, which in turn affects the gene SLC22A5. This gene is targeted by the drug Benzylpenicillin. These connections suggest that Benzylpenicillin may be effective in treating foodborne botulism.
Answer: YES"
14153,83763.0,Valproic acid,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'SCN2A', 'Valproic acid']",0.5,"Question: Is manic bipolar affective disorder an indication for Valproic acid?
Reasoning: The disease manic bipolar affective disorder is associated with the gene SCN2A, which is targeted by the drug Valproic acid. These connections suggest that Valproic acid may be effective in treating manic bipolar affective disorder.
Answer: YES"
15416,32456.0,Lorazepam,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'GABRA5', 'Lorazepam']",0.5,"Question: Is cutis verticis gyrata an indication for Lorazepam?
Reasoning: The disease cutis verticis gyrata is associated with the phenotype Seizure, which in turn affects the gene GABRA5. This gene is targeted by the drug Lorazepam. These connections suggest that Lorazepam may be effective in treating cutis verticis gyrata.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'VAMP2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene VAMP2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14296,37805.0,Atazanavir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Atazanavir']",0.5,"Question: Is HIV infectious disease an indication for Atazanavir?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Atazanavir. These connections suggest that Atazanavir may be effective in treating HIV infectious disease.
Answer: YES"
14024,30813.0,Prednisone,Addison disease,disease-phenotype-protein-drug,indication,"['Addison disease', 'Vomiting', 'ABCB1', 'Prednisone']",0.5,"Question: Is Addison disease an indication for Prednisone?
Reasoning: The disease Addison disease is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating Addison disease.
Answer: YES"
14275,83820.0,Doxorubicin,maligant granulosa cell tumor of ovary,disease-protein-drug,indication,"['maligant granulosa cell tumor of ovary', 'CYP1B1', 'Doxorubicin']",0.5,"Question: Is maligant granulosa cell tumor of ovary an indication for Doxorubicin?
Reasoning: The disease maligant granulosa cell tumor of ovary is associated with the gene CYP1B1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating maligant granulosa cell tumor of ovary.
Answer: YES"
20139,32033.0,Doxefazepam,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Doxefazepam']",0.5,"Question: Is insomnia (disease) an indication for Doxefazepam?
Reasoning: The disease insomnia (disease) is associated with the gene GABRB3, which is targeted by the drug Doxefazepam. These connections suggest that Doxefazepam may be effective in treating insomnia (disease).
Answer: YES"
15232,27933.0,Brexpiprazole,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'DRD2', 'Brexpiprazole']",0.5,"Question: Is anxiety disorder an indication for Brexpiprazole?
Reasoning: The disease anxiety disorder is associated with the gene DRD2, which is targeted by the drug Brexpiprazole. These connections suggest that Brexpiprazole may be effective in treating anxiety disorder.
Answer: YES"
14197,36209.0,Fenoprofen,arthropathy,disease-protein-drug,indication,"['arthropathy', 'PPARG', 'Fenoprofen']",0.5,"Question: Is arthropathy an indication for Fenoprofen?
Reasoning: The disease arthropathy is associated with the gene PPARG, which is targeted by the drug Fenoprofen. These connections suggest that Fenoprofen may be effective in treating arthropathy.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Respiratory insufficiency', 'SLC23A1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Respiratory insufficiency, which in turn affects the gene SLC23A1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'MAPT', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene MAPT. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'LEP', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene LEP. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15018,32834.0,Midostaurin,aggressive systemic mastocytosis,disease-phenotype-protein-drug,indication,"['aggressive systemic mastocytosis', 'Hepatomegaly', 'CYP1A2', 'Midostaurin']",0.5,"Question: Is aggressive systemic mastocytosis an indication for Midostaurin?
Reasoning: The disease aggressive systemic mastocytosis is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating aggressive systemic mastocytosis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ADRA1B', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ADRA1B. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'NQO1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene NQO1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GNB1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene GNB1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14200,37659.0,Enalapril,heart failure,disease-protein-drug,indication,"['heart failure', 'ALB', 'Enalapril']",0.5,"Question: Is heart failure an indication for Enalapril?
Reasoning: The disease heart failure is associated with the gene ALB, which is targeted by the drug Enalapril. These connections suggest that Enalapril may be effective in treating heart failure.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SLC30A1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene SLC30A1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14960,83791.0,Astemizole,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Astemizole']",0.5,"Question: Is vasomotor rhinitis an indication for Astemizole?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Astemizole. These connections suggest that Astemizole may be effective in treating vasomotor rhinitis.
Answer: YES"
14319,37805.0,Saquinavir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Saquinavir']",0.5,"Question: Is HIV infectious disease an indication for Saquinavir?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Saquinavir. These connections suggest that Saquinavir may be effective in treating HIV infectious disease.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'TBCK', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene TBCK. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15018,83856.0,Midostaurin,acute myeloid leukemia with CEBPA somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with CEBPA somatic mutations', 'KIT', 'Midostaurin']",0.5,"Question: Is acute myeloid leukemia with CEBPA somatic mutations an indication for Midostaurin?
Reasoning: The disease acute myeloid leukemia with CEBPA somatic mutations is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating acute myeloid leukemia with CEBPA somatic mutations.
Answer: YES"
14320,37888.0,Dexamethasone,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Dexamethasone']",0.5,"Question: Is allergic rhinitis an indication for Dexamethasone?
Reasoning: The disease allergic rhinitis is associated with the gene ALB, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating allergic rhinitis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'MACF1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene MACF1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15001,83779.0,Paliperidone,schizoaffective disorder,disease-protein-drug,indication,"['schizoaffective disorder', 'HTR2A', 'Paliperidone']",0.5,"Question: Is schizoaffective disorder an indication for Paliperidone?
Reasoning: The disease schizoaffective disorder is associated with the gene HTR2A, which is targeted by the drug Paliperidone. These connections suggest that Paliperidone may be effective in treating schizoaffective disorder.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Postural tremor', 'HTR1A', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Postural tremor, which in turn affects the gene HTR1A. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'HSD17B4', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene HSD17B4. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14023,33654.0,Triamcinolone,uveitis,disease-protein-drug,indication,"['uveitis', 'ALB', 'Triamcinolone']",0.5,"Question: Is uveitis an indication for Triamcinolone?
Reasoning: The disease uveitis is associated with the gene ALB, which is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating uveitis.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'NAGA', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene NAGA. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'GSDME', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene GSDME. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1B1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1B1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15739,83857.0,Ivosidenib,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'IDH1', 'Ivosidenib']",0.5,"Question: Is acute myeloid leukemia with t(8;16)(p11;p13) translocation an indication for Ivosidenib?
Reasoning: The disease acute myeloid leukemia with t(8;16)(p11;p13) translocation is associated with the gene IDH1, which is targeted by the drug Ivosidenib. These connections suggest that Ivosidenib may be effective in treating acute myeloid leukemia with t(8;16)(p11;p13) translocation.
Answer: YES"
14023,39821.0,Triamcinolone,keloid,disease-protein-drug,indication,"['keloid', 'ALB', 'Triamcinolone']",0.5,"Question: Is keloid an indication for Triamcinolone?
Reasoning: The disease keloid is associated with the gene ALB, which is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating keloid.
Answer: YES"
14401,37738.0,Vismodegib,basal cell carcinoma,disease-protein-drug,indication,"['basal cell carcinoma', 'SMO', 'Vismodegib']",0.5,"Question: Is basal cell carcinoma an indication for Vismodegib?
Reasoning: The disease basal cell carcinoma is associated with the gene SMO, which is targeted by the drug Vismodegib. These connections suggest that Vismodegib may be effective in treating basal cell carcinoma.
Answer: YES"
14188,32729.0,Ciprofloxacin,botulism,disease-phenotype-protein-drug,indication,"['botulism', 'Arrhythmia', 'KCNH2', 'Ciprofloxacin']",0.5,"Question: Is botulism an indication for Ciprofloxacin?
Reasoning: The disease botulism is associated with the phenotype Arrhythmia, which in turn affects the gene KCNH2. This gene is targeted by the drug Ciprofloxacin. These connections suggest that Ciprofloxacin may be effective in treating botulism.
Answer: YES"
14190,36581.0,Fluorouracil,colonic neoplasm,disease-protein-drug,indication,"['colonic neoplasm', 'TYMP', 'Fluorouracil']",0.5,"Question: Is colonic neoplasm an indication for Fluorouracil?
Reasoning: The disease colonic neoplasm is associated with the gene TYMP, which is targeted by the drug Fluorouracil. These connections suggest that Fluorouracil may be effective in treating colonic neoplasm.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'NOS1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene NOS1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14186,37152.0,Cisplatin,familial ovarian cancer,disease-protein-drug,indication,"['familial ovarian cancer', 'ATP7B', 'Cisplatin']",0.5,"Question: Is familial ovarian cancer an indication for Cisplatin?
Reasoning: The disease familial ovarian cancer is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating familial ovarian cancer.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'CHD7', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene CHD7. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'LNPEP', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene LNPEP. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'PIK3R1', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene PIK3R1. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Ataxia', 'RFC1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Ataxia, which in turn affects the gene RFC1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'GPR155', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene GPR155. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Short stature', 'KDM3B', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Short stature, which in turn affects the gene KDM3B. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14452,28547.0,Istradefylline,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'ADORA2A', 'Istradefylline']",0.5,"Question: Is Parkinson disease an indication for Istradefylline?
Reasoning: The disease Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene ADORA2A. This gene is targeted by the drug Istradefylline. These connections suggest that Istradefylline may be effective in treating Parkinson disease.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'TMTC2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene TMTC2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'GNB1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene GNB1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'AHR', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene AHR. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'SLC33A1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene SLC33A1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'TRRAP', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene TRRAP. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'RSPH4A', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene RSPH4A. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SNX27', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SNX27. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14024,39540.0,Prednisone,angioedema,disease-protein-drug,indication,"['angioedema', 'ALB', 'Prednisone']",0.5,"Question: Is angioedema an indication for Prednisone?
Reasoning: The disease angioedema is associated with the gene ALB, which is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating angioedema.
Answer: YES"
16842,31408.0,Pramipexole,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'HTR1A', 'Pramipexole']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Pramipexole?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the phenotype Resting tremor, which in turn affects the gene HTR1A. This gene is targeted by the drug Pramipexole. These connections suggest that Pramipexole may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
14320,39728.0,Dexamethasone,parapsoriasis,disease-protein-drug,indication,"['parapsoriasis', 'NOS2', 'Dexamethasone']",0.5,"Question: Is parapsoriasis an indication for Dexamethasone?
Reasoning: The disease parapsoriasis is associated with the gene NOS2, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating parapsoriasis.
Answer: YES"
15126,38575.0,Donepezil,cerebellar degeneration,disease-protein-drug,indication,"['cerebellar degeneration', 'BCHE', 'Donepezil']",0.5,"Question: Is cerebellar degeneration an indication for Donepezil?
Reasoning: The disease cerebellar degeneration is associated with the gene BCHE, which is targeted by the drug Donepezil. These connections suggest that Donepezil may be effective in treating cerebellar degeneration.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'NRP1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene NRP1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14320,35650.0,Dexamethasone,non-Hodgkin lymphoma,disease-protein-drug,indication,"['non-Hodgkin lymphoma', 'CYP2E1', 'Dexamethasone']",0.5,"Question: Is non-Hodgkin lymphoma an indication for Dexamethasone?
Reasoning: The disease non-Hodgkin lymphoma is associated with the gene CYP2E1, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating non-Hodgkin lymphoma.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GLUL', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene GLUL. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14207,39498.0,Imatinib,systemic mastocytosis,disease-protein-drug,indication,"['systemic mastocytosis', 'KIT', 'Imatinib']",0.5,"Question: Is systemic mastocytosis an indication for Imatinib?
Reasoning: The disease systemic mastocytosis is associated with the gene KIT, which is targeted by the drug Imatinib. These connections suggest that Imatinib may be effective in treating systemic mastocytosis.
Answer: YES"
14186,83822.0,Cisplatin,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,indication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ATP7B', 'Cisplatin']",0.5,"Question: Is theca steroid-producing cell malignant tumor of ovary, not further specified an indication for Cisplatin?
Reasoning: The disease theca steroid-producing cell malignant tumor of ovary, not further specified is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating theca steroid-producing cell malignant tumor of ovary, not further specified.
Answer: YES"
14208,27741.0,Testosterone,pituitary deficiency due to empty sella turcica syndrome,disease-protein-drug,indication,"['pituitary deficiency due to empty sella turcica syndrome', 'CYP19A1', 'Testosterone']",0.5,"Question: Is pituitary deficiency due to empty sella turcica syndrome an indication for Testosterone?
Reasoning: The disease pituitary deficiency due to empty sella turcica syndrome is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating pituitary deficiency due to empty sella turcica syndrome.
Answer: YES"
15018,83861.0,Midostaurin,acute myeloid leukemia with NPM1 somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with NPM1 somatic mutations', 'KIT', 'Midostaurin']",0.5,"Question: Is acute myeloid leukemia with NPM1 somatic mutations an indication for Midostaurin?
Reasoning: The disease acute myeloid leukemia with NPM1 somatic mutations is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating acute myeloid leukemia with NPM1 somatic mutations.
Answer: YES"
14320,33621.0,Dexamethasone,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'CYP2E1', 'Dexamethasone']",0.5,"Question: Is acute lymphoblastic leukemia (disease) an indication for Dexamethasone?
Reasoning: The disease acute lymphoblastic leukemia (disease) is associated with the gene CYP2E1, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating acute lymphoblastic leukemia (disease).
Answer: YES"
14170,36223.0,Trifluridine,malignant colon neoplasm,disease-protein-drug,indication,"['malignant colon neoplasm', 'TYMP', 'Trifluridine']",0.5,"Question: Is malignant colon neoplasm an indication for Trifluridine?
Reasoning: The disease malignant colon neoplasm is associated with the gene TYMP, which is targeted by the drug Trifluridine. These connections suggest that Trifluridine may be effective in treating malignant colon neoplasm.
Answer: YES"
14420,28313.0,Blonanserin,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Blonanserin']",0.5,"Question: Is schizophrenia an indication for Blonanserin?
Reasoning: The disease schizophrenia is associated with the gene DRD2, which is targeted by the drug Blonanserin. These connections suggest that Blonanserin may be effective in treating schizophrenia.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'TBCD', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene TBCD. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
17545,83862.0,Gemtuzumab ozogamicin,acute myeloblastic leukemia with maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia with maturation', 'CD33', 'Gemtuzumab ozogamicin']",0.5,"Question: Is acute myeloblastic leukemia with maturation an indication for Gemtuzumab ozogamicin?
Reasoning: The disease acute myeloblastic leukemia with maturation is associated with the gene CD33, which is targeted by the drug Gemtuzumab ozogamicin. These connections suggest that Gemtuzumab ozogamicin may be effective in treating acute myeloblastic leukemia with maturation.
Answer: YES"
14320,32384.0,Dexamethasone,adrenal insufficiency,disease-phenotype-protein-drug,indication,"['adrenal insufficiency', 'Hyperkalemia', 'CYP17A1', 'Dexamethasone']",0.5,"Question: Is adrenal insufficiency an indication for Dexamethasone?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hyperkalemia, which in turn affects the gene CYP17A1. This gene is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating adrenal insufficiency.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'FOXG1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene FOXG1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14685,35738.0,Progesterone,endometrial carcinoma (disease),disease-protein-drug,indication,"['endometrial carcinoma (disease)', 'PGR', 'Progesterone']",0.5,"Question: Is endometrial carcinoma (disease) an indication for Progesterone?
Reasoning: The disease endometrial carcinoma (disease) is associated with the gene PGR, which is targeted by the drug Progesterone. These connections suggest that Progesterone may be effective in treating endometrial carcinoma (disease).
Answer: YES"
15045,28714.0,Tezacaftor,cystic fibrosis,disease-protein-drug,indication,"['cystic fibrosis', 'CFTR', 'Tezacaftor']",0.5,"Question: Is cystic fibrosis an indication for Tezacaftor?
Reasoning: The disease cystic fibrosis is associated with the gene CFTR, which is targeted by the drug Tezacaftor. These connections suggest that Tezacaftor may be effective in treating cystic fibrosis.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'VEGFA', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene VEGFA. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14320,83781.0,Dexamethasone,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'HSD11B2', 'Dexamethasone']",0.5,"Question: Is intrinsic asthma an indication for Dexamethasone?
Reasoning: The disease intrinsic asthma is associated with the gene HSD11B2, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating intrinsic asthma.
Answer: YES"
14196,32241.0,Propranolol,laryngotracheal angioma,disease-phenotype-protein-drug,indication,"['laryngotracheal angioma', 'Apnea', 'HTR1A', 'Propranolol']",0.5,"Question: Is laryngotracheal angioma an indication for Propranolol?
Reasoning: The disease laryngotracheal angioma is associated with the phenotype Apnea, which in turn affects the gene HTR1A. This gene is targeted by the drug Propranolol. These connections suggest that Propranolol may be effective in treating laryngotracheal angioma.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CASP1', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CASP1. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'APOE', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene APOE. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15038,37743.0,Daclatasvir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Daclatasvir']",0.5,"Question: Is hepatitis C virus infection an indication for Daclatasvir?
Reasoning: The disease hepatitis C virus infection is associated with the gene CYP3A4, which is targeted by the drug Daclatasvir. These connections suggest that Daclatasvir may be effective in treating hepatitis C virus infection.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'GAMT', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene GAMT. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'HACE1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene HACE1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'STAT5B', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene STAT5B. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14885,27933.0,Moclobemide,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOB', 'Moclobemide']",0.5,"Question: Is anxiety disorder an indication for Moclobemide?
Reasoning: The disease anxiety disorder is associated with the gene MAOB, which is targeted by the drug Moclobemide. These connections suggest that Moclobemide may be effective in treating anxiety disorder.
Answer: YES"
14023,33534.0,Triamcinolone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Triamcinolone']",0.5,"Question: Is pediatric systemic lupus erythematosus an indication for Triamcinolone?
Reasoning: The disease pediatric systemic lupus erythematosus is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating pediatric systemic lupus erythematosus.
Answer: YES"
14141,39815.0,Phenytoin,visual epilepsy,disease-protein-drug,indication,"['visual epilepsy', 'ABCC2', 'Phenytoin']",0.5,"Question: Is visual epilepsy an indication for Phenytoin?
Reasoning: The disease visual epilepsy is associated with the gene ABCC2, which is targeted by the drug Phenytoin. These connections suggest that Phenytoin may be effective in treating visual epilepsy.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'KATNB1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene KATNB1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15416,39815.0,Lorazepam,visual epilepsy,disease-protein-drug,indication,"['visual epilepsy', 'GABRA5', 'Lorazepam']",0.5,"Question: Is visual epilepsy an indication for Lorazepam?
Reasoning: The disease visual epilepsy is associated with the gene GABRA5, which is targeted by the drug Lorazepam. These connections suggest that Lorazepam may be effective in treating visual epilepsy.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'TSEN15', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene TSEN15. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15299,32999.0,Trimethoprim,shigellosis,disease-phenotype-protein-drug,indication,"['shigellosis', 'Nausea', 'ABCB1', 'Trimethoprim']",0.5,"Question: Is shigellosis an indication for Trimethoprim?
Reasoning: The disease shigellosis is associated with the phenotype Nausea, which in turn affects the gene ABCB1. This gene is targeted by the drug Trimethoprim. These connections suggest that Trimethoprim may be effective in treating shigellosis.
Answer: YES"
18036,33575.0,Bacitracin,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Bacitracin']",1.0,"Question: Is diabetes mellitus (disease) an indication for Bacitracin?
Reasoning: The disease diabetes mellitus (disease) is associated with the phenotype Maternal diabetes, which in turn affects the gene AR. This gene is not targeted by the drug Bacitracin. These connections suggest that Bacitracin may not be effective in treating diabetes mellitus (disease).
Answer: NO"
18036,33575.0,Bacitracin,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'MBL2', 'Bacitracin']",1.0,"Question: Is diabetes mellitus (disease) an indication for Bacitracin?
Reasoning: The disease diabetes mellitus (disease) is associated with the phenotype Maternal diabetes, which in turn affects the gene MBL2. This gene is not targeted by the drug Bacitracin. These connections suggest that Bacitracin may not be effective in treating diabetes mellitus (disease).
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hyponatremia', 'TRPV4', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hyponatremia, which in turn affects the gene TRPV4. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14483,36043.0,Estradiol valerate,primary ovarian failure,disease-protein-drug,indication,"['primary ovarian failure', 'CYP2C19', 'Estradiol valerate']",0.5,"Question: Is primary ovarian failure an indication for Estradiol valerate?
Reasoning: The disease primary ovarian failure is associated with the gene CYP2C19, which is targeted by the drug Estradiol valerate. These connections suggest that Estradiol valerate may be effective in treating primary ovarian failure.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'FLT3', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene FLT3. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
15197,83841.0,Mianserin,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Mianserin']",0.5,"Question: Is endogenous depression an indication for Mianserin?
Reasoning: The disease endogenous depression is associated with the gene SLC6A4, which is targeted by the drug Mianserin. These connections suggest that Mianserin may be effective in treating endogenous depression.
Answer: YES"
14740,83794.0,Chlorambucil,"classic Hodgkin lymphoma, lymphocyte-rich type",disease-protein-drug,indication,"['classic Hodgkin lymphoma, lymphocyte-rich type', 'GSTP1', 'Chlorambucil']",0.5,"Question: Is classic Hodgkin lymphoma, lymphocyte-rich type an indication for Chlorambucil?
Reasoning: The disease classic Hodgkin lymphoma, lymphocyte-rich type is associated with the gene GSTP1, which is targeted by the drug Chlorambucil. These connections suggest that Chlorambucil may be effective in treating classic Hodgkin lymphoma, lymphocyte-rich type.
Answer: YES"
14023,37608.0,Triamcinolone,ciliary body disease,disease-protein-drug,indication,"['ciliary body disease', 'ALB', 'Triamcinolone']",0.5,"Question: Is ciliary body disease an indication for Triamcinolone?
Reasoning: The disease ciliary body disease is associated with the gene ALB, which is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating ciliary body disease.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'FH', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene FH. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14023,27366.0,Triamcinolone,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Triamcinolone']",0.5,"Question: Is spondyloarthropathy, susceptibility to an indication for Triamcinolone?
Reasoning: The disease spondyloarthropathy, susceptibility to is associated with the phenotype Arrhythmia, which in turn affects the gene PTGS2. This gene is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating spondyloarthropathy, susceptibility to.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'ENO3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene ENO3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'TSC1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene TSC1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14463,83853.0,Gilteritinib,acute myeloblastic leukemia without maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia without maturation', 'FLT3', 'Gilteritinib']",0.5,"Question: Is acute myeloblastic leukemia without maturation an indication for Gilteritinib?
Reasoning: The disease acute myeloblastic leukemia without maturation is associated with the gene FLT3, which is targeted by the drug Gilteritinib. These connections suggest that Gilteritinib may be effective in treating acute myeloblastic leukemia without maturation.
Answer: YES"
15295,33592.0,Triamterene,acidosis disorder,disease-phenotype-protein-drug,contraindication,"['acidosis disorder', 'Lactic acidosis', 'PLAT', 'Triamterene']",1.0,"Question: Is acidosis disorder an indication for Triamterene?
Reasoning: The disease acidosis disorder is associated with the phenotype Lactic acidosis, which in turn affects the gene PLAT. This gene is not targeted by the drug Triamterene. These connections suggest that Triamterene may not be effective in treating acidosis disorder.
Answer: NO"
15028,37743.0,Boceprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Boceprevir']",0.5,"Question: Is hepatitis C virus infection an indication for Boceprevir?
Reasoning: The disease hepatitis C virus infection is associated with the gene CYP3A4, which is targeted by the drug Boceprevir. These connections suggest that Boceprevir may be effective in treating hepatitis C virus infection.
Answer: YES"
15311,35641.0,Primidone,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GABRG2', 'Primidone']",0.5,"Question: Is epilepsy an indication for Primidone?
Reasoning: The disease epilepsy is associated with the gene GABRG2, which is targeted by the drug Primidone. These connections suggest that Primidone may be effective in treating epilepsy.
Answer: YES"
14961,83898.0,Simvastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Simvastatin']",0.5,"Question: Is obsolete familial combined hyperlipidemia an indication for Simvastatin?
Reasoning: The disease obsolete familial combined hyperlipidemia is associated with the gene HMGCR, which is targeted by the drug Simvastatin. These connections suggest that Simvastatin may be effective in treating obsolete familial combined hyperlipidemia.
Answer: YES"
14269,83777.0,Methylprednisolone,occupational dermatitis,disease-protein-drug,indication,"['occupational dermatitis', 'CYP1B1', 'Methylprednisolone']",0.5,"Question: Is occupational dermatitis an indication for Methylprednisolone?
Reasoning: The disease occupational dermatitis is associated with the gene CYP1B1, which is targeted by the drug Methylprednisolone. These connections suggest that Methylprednisolone may be effective in treating occupational dermatitis.
Answer: YES"
14466,84255.0,Favipiravir,"influenza, severe, susceptibility to",disease-protein-drug,indication,"['influenza, severe, susceptibility to', 'SLC22A8', 'Favipiravir']",0.5,"Question: Is influenza, severe, susceptibility to an indication for Favipiravir?
Reasoning: The disease influenza, severe, susceptibility to is associated with the gene SLC22A8, which is targeted by the drug Favipiravir. These connections suggest that Favipiravir may be effective in treating influenza, severe, susceptibility to.
Answer: YES"
14452,33241.0,Istradefylline,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'ADORA2A', 'Istradefylline']",0.5,"Question: Is hereditary late onset Parkinson disease an indication for Istradefylline?
Reasoning: The disease hereditary late onset Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene ADORA2A. This gene is targeted by the drug Istradefylline. These connections suggest that Istradefylline may be effective in treating hereditary late onset Parkinson disease.
Answer: YES"
14784,33675.0,Theophylline,asthma,disease-protein-drug,indication,"['asthma', 'PARP1', 'Theophylline']",0.5,"Question: Is asthma an indication for Theophylline?
Reasoning: The disease asthma is associated with the gene PARP1, which is targeted by the drug Theophylline. These connections suggest that Theophylline may be effective in treating asthma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'OPRM1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene OPRM1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'MTR', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene MTR. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14278,29078.0,Ketoprofen,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Ketoprofen']",0.5,"Question: Is rheumatoid arthritis an indication for Ketoprofen?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Ketoprofen. These connections suggest that Ketoprofen may be effective in treating rheumatoid arthritis.
Answer: YES"
14511,33459.0,Dantrolene,malignant hyperthermia of anesthesia,disease-protein-drug,indication,"['malignant hyperthermia of anesthesia', 'RYR1', 'Dantrolene']",0.5,"Question: Is malignant hyperthermia of anesthesia an indication for Dantrolene?
Reasoning: The disease malignant hyperthermia of anesthesia is associated with the gene RYR1, which is targeted by the drug Dantrolene. These connections suggest that Dantrolene may be effective in treating malignant hyperthermia of anesthesia.
Answer: YES"
15124,28974.0,Biperiden,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'CYP2D6', 'Biperiden']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Biperiden?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the gene CYP2D6, which is targeted by the drug Biperiden. These connections suggest that Biperiden may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
14030,32563.0,Prednisolone,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,indication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Prednisolone']",0.5,"Question: Is heparin-induced thrombocytopenia (disease) an indication for Prednisolone?
Reasoning: The disease heparin-induced thrombocytopenia (disease) is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Prednisolone. These connections suggest that Prednisolone may be effective in treating heparin-induced thrombocytopenia (disease).
Answer: YES"
15413,37150.0,Gemcitabine,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'TYMS', 'Gemcitabine']",0.5,"Question: Is malignant non-dysgerminomatous germ cell tumor of ovary an indication for Gemcitabine?
Reasoning: The disease malignant non-dysgerminomatous germ cell tumor of ovary is associated with the gene TYMS, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating malignant non-dysgerminomatous germ cell tumor of ovary.
Answer: YES"
14269,32325.0,Methylprednisolone,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Methylprednisolone']",0.5,"Question: Is juvenile idiopathic arthritis an indication for Methylprednisolone?
Reasoning: The disease juvenile idiopathic arthritis is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Methylprednisolone. These connections suggest that Methylprednisolone may be effective in treating juvenile idiopathic arthritis.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Fatigue', 'TGFBR2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Fatigue, which in turn affects the gene TGFBR2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'RNF13', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene RNF13. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
17583,32325.0,Etanercept,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Fever', 'TNF', 'Etanercept']",0.5,"Question: Is juvenile idiopathic arthritis an indication for Etanercept?
Reasoning: The disease juvenile idiopathic arthritis is associated with the phenotype Fever, which in turn affects the gene TNF. This gene is targeted by the drug Etanercept. These connections suggest that Etanercept may be effective in treating juvenile idiopathic arthritis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SLC6A1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SLC6A1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15420,32875.0,Pantoprazole,Zollinger-Ellison syndrome,disease-phenotype-protein-drug,indication,"['Zollinger-Ellison syndrome', 'Nausea', 'ABCB1', 'Pantoprazole']",0.5,"Question: Is Zollinger-Ellison syndrome an indication for Pantoprazole?
Reasoning: The disease Zollinger-Ellison syndrome is associated with the phenotype Nausea, which in turn affects the gene ABCB1. This gene is targeted by the drug Pantoprazole. These connections suggest that Pantoprazole may be effective in treating Zollinger-Ellison syndrome.
Answer: YES"
14024,31511.0,Prednisone,autoimmune thrombocytopenic,disease-phenotype-protein-drug,indication,"['autoimmune thrombocytopenic', 'Thrombocytopenia', 'ALB', 'Prednisone']",0.5,"Question: Is autoimmune thrombocytopenic an indication for Prednisone?
Reasoning: The disease autoimmune thrombocytopenic is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating autoimmune thrombocytopenic.
Answer: YES"
14186,36792.0,Cisplatin,ovarian mucinous adenocarcinoma,disease-protein-drug,indication,"['ovarian mucinous adenocarcinoma', 'ATP7B', 'Cisplatin']",0.5,"Question: Is ovarian mucinous adenocarcinoma an indication for Cisplatin?
Reasoning: The disease ovarian mucinous adenocarcinoma is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating ovarian mucinous adenocarcinoma.
Answer: YES"
15413,83818.0,Gemcitabine,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,indication,"['primary non-gestational choriocarcinoma of ovary', 'TYMS', 'Gemcitabine']",0.5,"Question: Is primary non-gestational choriocarcinoma of ovary an indication for Gemcitabine?
Reasoning: The disease primary non-gestational choriocarcinoma of ovary is associated with the gene TYMS, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating primary non-gestational choriocarcinoma of ovary.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'SERPINB4', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene SERPINB4. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14323,84310.0,Aripiprazole,autism (disease),disease-protein-drug,indication,"['autism (disease)', 'HTR5A', 'Aripiprazole']",0.5,"Question: Is autism (disease) an indication for Aripiprazole?
Reasoning: The disease autism (disease) is associated with the gene HTR5A, which is targeted by the drug Aripiprazole. These connections suggest that Aripiprazole may be effective in treating autism (disease).
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'BCL2L1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene BCL2L1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14990,83791.0,Chlorpheniramine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Chlorpheniramine']",0.5,"Question: Is vasomotor rhinitis an indication for Chlorpheniramine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Chlorpheniramine. These connections suggest that Chlorpheniramine may be effective in treating vasomotor rhinitis.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ADPRS', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ADPRS. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14321,28974.0,Levodopa,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'DRD1', 'Levodopa']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Levodopa?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the gene DRD1, which is targeted by the drug Levodopa. These connections suggest that Levodopa may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'MYO1B', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene MYO1B. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14830,32468.0,Amantadine,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Oculogyric crisis', 'DDC', 'Amantadine']",0.5,"Question: Is postencephalitic Parkinson disease an indication for Amantadine?
Reasoning: The disease postencephalitic Parkinson disease is associated with the phenotype Oculogyric crisis, which in turn affects the gene DDC. This gene is targeted by the drug Amantadine. These connections suggest that Amantadine may be effective in treating postencephalitic Parkinson disease.
Answer: YES"
14208,32217.0,Testosterone,hypopituitarism,disease-protein-drug,indication,"['hypopituitarism', 'CYP19A1', 'Testosterone']",0.5,"Question: Is hypopituitarism an indication for Testosterone?
Reasoning: The disease hypopituitarism is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating hypopituitarism.
Answer: YES"
14023,33077.0,Triamcinolone,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Hepatomegaly', 'ALB', 'Triamcinolone']",0.5,"Question: Is Hodgkins lymphoma an indication for Triamcinolone?
Reasoning: The disease Hodgkins lymphoma is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating Hodgkins lymphoma.
Answer: YES"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Generalized hypotonia', 'CDK8', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Generalized hypotonia, which in turn affects the gene CDK8. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'CNR1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene CNR1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16352,33605.0,Norepinephrine,hypotensive disorder,disease-protein-drug,indication,"['hypotensive disorder', 'ADRA1B', 'Norepinephrine']",0.5,"Question: Is hypotensive disorder an indication for Norepinephrine?
Reasoning: The disease hypotensive disorder is associated with the gene ADRA1B, which is targeted by the drug Norepinephrine. These connections suggest that Norepinephrine may be effective in treating hypotensive disorder.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Lethargy', 'ATG7', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Lethargy, which in turn affects the gene ATG7. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'ABCA3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene ABCA3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'FKTN', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene FKTN. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14314,30035.0,Naloxone,substance abuse/dependence,disease-protein-drug,indication,"['substance abuse/dependence', 'ABCB1', 'Naloxone']",0.5,"Question: Is substance abuse/dependence an indication for Naloxone?
Reasoning: The disease substance abuse/dependence is associated with the gene ABCB1, which is targeted by the drug Naloxone. These connections suggest that Naloxone may be effective in treating substance abuse/dependence.
Answer: YES"
15189,83995.0,Dapoxetine,psychologic dyspareunia,disease-protein-drug,indication,"['psychologic dyspareunia', 'CYP2D6', 'Dapoxetine']",0.5,"Question: Is psychologic dyspareunia an indication for Dapoxetine?
Reasoning: The disease psychologic dyspareunia is associated with the gene CYP2D6, which is targeted by the drug Dapoxetine. These connections suggest that Dapoxetine may be effective in treating psychologic dyspareunia.
Answer: YES"
15173,30664.0,Dextroamphetamine,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,indication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'ADRA1B', 'Dextroamphetamine']",0.5,"Question: Is X-linked adrenoleukodystrophy an indication for Dextroamphetamine?
Reasoning: The disease X-linked adrenoleukodystrophy is associated with the phenotype Neurodegeneration, which in turn affects the gene ADRA1B. This gene is targeted by the drug Dextroamphetamine. These connections suggest that Dextroamphetamine may be effective in treating X-linked adrenoleukodystrophy.
Answer: YES"
14280,28208.0,Glyburide,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'KCNJ11', 'Glyburide']",0.5,"Question: Is type 2 diabetes mellitus an indication for Glyburide?
Reasoning: The disease type 2 diabetes mellitus is associated with the phenotype Insulin resistance, which in turn affects the gene KCNJ11. This gene is targeted by the drug Glyburide. These connections suggest that Glyburide may be effective in treating type 2 diabetes mellitus.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Vomiting', 'ASPG', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Vomiting, which in turn affects the gene ASPG. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14282,33577.0,Irbesartan,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Irbesartan']",0.5,"Question: Is hypertensive disorder an indication for Irbesartan?
Reasoning: The disease hypertensive disorder is associated with the gene AGTR1, which is targeted by the drug Irbesartan. These connections suggest that Irbesartan may be effective in treating hypertensive disorder.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'INS', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene INS. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14477,84094.0,Testosterone enanthate,premature menopause,disease-protein-drug,indication,"['premature menopause', 'CYP2C19', 'Testosterone enanthate']",0.5,"Question: Is premature menopause an indication for Testosterone enanthate?
Reasoning: The disease premature menopause is associated with the gene CYP2C19, which is targeted by the drug Testosterone enanthate. These connections suggest that Testosterone enanthate may be effective in treating premature menopause.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'SRSF5', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene SRSF5. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16490,83791.0,Pheniramine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Pheniramine']",0.5,"Question: Is vasomotor rhinitis an indication for Pheniramine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Pheniramine. These connections suggest that Pheniramine may be effective in treating vasomotor rhinitis.
Answer: YES"
20151,33605.0,Mephentermine,hypotensive disorder,disease-protein-drug,indication,"['hypotensive disorder', 'ADRA1B', 'Mephentermine']",0.5,"Question: Is hypotensive disorder an indication for Mephentermine?
Reasoning: The disease hypotensive disorder is associated with the gene ADRA1B, which is targeted by the drug Mephentermine. These connections suggest that Mephentermine may be effective in treating hypotensive disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'SLC26A4', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene SLC26A4. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'CD226', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene CD226. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14320,29078.0,Dexamethasone,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Dexamethasone']",0.5,"Question: Is rheumatoid arthritis an indication for Dexamethasone?
Reasoning: The disease rheumatoid arthritis is associated with the gene ABCB1, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating rheumatoid arthritis.
Answer: YES"
14792,32589.0,Paclitaxel,Kaposi's sarcoma (disease),disease-phenotype-protein-drug,indication,"[""Kaposi's sarcoma (disease)"", 'Weight loss', 'MAPT', 'Paclitaxel']",0.5,"Question: Is Kaposi's sarcoma (disease) an indication for Paclitaxel?
Reasoning: The disease Kaposi's sarcoma (disease) is associated with the phenotype Weight loss, which in turn affects the gene MAPT. This gene is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating Kaposi's sarcoma (disease).
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OXR1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene OXR1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'NGF', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene NGF. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15055,31245.0,Deutetrabenazine,Huntington disease,disease-phenotype-protein-drug,indication,"['Huntington disease', 'Rigidity', 'CYP2D6', 'Deutetrabenazine']",0.5,"Question: Is Huntington disease an indication for Deutetrabenazine?
Reasoning: The disease Huntington disease is associated with the phenotype Rigidity, which in turn affects the gene CYP2D6. This gene is targeted by the drug Deutetrabenazine. These connections suggest that Deutetrabenazine may be effective in treating Huntington disease.
Answer: YES"
16753,32531.0,Lenalidomide,mantle cell lymphoma,disease-phenotype-protein-drug,indication,"['mantle cell lymphoma', 'Fever', 'PTGS2', 'Lenalidomide']",0.5,"Question: Is mantle cell lymphoma an indication for Lenalidomide?
Reasoning: The disease mantle cell lymphoma is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Lenalidomide. These connections suggest that Lenalidomide may be effective in treating mantle cell lymphoma.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'IL10', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene IL10. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CRH', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CRH. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14806,31408.0,Entacapone,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'CYP2D6', 'Entacapone']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Entacapone?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Entacapone. These connections suggest that Entacapone may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Short stature', 'SLC10A7', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Short stature, which in turn affects the gene SLC10A7. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CHRM1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene CHRM1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'ABHD5', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene ABHD5. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CXCR3', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CXCR3. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14194,83796.0,Methotrexate,lymphosarcoma,disease-protein-drug,indication,"['lymphosarcoma', 'MTHFR', 'Methotrexate']",0.5,"Question: Is lymphosarcoma an indication for Methotrexate?
Reasoning: The disease lymphosarcoma is associated with the gene MTHFR, which is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating lymphosarcoma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'COL11A2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene COL11A2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14208,36453.0,Testosterone,hypogonadism,disease-protein-drug,indication,"['hypogonadism', 'CYP19A1', 'Testosterone']",0.5,"Question: Is hypogonadism an indication for Testosterone?
Reasoning: The disease hypogonadism is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating hypogonadism.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ADPRS', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene ADPRS. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'SESN2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene SESN2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15430,35641.0,Pentobarbital,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GABRG2', 'Pentobarbital']",0.5,"Question: Is epilepsy an indication for Pentobarbital?
Reasoning: The disease epilepsy is associated with the gene GABRG2, which is targeted by the drug Pentobarbital. These connections suggest that Pentobarbital may be effective in treating epilepsy.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'FST', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene FST. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'APOE', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene APOE. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Vomiting', 'GNRH1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Vomiting, which in turn affects the gene GNRH1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CAT', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene CAT. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14062,29078.0,Diflunisal,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Diflunisal']",0.5,"Question: Is rheumatoid arthritis an indication for Diflunisal?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Diflunisal. These connections suggest that Diflunisal may be effective in treating rheumatoid arthritis.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'PIGM', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene PIGM. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Myoclonus', 'MECP2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Myoclonus, which in turn affects the gene MECP2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'FOLR1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene FOLR1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14557,27361.0,Turoctocog alfa pegol,hemophilia,disease-protein-drug,indication,"['hemophilia', 'F9', 'Turoctocog alfa pegol']",0.5,"Question: Is hemophilia an indication for Turoctocog alfa pegol?
Reasoning: The disease hemophilia is associated with the gene F9, which is targeted by the drug Turoctocog alfa pegol. These connections suggest that Turoctocog alfa pegol may be effective in treating hemophilia.
Answer: YES"
14158,27366.0,Indomethacin,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Indomethacin']",0.5,"Question: Is spondyloarthropathy, susceptibility to an indication for Indomethacin?
Reasoning: The disease spondyloarthropathy, susceptibility to is associated with the phenotype Arrhythmia, which in turn affects the gene PTGS2. This gene is targeted by the drug Indomethacin. These connections suggest that Indomethacin may be effective in treating spondyloarthropathy, susceptibility to.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'MMP15', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene MMP15. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14955,84154.0,Vincristine,"primary cutaneous diffuse large B-cell lymphoma, Leg type",disease-protein-drug,indication,"['primary cutaneous diffuse large B-cell lymphoma, Leg type', 'ABCB1', 'Vincristine']",0.5,"Question: Is primary cutaneous diffuse large B-cell lymphoma, Leg type an indication for Vincristine?
Reasoning: The disease primary cutaneous diffuse large B-cell lymphoma, Leg type is associated with the gene ABCB1, which is targeted by the drug Vincristine. These connections suggest that Vincristine may be effective in treating primary cutaneous diffuse large B-cell lymphoma, Leg type.
Answer: YES"
15836,36035.0,Telmisartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Telmisartan']",0.5,"Question: Is hypertension an indication for Telmisartan?
Reasoning: The disease hypertension is associated with the gene AGTR1, which is targeted by the drug Telmisartan. These connections suggest that Telmisartan may be effective in treating hypertension.
Answer: YES"
15539,37334.0,Ixabepilone,breast carcinoma,disease-protein-drug,indication,"['breast carcinoma', 'ABCB1', 'Ixabepilone']",0.5,"Question: Is breast carcinoma an indication for Ixabepilone?
Reasoning: The disease breast carcinoma is associated with the gene ABCB1, which is targeted by the drug Ixabepilone. These connections suggest that Ixabepilone may be effective in treating breast carcinoma.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'POLG', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene POLG. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
17270,32759.0,Pimavanserin,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'DRD2', 'Pimavanserin']",0.5,"Question: Is hemiparkinsonism-hemiatrophy syndrome an indication for Pimavanserin?
Reasoning: The disease hemiparkinsonism-hemiatrophy syndrome is associated with the gene DRD2, which is targeted by the drug Pimavanserin. These connections suggest that Pimavanserin may be effective in treating hemiparkinsonism-hemiatrophy syndrome.
Answer: YES"
15903,27581.0,Von Willebrand Factor Human,von Willebrand disease,disease-phenotype-protein-drug,indication,"['von Willebrand disease', 'Abnormal bleeding', 'COL1A1', 'Von Willebrand Factor Human']",0.5,"Question: Is von Willebrand disease an indication for Von Willebrand Factor Human?
Reasoning: The disease von Willebrand disease is associated with the phenotype Abnormal bleeding, which in turn affects the gene COL1A1. This gene is targeted by the drug Von Willebrand Factor Human. These connections suggest that Von Willebrand Factor Human may be effective in treating von Willebrand disease.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PTGS2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene PTGS2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14212,33577.0,Verapamil,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Verapamil']",0.5,"Question: Is hypertensive disorder an indication for Verapamil?
Reasoning: The disease hypertensive disorder is associated with the gene CYP3A5, which is targeted by the drug Verapamil. These connections suggest that Verapamil may be effective in treating hypertensive disorder.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'CDK8', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene CDK8. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'GRIA2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene GRIA2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'APC2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene APC2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Mitral regurgitation', 'LMCD1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Mitral regurgitation, which in turn affects the gene LMCD1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'CDH23', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene CDH23. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'ATP1A1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene ATP1A1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14295,36091.0,Promethazine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'ALB', 'Promethazine']",0.5,"Question: Is atopic conjunctivitis an indication for Promethazine?
Reasoning: The disease atopic conjunctivitis is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is targeted by the drug Promethazine. These connections suggest that Promethazine may be effective in treating atopic conjunctivitis.
Answer: YES"
14266,36091.0,Fexofenadine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'ALB', 'Fexofenadine']",0.5,"Question: Is atopic conjunctivitis an indication for Fexofenadine?
Reasoning: The disease atopic conjunctivitis is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is targeted by the drug Fexofenadine. These connections suggest that Fexofenadine may be effective in treating atopic conjunctivitis.
Answer: YES"
14155,31116.0,Gefitinib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Gefitinib']",0.5,"Question: Is lung cancer an indication for Gefitinib?
Reasoning: The disease lung cancer is associated with the gene ABCB1, which is targeted by the drug Gefitinib. These connections suggest that Gefitinib may be effective in treating lung cancer.
Answer: YES"
14792,83821.0,Paclitaxel,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,indication,"['malignant Sertoli-Leydig cell tumor of ovary', 'CYP1B1', 'Paclitaxel']",0.5,"Question: Is malignant Sertoli-Leydig cell tumor of ovary an indication for Paclitaxel?
Reasoning: The disease malignant Sertoli-Leydig cell tumor of ovary is associated with the gene CYP1B1, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating malignant Sertoli-Leydig cell tumor of ovary.
Answer: YES"
17231,37888.0,Dexbrompheniramine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Dexbrompheniramine']",0.5,"Question: Is allergic rhinitis an indication for Dexbrompheniramine?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Dexbrompheniramine. These connections suggest that Dexbrompheniramine may be effective in treating allergic rhinitis.
Answer: YES"
15979,27361.0,Coagulation Factor IX Human,hemophilia,disease-phenotype-protein-drug,indication,"['hemophilia', 'Thromboembolism', 'F7', 'Coagulation Factor IX Human']",0.5,"Question: Is hemophilia an indication for Coagulation Factor IX Human?
Reasoning: The disease hemophilia is associated with the phenotype Thromboembolism, which in turn affects the gene F7. This gene is targeted by the drug Coagulation Factor IX Human. These connections suggest that Coagulation Factor IX Human may be effective in treating hemophilia.
Answer: YES"
14737,83821.0,Carboplatin,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,indication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ATP7B', 'Carboplatin']",0.5,"Question: Is malignant Sertoli-Leydig cell tumor of ovary an indication for Carboplatin?
Reasoning: The disease malignant Sertoli-Leydig cell tumor of ovary is associated with the gene ATP7B, which is targeted by the drug Carboplatin. These connections suggest that Carboplatin may be effective in treating malignant Sertoli-Leydig cell tumor of ovary.
Answer: YES"
14187,33688.0,Erlotinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Erlotinib']",0.5,"Question: Is non-small cell lung carcinoma (disease) an indication for Erlotinib?
Reasoning: The disease non-small cell lung carcinoma (disease) is associated with the gene ABCB1, which is targeted by the drug Erlotinib. These connections suggest that Erlotinib may be effective in treating non-small cell lung carcinoma (disease).
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'SLC17A6', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene SLC17A6. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'IDH2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene IDH2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14207,37613.0,Imatinib,hypereosinophilic syndrome,disease-protein-drug,indication,"['hypereosinophilic syndrome', 'PDGFRA', 'Imatinib']",0.5,"Question: Is hypereosinophilic syndrome an indication for Imatinib?
Reasoning: The disease hypereosinophilic syndrome is associated with the gene PDGFRA, which is targeted by the drug Imatinib. These connections suggest that Imatinib may be effective in treating hypereosinophilic syndrome.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'ACHE', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Action tremor, which in turn affects the gene ACHE. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'SLC8A1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene SLC8A1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'WDR37', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene WDR37. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
17215,29614.0,Salmon calcitonin,osteoporosis,disease-protein-drug,indication,"['osteoporosis', 'CALCR', 'Salmon calcitonin']",0.5,"Question: Is osteoporosis an indication for Salmon calcitonin?
Reasoning: The disease osteoporosis is associated with the gene CALCR, which is targeted by the drug Salmon calcitonin. These connections suggest that Salmon calcitonin may be effective in treating osteoporosis.
Answer: YES"
14180,27933.0,Buspirone,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Buspirone']",0.5,"Question: Is anxiety disorder an indication for Buspirone?
Reasoning: The disease anxiety disorder is associated with the gene ABCB1, which is targeted by the drug Buspirone. These connections suggest that Buspirone may be effective in treating anxiety disorder.
Answer: YES"
15887,37784.0,Certolizumab pegol,Crohn disease,disease-protein-drug,indication,"['Crohn disease', 'TNF', 'Certolizumab pegol']",0.5,"Question: Is Crohn disease an indication for Certolizumab pegol?
Reasoning: The disease Crohn disease is associated with the gene TNF, which is targeted by the drug Certolizumab pegol. These connections suggest that Certolizumab pegol may be effective in treating Crohn disease.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CLPB', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CLPB. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14190,29945.0,Fluorouracil,gastric cancer,disease-protein-drug,indication,"['gastric cancer', 'TYMP', 'Fluorouracil']",0.5,"Question: Is gastric cancer an indication for Fluorouracil?
Reasoning: The disease gastric cancer is associated with the gene TYMP, which is targeted by the drug Fluorouracil. These connections suggest that Fluorouracil may be effective in treating gastric cancer.
Answer: YES"
14338,30773.0,Colchicine,autosomal recessive familial Mediterranean fever,disease-phenotype-protein-drug,indication,"['autosomal recessive familial Mediterranean fever', 'Hepatomegaly', 'ALB', 'Colchicine']",0.5,"Question: Is autosomal recessive familial Mediterranean fever an indication for Colchicine?
Reasoning: The disease autosomal recessive familial Mediterranean fever is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Colchicine. These connections suggest that Colchicine may be effective in treating autosomal recessive familial Mediterranean fever.
Answer: YES"
15475,35641.0,Felbamate,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GRIN2A', 'Felbamate']",0.5,"Question: Is epilepsy an indication for Felbamate?
Reasoning: The disease epilepsy is associated with the gene GRIN2A, which is targeted by the drug Felbamate. These connections suggest that Felbamate may be effective in treating epilepsy.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CABCOCO1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene CABCOCO1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
19504,33327.0,Metreleptin,Berardinelli-Seip congenital lipodystrophy,disease-phenotype-protein-drug,indication,"['Berardinelli-Seip congenital lipodystrophy', 'Hepatomegaly', 'LEPR', 'Metreleptin']",0.5,"Question: Is Berardinelli-Seip congenital lipodystrophy an indication for Metreleptin?
Reasoning: The disease Berardinelli-Seip congenital lipodystrophy is associated with the phenotype Hepatomegaly, which in turn affects the gene LEPR. This gene is targeted by the drug Metreleptin. These connections suggest that Metreleptin may be effective in treating Berardinelli-Seip congenital lipodystrophy.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Lethargy', 'ATG7', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Lethargy, which in turn affects the gene ATG7. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'NOS3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene NOS3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Respiratory insufficiency', 'IGF1R', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Respiratory insufficiency, which in turn affects the gene IGF1R. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TUBA8', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TUBA8. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14306,28208.0,Pioglitazone,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'PPARG', 'Pioglitazone']",0.5,"Question: Is type 2 diabetes mellitus an indication for Pioglitazone?
Reasoning: The disease type 2 diabetes mellitus is associated with the phenotype Insulin resistance, which in turn affects the gene PPARG. This gene is targeted by the drug Pioglitazone. These connections suggest that Pioglitazone may be effective in treating type 2 diabetes mellitus.
Answer: YES"
14789,30654.0,Daunorubicin,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Daunorubicin']",0.5,"Question: Is acute lymphoblastic/lymphocytic leukemia an indication for Daunorubicin?
Reasoning: The disease acute lymphoblastic/lymphocytic leukemia is associated with the gene ABCG2, which is targeted by the drug Daunorubicin. These connections suggest that Daunorubicin may be effective in treating acute lymphoblastic/lymphocytic leukemia.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hypotonia', 'NSD2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hypotonia, which in turn affects the gene NSD2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14220,33241.0,Apomorphine,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'HTR1A', 'Apomorphine']",0.5,"Question: Is hereditary late onset Parkinson disease an indication for Apomorphine?
Reasoning: The disease hereditary late onset Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene HTR1A. This gene is targeted by the drug Apomorphine. These connections suggest that Apomorphine may be effective in treating hereditary late onset Parkinson disease.
Answer: YES"
14428,37805.0,Tenofovir alafenamide,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Tenofovir alafenamide']",0.5,"Question: Is HIV infectious disease an indication for Tenofovir alafenamide?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Tenofovir alafenamide. These connections suggest that Tenofovir alafenamide may be effective in treating HIV infectious disease.
Answer: YES"
14186,39603.0,Cisplatin,malignant sex cord stromal tumor of ovary,disease-protein-drug,indication,"['malignant sex cord stromal tumor of ovary', 'ATP7B', 'Cisplatin']",0.5,"Question: Is malignant sex cord stromal tumor of ovary an indication for Cisplatin?
Reasoning: The disease malignant sex cord stromal tumor of ovary is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating malignant sex cord stromal tumor of ovary.
Answer: YES"
15551,83928.0,Brivaracetam,partial motor epilepsy,disease-protein-drug,indication,"['partial motor epilepsy', 'SCN3A', 'Brivaracetam']",0.5,"Question: Is partial motor epilepsy an indication for Brivaracetam?
Reasoning: The disease partial motor epilepsy is associated with the gene SCN3A, which is targeted by the drug Brivaracetam. These connections suggest that Brivaracetam may be effective in treating partial motor epilepsy.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'HLA-DRB4', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene HLA-DRB4. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14030,39245.0,Prednisolone,panuveitis (disease),disease-protein-drug,indication,"['panuveitis (disease)', 'ALB', 'Prednisolone']",0.5,"Question: Is panuveitis (disease) an indication for Prednisolone?
Reasoning: The disease panuveitis (disease) is associated with the gene ALB, which is targeted by the drug Prednisolone. These connections suggest that Prednisolone may be effective in treating panuveitis (disease).
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'EIF2AK4', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene EIF2AK4. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'TGFA', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene TGFA. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'FBLN5', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene FBLN5. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Short stature', 'RSPH4A', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Short stature, which in turn affects the gene RSPH4A. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'BCL2L1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene BCL2L1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'FGF12', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene FGF12. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'SLC29A3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene SLC29A3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Abnormal bleeding', 'COL5A1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Abnormal bleeding, which in turn affects the gene COL5A1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GHRL', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene GHRL. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
17545,83855.0,Gemtuzumab ozogamicin,acute myeloid leukemia with t(8;21)(q22;q22) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;21)(q22;q22) translocation', 'CD33', 'Gemtuzumab ozogamicin']",0.5,"Question: Is acute myeloid leukemia with t(8;21)(q22;q22) translocation an indication for Gemtuzumab ozogamicin?
Reasoning: The disease acute myeloid leukemia with t(8;21)(q22;q22) translocation is associated with the gene CD33, which is targeted by the drug Gemtuzumab ozogamicin. These connections suggest that Gemtuzumab ozogamicin may be effective in treating acute myeloid leukemia with t(8;21)(q22;q22) translocation.
Answer: YES"
14208,38179.0,Testosterone,congenital hypogonadotropic hypogonadism,disease-protein-drug,indication,"['congenital hypogonadotropic hypogonadism', 'CYP19A1', 'Testosterone']",0.5,"Question: Is congenital hypogonadotropic hypogonadism an indication for Testosterone?
Reasoning: The disease congenital hypogonadotropic hypogonadism is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating congenital hypogonadotropic hypogonadism.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'SPAG5', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene SPAG5. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
15914,33314.0,Minocycline,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'MAPK14', 'Minocycline']",0.5,"Question: Is leptospirosis an indication for Minocycline?
Reasoning: The disease leptospirosis is associated with the phenotype Hepatomegaly, which in turn affects the gene MAPK14. This gene is targeted by the drug Minocycline. These connections suggest that Minocycline may be effective in treating leptospirosis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'SLC17A8', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene SLC17A8. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14664,38741.0,Sapropterin,disorder of phenylalanine metabolism,disease-protein-drug,indication,"['disorder of phenylalanine metabolism', 'PAH', 'Sapropterin']",0.5,"Question: Is disorder of phenylalanine metabolism an indication for Sapropterin?
Reasoning: The disease disorder of phenylalanine metabolism is associated with the gene PAH, which is targeted by the drug Sapropterin. These connections suggest that Sapropterin may be effective in treating disorder of phenylalanine metabolism.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'CHIA', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene CHIA. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14792,33688.0,Paclitaxel,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Paclitaxel']",0.5,"Question: Is non-small cell lung carcinoma (disease) an indication for Paclitaxel?
Reasoning: The disease non-small cell lung carcinoma (disease) is associated with the gene ABCB1, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating non-small cell lung carcinoma (disease).
Answer: YES"
14792,83820.0,Paclitaxel,maligant granulosa cell tumor of ovary,disease-protein-drug,indication,"['maligant granulosa cell tumor of ovary', 'CYP1B1', 'Paclitaxel']",0.5,"Question: Is maligant granulosa cell tumor of ovary an indication for Paclitaxel?
Reasoning: The disease maligant granulosa cell tumor of ovary is associated with the gene CYP1B1, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating maligant granulosa cell tumor of ovary.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'RNF13', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene RNF13. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15594,83794.0,Brentuximab vedotin,"classic Hodgkin lymphoma, lymphocyte-rich type",disease-protein-drug,indication,"['classic Hodgkin lymphoma, lymphocyte-rich type', 'TNFRSF8', 'Brentuximab vedotin']",0.5,"Question: Is classic Hodgkin lymphoma, lymphocyte-rich type an indication for Brentuximab vedotin?
Reasoning: The disease classic Hodgkin lymphoma, lymphocyte-rich type is associated with the gene TNFRSF8, which is targeted by the drug Brentuximab vedotin. These connections suggest that Brentuximab vedotin may be effective in treating classic Hodgkin lymphoma, lymphocyte-rich type.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'TBC1D20', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene TBC1D20. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14499,28714.0,Elexacaftor,cystic fibrosis,disease-protein-drug,indication,"['cystic fibrosis', 'CFTR', 'Elexacaftor']",0.5,"Question: Is cystic fibrosis an indication for Elexacaftor?
Reasoning: The disease cystic fibrosis is associated with the gene CFTR, which is targeted by the drug Elexacaftor. These connections suggest that Elexacaftor may be effective in treating cystic fibrosis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'OCLN', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene OCLN. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14477,31630.0,Testosterone enanthate,androgen insensitivity syndrome,disease-phenotype-protein-drug,indication,"['androgen insensitivity syndrome', 'Male infertility', 'CYP1A1', 'Testosterone enanthate']",0.5,"Question: Is androgen insensitivity syndrome an indication for Testosterone enanthate?
Reasoning: The disease androgen insensitivity syndrome is associated with the phenotype Male infertility, which in turn affects the gene CYP1A1. This gene is targeted by the drug Testosterone enanthate. These connections suggest that Testosterone enanthate may be effective in treating androgen insensitivity syndrome.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ZMIZ1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ZMIZ1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14484,37805.0,Tenofovir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Tenofovir']",0.5,"Question: Is HIV infectious disease an indication for Tenofovir?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Tenofovir. These connections suggest that Tenofovir may be effective in treating HIV infectious disease.
Answer: YES"
17256,37888.0,Chlorcyclizine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Chlorcyclizine']",0.5,"Question: Is allergic rhinitis an indication for Chlorcyclizine?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Chlorcyclizine. These connections suggest that Chlorcyclizine may be effective in treating allergic rhinitis.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'IGFBP1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene IGFBP1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
15194,28313.0,Cariprazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'HRH1', 'Cariprazine']",0.5,"Question: Is schizophrenia an indication for Cariprazine?
Reasoning: The disease schizophrenia is associated with the gene HRH1, which is targeted by the drug Cariprazine. These connections suggest that Cariprazine may be effective in treating schizophrenia.
Answer: YES"
17605,29375.0,Cetuximab,squamous cell carcinoma,disease-protein-drug,indication,"['squamous cell carcinoma', 'EGFR', 'Cetuximab']",0.5,"Question: Is squamous cell carcinoma an indication for Cetuximab?
Reasoning: The disease squamous cell carcinoma is associated with the gene EGFR, which is targeted by the drug Cetuximab. These connections suggest that Cetuximab may be effective in treating squamous cell carcinoma.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'AGT', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene AGT. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15116,83841.0,Paroxetine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'HTR1B', 'Paroxetine']",0.5,"Question: Is endogenous depression an indication for Paroxetine?
Reasoning: The disease endogenous depression is associated with the gene HTR1B, which is targeted by the drug Paroxetine. These connections suggest that Paroxetine may be effective in treating endogenous depression.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CCL17', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CCL17. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PNKP', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene PNKP. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'IGFBP3', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene IGFBP3. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14173,83760.0,Imipramine,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A4', 'Imipramine']",0.5,"Question: Is dysthymic disorder an indication for Imipramine?
Reasoning: The disease dysthymic disorder is associated with the gene SLC6A4, which is targeted by the drug Imipramine. These connections suggest that Imipramine may be effective in treating dysthymic disorder.
Answer: YES"
14028,29078.0,Hydrocortisone,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Hydrocortisone']",0.5,"Question: Is rheumatoid arthritis an indication for Hydrocortisone?
Reasoning: The disease rheumatoid arthritis is associated with the gene ABCB1, which is targeted by the drug Hydrocortisone. These connections suggest that Hydrocortisone may be effective in treating rheumatoid arthritis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Ataxia', 'SYNE1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Ataxia, which in turn affects the gene SYNE1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15739,37714.0,Ivosidenib,unclassified acute myeloid leukemia,disease-protein-drug,indication,"['unclassified acute myeloid leukemia', 'IDH1', 'Ivosidenib']",0.5,"Question: Is unclassified acute myeloid leukemia an indication for Ivosidenib?
Reasoning: The disease unclassified acute myeloid leukemia is associated with the gene IDH1, which is targeted by the drug Ivosidenib. These connections suggest that Ivosidenib may be effective in treating unclassified acute myeloid leukemia.
Answer: YES"
14424,39480.0,Methylene blue,methemoglobinemia,disease-protein-drug,indication,"['methemoglobinemia', 'CYP1A2', 'Methylene blue']",0.5,"Question: Is methemoglobinemia an indication for Methylene blue?
Reasoning: The disease methemoglobinemia is associated with the gene CYP1A2, which is targeted by the drug Methylene blue. These connections suggest that Methylene blue may be effective in treating methemoglobinemia.
Answer: YES"
14604,29173.0,Etoposide,small cell lung carcinoma,disease-protein-drug,indication,"['small cell lung carcinoma', 'UGT1A1', 'Etoposide']",0.5,"Question: Is small cell lung carcinoma an indication for Etoposide?
Reasoning: The disease small cell lung carcinoma is associated with the gene UGT1A1, which is targeted by the drug Etoposide. These connections suggest that Etoposide may be effective in treating small cell lung carcinoma.
Answer: YES"
14999,30318.0,Quetiapine,autosomal recessive severe congenital neutropenia due to JAGN1 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to JAGN1 deficiency', 'Short stature', 'FBXL3', 'Quetiapine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to JAGN1 deficiency an indication for Quetiapine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to JAGN1 deficiency is associated with the phenotype Short stature, which in turn affects the gene FBXL3. This gene is not targeted by the drug Quetiapine. These connections suggest that Quetiapine may not be effective in treating autosomal recessive severe congenital neutropenia due to JAGN1 deficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TSFM', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TSFM. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15493,28974.0,Bromocriptine,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'HTR1A', 'Bromocriptine']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Bromocriptine?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the phenotype Resting tremor, which in turn affects the gene HTR1A. This gene is targeted by the drug Bromocriptine. These connections suggest that Bromocriptine may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'NFE2L2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene NFE2L2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'GOT2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene GOT2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ZNF142', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ZNF142. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Short stature', 'RSPH4A', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Short stature, which in turn affects the gene RSPH4A. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15295,33592.0,Triamterene,acidosis disorder,disease-phenotype-protein-drug,contraindication,"['acidosis disorder', 'Lactic acidosis', 'DNM1L', 'Triamterene']",1.0,"Question: Is acidosis disorder an indication for Triamterene?
Reasoning: The disease acidosis disorder is associated with the phenotype Lactic acidosis, which in turn affects the gene DNM1L. This gene is not targeted by the drug Triamterene. These connections suggest that Triamterene may not be effective in treating acidosis disorder.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'LOXHD1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene LOXHD1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14028,32584.0,Hydrocortisone,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,indication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Hydrocortisone']",0.5,"Question: Is inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency an indication for Hydrocortisone?
Reasoning: The disease inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Hydrocortisone. These connections suggest that Hydrocortisone may be effective in treating inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency.
Answer: YES"
14737,37150.0,Carboplatin,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ATP7B', 'Carboplatin']",0.5,"Question: Is malignant non-dysgerminomatous germ cell tumor of ovary an indication for Carboplatin?
Reasoning: The disease malignant non-dysgerminomatous germ cell tumor of ovary is associated with the gene ATP7B, which is targeted by the drug Carboplatin. These connections suggest that Carboplatin may be effective in treating malignant non-dysgerminomatous germ cell tumor of ovary.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'ALPL', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene ALPL. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14223,31912.0,Risperidone,autism susceptibility 1,disease-phenotype-protein-drug,indication,"['autism susceptibility 1', 'Seizure', 'DRD1', 'Risperidone']",0.5,"Question: Is autism susceptibility 1 an indication for Risperidone?
Reasoning: The disease autism susceptibility 1 is associated with the phenotype Seizure, which in turn affects the gene DRD1. This gene is targeted by the drug Risperidone. These connections suggest that Risperidone may be effective in treating autism susceptibility 1.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'LSS', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene LSS. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Respiratory insufficiency', 'PDYN', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Respiratory insufficiency, which in turn affects the gene PDYN. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'ACHE', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene ACHE. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14839,28313.0,Sulpiride,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Sulpiride']",0.5,"Question: Is schizophrenia an indication for Sulpiride?
Reasoning: The disease schizophrenia is associated with the gene DRD2, which is targeted by the drug Sulpiride. These connections suggest that Sulpiride may be effective in treating schizophrenia.
Answer: YES"
15413,37152.0,Gemcitabine,familial ovarian cancer,disease-protein-drug,indication,"['familial ovarian cancer', 'TYMS', 'Gemcitabine']",0.5,"Question: Is familial ovarian cancer an indication for Gemcitabine?
Reasoning: The disease familial ovarian cancer is associated with the gene TYMS, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating familial ovarian cancer.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'SPP1', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene SPP1. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'PDYN', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene PDYN. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'NR1I2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene NR1I2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PET100', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene PET100. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14544,33593.0,Bupropion,obesity disorder,disease-protein-drug,indication,"['obesity disorder', 'CYP2E1', 'Bupropion']",0.5,"Question: Is obesity disorder an indication for Bupropion?
Reasoning: The disease obesity disorder is associated with the gene CYP2E1, which is targeted by the drug Bupropion. These connections suggest that Bupropion may be effective in treating obesity disorder.
Answer: YES"
15596,36935.0,Cabozantinib,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'MET', 'Cabozantinib']",0.5,"Question: Is renal cell adenocarcinoma an indication for Cabozantinib?
Reasoning: The disease renal cell adenocarcinoma is associated with the gene MET, which is targeted by the drug Cabozantinib. These connections suggest that Cabozantinib may be effective in treating renal cell adenocarcinoma.
Answer: YES"
15124,32468.0,Biperiden,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Resting tremor', 'CYP2D6', 'Biperiden']",0.5,"Question: Is postencephalitic Parkinson disease an indication for Biperiden?
Reasoning: The disease postencephalitic Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Biperiden. These connections suggest that Biperiden may be effective in treating postencephalitic Parkinson disease.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Neurodevelopmental delay', 'THRA', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Neurodevelopmental delay, which in turn affects the gene THRA. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'RPS6KA3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene RPS6KA3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
17270,32974.0,Pimavanserin,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'DRD2', 'Pimavanserin']",0.5,"Question: Is atypical juvenile parkinsonism an indication for Pimavanserin?
Reasoning: The disease atypical juvenile parkinsonism is associated with the gene DRD2, which is targeted by the drug Pimavanserin. These connections suggest that Pimavanserin may be effective in treating atypical juvenile parkinsonism.
Answer: YES"
17270,28801.0,Pimavanserin,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DRD2', 'Pimavanserin']",0.5,"Question: Is juvenile onset Parkinson disease 19A an indication for Pimavanserin?
Reasoning: The disease juvenile onset Parkinson disease 19A is associated with the gene DRD2, which is targeted by the drug Pimavanserin. These connections suggest that Pimavanserin may be effective in treating juvenile onset Parkinson disease 19A.
Answer: YES"
17417,28158.0,Natalizumab,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'ICAM1', 'Natalizumab']",0.5,"Question: Is inflammatory bowel disease an indication for Natalizumab?
Reasoning: The disease inflammatory bowel disease is associated with the gene ICAM1, which is targeted by the drug Natalizumab. These connections suggest that Natalizumab may be effective in treating inflammatory bowel disease.
Answer: YES"
14262,36209.0,Salicylic acid,arthropathy,disease-protein-drug,indication,"['arthropathy', 'AKR1C1', 'Salicylic acid']",0.5,"Question: Is arthropathy an indication for Salicylic acid?
Reasoning: The disease arthropathy is associated with the gene AKR1C1, which is targeted by the drug Salicylic acid. These connections suggest that Salicylic acid may be effective in treating arthropathy.
Answer: YES"
14186,37082.0,Cisplatin,malignant germ cell tumor of ovary,disease-protein-drug,indication,"['malignant germ cell tumor of ovary', 'ATP7B', 'Cisplatin']",0.5,"Question: Is malignant germ cell tumor of ovary an indication for Cisplatin?
Reasoning: The disease malignant germ cell tumor of ovary is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating malignant germ cell tumor of ovary.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'KAT8', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene KAT8. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Facial asymmetry', 'ZIC3', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Facial asymmetry, which in turn affects the gene ZIC3. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'PTPRJ', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene PTPRJ. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'FKTN', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene FKTN. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PACS2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene PACS2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'PIGB', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene PIGB. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16825,32296.0,Ardeparin,acquired purpura fulminans,disease-protein-drug,indication,"['acquired purpura fulminans', 'SERPINC1', 'Ardeparin']",0.5,"Question: Is acquired purpura fulminans an indication for Ardeparin?
Reasoning: The disease acquired purpura fulminans is associated with the gene SERPINC1, which is targeted by the drug Ardeparin. These connections suggest that Ardeparin may be effective in treating acquired purpura fulminans.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'MIR96', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene MIR96. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Generalized hypotonia', 'PIGP', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Generalized hypotonia, which in turn affects the gene PIGP. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
17350,29387.0,Etelcalcetide,hyperparathyroidism,disease-protein-drug,indication,"['hyperparathyroidism', 'CASR', 'Etelcalcetide']",0.5,"Question: Is hyperparathyroidism an indication for Etelcalcetide?
Reasoning: The disease hyperparathyroidism is associated with the gene CASR, which is targeted by the drug Etelcalcetide. These connections suggest that Etelcalcetide may be effective in treating hyperparathyroidism.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'TRH', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Action tremor, which in turn affects the gene TRH. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16215,33577.0,Fimasartan,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Fimasartan']",0.5,"Question: Is hypertensive disorder an indication for Fimasartan?
Reasoning: The disease hypertensive disorder is associated with the gene AGTR1, which is targeted by the drug Fimasartan. These connections suggest that Fimasartan may be effective in treating hypertensive disorder.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Delayed speech and language development', 'MED13', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Delayed speech and language development, which in turn affects the gene MED13. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'IL5RA', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene IL5RA. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14831,28974.0,Droxidopa,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'ADRB2', 'Droxidopa']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Droxidopa?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the phenotype Resting tremor, which in turn affects the gene ADRB2. This gene is targeted by the drug Droxidopa. These connections suggest that Droxidopa may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
15018,84327.0,Midostaurin,aleukemic mast cell leukemia,disease-protein-drug,indication,"['aleukemic mast cell leukemia', 'KIT', 'Midostaurin']",0.5,"Question: Is aleukemic mast cell leukemia an indication for Midostaurin?
Reasoning: The disease aleukemic mast cell leukemia is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating aleukemic mast cell leukemia.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'ARSB', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene ARSB. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'ADORA2A', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene ADORA2A. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'SNX27', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene SNX27. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ADORA2A', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ADORA2A. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14186,36794.0,Cisplatin,ovarian adenocarcinoma,disease-protein-drug,indication,"['ovarian adenocarcinoma', 'ATP7B', 'Cisplatin']",0.5,"Question: Is ovarian adenocarcinoma an indication for Cisplatin?
Reasoning: The disease ovarian adenocarcinoma is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating ovarian adenocarcinoma.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SLC35A1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene SLC35A1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14196,30820.0,Propranolol,tufted angioma (disease),disease-phenotype-protein-drug,indication,"['tufted angioma (disease)', 'Pain', 'HTR1A', 'Propranolol']",0.5,"Question: Is tufted angioma (disease) an indication for Propranolol?
Reasoning: The disease tufted angioma (disease) is associated with the phenotype Pain, which in turn affects the gene HTR1A. This gene is targeted by the drug Propranolol. These connections suggest that Propranolol may be effective in treating tufted angioma (disease).
Answer: YES"
14275,37423.0,Doxorubicin,ovarian clear cell adenocarcinoma,disease-protein-drug,indication,"['ovarian clear cell adenocarcinoma', 'CYP1B1', 'Doxorubicin']",0.5,"Question: Is ovarian clear cell adenocarcinoma an indication for Doxorubicin?
Reasoning: The disease ovarian clear cell adenocarcinoma is associated with the gene CYP1B1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating ovarian clear cell adenocarcinoma.
Answer: YES"
20162,35953.0,Alirocumab,atherosclerosis,disease-protein-drug,indication,"['atherosclerosis', 'PCSK9', 'Alirocumab']",0.5,"Question: Is atherosclerosis an indication for Alirocumab?
Reasoning: The disease atherosclerosis is associated with the gene PCSK9, which is targeted by the drug Alirocumab. These connections suggest that Alirocumab may be effective in treating atherosclerosis.
Answer: YES"
15030,30039.0,Ponatinib,"chronic myelogenous leukemia, BCR-ABL1 positive",disease-protein-drug,indication,"['chronic myelogenous leukemia, BCR-ABL1 positive', 'ABL1', 'Ponatinib']",0.5,"Question: Is chronic myelogenous leukemia, BCR-ABL1 positive an indication for Ponatinib?
Reasoning: The disease chronic myelogenous leukemia, BCR-ABL1 positive is associated with the gene ABL1, which is targeted by the drug Ponatinib. These connections suggest that Ponatinib may be effective in treating chronic myelogenous leukemia, BCR-ABL1 positive.
Answer: YES"
14024,32746.0,Prednisone,Stevens-Johnson syndrome,disease-protein-drug,indication,"['Stevens-Johnson syndrome', 'ALB', 'Prednisone']",0.5,"Question: Is Stevens-Johnson syndrome an indication for Prednisone?
Reasoning: The disease Stevens-Johnson syndrome is associated with the gene ALB, which is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating Stevens-Johnson syndrome.
Answer: YES"
14030,37888.0,Prednisolone,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Prednisolone']",0.5,"Question: Is allergic rhinitis an indication for Prednisolone?
Reasoning: The disease allergic rhinitis is associated with the gene ALB, which is targeted by the drug Prednisolone. These connections suggest that Prednisolone may be effective in treating allergic rhinitis.
Answer: YES"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'SREBF1', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene SREBF1. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
14178,28313.0,Chlorpromazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'CYP2E1', 'Chlorpromazine']",0.5,"Question: Is schizophrenia an indication for Chlorpromazine?
Reasoning: The disease schizophrenia is associated with the gene CYP2E1, which is targeted by the drug Chlorpromazine. These connections suggest that Chlorpromazine may be effective in treating schizophrenia.
Answer: YES"
15094,83841.0,Mirtazapine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Mirtazapine']",0.5,"Question: Is endogenous depression an indication for Mirtazapine?
Reasoning: The disease endogenous depression is associated with the gene SLC6A4, which is targeted by the drug Mirtazapine. These connections suggest that Mirtazapine may be effective in treating endogenous depression.
Answer: YES"
14831,31408.0,Droxidopa,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'DDC', 'Droxidopa']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Droxidopa?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the gene DDC, which is targeted by the drug Droxidopa. These connections suggest that Droxidopa may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SLC12A5', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SLC12A5. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'KRAS', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene KRAS. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'FAAH', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene FAAH. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'HCN1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene HCN1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14792,37967.0,Paclitaxel,ovarian endometrioid adenocarcinoma,disease-protein-drug,indication,"['ovarian endometrioid adenocarcinoma', 'CYP1B1', 'Paclitaxel']",0.5,"Question: Is ovarian endometrioid adenocarcinoma an indication for Paclitaxel?
Reasoning: The disease ovarian endometrioid adenocarcinoma is associated with the gene CYP1B1, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating ovarian endometrioid adenocarcinoma.
Answer: YES"
14220,31408.0,Apomorphine,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'DRD1', 'Apomorphine']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Apomorphine?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the gene DRD1, which is targeted by the drug Apomorphine. These connections suggest that Apomorphine may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'TIMM8A', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene TIMM8A. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15858,31384.0,Migalastat,Fabry disease,disease-protein-drug,indication,"['Fabry disease', 'GLA', 'Migalastat']",0.5,"Question: Is Fabry disease an indication for Migalastat?
Reasoning: The disease Fabry disease is associated with the gene GLA, which is targeted by the drug Migalastat. These connections suggest that Migalastat may be effective in treating Fabry disease.
Answer: YES"
14999,30318.0,Quetiapine,autosomal recessive severe congenital neutropenia due to JAGN1 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to JAGN1 deficiency', 'Short stature', 'EIF4A3', 'Quetiapine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to JAGN1 deficiency an indication for Quetiapine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to JAGN1 deficiency is associated with the phenotype Short stature, which in turn affects the gene EIF4A3. This gene is not targeted by the drug Quetiapine. These connections suggest that Quetiapine may not be effective in treating autosomal recessive severe congenital neutropenia due to JAGN1 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'MYO15A', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene MYO15A. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15294,28780.0,Tacrine,Alzheimer disease,disease-phenotype-protein-drug,indication,"['Alzheimer disease', 'Seizure', 'BCHE', 'Tacrine']",0.5,"Question: Is Alzheimer disease an indication for Tacrine?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene BCHE. This gene is targeted by the drug Tacrine. These connections suggest that Tacrine may be effective in treating Alzheimer disease.
Answer: YES"
15413,36792.0,Gemcitabine,ovarian mucinous adenocarcinoma,disease-protein-drug,indication,"['ovarian mucinous adenocarcinoma', 'TYMS', 'Gemcitabine']",0.5,"Question: Is ovarian mucinous adenocarcinoma an indication for Gemcitabine?
Reasoning: The disease ovarian mucinous adenocarcinoma is associated with the gene TYMS, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating ovarian mucinous adenocarcinoma.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'CSF2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene CSF2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14269,29078.0,Methylprednisolone,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Methylprednisolone']",0.5,"Question: Is rheumatoid arthritis an indication for Methylprednisolone?
Reasoning: The disease rheumatoid arthritis is associated with the gene ABCB1, which is targeted by the drug Methylprednisolone. These connections suggest that Methylprednisolone may be effective in treating rheumatoid arthritis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'KAT8', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene KAT8. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'PEPD', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene PEPD. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
15098,27843.0,Promazine,acute intermittent porphyria,disease-phenotype-protein-drug,indication,"['acute intermittent porphyria', 'Tachycardia', 'DRD2', 'Promazine']",0.5,"Question: Is acute intermittent porphyria an indication for Promazine?
Reasoning: The disease acute intermittent porphyria is associated with the phenotype Tachycardia, which in turn affects the gene DRD2. This gene is targeted by the drug Promazine. These connections suggest that Promazine may be effective in treating acute intermittent porphyria.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'KPTN', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene KPTN. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16011,38242.0,Loxapine,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'HTR5A', 'Loxapine']",0.5,"Question: Is bipolar disorder an indication for Loxapine?
Reasoning: The disease bipolar disorder is associated with the gene HTR5A, which is targeted by the drug Loxapine. These connections suggest that Loxapine may be effective in treating bipolar disorder.
Answer: YES"
15970,30039.0,Radotinib,"chronic myelogenous leukemia, BCR-ABL1 positive",disease-protein-drug,indication,"['chronic myelogenous leukemia, BCR-ABL1 positive', 'ABL1', 'Radotinib']",0.5,"Question: Is chronic myelogenous leukemia, BCR-ABL1 positive an indication for Radotinib?
Reasoning: The disease chronic myelogenous leukemia, BCR-ABL1 positive is associated with the gene ABL1, which is targeted by the drug Radotinib. These connections suggest that Radotinib may be effective in treating chronic myelogenous leukemia, BCR-ABL1 positive.
Answer: YES"
14168,84246.0,Spironolactone,Waterhouse-Friderichsen syndrome,disease-protein-drug,indication,"['Waterhouse-Friderichsen syndrome', 'CYP11B1', 'Spironolactone']",0.5,"Question: Is Waterhouse-Friderichsen syndrome an indication for Spironolactone?
Reasoning: The disease Waterhouse-Friderichsen syndrome is associated with the gene CYP11B1, which is targeted by the drug Spironolactone. These connections suggest that Spironolactone may be effective in treating Waterhouse-Friderichsen syndrome.
Answer: YES"
15430,32033.0,Pentobarbital,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Pentobarbital']",0.5,"Question: Is insomnia (disease) an indication for Pentobarbital?
Reasoning: The disease insomnia (disease) is associated with the gene GABRB3, which is targeted by the drug Pentobarbital. These connections suggest that Pentobarbital may be effective in treating insomnia (disease).
Answer: YES"
15781,29078.0,Acetylsalicylic acid,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Acetylsalicylic acid']",0.5,"Question: Is rheumatoid arthritis an indication for Acetylsalicylic acid?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Acetylsalicylic acid. These connections suggest that Acetylsalicylic acid may be effective in treating rheumatoid arthritis.
Answer: YES"
14269,83789.0,Methylprednisolone,serum sickness,disease-protein-drug,indication,"['serum sickness', 'ALB', 'Methylprednisolone']",0.5,"Question: Is serum sickness an indication for Methylprednisolone?
Reasoning: The disease serum sickness is associated with the gene ALB, which is targeted by the drug Methylprednisolone. These connections suggest that Methylprednisolone may be effective in treating serum sickness.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'CLU', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene CLU. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'ITGA2B', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene ITGA2B. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14952,35915.0,Haloperidol,mental disorder,disease-protein-drug,indication,"['mental disorder', 'HTR2A', 'Haloperidol']",0.5,"Question: Is mental disorder an indication for Haloperidol?
Reasoning: The disease mental disorder is associated with the gene HTR2A, which is targeted by the drug Haloperidol. These connections suggest that Haloperidol may be effective in treating mental disorder.
Answer: YES"
14792,32307.0,Paclitaxel,desmoplastic small round cell tumor,disease-phenotype-protein-drug,indication,"['desmoplastic small round cell tumor', 'Hepatomegaly', 'NR1I2', 'Paclitaxel']",0.5,"Question: Is desmoplastic small round cell tumor an indication for Paclitaxel?
Reasoning: The disease desmoplastic small round cell tumor is associated with the phenotype Hepatomegaly, which in turn affects the gene NR1I2. This gene is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating desmoplastic small round cell tumor.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'CRYGD', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene CRYGD. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14965,33577.0,Eplerenone,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Eplerenone']",0.5,"Question: Is hypertensive disorder an indication for Eplerenone?
Reasoning: The disease hypertensive disorder is associated with the gene CYP3A5, which is targeted by the drug Eplerenone. These connections suggest that Eplerenone may be effective in treating hypertensive disorder.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CRH', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CRH. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14295,33683.0,Promethazine,urticaria (disease),disease-protein-drug,indication,"['urticaria (disease)', 'ALB', 'Promethazine']",0.5,"Question: Is urticaria (disease) an indication for Promethazine?
Reasoning: The disease urticaria (disease) is associated with the gene ALB, which is targeted by the drug Promethazine. These connections suggest that Promethazine may be effective in treating urticaria (disease).
Answer: YES"
14516,31380.0,Tegafur,diffuse gastric adenocarcinoma,disease-protein-drug,indication,"['diffuse gastric adenocarcinoma', 'CYP2A6', 'Tegafur']",0.5,"Question: Is diffuse gastric adenocarcinoma an indication for Tegafur?
Reasoning: The disease diffuse gastric adenocarcinoma is associated with the gene CYP2A6, which is targeted by the drug Tegafur. These connections suggest that Tegafur may be effective in treating diffuse gastric adenocarcinoma.
Answer: YES"
14875,32617.0,Tretamine,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'BCHE', 'Tretamine']",0.5,"Question: Is hereditary breast ovarian cancer syndrome an indication for Tretamine?
Reasoning: The disease hereditary breast ovarian cancer syndrome is associated with the gene BCHE, which is targeted by the drug Tretamine. These connections suggest that Tretamine may be effective in treating hereditary breast ovarian cancer syndrome.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'MIR192', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene MIR192. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15612,33450.0,Siltuximab,Kimura disease,disease-protein-drug,indication,"['Kimura disease', 'IL6', 'Siltuximab']",0.5,"Question: Is Kimura disease an indication for Siltuximab?
Reasoning: The disease Kimura disease is associated with the gene IL6, which is targeted by the drug Siltuximab. These connections suggest that Siltuximab may be effective in treating Kimura disease.
Answer: YES"
14713,83861.0,Decitabine,acute myeloid leukemia with NPM1 somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with NPM1 somatic mutations', 'DNMT3A', 'Decitabine']",0.5,"Question: Is acute myeloid leukemia with NPM1 somatic mutations an indication for Decitabine?
Reasoning: The disease acute myeloid leukemia with NPM1 somatic mutations is associated with the gene DNMT3A, which is targeted by the drug Decitabine. These connections suggest that Decitabine may be effective in treating acute myeloid leukemia with NPM1 somatic mutations.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'IL6', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene IL6. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14028,32815.0,Hydrocortisone,Trichinellosis,disease-phenotype-protein-drug,indication,"['Trichinellosis', 'Nausea', 'ABCB1', 'Hydrocortisone']",0.5,"Question: Is Trichinellosis an indication for Hydrocortisone?
Reasoning: The disease Trichinellosis is associated with the phenotype Nausea, which in turn affects the gene ABCB1. This gene is targeted by the drug Hydrocortisone. These connections suggest that Hydrocortisone may be effective in treating Trichinellosis.
Answer: YES"
15124,28547.0,Biperiden,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Biperiden']",0.5,"Question: Is Parkinson disease an indication for Biperiden?
Reasoning: The disease Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Biperiden. These connections suggest that Biperiden may be effective in treating Parkinson disease.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'HCN1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene HCN1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Feeding difficulties', 'CDK8', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Feeding difficulties, which in turn affects the gene CDK8. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14975,36935.0,Sirolimus,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'MTOR', 'Sirolimus']",0.5,"Question: Is renal cell adenocarcinoma an indication for Sirolimus?
Reasoning: The disease renal cell adenocarcinoma is associated with the gene MTOR, which is targeted by the drug Sirolimus. These connections suggest that Sirolimus may be effective in treating renal cell adenocarcinoma.
Answer: YES"
14163,33577.0,Diltiazem,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Diltiazem']",0.5,"Question: Is hypertensive disorder an indication for Diltiazem?
Reasoning: The disease hypertensive disorder is associated with the gene CYP3A5, which is targeted by the drug Diltiazem. These connections suggest that Diltiazem may be effective in treating hypertensive disorder.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'ACTG1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene ACTG1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'ITGB3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene ITGB3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15040,37743.0,Paritaprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Paritaprevir']",0.5,"Question: Is hepatitis C virus infection an indication for Paritaprevir?
Reasoning: The disease hepatitis C virus infection is associated with the gene CYP3A4, which is targeted by the drug Paritaprevir. These connections suggest that Paritaprevir may be effective in treating hepatitis C virus infection.
Answer: YES"
14186,37466.0,Cisplatin,ovarian small cell carcinoma,disease-protein-drug,indication,"['ovarian small cell carcinoma', 'ATP7B', 'Cisplatin']",0.5,"Question: Is ovarian small cell carcinoma an indication for Cisplatin?
Reasoning: The disease ovarian small cell carcinoma is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating ovarian small cell carcinoma.
Answer: YES"
14292,39622.0,Oxybutynin,cauda equina syndrome,disease-protein-drug,indication,"['cauda equina syndrome', 'CHRM2', 'Oxybutynin']",0.5,"Question: Is cauda equina syndrome an indication for Oxybutynin?
Reasoning: The disease cauda equina syndrome is associated with the gene CHRM2, which is targeted by the drug Oxybutynin. These connections suggest that Oxybutynin may be effective in treating cauda equina syndrome.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SSTR2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene SSTR2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'NGFR', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene NGFR. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'PITX2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene PITX2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15597,27610.0,Ruxolitinib,primary myelofibrosis,disease-phenotype-protein-drug,indication,"['primary myelofibrosis', 'Venous thrombosis', 'JAK2', 'Ruxolitinib']",0.5,"Question: Is primary myelofibrosis an indication for Ruxolitinib?
Reasoning: The disease primary myelofibrosis is associated with the phenotype Venous thrombosis, which in turn affects the gene JAK2. This gene is targeted by the drug Ruxolitinib. These connections suggest that Ruxolitinib may be effective in treating primary myelofibrosis.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'FUCA1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene FUCA1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'IL3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene IL3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14737,83818.0,Carboplatin,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,indication,"['primary non-gestational choriocarcinoma of ovary', 'ATP7B', 'Carboplatin']",0.5,"Question: Is primary non-gestational choriocarcinoma of ovary an indication for Carboplatin?
Reasoning: The disease primary non-gestational choriocarcinoma of ovary is associated with the gene ATP7B, which is targeted by the drug Carboplatin. These connections suggest that Carboplatin may be effective in treating primary non-gestational choriocarcinoma of ovary.
Answer: YES"
14544,83841.0,Bupropion,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'CYP2C9', 'Bupropion']",0.5,"Question: Is endogenous depression an indication for Bupropion?
Reasoning: The disease endogenous depression is associated with the gene CYP2C9, which is targeted by the drug Bupropion. These connections suggest that Bupropion may be effective in treating endogenous depression.
Answer: YES"
14178,83779.0,Chlorpromazine,schizoaffective disorder,disease-protein-drug,indication,"['schizoaffective disorder', 'DRD5', 'Chlorpromazine']",0.5,"Question: Is schizoaffective disorder an indication for Chlorpromazine?
Reasoning: The disease schizoaffective disorder is associated with the gene DRD5, which is targeted by the drug Chlorpromazine. These connections suggest that Chlorpromazine may be effective in treating schizoaffective disorder.
Answer: YES"
14193,37888.0,Hydroxyzine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Hydroxyzine']",0.5,"Question: Is allergic rhinitis an indication for Hydroxyzine?
Reasoning: The disease allergic rhinitis is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is targeted by the drug Hydroxyzine. These connections suggest that Hydroxyzine may be effective in treating allergic rhinitis.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'ATG5', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene ATG5. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14719,35771.0,Epirubicin,breast neoplasm,disease-protein-drug,indication,"['breast neoplasm', 'TOP2A', 'Epirubicin']",0.5,"Question: Is breast neoplasm an indication for Epirubicin?
Reasoning: The disease breast neoplasm is associated with the gene TOP2A, which is targeted by the drug Epirubicin. These connections suggest that Epirubicin may be effective in treating breast neoplasm.
Answer: YES"
14351,28313.0,Thiothixene,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Thiothixene']",0.5,"Question: Is schizophrenia an indication for Thiothixene?
Reasoning: The disease schizophrenia is associated with the gene DRD2, which is targeted by the drug Thiothixene. These connections suggest that Thiothixene may be effective in treating schizophrenia.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Vomiting', 'IFNA2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Vomiting, which in turn affects the gene IFNA2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CHRNA5', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CHRNA5. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
19222,27933.0,Isocarboxazid,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOB', 'Isocarboxazid']",0.5,"Question: Is anxiety disorder an indication for Isocarboxazid?
Reasoning: The disease anxiety disorder is associated with the gene MAOB, which is targeted by the drug Isocarboxazid. These connections suggest that Isocarboxazid may be effective in treating anxiety disorder.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'GALNT13', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene GALNT13. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TBCK', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TBCK. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15822,29955.0,Ursodeoxycholic acid,Reynolds syndrome,disease-protein-drug,indication,"['Reynolds syndrome', 'ABCC2', 'Ursodeoxycholic acid']",0.5,"Question: Is Reynolds syndrome an indication for Ursodeoxycholic acid?
Reasoning: The disease Reynolds syndrome is associated with the gene ABCC2, which is targeted by the drug Ursodeoxycholic acid. These connections suggest that Ursodeoxycholic acid may be effective in treating Reynolds syndrome.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'MECP2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene MECP2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14946,33577.0,Nisoldipine,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Nisoldipine']",0.5,"Question: Is hypertensive disorder an indication for Nisoldipine?
Reasoning: The disease hypertensive disorder is associated with the gene CYP3A5, which is targeted by the drug Nisoldipine. These connections suggest that Nisoldipine may be effective in treating hypertensive disorder.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'PPP2CA', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene PPP2CA. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'KCNA5', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene KCNA5. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SLC12A5', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene SLC12A5. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Respiratory insufficiency', 'TRH', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Respiratory insufficiency, which in turn affects the gene TRH. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15090,32456.0,Clobazam,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'GABRA5', 'Clobazam']",0.5,"Question: Is cutis verticis gyrata an indication for Clobazam?
Reasoning: The disease cutis verticis gyrata is associated with the phenotype Seizure, which in turn affects the gene GABRA5. This gene is targeted by the drug Clobazam. These connections suggest that Clobazam may be effective in treating cutis verticis gyrata.
Answer: YES"
15018,38274.0,Midostaurin,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'KIT', 'Midostaurin']",0.5,"Question: Is inherited acute myeloid leukemia an indication for Midostaurin?
Reasoning: The disease inherited acute myeloid leukemia is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating inherited acute myeloid leukemia.
Answer: YES"
14159,37888.0,Ipratropium,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Ipratropium']",0.5,"Question: Is allergic rhinitis an indication for Ipratropium?
Reasoning: The disease allergic rhinitis is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is targeted by the drug Ipratropium. These connections suggest that Ipratropium may be effective in treating allergic rhinitis.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CCL11', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CCL11. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Lethargy', 'ABAT', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Lethargy, which in turn affects the gene ABAT. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'APP', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene APP. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14885,83760.0,Moclobemide,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'MAOB', 'Moclobemide']",0.5,"Question: Is dysthymic disorder an indication for Moclobemide?
Reasoning: The disease dysthymic disorder is associated with the gene MAOB, which is targeted by the drug Moclobemide. These connections suggest that Moclobemide may be effective in treating dysthymic disorder.
Answer: YES"
14806,28801.0,Entacapone,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'CYP2D6', 'Entacapone']",0.5,"Question: Is juvenile onset Parkinson disease 19A an indication for Entacapone?
Reasoning: The disease juvenile onset Parkinson disease 19A is associated with the phenotype Tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Entacapone. These connections suggest that Entacapone may be effective in treating juvenile onset Parkinson disease 19A.
Answer: YES"
17605,28849.0,Cetuximab,colorectal cancer,disease-protein-drug,indication,"['colorectal cancer', 'EGFR', 'Cetuximab']",0.5,"Question: Is colorectal cancer an indication for Cetuximab?
Reasoning: The disease colorectal cancer is associated with the gene EGFR, which is targeted by the drug Cetuximab. These connections suggest that Cetuximab may be effective in treating colorectal cancer.
Answer: YES"
14601,33675.0,Zafirlukast,asthma,disease-protein-drug,indication,"['asthma', 'PTGS1', 'Zafirlukast']",0.5,"Question: Is asthma an indication for Zafirlukast?
Reasoning: The disease asthma is associated with the gene PTGS1, which is targeted by the drug Zafirlukast. These connections suggest that Zafirlukast may be effective in treating asthma.
Answer: YES"
15505,36035.0,Tasosartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Tasosartan']",0.5,"Question: Is hypertension an indication for Tasosartan?
Reasoning: The disease hypertension is associated with the gene AGTR1, which is targeted by the drug Tasosartan. These connections suggest that Tasosartan may be effective in treating hypertension.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'SIX1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene SIX1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'AHR', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene AHR. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CLU', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CLU. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'PRLR', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene PRLR. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
15294,38575.0,Tacrine,cerebellar degeneration,disease-protein-drug,indication,"['cerebellar degeneration', 'BCHE', 'Tacrine']",0.5,"Question: Is cerebellar degeneration an indication for Tacrine?
Reasoning: The disease cerebellar degeneration is associated with the gene BCHE, which is targeted by the drug Tacrine. These connections suggest that Tacrine may be effective in treating cerebellar degeneration.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'FANCG', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene FANCG. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'GHRL', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene GHRL. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'APEX1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene APEX1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'AP4S1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene AP4S1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TANC2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TANC2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15413,83820.0,Gemcitabine,maligant granulosa cell tumor of ovary,disease-protein-drug,indication,"['maligant granulosa cell tumor of ovary', 'TYMS', 'Gemcitabine']",0.5,"Question: Is maligant granulosa cell tumor of ovary an indication for Gemcitabine?
Reasoning: The disease maligant granulosa cell tumor of ovary is associated with the gene TYMS, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating maligant granulosa cell tumor of ovary.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'ZMIZ1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene ZMIZ1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14140,38242.0,Ziprasidone,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'HTR5A', 'Ziprasidone']",0.5,"Question: Is bipolar disorder an indication for Ziprasidone?
Reasoning: The disease bipolar disorder is associated with the gene HTR5A, which is targeted by the drug Ziprasidone. These connections suggest that Ziprasidone may be effective in treating bipolar disorder.
Answer: YES"
15160,35897.0,Arformoterol,pulmonary emphysema,disease-protein-drug,indication,"['pulmonary emphysema', 'CYP2A6', 'Arformoterol']",0.5,"Question: Is pulmonary emphysema an indication for Arformoterol?
Reasoning: The disease pulmonary emphysema is associated with the gene CYP2A6, which is targeted by the drug Arformoterol. These connections suggest that Arformoterol may be effective in treating pulmonary emphysema.
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'KLK10', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene KLK10. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CD274', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene CD274. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'GDF2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene GDF2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15599,32621.0,Regorafenib,pediatric hepatocellular carcinoma,disease-protein-drug,indication,"['pediatric hepatocellular carcinoma', 'ABCB1', 'Regorafenib']",0.5,"Question: Is pediatric hepatocellular carcinoma an indication for Regorafenib?
Reasoning: The disease pediatric hepatocellular carcinoma is associated with the gene ABCB1, which is targeted by the drug Regorafenib. These connections suggest that Regorafenib may be effective in treating pediatric hepatocellular carcinoma.
Answer: YES"
14030,30990.0,Prednisolone,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Hepatomegaly', 'ALB', 'Prednisolone']",0.5,"Question: Is mycosis fungoides and variants an indication for Prednisolone?
Reasoning: The disease mycosis fungoides and variants is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Prednisolone. These connections suggest that Prednisolone may be effective in treating mycosis fungoides and variants.
Answer: YES"
19207,28801.0,Carbidopa,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DDC', 'Carbidopa']",0.5,"Question: Is juvenile onset Parkinson disease 19A an indication for Carbidopa?
Reasoning: The disease juvenile onset Parkinson disease 19A is associated with the gene DDC, which is targeted by the drug Carbidopa. These connections suggest that Carbidopa may be effective in treating juvenile onset Parkinson disease 19A.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'BCHE', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene BCHE. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'LNPK', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene LNPK. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'PIGM', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene PIGM. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'RDX', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene RDX. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15413,83817.0,Gemcitabine,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary site-specific ovarian cancer syndrome', 'TYMS', 'Gemcitabine']",0.5,"Question: Is hereditary site-specific ovarian cancer syndrome an indication for Gemcitabine?
Reasoning: The disease hereditary site-specific ovarian cancer syndrome is associated with the gene TYMS, which is targeted by the drug Gemcitabine. These connections suggest that Gemcitabine may be effective in treating hereditary site-specific ovarian cancer syndrome.
Answer: YES"
14975,29275.0,Sirolimus,lymphangioleiomyomatosis,disease-phenotype-protein-drug,indication,"['lymphangioleiomyomatosis', 'Seizure', 'FGF2', 'Sirolimus']",0.5,"Question: Is lymphangioleiomyomatosis an indication for Sirolimus?
Reasoning: The disease lymphangioleiomyomatosis is associated with the phenotype Seizure, which in turn affects the gene FGF2. This gene is targeted by the drug Sirolimus. These connections suggest that Sirolimus may be effective in treating lymphangioleiomyomatosis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ALPL', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ALPL. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'PDYN', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene PDYN. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14023,32563.0,Triamcinolone,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,indication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Triamcinolone']",0.5,"Question: Is heparin-induced thrombocytopenia (disease) an indication for Triamcinolone?
Reasoning: The disease heparin-induced thrombocytopenia (disease) is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating heparin-induced thrombocytopenia (disease).
Answer: YES"
16510,31107.0,Bevacizumab,cervical cancer,disease-protein-drug,indication,"['cervical cancer', 'VEGFA', 'Bevacizumab']",0.5,"Question: Is cervical cancer an indication for Bevacizumab?
Reasoning: The disease cervical cancer is associated with the gene VEGFA, which is targeted by the drug Bevacizumab. These connections suggest that Bevacizumab may be effective in treating cervical cancer.
Answer: YES"
14140,28313.0,Ziprasidone,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'ABCB1', 'Ziprasidone']",0.5,"Question: Is schizophrenia an indication for Ziprasidone?
Reasoning: The disease schizophrenia is associated with the gene ABCB1, which is targeted by the drug Ziprasidone. These connections suggest that Ziprasidone may be effective in treating schizophrenia.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'NSF', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene NSF. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'ADIPOQ', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene ADIPOQ. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'KCNJ11', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene KCNJ11. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'GTF3C3', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene GTF3C3. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14220,28801.0,Apomorphine,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DRD1', 'Apomorphine']",0.5,"Question: Is juvenile onset Parkinson disease 19A an indication for Apomorphine?
Reasoning: The disease juvenile onset Parkinson disease 19A is associated with the gene DRD1, which is targeted by the drug Apomorphine. These connections suggest that Apomorphine may be effective in treating juvenile onset Parkinson disease 19A.
Answer: YES"
16056,31408.0,Procyclidine,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'CHRM4', 'Procyclidine']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Procyclidine?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the phenotype Resting tremor, which in turn affects the gene CHRM4. This gene is targeted by the drug Procyclidine. These connections suggest that Procyclidine may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
15492,35963.0,Estramustine,prostate carcinoma,disease-protein-drug,indication,"['prostate carcinoma', 'ESR1', 'Estramustine']",0.5,"Question: Is prostate carcinoma an indication for Estramustine?
Reasoning: The disease prostate carcinoma is associated with the gene ESR1, which is targeted by the drug Estramustine. These connections suggest that Estramustine may be effective in treating prostate carcinoma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CHAT', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CHAT. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'P4HTM', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene P4HTM. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14275,33077.0,Doxorubicin,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Hepatomegaly', 'NOS3', 'Doxorubicin']",0.5,"Question: Is Hodgkins lymphoma an indication for Doxorubicin?
Reasoning: The disease Hodgkins lymphoma is associated with the phenotype Hepatomegaly, which in turn affects the gene NOS3. This gene is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating Hodgkins lymphoma.
Answer: YES"
14144,29865.0,Topiramate,Lennox-Gastaut syndrome,disease-protein-drug,indication,"['Lennox-Gastaut syndrome', 'SCN1A', 'Topiramate']",0.5,"Question: Is Lennox-Gastaut syndrome an indication for Topiramate?
Reasoning: The disease Lennox-Gastaut syndrome is associated with the gene SCN1A, which is targeted by the drug Topiramate. These connections suggest that Topiramate may be effective in treating Lennox-Gastaut syndrome.
Answer: YES"
14792,32589.0,Paclitaxel,Kaposi's sarcoma (disease),disease-protein-drug,indication,"[""Kaposi's sarcoma (disease)"", 'BCL2', 'Paclitaxel']",0.5,"Question: Is Kaposi's sarcoma (disease) an indication for Paclitaxel?
Reasoning: The disease Kaposi's sarcoma (disease) is associated with the gene BCL2, which is targeted by the drug Paclitaxel. These connections suggest that Paclitaxel may be effective in treating Kaposi's sarcoma (disease).
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Short stature', 'PUS7', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Short stature, which in turn affects the gene PUS7. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15250,27610.0,Fedratinib,primary myelofibrosis,disease-protein-drug,indication,"['primary myelofibrosis', 'JAK2', 'Fedratinib']",0.5,"Question: Is primary myelofibrosis an indication for Fedratinib?
Reasoning: The disease primary myelofibrosis is associated with the gene JAK2, which is targeted by the drug Fedratinib. These connections suggest that Fedratinib may be effective in treating primary myelofibrosis.
Answer: YES"
15110,83778.0,Fluphenazine,schizophreniform disorder,disease-protein-drug,indication,"['schizophreniform disorder', 'HTR2A', 'Fluphenazine']",0.5,"Question: Is schizophreniform disorder an indication for Fluphenazine?
Reasoning: The disease schizophreniform disorder is associated with the gene HTR2A, which is targeted by the drug Fluphenazine. These connections suggest that Fluphenazine may be effective in treating schizophreniform disorder.
Answer: YES"
17174,83911.0,Rivastigmine,Reye syndrome,disease-protein-drug,indication,"['Reye syndrome', 'BCHE', 'Rivastigmine']",0.5,"Question: Is Reye syndrome an indication for Rivastigmine?
Reasoning: The disease Reye syndrome is associated with the gene BCHE, which is targeted by the drug Rivastigmine. These connections suggest that Rivastigmine may be effective in treating Reye syndrome.
Answer: YES"
16056,32974.0,Procyclidine,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'CHRM4', 'Procyclidine']",0.5,"Question: Is atypical juvenile parkinsonism an indication for Procyclidine?
Reasoning: The disease atypical juvenile parkinsonism is associated with the phenotype Resting tremor, which in turn affects the gene CHRM4. This gene is targeted by the drug Procyclidine. These connections suggest that Procyclidine may be effective in treating atypical juvenile parkinsonism.
Answer: YES"
14194,31116.0,Methotrexate,lung cancer,disease-protein-drug,indication,"['lung cancer', 'MTHFR', 'Methotrexate']",0.5,"Question: Is lung cancer an indication for Methotrexate?
Reasoning: The disease lung cancer is associated with the gene MTHFR, which is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating lung cancer.
Answer: YES"
15784,33575.0,Gliquidone,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'ABCC8', 'Gliquidone']",0.5,"Question: Is diabetes mellitus (disease) an indication for Gliquidone?
Reasoning: The disease diabetes mellitus (disease) is associated with the gene ABCC8, which is targeted by the drug Gliquidone. These connections suggest that Gliquidone may be effective in treating diabetes mellitus (disease).
Answer: YES"
17023,84174.0,Tafamidis,AH amyloidosis,disease-protein-drug,indication,"['AH amyloidosis', 'TTR', 'Tafamidis']",0.5,"Question: Is AH amyloidosis an indication for Tafamidis?
Reasoning: The disease AH amyloidosis is associated with the gene TTR, which is targeted by the drug Tafamidis. These connections suggest that Tafamidis may be effective in treating AH amyloidosis.
Answer: YES"
14194,31481.0,Methotrexate,bone osteosarcoma,disease-phenotype-protein-drug,indication,"['bone osteosarcoma', 'Pain', 'ALB', 'Methotrexate']",0.5,"Question: Is bone osteosarcoma an indication for Methotrexate?
Reasoning: The disease bone osteosarcoma is associated with the phenotype Pain, which in turn affects the gene ALB. This gene is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating bone osteosarcoma.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'TMX2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene TMX2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TRPM3', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TRPM3. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14298,33598.0,Rosuvastatin,stroke disorder,disease-protein-drug,indication,"['stroke disorder', 'ALB', 'Rosuvastatin']",0.5,"Question: Is stroke disorder an indication for Rosuvastatin?
Reasoning: The disease stroke disorder is associated with the gene ALB, which is targeted by the drug Rosuvastatin. These connections suggest that Rosuvastatin may be effective in treating stroke disorder.
Answer: YES"
15018,83854.0,Midostaurin,acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor,disease-protein-drug,indication,"['acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor', 'KIT', 'Midostaurin']",0.5,"Question: Is acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor an indication for Midostaurin?
Reasoning: The disease acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor.
Answer: YES"
14320,84156.0,Dexamethasone,plasmablastic lymphoma,disease-protein-drug,indication,"['plasmablastic lymphoma', 'ABCB1', 'Dexamethasone']",0.5,"Question: Is plasmablastic lymphoma an indication for Dexamethasone?
Reasoning: The disease plasmablastic lymphoma is associated with the gene ABCB1, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating plasmablastic lymphoma.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Delayed speech and language development', 'DPYD', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Delayed speech and language development, which in turn affects the gene DPYD. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'DHPS', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene DHPS. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15035,38957.0,Vortioxetine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'HTR1B', 'Vortioxetine']",0.5,"Question: Is major depressive disorder an indication for Vortioxetine?
Reasoning: The disease major depressive disorder is associated with the gene HTR1B, which is targeted by the drug Vortioxetine. These connections suggest that Vortioxetine may be effective in treating major depressive disorder.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ABAT', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ABAT. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'SLC29A3', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene SLC29A3. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14685,30827.0,Progesterone,endometrial cancer,disease-protein-drug,indication,"['endometrial cancer', 'PGR', 'Progesterone']",0.5,"Question: Is endometrial cancer an indication for Progesterone?
Reasoning: The disease endometrial cancer is associated with the gene PGR, which is targeted by the drug Progesterone. These connections suggest that Progesterone may be effective in treating endometrial cancer.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'CLRN1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene CLRN1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'KMT2E', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene KMT2E. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15002,36937.0,Sunitinib,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'FLT4', 'Sunitinib']",0.5,"Question: Is clear cell renal carcinoma an indication for Sunitinib?
Reasoning: The disease clear cell renal carcinoma is associated with the gene FLT4, which is targeted by the drug Sunitinib. These connections suggest that Sunitinib may be effective in treating clear cell renal carcinoma.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'HNRNPR', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene HNRNPR. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hyperkalemia', 'INS', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hyperkalemia, which in turn affects the gene INS. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14656,32456.0,Cannabidiol,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'OPRM1', 'Cannabidiol']",0.5,"Question: Is cutis verticis gyrata an indication for Cannabidiol?
Reasoning: The disease cutis verticis gyrata is associated with the phenotype Seizure, which in turn affects the gene OPRM1. This gene is targeted by the drug Cannabidiol. These connections suggest that Cannabidiol may be effective in treating cutis verticis gyrata.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'SIGMAR1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene SIGMAR1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15263,38274.0,Enasidenib,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'IDH2', 'Enasidenib']",0.5,"Question: Is inherited acute myeloid leukemia an indication for Enasidenib?
Reasoning: The disease inherited acute myeloid leukemia is associated with the gene IDH2, which is targeted by the drug Enasidenib. These connections suggest that Enasidenib may be effective in treating inherited acute myeloid leukemia.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Vomiting', 'IFNA2', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Vomiting, which in turn affects the gene IFNA2. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Motor delay', 'PAX7', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Motor delay, which in turn affects the gene PAX7. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
14230,33314.0,Tetracycline,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'ALB', 'Tetracycline']",0.5,"Question: Is leptospirosis an indication for Tetracycline?
Reasoning: The disease leptospirosis is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Tetracycline. These connections suggest that Tetracycline may be effective in treating leptospirosis.
Answer: YES"
14275,36812.0,Doxorubicin,lung neoplasm,disease-protein-drug,indication,"['lung neoplasm', 'NOS2', 'Doxorubicin']",0.5,"Question: Is lung neoplasm an indication for Doxorubicin?
Reasoning: The disease lung neoplasm is associated with the gene NOS2, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating lung neoplasm.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'POMC', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene POMC. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'FA2H', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene FA2H. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14019,31511.0,Betamethasone,autoimmune thrombocytopenic,disease-phenotype-protein-drug,indication,"['autoimmune thrombocytopenic', 'Thrombocytopenia', 'ALB', 'Betamethasone']",0.5,"Question: Is autoimmune thrombocytopenic an indication for Betamethasone?
Reasoning: The disease autoimmune thrombocytopenic is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Betamethasone. These connections suggest that Betamethasone may be effective in treating autoimmune thrombocytopenic.
Answer: YES"
14168,36432.0,Spironolactone,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'NR3C2', 'Spironolactone']",0.5,"Question: Is congestive heart failure an indication for Spironolactone?
Reasoning: The disease congestive heart failure is associated with the gene NR3C2, which is targeted by the drug Spironolactone. These connections suggest that Spironolactone may be effective in treating congestive heart failure.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'OPRK1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene OPRK1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16495,83862.0,Quizartinib,acute myeloblastic leukemia with maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia with maturation', 'FLT3', 'Quizartinib']",0.5,"Question: Is acute myeloblastic leukemia with maturation an indication for Quizartinib?
Reasoning: The disease acute myeloblastic leukemia with maturation is associated with the gene FLT3, which is targeted by the drug Quizartinib. These connections suggest that Quizartinib may be effective in treating acute myeloblastic leukemia with maturation.
Answer: YES"
17030,33688.0,Alectinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Alectinib']",0.5,"Question: Is non-small cell lung carcinoma (disease) an indication for Alectinib?
Reasoning: The disease non-small cell lung carcinoma (disease) is associated with the gene ABCB1, which is targeted by the drug Alectinib. These connections suggest that Alectinib may be effective in treating non-small cell lung carcinoma (disease).
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'PIGB', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene PIGB. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14999,30318.0,Quetiapine,autosomal recessive severe congenital neutropenia due to JAGN1 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to JAGN1 deficiency', 'Short stature', 'IQSEC1', 'Quetiapine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to JAGN1 deficiency an indication for Quetiapine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to JAGN1 deficiency is associated with the phenotype Short stature, which in turn affects the gene IQSEC1. This gene is not targeted by the drug Quetiapine. These connections suggest that Quetiapine may not be effective in treating autosomal recessive severe congenital neutropenia due to JAGN1 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'RBFOX1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene RBFOX1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14024,29854.0,Prednisone,hereditary angioedema,disease-phenotype-protein-drug,indication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Prednisone']",0.5,"Question: Is hereditary angioedema an indication for Prednisone?
Reasoning: The disease hereditary angioedema is associated with the phenotype Nausea, which in turn affects the gene ABCB1. This gene is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating hereditary angioedema.
Answer: YES"
14262,29078.0,Salicylic acid,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Salicylic acid']",0.5,"Question: Is rheumatoid arthritis an indication for Salicylic acid?
Reasoning: The disease rheumatoid arthritis is associated with the gene PTGS1, which is targeted by the drug Salicylic acid. These connections suggest that Salicylic acid may be effective in treating rheumatoid arthritis.
Answer: YES"
14249,36091.0,Pseudoephedrine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'TNF', 'Pseudoephedrine']",0.5,"Question: Is atopic conjunctivitis an indication for Pseudoephedrine?
Reasoning: The disease atopic conjunctivitis is associated with the phenotype Allergy, which in turn affects the gene TNF. This gene is targeted by the drug Pseudoephedrine. These connections suggest that Pseudoephedrine may be effective in treating atopic conjunctivitis.
Answer: YES"
20194,39208.0,Mogamulizumab,primary cutaneous T-cell lymphoma,disease-protein-drug,indication,"['primary cutaneous T-cell lymphoma', 'CCR4', 'Mogamulizumab']",0.5,"Question: Is primary cutaneous T-cell lymphoma an indication for Mogamulizumab?
Reasoning: The disease primary cutaneous T-cell lymphoma is associated with the gene CCR4, which is targeted by the drug Mogamulizumab. These connections suggest that Mogamulizumab may be effective in treating primary cutaneous T-cell lymphoma.
Answer: YES"
14030,32746.0,Prednisolone,Stevens-Johnson syndrome,disease-protein-drug,indication,"['Stevens-Johnson syndrome', 'ALB', 'Prednisolone']",0.5,"Question: Is Stevens-Johnson syndrome an indication for Prednisolone?
Reasoning: The disease Stevens-Johnson syndrome is associated with the gene ALB, which is targeted by the drug Prednisolone. These connections suggest that Prednisolone may be effective in treating Stevens-Johnson syndrome.
Answer: YES"
14342,32518.0,Testosterone propionate,trisomy 13,disease-phenotype-protein-drug,indication,"['trisomy 13', 'Intrauterine growth retardation', 'COMT', 'Testosterone propionate']",0.5,"Question: Is trisomy 13 an indication for Testosterone propionate?
Reasoning: The disease trisomy 13 is associated with the phenotype Intrauterine growth retardation, which in turn affects the gene COMT. This gene is targeted by the drug Testosterone propionate. These connections suggest that Testosterone propionate may be effective in treating trisomy 13.
Answer: YES"
14275,83818.0,Doxorubicin,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,indication,"['primary non-gestational choriocarcinoma of ovary', 'CYP1B1', 'Doxorubicin']",0.5,"Question: Is primary non-gestational choriocarcinoma of ovary an indication for Doxorubicin?
Reasoning: The disease primary non-gestational choriocarcinoma of ovary is associated with the gene CYP1B1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating primary non-gestational choriocarcinoma of ovary.
Answer: YES"
16054,32468.0,Trihexyphenidyl,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Resting tremor', 'CHRM4', 'Trihexyphenidyl']",0.5,"Question: Is postencephalitic Parkinson disease an indication for Trihexyphenidyl?
Reasoning: The disease postencephalitic Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene CHRM4. This gene is targeted by the drug Trihexyphenidyl. These connections suggest that Trihexyphenidyl may be effective in treating postencephalitic Parkinson disease.
Answer: YES"
14952,83779.0,Haloperidol,schizoaffective disorder,disease-protein-drug,indication,"['schizoaffective disorder', 'HTR2A', 'Haloperidol']",0.5,"Question: Is schizoaffective disorder an indication for Haloperidol?
Reasoning: The disease schizoaffective disorder is associated with the gene HTR2A, which is targeted by the drug Haloperidol. These connections suggest that Haloperidol may be effective in treating schizoaffective disorder.
Answer: YES"
14177,38957.0,Duloxetine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Duloxetine']",0.5,"Question: Is major depressive disorder an indication for Duloxetine?
Reasoning: The disease major depressive disorder is associated with the gene SLC6A4, which is targeted by the drug Duloxetine. These connections suggest that Duloxetine may be effective in treating major depressive disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ATP7A', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ATP7A. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15018,28542.0,Midostaurin,mastocytosis,disease-phenotype-protein-drug,indication,"['mastocytosis', 'Hepatomegaly', 'CYP1A2', 'Midostaurin']",0.5,"Question: Is mastocytosis an indication for Midostaurin?
Reasoning: The disease mastocytosis is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A2. This gene is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating mastocytosis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'TJP2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene TJP2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14288,32729.0,Benzylpenicillin,botulism,disease-phenotype-protein-drug,indication,"['botulism', 'Arrhythmia', 'SLC22A5', 'Benzylpenicillin']",0.5,"Question: Is botulism an indication for Benzylpenicillin?
Reasoning: The disease botulism is associated with the phenotype Arrhythmia, which in turn affects the gene SLC22A5. This gene is targeted by the drug Benzylpenicillin. These connections suggest that Benzylpenicillin may be effective in treating botulism.
Answer: YES"
14208,27249.0,Testosterone,isolated growth hormone deficiency,disease-protein-drug,indication,"['isolated growth hormone deficiency', 'CYP19A1', 'Testosterone']",0.5,"Question: Is isolated growth hormone deficiency an indication for Testosterone?
Reasoning: The disease isolated growth hormone deficiency is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating isolated growth hormone deficiency.
Answer: YES"
14194,32325.0,Methotrexate,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ABCC3', 'Methotrexate']",0.5,"Question: Is juvenile idiopathic arthritis an indication for Methotrexate?
Reasoning: The disease juvenile idiopathic arthritis is associated with the phenotype Hepatomegaly, which in turn affects the gene ABCC3. This gene is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating juvenile idiopathic arthritis.
Answer: YES"
14740,29993.0,Chlorambucil,classic Hodgkin lymphoma,disease-protein-drug,indication,"['classic Hodgkin lymphoma', 'GSTP1', 'Chlorambucil']",0.5,"Question: Is classic Hodgkin lymphoma an indication for Chlorambucil?
Reasoning: The disease classic Hodgkin lymphoma is associated with the gene GSTP1, which is targeted by the drug Chlorambucil. These connections suggest that Chlorambucil may be effective in treating classic Hodgkin lymphoma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'PNPT1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene PNPT1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'TMEM70', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene TMEM70. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'PSEN1', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene PSEN1. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
17252,37888.0,Antazoline,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Antazoline']",0.5,"Question: Is allergic rhinitis an indication for Antazoline?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Antazoline. These connections suggest that Antazoline may be effective in treating allergic rhinitis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'FGF2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene FGF2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ADRA1B', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ADRA1B. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
17601,29078.0,Golimumab,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'TNF', 'Golimumab']",0.5,"Question: Is rheumatoid arthritis an indication for Golimumab?
Reasoning: The disease rheumatoid arthritis is associated with the gene TNF, which is targeted by the drug Golimumab. These connections suggest that Golimumab may be effective in treating rheumatoid arthritis.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Infertility', 'KL', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Infertility, which in turn affects the gene KL. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15511,83781.0,Pranlukast,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'RNASE3', 'Pranlukast']",0.5,"Question: Is intrinsic asthma an indication for Pranlukast?
Reasoning: The disease intrinsic asthma is associated with the gene RNASE3, which is targeted by the drug Pranlukast. These connections suggest that Pranlukast may be effective in treating intrinsic asthma.
Answer: YES"
15892,36315.0,Ferric maltol,deficiency anemia,disease-protein-drug,indication,"['deficiency anemia', 'SLC11A2', 'Ferric maltol']",0.5,"Question: Is deficiency anemia an indication for Ferric maltol?
Reasoning: The disease deficiency anemia is associated with the gene SLC11A2, which is targeted by the drug Ferric maltol. These connections suggest that Ferric maltol may be effective in treating deficiency anemia.
Answer: YES"
14155,33688.0,Gefitinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Gefitinib']",0.5,"Question: Is non-small cell lung carcinoma (disease) an indication for Gefitinib?
Reasoning: The disease non-small cell lung carcinoma (disease) is associated with the gene ABCB1, which is targeted by the drug Gefitinib. These connections suggest that Gefitinib may be effective in treating non-small cell lung carcinoma (disease).
Answer: YES"
14187,31116.0,Erlotinib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Erlotinib']",0.5,"Question: Is lung cancer an indication for Erlotinib?
Reasoning: The disease lung cancer is associated with the gene ABCB1, which is targeted by the drug Erlotinib. These connections suggest that Erlotinib may be effective in treating lung cancer.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'IMPA1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene IMPA1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14141,35641.0,Phenytoin,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GABRG2', 'Phenytoin']",0.5,"Question: Is epilepsy an indication for Phenytoin?
Reasoning: The disease epilepsy is associated with the gene GABRG2, which is targeted by the drug Phenytoin. These connections suggest that Phenytoin may be effective in treating epilepsy.
Answer: YES"
15269,29078.0,Upadacitinib,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Upadacitinib']",0.5,"Question: Is rheumatoid arthritis an indication for Upadacitinib?
Reasoning: The disease rheumatoid arthritis is associated with the gene ABCB1, which is targeted by the drug Upadacitinib. These connections suggest that Upadacitinib may be effective in treating rheumatoid arthritis.
Answer: YES"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'RETN', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene RETN. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
14955,84156.0,Vincristine,plasmablastic lymphoma,disease-protein-drug,indication,"['plasmablastic lymphoma', 'ABCB1', 'Vincristine']",0.5,"Question: Is plasmablastic lymphoma an indication for Vincristine?
Reasoning: The disease plasmablastic lymphoma is associated with the gene ABCB1, which is targeted by the drug Vincristine. These connections suggest that Vincristine may be effective in treating plasmablastic lymphoma.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ZMIZ1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ZMIZ1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
17584,32325.0,Adalimumab,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Fever', 'TNF', 'Adalimumab']",0.5,"Question: Is juvenile idiopathic arthritis an indication for Adalimumab?
Reasoning: The disease juvenile idiopathic arthritis is associated with the phenotype Fever, which in turn affects the gene TNF. This gene is targeted by the drug Adalimumab. These connections suggest that Adalimumab may be effective in treating juvenile idiopathic arthritis.
Answer: YES"
14831,28547.0,Droxidopa,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'ADRB2', 'Droxidopa']",0.5,"Question: Is Parkinson disease an indication for Droxidopa?
Reasoning: The disease Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene ADRB2. This gene is targeted by the drug Droxidopa. These connections suggest that Droxidopa may be effective in treating Parkinson disease.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CNR1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CNR1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CHRNA3', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene CHRNA3. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'APC2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene APC2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15131,28313.0,Mesoridazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Mesoridazine']",0.5,"Question: Is schizophrenia an indication for Mesoridazine?
Reasoning: The disease schizophrenia is associated with the gene DRD2, which is targeted by the drug Mesoridazine. These connections suggest that Mesoridazine may be effective in treating schizophrenia.
Answer: YES"
15193,32974.0,Rotigotine,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'CYP2D6', 'Rotigotine']",0.5,"Question: Is atypical juvenile parkinsonism an indication for Rotigotine?
Reasoning: The disease atypical juvenile parkinsonism is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Rotigotine. These connections suggest that Rotigotine may be effective in treating atypical juvenile parkinsonism.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PIGM', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene PIGM. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14947,83898.0,Cerivastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Cerivastatin']",0.5,"Question: Is obsolete familial combined hyperlipidemia an indication for Cerivastatin?
Reasoning: The disease obsolete familial combined hyperlipidemia is associated with the gene HMGCR, which is targeted by the drug Cerivastatin. These connections suggest that Cerivastatin may be effective in treating obsolete familial combined hyperlipidemia.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'KRAS', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene KRAS. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
15124,32974.0,Biperiden,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'CYP2D6', 'Biperiden']",0.5,"Question: Is atypical juvenile parkinsonism an indication for Biperiden?
Reasoning: The disease atypical juvenile parkinsonism is associated with the gene CYP2D6, which is targeted by the drug Biperiden. These connections suggest that Biperiden may be effective in treating atypical juvenile parkinsonism.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CHRNA7', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CHRNA7. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Delayed speech and language development', 'TRPV4', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Delayed speech and language development, which in turn affects the gene TRPV4. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15180,33542.0,Fusidic acid,scrub typhus,disease-phenotype-protein-drug,indication,"['scrub typhus', 'Tremor', 'CYP2D6', 'Fusidic acid']",0.5,"Question: Is scrub typhus an indication for Fusidic acid?
Reasoning: The disease scrub typhus is associated with the phenotype Tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Fusidic acid. These connections suggest that Fusidic acid may be effective in treating scrub typhus.
Answer: YES"
16041,33350.0,Mecasermin rinfabate,growth hormone insensitivity syndrome,disease-phenotype-protein-drug,indication,"['growth hormone insensitivity syndrome', 'Insulin resistance', 'INSR', 'Mecasermin rinfabate']",0.5,"Question: Is growth hormone insensitivity syndrome an indication for Mecasermin rinfabate?
Reasoning: The disease growth hormone insensitivity syndrome is associated with the phenotype Insulin resistance, which in turn affects the gene INSR. This gene is targeted by the drug Mecasermin rinfabate. These connections suggest that Mecasermin rinfabate may be effective in treating growth hormone insensitivity syndrome.
Answer: YES"
14294,32456.0,Clonazepam,cutis verticis gyrata,disease-protein-drug,indication,"['cutis verticis gyrata', 'GABRB3', 'Clonazepam']",0.5,"Question: Is cutis verticis gyrata an indication for Clonazepam?
Reasoning: The disease cutis verticis gyrata is associated with the gene GABRB3, which is targeted by the drug Clonazepam. These connections suggest that Clonazepam may be effective in treating cutis verticis gyrata.
Answer: YES"
14269,32746.0,Methylprednisolone,Stevens-Johnson syndrome,disease-phenotype-protein-drug,indication,"['Stevens-Johnson syndrome', 'Thrombocytopenia', 'ALB', 'Methylprednisolone']",0.5,"Question: Is Stevens-Johnson syndrome an indication for Methylprednisolone?
Reasoning: The disease Stevens-Johnson syndrome is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Methylprednisolone. These connections suggest that Methylprednisolone may be effective in treating Stevens-Johnson syndrome.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'NAGA', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene NAGA. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'USH1C', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene USH1C. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'AP2M1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene AP2M1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'CUX2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene CUX2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
19217,28849.0,Tipiracil,colorectal cancer,disease-protein-drug,indication,"['colorectal cancer', 'TYMP', 'Tipiracil']",0.5,"Question: Is colorectal cancer an indication for Tipiracil?
Reasoning: The disease colorectal cancer is associated with the gene TYMP, which is targeted by the drug Tipiracil. These connections suggest that Tipiracil may be effective in treating colorectal cancer.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'AP2M1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene AP2M1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'CYGB', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene CYGB. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14229,29361.0,Tretinoin,acute promyelocytic leukemia,disease-protein-drug,indication,"['acute promyelocytic leukemia', 'RARA', 'Tretinoin']",0.5,"Question: Is acute promyelocytic leukemia an indication for Tretinoin?
Reasoning: The disease acute promyelocytic leukemia is associated with the gene RARA, which is targeted by the drug Tretinoin. These connections suggest that Tretinoin may be effective in treating acute promyelocytic leukemia.
Answer: YES"
17437,37919.0,Metyrosine,adrenal gland pheochromocytoma,disease-protein-drug,indication,"['adrenal gland pheochromocytoma', 'TH', 'Metyrosine']",0.5,"Question: Is adrenal gland pheochromocytoma an indication for Metyrosine?
Reasoning: The disease adrenal gland pheochromocytoma is associated with the gene TH, which is targeted by the drug Metyrosine. These connections suggest that Metyrosine may be effective in treating adrenal gland pheochromocytoma.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CHRNA3', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene CHRNA3. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'TNF', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Nausea, which in turn affects the gene TNF. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
15441,32033.0,Eszopiclone,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Eszopiclone']",0.5,"Question: Is insomnia (disease) an indication for Eszopiclone?
Reasoning: The disease insomnia (disease) is associated with the gene GABRB3, which is targeted by the drug Eszopiclone. These connections suggest that Eszopiclone may be effective in treating insomnia (disease).
Answer: YES"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'PLTP', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene PLTP. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PTGS2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene PTGS2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'PRKN', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene PRKN. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14380,83763.0,Asenapine,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'HTR2A', 'Asenapine']",0.5,"Question: Is manic bipolar affective disorder an indication for Asenapine?
Reasoning: The disease manic bipolar affective disorder is associated with the gene HTR2A, which is targeted by the drug Asenapine. These connections suggest that Asenapine may be effective in treating manic bipolar affective disorder.
Answer: YES"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'LEP', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene LEP. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
14019,37888.0,Betamethasone,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Betamethasone']",0.5,"Question: Is allergic rhinitis an indication for Betamethasone?
Reasoning: The disease allergic rhinitis is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is targeted by the drug Betamethasone. These connections suggest that Betamethasone may be effective in treating allergic rhinitis.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Short stature', 'IGFALS', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Short stature, which in turn affects the gene IGFALS. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Joint laxity', 'ZNF469', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Joint laxity, which in turn affects the gene ZNF469. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SLC6A1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene SLC6A1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'P4HTM', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene P4HTM. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15493,32759.0,Bromocriptine,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'ABCB1', 'Bromocriptine']",0.5,"Question: Is hemiparkinsonism-hemiatrophy syndrome an indication for Bromocriptine?
Reasoning: The disease hemiparkinsonism-hemiatrophy syndrome is associated with the gene ABCB1, which is targeted by the drug Bromocriptine. These connections suggest that Bromocriptine may be effective in treating hemiparkinsonism-hemiatrophy syndrome.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'CYP27A1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene CYP27A1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15770,28208.0,Glimepiride,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'KCNJ11', 'Glimepiride']",0.5,"Question: Is type 2 diabetes mellitus an indication for Glimepiride?
Reasoning: The disease type 2 diabetes mellitus is associated with the gene KCNJ11, which is targeted by the drug Glimepiride. These connections suggest that Glimepiride may be effective in treating type 2 diabetes mellitus.
Answer: YES"
15519,32033.0,Nitrazepam,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Nitrazepam']",0.5,"Question: Is insomnia (disease) an indication for Nitrazepam?
Reasoning: The disease insomnia (disease) is associated with the gene GABRB3, which is targeted by the drug Nitrazepam. These connections suggest that Nitrazepam may be effective in treating insomnia (disease).
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'ATP7A', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene ATP7A. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15282,28208.0,Insulin lispro,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'INSR', 'Insulin lispro']",0.5,"Question: Is type 2 diabetes mellitus an indication for Insulin lispro?
Reasoning: The disease type 2 diabetes mellitus is associated with the phenotype Insulin resistance, which in turn affects the gene INSR. This gene is targeted by the drug Insulin lispro. These connections suggest that Insulin lispro may be effective in treating type 2 diabetes mellitus.
Answer: YES"
14030,27648.0,Prednisolone,familial glucocorticoid deficiency,disease-phenotype-protein-drug,indication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Prednisolone']",0.5,"Question: Is familial glucocorticoid deficiency an indication for Prednisolone?
Reasoning: The disease familial glucocorticoid deficiency is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Prednisolone. These connections suggest that Prednisolone may be effective in treating familial glucocorticoid deficiency.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'FKTN', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene FKTN. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14183,29078.0,Tolmetin,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'MPO', 'Tolmetin']",0.5,"Question: Is rheumatoid arthritis an indication for Tolmetin?
Reasoning: The disease rheumatoid arthritis is associated with the gene MPO, which is targeted by the drug Tolmetin. These connections suggest that Tolmetin may be effective in treating rheumatoid arthritis.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'PCYT2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene PCYT2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'TIMM8A', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene TIMM8A. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14320,32563.0,Dexamethasone,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,indication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Dexamethasone']",0.5,"Question: Is heparin-induced thrombocytopenia (disease) an indication for Dexamethasone?
Reasoning: The disease heparin-induced thrombocytopenia (disease) is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating heparin-induced thrombocytopenia (disease).
Answer: YES"
15505,33577.0,Tasosartan,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Tasosartan']",0.5,"Question: Is hypertensive disorder an indication for Tasosartan?
Reasoning: The disease hypertensive disorder is associated with the gene AGTR1, which is targeted by the drug Tasosartan. These connections suggest that Tasosartan may be effective in treating hypertensive disorder.
Answer: YES"
14320,84154.0,Dexamethasone,"primary cutaneous diffuse large B-cell lymphoma, Leg type",disease-protein-drug,indication,"['primary cutaneous diffuse large B-cell lymphoma, Leg type', 'ABCB1', 'Dexamethasone']",0.5,"Question: Is primary cutaneous diffuse large B-cell lymphoma, Leg type an indication for Dexamethasone?
Reasoning: The disease primary cutaneous diffuse large B-cell lymphoma, Leg type is associated with the gene ABCB1, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating primary cutaneous diffuse large B-cell lymphoma, Leg type.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'ADORA2A', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene ADORA2A. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'GTF3C3', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene GTF3C3. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14385,33575.0,Liraglutide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'GLP1R', 'Liraglutide']",0.5,"Question: Is diabetes mellitus (disease) an indication for Liraglutide?
Reasoning: The disease diabetes mellitus (disease) is associated with the gene GLP1R, which is targeted by the drug Liraglutide. These connections suggest that Liraglutide may be effective in treating diabetes mellitus (disease).
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hypotonia', 'P4HTM', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hypotonia, which in turn affects the gene P4HTM. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'SLC29A3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene SLC29A3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14200,36432.0,Enalapril,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'ALB', 'Enalapril']",0.5,"Question: Is congestive heart failure an indication for Enalapril?
Reasoning: The disease congestive heart failure is associated with the gene ALB, which is targeted by the drug Enalapril. These connections suggest that Enalapril may be effective in treating congestive heart failure.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'IMPA1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene IMPA1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15739,38274.0,Ivosidenib,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'IDH1', 'Ivosidenib']",0.5,"Question: Is inherited acute myeloid leukemia an indication for Ivosidenib?
Reasoning: The disease inherited acute myeloid leukemia is associated with the gene IDH1, which is targeted by the drug Ivosidenib. These connections suggest that Ivosidenib may be effective in treating inherited acute myeloid leukemia.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'FOLR1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene FOLR1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'PPBP', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene PPBP. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'OTOA', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene OTOA. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'KIAA1109', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene KIAA1109. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'TCF4', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene TCF4. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Ataxia', 'SNX14', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Ataxia, which in turn affects the gene SNX14. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'GIPC3', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene GIPC3. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'GIT1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene GIT1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
18195,36000.0,Gimeracil,gastric neoplasm,disease-protein-drug,indication,"['gastric neoplasm', 'DPYD', 'Gimeracil']",0.5,"Question: Is gastric neoplasm an indication for Gimeracil?
Reasoning: The disease gastric neoplasm is associated with the gene DPYD, which is targeted by the drug Gimeracil. These connections suggest that Gimeracil may be effective in treating gastric neoplasm.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Neurodevelopmental delay', 'MYSM1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Neurodevelopmental delay, which in turn affects the gene MYSM1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
17233,37888.0,Carbinoxamine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Carbinoxamine']",0.5,"Question: Is allergic rhinitis an indication for Carbinoxamine?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Carbinoxamine. These connections suggest that Carbinoxamine may be effective in treating allergic rhinitis.
Answer: YES"
14232,83791.0,Olopatadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Olopatadine']",0.5,"Question: Is vasomotor rhinitis an indication for Olopatadine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Olopatadine. These connections suggest that Olopatadine may be effective in treating vasomotor rhinitis.
Answer: YES"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'STS', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene STS. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
15481,32617.0,Topotecan,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Topotecan']",0.5,"Question: Is hereditary breast ovarian cancer syndrome an indication for Topotecan?
Reasoning: The disease hereditary breast ovarian cancer syndrome is associated with the gene ABCB1, which is targeted by the drug Topotecan. These connections suggest that Topotecan may be effective in treating hereditary breast ovarian cancer syndrome.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'ASAH2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene ASAH2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14194,29078.0,Methotrexate,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'MTHFR', 'Methotrexate']",0.5,"Question: Is rheumatoid arthritis an indication for Methotrexate?
Reasoning: The disease rheumatoid arthritis is associated with the gene MTHFR, which is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating rheumatoid arthritis.
Answer: YES"
14275,84160.0,Doxorubicin,primary mediastinal large B-cell lymphoma,disease-protein-drug,indication,"['primary mediastinal large B-cell lymphoma', 'ABCB1', 'Doxorubicin']",0.5,"Question: Is primary mediastinal large B-cell lymphoma an indication for Doxorubicin?
Reasoning: The disease primary mediastinal large B-cell lymphoma is associated with the gene ABCB1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating primary mediastinal large B-cell lymphoma.
Answer: YES"
15367,30494.0,Pomalidomide,plasma cell myeloma,disease-protein-drug,indication,"['plasma cell myeloma', 'CRBN', 'Pomalidomide']",0.5,"Question: Is plasma cell myeloma an indication for Pomalidomide?
Reasoning: The disease plasma cell myeloma is associated with the gene CRBN, which is targeted by the drug Pomalidomide. These connections suggest that Pomalidomide may be effective in treating plasma cell myeloma.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'SIX1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene SIX1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'CEACAM6', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene CEACAM6. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14911,83802.0,Allopurinol,obsolete hyperuricemia (disease),disease-protein-drug,indication,"['obsolete hyperuricemia (disease)', 'ABCG2', 'Allopurinol']",0.5,"Question: Is obsolete hyperuricemia (disease) an indication for Allopurinol?
Reasoning: The disease obsolete hyperuricemia (disease) is associated with the gene ABCG2, which is targeted by the drug Allopurinol. These connections suggest that Allopurinol may be effective in treating obsolete hyperuricemia (disease).
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Ataxia', 'RFC1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Ataxia, which in turn affects the gene RFC1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GALC', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene GALC. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'TRAPPC4', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene TRAPPC4. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14313,28502.0,Arsenic trioxide,myelomonocytic leukemia,disease-phenotype-protein-drug,indication,"['myelomonocytic leukemia', 'Thrombocytopenia', 'ALB', 'Arsenic trioxide']",0.5,"Question: Is myelomonocytic leukemia an indication for Arsenic trioxide?
Reasoning: The disease myelomonocytic leukemia is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Arsenic trioxide. These connections suggest that Arsenic trioxide may be effective in treating myelomonocytic leukemia.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'PCDH15', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene PCDH15. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'TRIOBP', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene TRIOBP. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15018,83857.0,Midostaurin,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'KIT', 'Midostaurin']",0.5,"Question: Is acute myeloid leukemia with t(8;16)(p11;p13) translocation an indication for Midostaurin?
Reasoning: The disease acute myeloid leukemia with t(8;16)(p11;p13) translocation is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating acute myeloid leukemia with t(8;16)(p11;p13) translocation.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'WFS1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene WFS1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'APP', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene APP. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15110,28313.0,Fluphenazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'CYP2E1', 'Fluphenazine']",0.5,"Question: Is schizophrenia an indication for Fluphenazine?
Reasoning: The disease schizophrenia is associated with the gene CYP2E1, which is targeted by the drug Fluphenazine. These connections suggest that Fluphenazine may be effective in treating schizophrenia.
Answer: YES"
17246,83791.0,Clofedanol,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Clofedanol']",0.5,"Question: Is vasomotor rhinitis an indication for Clofedanol?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Clofedanol. These connections suggest that Clofedanol may be effective in treating vasomotor rhinitis.
Answer: YES"
16842,28547.0,Pramipexole,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DRD2', 'Pramipexole']",0.5,"Question: Is Parkinson disease an indication for Pramipexole?
Reasoning: The disease Parkinson disease is associated with the gene DRD2, which is targeted by the drug Pramipexole. These connections suggest that Pramipexole may be effective in treating Parkinson disease.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'OXT', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene OXT. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15493,32468.0,Bromocriptine,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Resting tremor', 'HTR1A', 'Bromocriptine']",0.5,"Question: Is postencephalitic Parkinson disease an indication for Bromocriptine?
Reasoning: The disease postencephalitic Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene HTR1A. This gene is targeted by the drug Bromocriptine. These connections suggest that Bromocriptine may be effective in treating postencephalitic Parkinson disease.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'MYO1A', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene MYO1A. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'CYP1A2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene CYP1A2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'MIR192', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene MIR192. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14954,37334.0,Cyclophosphamide,breast carcinoma,disease-protein-drug,indication,"['breast carcinoma', 'CYP3A4', 'Cyclophosphamide']",0.5,"Question: Is breast carcinoma an indication for Cyclophosphamide?
Reasoning: The disease breast carcinoma is associated with the gene CYP3A4, which is targeted by the drug Cyclophosphamide. These connections suggest that Cyclophosphamide may be effective in treating breast carcinoma.
Answer: YES"
14999,30318.0,Quetiapine,autosomal recessive severe congenital neutropenia due to JAGN1 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to JAGN1 deficiency', 'Short stature', 'PUS7', 'Quetiapine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to JAGN1 deficiency an indication for Quetiapine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to JAGN1 deficiency is associated with the phenotype Short stature, which in turn affects the gene PUS7. This gene is not targeted by the drug Quetiapine. These connections suggest that Quetiapine may not be effective in treating autosomal recessive severe congenital neutropenia due to JAGN1 deficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'CD69', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene CD69. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Ascites', 'CHRM3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Ascites, which in turn affects the gene CHRM3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
17545,83860.0,Gemtuzumab ozogamicin,acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2),disease-protein-drug,indication,"['acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)', 'CD33', 'Gemtuzumab ozogamicin']",0.5,"Question: Is acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) an indication for Gemtuzumab ozogamicin?
Reasoning: The disease acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) is associated with the gene CD33, which is targeted by the drug Gemtuzumab ozogamicin. These connections suggest that Gemtuzumab ozogamicin may be effective in treating acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2).
Answer: YES"
17257,37703.0,Butriptyline,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A4', 'Butriptyline']",0.5,"Question: Is neurotic disorder an indication for Butriptyline?
Reasoning: The disease neurotic disorder is associated with the gene SLC6A4, which is targeted by the drug Butriptyline. These connections suggest that Butriptyline may be effective in treating neurotic disorder.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'EYA1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene EYA1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14194,36458.0,Methotrexate,Langerhans cell histiocytosis,disease-protein-drug,indication,"['Langerhans cell histiocytosis', 'MTHFR', 'Methotrexate']",0.5,"Question: Is Langerhans cell histiocytosis an indication for Methotrexate?
Reasoning: The disease Langerhans cell histiocytosis is associated with the gene MTHFR, which is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating Langerhans cell histiocytosis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'MASTL', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene MASTL. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14275,37082.0,Doxorubicin,malignant germ cell tumor of ovary,disease-protein-drug,indication,"['malignant germ cell tumor of ovary', 'CYP1B1', 'Doxorubicin']",0.5,"Question: Is malignant germ cell tumor of ovary an indication for Doxorubicin?
Reasoning: The disease malignant germ cell tumor of ovary is associated with the gene CYP1B1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating malignant germ cell tumor of ovary.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'FOS', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene FOS. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'MN1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene MN1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15098,35915.0,Promazine,mental disorder,disease-protein-drug,indication,"['mental disorder', 'HTR2A', 'Promazine']",0.5,"Question: Is mental disorder an indication for Promazine?
Reasoning: The disease mental disorder is associated with the gene HTR2A, which is targeted by the drug Promazine. These connections suggest that Promazine may be effective in treating mental disorder.
Answer: YES"
14186,83817.0,Cisplatin,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary site-specific ovarian cancer syndrome', 'ATP7B', 'Cisplatin']",0.5,"Question: Is hereditary site-specific ovarian cancer syndrome an indication for Cisplatin?
Reasoning: The disease hereditary site-specific ovarian cancer syndrome is associated with the gene ATP7B, which is targeted by the drug Cisplatin. These connections suggest that Cisplatin may be effective in treating hereditary site-specific ovarian cancer syndrome.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'IFNG', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Nausea, which in turn affects the gene IFNG. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
20153,28547.0,Metixene,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'CHRM4', 'Metixene']",0.5,"Question: Is Parkinson disease an indication for Metixene?
Reasoning: The disease Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene CHRM4. This gene is targeted by the drug Metixene. These connections suggest that Metixene may be effective in treating Parkinson disease.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PVALB', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene PVALB. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ATP1A1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene ATP1A1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'SELP', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene SELP. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14196,33398.0,Propranolol,retinal capillary malformation,disease-phenotype-protein-drug,indication,"['retinal capillary malformation', 'Pain', 'HTR1A', 'Propranolol']",0.5,"Question: Is retinal capillary malformation an indication for Propranolol?
Reasoning: The disease retinal capillary malformation is associated with the phenotype Pain, which in turn affects the gene HTR1A. This gene is targeted by the drug Propranolol. These connections suggest that Propranolol may be effective in treating retinal capillary malformation.
Answer: YES"
14321,32468.0,Levodopa,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Oculogyric crisis', 'DDC', 'Levodopa']",0.5,"Question: Is postencephalitic Parkinson disease an indication for Levodopa?
Reasoning: The disease postencephalitic Parkinson disease is associated with the phenotype Oculogyric crisis, which in turn affects the gene DDC. This gene is targeted by the drug Levodopa. These connections suggest that Levodopa may be effective in treating postencephalitic Parkinson disease.
Answer: YES"
15263,83856.0,Enasidenib,acute myeloid leukemia with CEBPA somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with CEBPA somatic mutations', 'IDH2', 'Enasidenib']",0.5,"Question: Is acute myeloid leukemia with CEBPA somatic mutations an indication for Enasidenib?
Reasoning: The disease acute myeloid leukemia with CEBPA somatic mutations is associated with the gene IDH2, which is targeted by the drug Enasidenib. These connections suggest that Enasidenib may be effective in treating acute myeloid leukemia with CEBPA somatic mutations.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SSTR2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene SSTR2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'GBA', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene GBA. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14019,32815.0,Betamethasone,Trichinellosis,disease-phenotype-protein-drug,indication,"['Trichinellosis', 'Nausea', 'ABCB1', 'Betamethasone']",0.5,"Question: Is Trichinellosis an indication for Betamethasone?
Reasoning: The disease Trichinellosis is associated with the phenotype Nausea, which in turn affects the gene ABCB1. This gene is targeted by the drug Betamethasone. These connections suggest that Betamethasone may be effective in treating Trichinellosis.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene ALB. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14208,33166.0,Testosterone,isolated congenital growth hormone deficiency,disease-protein-drug,indication,"['isolated congenital growth hormone deficiency', 'CYP19A1', 'Testosterone']",0.5,"Question: Is isolated congenital growth hormone deficiency an indication for Testosterone?
Reasoning: The disease isolated congenital growth hormone deficiency is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating isolated congenital growth hormone deficiency.
Answer: YES"
14190,37273.0,Fluorouracil,gastric carcinoma,disease-protein-drug,indication,"['gastric carcinoma', 'TYMP', 'Fluorouracil']",0.5,"Question: Is gastric carcinoma an indication for Fluorouracil?
Reasoning: The disease gastric carcinoma is associated with the gene TYMP, which is targeted by the drug Fluorouracil. These connections suggest that Fluorouracil may be effective in treating gastric carcinoma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'DPM2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene DPM2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'MYO7A', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene MYO7A. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
17720,33688.0,Olmutinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'EGFR', 'Olmutinib']",0.5,"Question: Is non-small cell lung carcinoma (disease) an indication for Olmutinib?
Reasoning: The disease non-small cell lung carcinoma (disease) is associated with the gene EGFR, which is targeted by the drug Olmutinib. These connections suggest that Olmutinib may be effective in treating non-small cell lung carcinoma (disease).
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'TLR4', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene TLR4. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'NTNG2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene NTNG2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14950,37888.0,Loratadine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'CYP1A1', 'Loratadine']",0.5,"Question: Is allergic rhinitis an indication for Loratadine?
Reasoning: The disease allergic rhinitis is associated with the phenotype Allergy, which in turn affects the gene CYP1A1. This gene is targeted by the drug Loratadine. These connections suggest that Loratadine may be effective in treating allergic rhinitis.
Answer: YES"
14177,83840.0,Duloxetine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Duloxetine']",0.5,"Question: Is unipolar depression an indication for Duloxetine?
Reasoning: The disease unipolar depression is associated with the gene ABCB1, which is targeted by the drug Duloxetine. These connections suggest that Duloxetine may be effective in treating unipolar depression.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'TNF', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene TNF. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14940,84192.0,Lidocaine,postherpetic neuralgia,disease-protein-drug,indication,"['postherpetic neuralgia', 'SCN9A', 'Lidocaine']",0.5,"Question: Is postherpetic neuralgia an indication for Lidocaine?
Reasoning: The disease postherpetic neuralgia is associated with the gene SCN9A, which is targeted by the drug Lidocaine. These connections suggest that Lidocaine may be effective in treating postherpetic neuralgia.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'POLD1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene POLD1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14945,32621.0,Sorafenib,pediatric hepatocellular carcinoma,disease-protein-drug,indication,"['pediatric hepatocellular carcinoma', 'ABCB1', 'Sorafenib']",0.5,"Question: Is pediatric hepatocellular carcinoma an indication for Sorafenib?
Reasoning: The disease pediatric hepatocellular carcinoma is associated with the gene ABCB1, which is targeted by the drug Sorafenib. These connections suggest that Sorafenib may be effective in treating pediatric hepatocellular carcinoma.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TRAPPC4', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TRAPPC4. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14283,83802.0,Probenecid,obsolete hyperuricemia (disease),disease-protein-drug,indication,"['obsolete hyperuricemia (disease)', 'SLC2A9', 'Probenecid']",0.5,"Question: Is obsolete hyperuricemia (disease) an indication for Probenecid?
Reasoning: The disease obsolete hyperuricemia (disease) is associated with the gene SLC2A9, which is targeted by the drug Probenecid. These connections suggest that Probenecid may be effective in treating obsolete hyperuricemia (disease).
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'NOTCH3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene NOTCH3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'APP', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene APP. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14238,27366.0,Naproxen,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Naproxen']",0.5,"Question: Is spondyloarthropathy, susceptibility to an indication for Naproxen?
Reasoning: The disease spondyloarthropathy, susceptibility to is associated with the phenotype Arrhythmia, which in turn affects the gene PTGS2. This gene is targeted by the drug Naproxen. These connections suggest that Naproxen may be effective in treating spondyloarthropathy, susceptibility to.
Answer: YES"
14023,29078.0,Triamcinolone,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Triamcinolone']",0.5,"Question: Is rheumatoid arthritis an indication for Triamcinolone?
Reasoning: The disease rheumatoid arthritis is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating rheumatoid arthritis.
Answer: YES"
14799,28208.0,Insulin human,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'INSR', 'Insulin human']",0.5,"Question: Is type 2 diabetes mellitus an indication for Insulin human?
Reasoning: The disease type 2 diabetes mellitus is associated with the phenotype Insulin resistance, which in turn affects the gene INSR. This gene is targeted by the drug Insulin human. These connections suggest that Insulin human may be effective in treating type 2 diabetes mellitus.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'RHOBTB2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene RHOBTB2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14320,32815.0,Dexamethasone,Trichinellosis,disease-phenotype-protein-drug,indication,"['Trichinellosis', 'Nausea', 'ABCB1', 'Dexamethasone']",0.5,"Question: Is Trichinellosis an indication for Dexamethasone?
Reasoning: The disease Trichinellosis is associated with the phenotype Nausea, which in turn affects the gene ABCB1. This gene is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating Trichinellosis.
Answer: YES"
16056,28801.0,Procyclidine,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'CHRM4', 'Procyclidine']",0.5,"Question: Is juvenile onset Parkinson disease 19A an indication for Procyclidine?
Reasoning: The disease juvenile onset Parkinson disease 19A is associated with the phenotype Tremor, which in turn affects the gene CHRM4. This gene is targeted by the drug Procyclidine. These connections suggest that Procyclidine may be effective in treating juvenile onset Parkinson disease 19A.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'HDC', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene HDC. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14965,36035.0,Eplerenone,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Eplerenone']",0.5,"Question: Is hypertension an indication for Eplerenone?
Reasoning: The disease hypertension is associated with the gene CYP3A5, which is targeted by the drug Eplerenone. These connections suggest that Eplerenone may be effective in treating hypertension.
Answer: YES"
16214,36035.0,Azilsartan medoxomil,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Azilsartan medoxomil']",0.5,"Question: Is hypertension an indication for Azilsartan medoxomil?
Reasoning: The disease hypertension is associated with the gene AGTR1, which is targeted by the drug Azilsartan medoxomil. These connections suggest that Azilsartan medoxomil may be effective in treating hypertension.
Answer: YES"
19207,33241.0,Carbidopa,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'DDC', 'Carbidopa']",0.5,"Question: Is hereditary late onset Parkinson disease an indication for Carbidopa?
Reasoning: The disease hereditary late onset Parkinson disease is associated with the gene DDC, which is targeted by the drug Carbidopa. These connections suggest that Carbidopa may be effective in treating hereditary late onset Parkinson disease.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TSC2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TSC2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
17170,31650.0,Pyridostigmine,myasthenia gravis,disease-phenotype-protein-drug,indication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Pyridostigmine']",0.5,"Question: Is myasthenia gravis an indication for Pyridostigmine?
Reasoning: The disease myasthenia gravis is associated with the phenotype Seizure, which in turn affects the gene BCHE. This gene is targeted by the drug Pyridostigmine. These connections suggest that Pyridostigmine may be effective in treating myasthenia gravis.
Answer: YES"
15055,32740.0,Deutetrabenazine,Huntington disease-like syndrome due to C9ORF72 expansions,disease-phenotype-protein-drug,indication,"['Huntington disease-like syndrome due to C9ORF72 expansions', 'Rigidity', 'CYP2D6', 'Deutetrabenazine']",0.5,"Question: Is Huntington disease-like syndrome due to C9ORF72 expansions an indication for Deutetrabenazine?
Reasoning: The disease Huntington disease-like syndrome due to C9ORF72 expansions is associated with the phenotype Rigidity, which in turn affects the gene CYP2D6. This gene is targeted by the drug Deutetrabenazine. These connections suggest that Deutetrabenazine may be effective in treating Huntington disease-like syndrome due to C9ORF72 expansions.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'TRPM3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene TRPM3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15082,27933.0,Citalopram,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Citalopram']",0.5,"Question: Is anxiety disorder an indication for Citalopram?
Reasoning: The disease anxiety disorder is associated with the gene ABCB1, which is targeted by the drug Citalopram. These connections suggest that Citalopram may be effective in treating anxiety disorder.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'KCNMA1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene KCNMA1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14499,28714.0,Elexacaftor,cystic fibrosis,disease-phenotype-protein-drug,indication,"['cystic fibrosis', 'Male infertility', 'CFTR', 'Elexacaftor']",0.5,"Question: Is cystic fibrosis an indication for Elexacaftor?
Reasoning: The disease cystic fibrosis is associated with the phenotype Male infertility, which in turn affects the gene CFTR. This gene is targeted by the drug Elexacaftor. These connections suggest that Elexacaftor may be effective in treating cystic fibrosis.
Answer: YES"
14194,28830.0,Methotrexate,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'MTHFR', 'Methotrexate']",0.5,"Question: Is leukemia, lymphocytic, susceptibility to an indication for Methotrexate?
Reasoning: The disease leukemia, lymphocytic, susceptibility to is associated with the gene MTHFR, which is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating leukemia, lymphocytic, susceptibility to.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'MBOAT2', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene MBOAT2. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'TGFB1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene TGFB1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'VAMP2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene VAMP2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'ABHD12', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene ABHD12. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'NGFR', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene NGFR. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'ALAD', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene ALAD. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'KMT2E', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene KMT2E. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'ACAT1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene ACAT1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14794,84261.0,Dasatinib,"blast phase chronic myelogenous leukemia, BCR-ABL1 positive",disease-protein-drug,indication,"['blast phase chronic myelogenous leukemia, BCR-ABL1 positive', 'BCR', 'Dasatinib']",0.5,"Question: Is blast phase chronic myelogenous leukemia, BCR-ABL1 positive an indication for Dasatinib?
Reasoning: The disease blast phase chronic myelogenous leukemia, BCR-ABL1 positive is associated with the gene BCR, which is targeted by the drug Dasatinib. These connections suggest that Dasatinib may be effective in treating blast phase chronic myelogenous leukemia, BCR-ABL1 positive.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'MT3', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene MT3. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14906,27933.0,Toloxatone,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOA', 'Toloxatone']",0.5,"Question: Is anxiety disorder an indication for Toloxatone?
Reasoning: The disease anxiety disorder is associated with the gene MAOA, which is targeted by the drug Toloxatone. These connections suggest that Toloxatone may be effective in treating anxiety disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SLC35A1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SLC35A1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14516,29945.0,Tegafur,gastric cancer,disease-protein-drug,indication,"['gastric cancer', 'CYP2A6', 'Tegafur']",0.5,"Question: Is gastric cancer an indication for Tegafur?
Reasoning: The disease gastric cancer is associated with the gene CYP2A6, which is targeted by the drug Tegafur. These connections suggest that Tegafur may be effective in treating gastric cancer.
Answer: YES"
14024,27452.0,Prednisone,Diamond-Blackfan anemia,disease-phenotype-protein-drug,indication,"['Diamond-Blackfan anemia', 'Thrombocytopenia', 'ALB', 'Prednisone']",0.5,"Question: Is Diamond-Blackfan anemia an indication for Prednisone?
Reasoning: The disease Diamond-Blackfan anemia is associated with the phenotype Thrombocytopenia, which in turn affects the gene ALB. This gene is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating Diamond-Blackfan anemia.
Answer: YES"
15231,28005.0,Stiripentol,developmental and epileptic encephalopathy,disease-phenotype-protein-drug,indication,"['developmental and epileptic encephalopathy', 'Decreased liver function', 'CYP1A2', 'Stiripentol']",0.5,"Question: Is developmental and epileptic encephalopathy an indication for Stiripentol?
Reasoning: The disease developmental and epileptic encephalopathy is associated with the phenotype Decreased liver function, which in turn affects the gene CYP1A2. This gene is targeted by the drug Stiripentol. These connections suggest that Stiripentol may be effective in treating developmental and epileptic encephalopathy.
Answer: YES"
14452,30093.0,Istradefylline,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'ADORA2A', 'Istradefylline']",0.5,"Question: Is parkinsonian-pyramidal syndrome an indication for Istradefylline?
Reasoning: The disease parkinsonian-pyramidal syndrome is associated with the phenotype Tremor, which in turn affects the gene ADORA2A. This gene is targeted by the drug Istradefylline. These connections suggest that Istradefylline may be effective in treating parkinsonian-pyramidal syndrome.
Answer: YES"
14758,37273.0,Capecitabine,gastric carcinoma,disease-protein-drug,indication,"['gastric carcinoma', 'TYMP', 'Capecitabine']",0.5,"Question: Is gastric carcinoma an indication for Capecitabine?
Reasoning: The disease gastric carcinoma is associated with the gene TYMP, which is targeted by the drug Capecitabine. These connections suggest that Capecitabine may be effective in treating gastric carcinoma.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'ACE', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene ACE. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14042,33534.0,Hydrocortisone acetate,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Vomiting', 'ABCB1', 'Hydrocortisone acetate']",0.5,"Question: Is pediatric systemic lupus erythematosus an indication for Hydrocortisone acetate?
Reasoning: The disease pediatric systemic lupus erythematosus is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Hydrocortisone acetate. These connections suggest that Hydrocortisone acetate may be effective in treating pediatric systemic lupus erythematosus.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'COL3A1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene COL3A1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'LIF', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene LIF. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'HRH3', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene HRH3. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'ILDR1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene ILDR1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Delayed speech and language development', 'POU3F3', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Delayed speech and language development, which in turn affects the gene POU3F3. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'PSEN1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene PSEN1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'MECP2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene MECP2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'SALL4', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene SALL4. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15018,83852.0,Midostaurin,acute myeloid leukemia with minimal differentiation,disease-protein-drug,indication,"['acute myeloid leukemia with minimal differentiation', 'KIT', 'Midostaurin']",0.5,"Question: Is acute myeloid leukemia with minimal differentiation an indication for Midostaurin?
Reasoning: The disease acute myeloid leukemia with minimal differentiation is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating acute myeloid leukemia with minimal differentiation.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SST', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene SST. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'SLC2A4', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene SLC2A4. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'SLC26A5', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene SLC26A5. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'SLC26A4', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene SLC26A4. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'FKRP', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene FKRP. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Generalized hypotonia', 'AP2M1', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Generalized hypotonia, which in turn affects the gene AP2M1. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'RNF13', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene RNF13. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'KCNK4', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene KCNK4. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14904,28974.0,Safinamide,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'CYP2D6', 'Safinamide']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Safinamide?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Safinamide. These connections suggest that Safinamide may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CYP27A1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene CYP27A1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'LMX1A', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene LMX1A. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Vomiting', 'IFNG', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Vomiting, which in turn affects the gene IFNG. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'JAK2', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene JAK2. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
19504,31864.0,Metreleptin,lipodystrophy,disease-phenotype-protein-drug,indication,"['lipodystrophy', 'Hepatomegaly', 'LEPR', 'Metreleptin']",0.5,"Question: Is lipodystrophy an indication for Metreleptin?
Reasoning: The disease lipodystrophy is associated with the phenotype Hepatomegaly, which in turn affects the gene LEPR. This gene is targeted by the drug Metreleptin. These connections suggest that Metreleptin may be effective in treating lipodystrophy.
Answer: YES"
14052,84142.0,Vitamin A,vitamin A deficiency (disease),disease-protein-drug,indication,"['vitamin A deficiency (disease)', 'LRAT', 'Vitamin A']",0.5,"Question: Is vitamin A deficiency (disease) an indication for Vitamin A?
Reasoning: The disease vitamin A deficiency (disease) is associated with the gene LRAT, which is targeted by the drug Vitamin A. These connections suggest that Vitamin A may be effective in treating vitamin A deficiency (disease).
Answer: YES"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'RBP4', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene RBP4. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'KARS1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene KARS1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14619,27361.0,"Antihemophilic factor, human recombinant",hemophilia,disease-phenotype-protein-drug,indication,"['hemophilia', 'Thromboembolism', 'PROC', 'Antihemophilic factor, human recombinant']",0.5,"Question: Is hemophilia an indication for Antihemophilic factor, human recombinant?
Reasoning: The disease hemophilia is associated with the phenotype Thromboembolism, which in turn affects the gene PROC. This gene is targeted by the drug Antihemophilic factor, human recombinant. These connections suggest that Antihemophilic factor, human recombinant may be effective in treating hemophilia.
Answer: YES"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'PF4', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene PF4. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'DIAPH1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene DIAPH1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14287,36209.0,Ibuprofen,arthropathy,disease-protein-drug,indication,"['arthropathy', 'PPARG', 'Ibuprofen']",0.5,"Question: Is arthropathy an indication for Ibuprofen?
Reasoning: The disease arthropathy is associated with the gene PPARG, which is targeted by the drug Ibuprofen. These connections suggest that Ibuprofen may be effective in treating arthropathy.
Answer: YES"
14297,33603.0,Atorvastatin,arteriosclerosis disorder,disease-protein-drug,indication,"['arteriosclerosis disorder', 'AHR', 'Atorvastatin']",0.5,"Question: Is arteriosclerosis disorder an indication for Atorvastatin?
Reasoning: The disease arteriosclerosis disorder is associated with the gene AHR, which is targeted by the drug Atorvastatin. These connections suggest that Atorvastatin may be effective in treating arteriosclerosis disorder.
Answer: YES"
16341,33622.0,Iron,microcytic anemia,disease-protein-drug,indication,"['microcytic anemia', 'TFRC', 'Iron']",0.5,"Question: Is microcytic anemia an indication for Iron?
Reasoning: The disease microcytic anemia is associated with the gene TFRC, which is targeted by the drug Iron. These connections suggest that Iron may be effective in treating microcytic anemia.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Elevated hepatic transaminase', 'IL9R', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Elevated hepatic transaminase, which in turn affects the gene IL9R. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CDK8', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene CDK8. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TSC1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TSC1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'IFNA2', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene IFNA2. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Delayed speech and language development', 'PTEN', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Delayed speech and language development, which in turn affects the gene PTEN. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'SST', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene SST. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'DEGS1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene DEGS1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'IGF2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene IGF2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Delayed speech and language development', 'CNTNAP2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Delayed speech and language development, which in turn affects the gene CNTNAP2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14999,30318.0,Quetiapine,autosomal recessive severe congenital neutropenia due to JAGN1 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to JAGN1 deficiency', 'Short stature', 'SLC2A2', 'Quetiapine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to JAGN1 deficiency an indication for Quetiapine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to JAGN1 deficiency is associated with the phenotype Short stature, which in turn affects the gene SLC2A2. This gene is not targeted by the drug Quetiapine. These connections suggest that Quetiapine may not be effective in treating autosomal recessive severe congenital neutropenia due to JAGN1 deficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Delayed puberty', 'IGFALS', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Delayed puberty, which in turn affects the gene IGFALS. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'HSD17B1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene HSD17B1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'IFNB1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene IFNB1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'COL13A1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene COL13A1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'OPRM1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene OPRM1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14023,31723.0,Triamcinolone,autoimmune hemolytic anemia,disease-phenotype-protein-drug,indication,"['autoimmune hemolytic anemia', 'Tachycardia', 'BCHE', 'Triamcinolone']",0.5,"Question: Is autoimmune hemolytic anemia an indication for Triamcinolone?
Reasoning: The disease autoimmune hemolytic anemia is associated with the phenotype Tachycardia, which in turn affects the gene BCHE. This gene is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating autoimmune hemolytic anemia.
Answer: YES"
15490,28547.0,Pergolide,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DRD1', 'Pergolide']",0.5,"Question: Is Parkinson disease an indication for Pergolide?
Reasoning: The disease Parkinson disease is associated with the gene DRD1, which is targeted by the drug Pergolide. These connections suggest that Pergolide may be effective in treating Parkinson disease.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Postural tremor', 'TRH', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Postural tremor, which in turn affects the gene TRH. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'GPR155', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene GPR155. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15263,83857.0,Enasidenib,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'IDH2', 'Enasidenib']",0.5,"Question: Is acute myeloid leukemia with t(8;16)(p11;p13) translocation an indication for Enasidenib?
Reasoning: The disease acute myeloid leukemia with t(8;16)(p11;p13) translocation is associated with the gene IDH2, which is targeted by the drug Enasidenib. These connections suggest that Enasidenib may be effective in treating acute myeloid leukemia with t(8;16)(p11;p13) translocation.
Answer: YES"
14024,35884.0,Prednisone,diffuse large B-cell lymphoma,disease-protein-drug,indication,"['diffuse large B-cell lymphoma', 'ABCB1', 'Prednisone']",0.5,"Question: Is diffuse large B-cell lymphoma an indication for Prednisone?
Reasoning: The disease diffuse large B-cell lymphoma is associated with the gene ABCB1, which is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating diffuse large B-cell lymphoma.
Answer: YES"
14208,33453.0,Testosterone,Kallmann syndrome,disease-protein-drug,indication,"['Kallmann syndrome', 'CYP19A1', 'Testosterone']",0.5,"Question: Is Kallmann syndrome an indication for Testosterone?
Reasoning: The disease Kallmann syndrome is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating Kallmann syndrome.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'CYCS', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Thrombocytopenia, which in turn affects the gene CYCS. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ALAD', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ALAD. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ITGB2', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene ITGB2. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Abnormal bleeding', 'PTPN11', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Abnormal bleeding, which in turn affects the gene PTPN11. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14560,39444.0,Ergocalciferol,osteomalacia (disease),disease-protein-drug,indication,"['osteomalacia (disease)', 'VDR', 'Ergocalciferol']",0.5,"Question: Is osteomalacia (disease) an indication for Ergocalciferol?
Reasoning: The disease osteomalacia (disease) is associated with the gene VDR, which is targeted by the drug Ergocalciferol. These connections suggest that Ergocalciferol may be effective in treating osteomalacia (disease).
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Infertility', 'LEPR', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Infertility, which in turn affects the gene LEPR. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
18611,31116.0,Lonidamine,lung cancer,disease-protein-drug,indication,"['lung cancer', 'HK1', 'Lonidamine']",0.5,"Question: Is lung cancer an indication for Lonidamine?
Reasoning: The disease lung cancer is associated with the gene HK1, which is targeted by the drug Lonidamine. These connections suggest that Lonidamine may be effective in treating lung cancer.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'ESPN', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene ESPN. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'MACF1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene MACF1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
17315,27921.0,Dexmethylphenidate,attention deficit-hyperactivity disorder,disease-protein-drug,indication,"['attention deficit-hyperactivity disorder', 'SLC6A3', 'Dexmethylphenidate']",0.5,"Question: Is attention deficit-hyperactivity disorder an indication for Dexmethylphenidate?
Reasoning: The disease attention deficit-hyperactivity disorder is associated with the gene SLC6A3, which is targeted by the drug Dexmethylphenidate. These connections suggest that Dexmethylphenidate may be effective in treating attention deficit-hyperactivity disorder.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TRRAP', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TRRAP. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'DSG1', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene DSG1. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14346,37805.0,Lopinavir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Lopinavir']",0.5,"Question: Is HIV infectious disease an indication for Lopinavir?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Lopinavir. These connections suggest that Lopinavir may be effective in treating HIV infectious disease.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'GABRA5', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene GABRA5. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14249,37888.0,Pseudoephedrine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'TNF', 'Pseudoephedrine']",0.5,"Question: Is allergic rhinitis an indication for Pseudoephedrine?
Reasoning: The disease allergic rhinitis is associated with the phenotype Allergy, which in turn affects the gene TNF. This gene is targeted by the drug Pseudoephedrine. These connections suggest that Pseudoephedrine may be effective in treating allergic rhinitis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'EYA4', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene EYA4. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15086,83791.0,Clemastine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Clemastine']",0.5,"Question: Is vasomotor rhinitis an indication for Clemastine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Clemastine. These connections suggest that Clemastine may be effective in treating vasomotor rhinitis.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'PHACTR1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene PHACTR1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15858,30905.0,Migalastat,chylomicron retention disease,disease-protein-drug,indication,"['chylomicron retention disease', 'GLA', 'Migalastat']",0.5,"Question: Is chylomicron retention disease an indication for Migalastat?
Reasoning: The disease chylomicron retention disease is associated with the gene GLA, which is targeted by the drug Migalastat. These connections suggest that Migalastat may be effective in treating chylomicron retention disease.
Answer: YES"
16056,32759.0,Procyclidine,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'CHRM4', 'Procyclidine']",0.5,"Question: Is hemiparkinsonism-hemiatrophy syndrome an indication for Procyclidine?
Reasoning: The disease hemiparkinsonism-hemiatrophy syndrome is associated with the phenotype Tremor, which in turn affects the gene CHRM4. This gene is targeted by the drug Procyclidine. These connections suggest that Procyclidine may be effective in treating hemiparkinsonism-hemiatrophy syndrome.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TSFM', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TSFM. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hyponatremia', 'AVP', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hyponatremia, which in turn affects the gene AVP. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'AP3D1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene AP3D1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14019,28158.0,Betamethasone,inflammatory bowel disease,disease-phenotype-protein-drug,indication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Betamethasone']",0.5,"Question: Is inflammatory bowel disease an indication for Betamethasone?
Reasoning: The disease inflammatory bowel disease is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Betamethasone. These connections suggest that Betamethasone may be effective in treating inflammatory bowel disease.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Neurodevelopmental delay', 'KCNK4', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Neurodevelopmental delay, which in turn affects the gene KCNK4. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'MLC1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene MLC1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15332,29113.0,Insulin glulisine,diabetic ketoacidosis,disease-phenotype-protein-drug,indication,"['diabetic ketoacidosis', 'Insulin resistance', 'INSR', 'Insulin glulisine']",0.5,"Question: Is diabetic ketoacidosis an indication for Insulin glulisine?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene INSR. This gene is targeted by the drug Insulin glulisine. These connections suggest that Insulin glulisine may be effective in treating diabetic ketoacidosis.
Answer: YES"
15211,27933.0,Desvenlafaxine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'SLC6A2', 'Desvenlafaxine']",0.5,"Question: Is anxiety disorder an indication for Desvenlafaxine?
Reasoning: The disease anxiety disorder is associated with the gene SLC6A2, which is targeted by the drug Desvenlafaxine. These connections suggest that Desvenlafaxine may be effective in treating anxiety disorder.
Answer: YES"
14807,33675.0,Epinephrine,asthma,disease-protein-drug,indication,"['asthma', 'TNF', 'Epinephrine']",0.5,"Question: Is asthma an indication for Epinephrine?
Reasoning: The disease asthma is associated with the gene TNF, which is targeted by the drug Epinephrine. These connections suggest that Epinephrine may be effective in treating asthma.
Answer: YES"
17545,83856.0,Gemtuzumab ozogamicin,acute myeloid leukemia with CEBPA somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with CEBPA somatic mutations', 'CD33', 'Gemtuzumab ozogamicin']",0.5,"Question: Is acute myeloid leukemia with CEBPA somatic mutations an indication for Gemtuzumab ozogamicin?
Reasoning: The disease acute myeloid leukemia with CEBPA somatic mutations is associated with the gene CD33, which is targeted by the drug Gemtuzumab ozogamicin. These connections suggest that Gemtuzumab ozogamicin may be effective in treating acute myeloid leukemia with CEBPA somatic mutations.
Answer: YES"
15209,83840.0,Vilazodone,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'CYP2C19', 'Vilazodone']",0.5,"Question: Is unipolar depression an indication for Vilazodone?
Reasoning: The disease unipolar depression is associated with the gene CYP2C19, which is targeted by the drug Vilazodone. These connections suggest that Vilazodone may be effective in treating unipolar depression.
Answer: YES"
14024,84158.0,Prednisone,T-cell/histiocyte rich large B cell lymphoma,disease-protein-drug,indication,"['T-cell/histiocyte rich large B cell lymphoma', 'ABCB1', 'Prednisone']",0.5,"Question: Is T-cell/histiocyte rich large B cell lymphoma an indication for Prednisone?
Reasoning: The disease T-cell/histiocyte rich large B cell lymphoma is associated with the gene ABCB1, which is targeted by the drug Prednisone. These connections suggest that Prednisone may be effective in treating T-cell/histiocyte rich large B cell lymphoma.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TBCK', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TBCK. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'PEPD', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene PEPD. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Muscle weakness', 'AMPD1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Muscle weakness, which in turn affects the gene AMPD1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CACNA1B', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene CACNA1B. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14454,32504.0,Nifurtimox,Chagas disease,disease-phenotype-protein-drug,indication,"['Chagas disease', 'Hepatomegaly', 'ALB', 'Nifurtimox']",0.5,"Question: Is Chagas disease an indication for Nifurtimox?
Reasoning: The disease Chagas disease is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Nifurtimox. These connections suggest that Nifurtimox may be effective in treating Chagas disease.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'NARS2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene NARS2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14542,27933.0,Maprotiline,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'SLC6A2', 'Maprotiline']",0.5,"Question: Is anxiety disorder an indication for Maprotiline?
Reasoning: The disease anxiety disorder is associated with the gene SLC6A2, which is targeted by the drug Maprotiline. These connections suggest that Maprotiline may be effective in treating anxiety disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PET100', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene PET100. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14196,36035.0,Propranolol,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Propranolol']",0.5,"Question: Is hypertension an indication for Propranolol?
Reasoning: The disease hypertension is associated with the gene CYP3A5, which is targeted by the drug Propranolol. These connections suggest that Propranolol may be effective in treating hypertension.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'P4HTM', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene P4HTM. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
17224,83781.0,Ibudilast,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'PDE4D', 'Ibudilast']",0.5,"Question: Is intrinsic asthma an indication for Ibudilast?
Reasoning: The disease intrinsic asthma is associated with the gene PDE4D, which is targeted by the drug Ibudilast. These connections suggest that Ibudilast may be effective in treating intrinsic asthma.
Answer: YES"
14023,29993.0,Triamcinolone,classic Hodgkin lymphoma,disease-phenotype-protein-drug,indication,"['classic Hodgkin lymphoma', 'Hepatomegaly', 'ALB', 'Triamcinolone']",0.5,"Question: Is classic Hodgkin lymphoma an indication for Triamcinolone?
Reasoning: The disease classic Hodgkin lymphoma is associated with the phenotype Hepatomegaly, which in turn affects the gene ALB. This gene is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating classic Hodgkin lymphoma.
Answer: YES"
14321,28801.0,Levodopa,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Seizure', 'DRD1', 'Levodopa']",0.5,"Question: Is juvenile onset Parkinson disease 19A an indication for Levodopa?
Reasoning: The disease juvenile onset Parkinson disease 19A is associated with the phenotype Seizure, which in turn affects the gene DRD1. This gene is targeted by the drug Levodopa. These connections suggest that Levodopa may be effective in treating juvenile onset Parkinson disease 19A.
Answer: YES"
14956,36743.0,Carbamazepine,partial epilepsy,disease-protein-drug,indication,"['partial epilepsy', 'ABCC2', 'Carbamazepine']",0.5,"Question: Is partial epilepsy an indication for Carbamazepine?
Reasoning: The disease partial epilepsy is associated with the gene ABCC2, which is targeted by the drug Carbamazepine. These connections suggest that Carbamazepine may be effective in treating partial epilepsy.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Abnormal bleeding', 'ACVRL1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Abnormal bleeding, which in turn affects the gene ACVRL1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'CD68', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene CD68. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14737,39615.0,Carboplatin,borderline epithelial tumor of ovary,disease-protein-drug,indication,"['borderline epithelial tumor of ovary', 'ATP7B', 'Carboplatin']",0.5,"Question: Is borderline epithelial tumor of ovary an indication for Carboplatin?
Reasoning: The disease borderline epithelial tumor of ovary is associated with the gene ATP7B, which is targeted by the drug Carboplatin. These connections suggest that Carboplatin may be effective in treating borderline epithelial tumor of ovary.
Answer: YES"
14194,35650.0,Methotrexate,non-Hodgkin lymphoma,disease-protein-drug,indication,"['non-Hodgkin lymphoma', 'MTHFR', 'Methotrexate']",0.5,"Question: Is non-Hodgkin lymphoma an indication for Methotrexate?
Reasoning: The disease non-Hodgkin lymphoma is associated with the gene MTHFR, which is targeted by the drug Methotrexate. These connections suggest that Methotrexate may be effective in treating non-Hodgkin lymphoma.
Answer: YES"
14999,30318.0,Quetiapine,autosomal recessive severe congenital neutropenia due to JAGN1 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to JAGN1 deficiency', 'Short stature', 'AMMECR1', 'Quetiapine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to JAGN1 deficiency an indication for Quetiapine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to JAGN1 deficiency is associated with the phenotype Short stature, which in turn affects the gene AMMECR1. This gene is not targeted by the drug Quetiapine. These connections suggest that Quetiapine may not be effective in treating autosomal recessive severe congenital neutropenia due to JAGN1 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Delayed speech and language development', 'MED12L', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Delayed speech and language development, which in turn affects the gene MED12L. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
17746,83776.0,Eldecalcitol,postmenopausal osteoporosis,disease-protein-drug,indication,"['postmenopausal osteoporosis', 'VDR', 'Eldecalcitol']",0.5,"Question: Is postmenopausal osteoporosis an indication for Eldecalcitol?
Reasoning: The disease postmenopausal osteoporosis is associated with the gene VDR, which is targeted by the drug Eldecalcitol. These connections suggest that Eldecalcitol may be effective in treating postmenopausal osteoporosis.
Answer: YES"
15683,31116.0,Brigatinib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'MET', 'Brigatinib']",0.5,"Question: Is lung cancer an indication for Brigatinib?
Reasoning: The disease lung cancer is associated with the gene MET, which is targeted by the drug Brigatinib. These connections suggest that Brigatinib may be effective in treating lung cancer.
Answer: YES"
17318,30664.0,Solriamfetol,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,indication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'SLC6A3', 'Solriamfetol']",0.5,"Question: Is X-linked adrenoleukodystrophy an indication for Solriamfetol?
Reasoning: The disease X-linked adrenoleukodystrophy is associated with the phenotype Neurodegeneration, which in turn affects the gene SLC6A3. This gene is targeted by the drug Solriamfetol. These connections suggest that Solriamfetol may be effective in treating X-linked adrenoleukodystrophy.
Answer: YES"
15263,83854.0,Enasidenib,acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor,disease-protein-drug,indication,"['acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor', 'IDH2', 'Enasidenib']",0.5,"Question: Is acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor an indication for Enasidenib?
Reasoning: The disease acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor is associated with the gene IDH2, which is targeted by the drug Enasidenib. These connections suggest that Enasidenib may be effective in treating acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'NSF', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene NSF. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15187,30039.0,Nilotinib,"chronic myelogenous leukemia, BCR-ABL1 positive",disease-protein-drug,indication,"['chronic myelogenous leukemia, BCR-ABL1 positive', 'ABL1', 'Nilotinib']",0.5,"Question: Is chronic myelogenous leukemia, BCR-ABL1 positive an indication for Nilotinib?
Reasoning: The disease chronic myelogenous leukemia, BCR-ABL1 positive is associated with the gene ABL1, which is targeted by the drug Nilotinib. These connections suggest that Nilotinib may be effective in treating chronic myelogenous leukemia, BCR-ABL1 positive.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Delayed puberty', 'BSCL2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Delayed puberty, which in turn affects the gene BSCL2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15416,32456.0,Lorazepam,cutis verticis gyrata,disease-protein-drug,indication,"['cutis verticis gyrata', 'GABRB3', 'Lorazepam']",0.5,"Question: Is cutis verticis gyrata an indication for Lorazepam?
Reasoning: The disease cutis verticis gyrata is associated with the gene GABRB3, which is targeted by the drug Lorazepam. These connections suggest that Lorazepam may be effective in treating cutis verticis gyrata.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'ALKBH8', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene ALKBH8. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'ABCB1', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Nausea, which in turn affects the gene ABCB1. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
14161,27933.0,Olanzapine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Olanzapine']",0.5,"Question: Is anxiety disorder an indication for Olanzapine?
Reasoning: The disease anxiety disorder is associated with the gene ABCB1, which is targeted by the drug Olanzapine. These connections suggest that Olanzapine may be effective in treating anxiety disorder.
Answer: YES"
15597,83871.0,Ruxolitinib,myelofibrosis,disease-protein-drug,indication,"['myelofibrosis', 'JAK2', 'Ruxolitinib']",0.5,"Question: Is myelofibrosis an indication for Ruxolitinib?
Reasoning: The disease myelofibrosis is associated with the gene JAK2, which is targeted by the drug Ruxolitinib. These connections suggest that Ruxolitinib may be effective in treating myelofibrosis.
Answer: YES"
15783,83791.0,Cyclizine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Cyclizine']",0.5,"Question: Is vasomotor rhinitis an indication for Cyclizine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Cyclizine. These connections suggest that Cyclizine may be effective in treating vasomotor rhinitis.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'FAS', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene FAS. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14138,37805.0,Nevirapine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Nevirapine']",0.5,"Question: Is HIV infectious disease an indication for Nevirapine?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Nevirapine. These connections suggest that Nevirapine may be effective in treating HIV infectious disease.
Answer: YES"
14942,83791.0,Terfenadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Terfenadine']",0.5,"Question: Is vasomotor rhinitis an indication for Terfenadine?
Reasoning: The disease vasomotor rhinitis is associated with the gene HRH1, which is targeted by the drug Terfenadine. These connections suggest that Terfenadine may be effective in treating vasomotor rhinitis.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'POMC', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene POMC. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'ABHD12', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene ABHD12. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'MIF', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene MIF. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hypotonia', 'RRM2B', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Hypotonia, which in turn affects the gene RRM2B. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14831,31408.0,Droxidopa,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'ADRB2', 'Droxidopa']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Droxidopa?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the phenotype Resting tremor, which in turn affects the gene ADRB2. This gene is targeted by the drug Droxidopa. These connections suggest that Droxidopa may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'ESPN', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene ESPN. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'MPDU1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene MPDU1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14621,32354.0,Lonoctocog alfa,symptomatic form of hemophilia in female carriers,disease-protein-drug,indication,"['symptomatic form of hemophilia in female carriers', 'F9', 'Lonoctocog alfa']",0.5,"Question: Is symptomatic form of hemophilia in female carriers an indication for Lonoctocog alfa?
Reasoning: The disease symptomatic form of hemophilia in female carriers is associated with the gene F9, which is targeted by the drug Lonoctocog alfa. These connections suggest that Lonoctocog alfa may be effective in treating symptomatic form of hemophilia in female carriers.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'MN1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene MN1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16495,28520.0,Quizartinib,myeloid leukemia,disease-protein-drug,indication,"['myeloid leukemia', 'FLT3', 'Quizartinib']",0.5,"Question: Is myeloid leukemia an indication for Quizartinib?
Reasoning: The disease myeloid leukemia is associated with the gene FLT3, which is targeted by the drug Quizartinib. These connections suggest that Quizartinib may be effective in treating myeloid leukemia.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Delayed puberty', 'CRH', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Delayed puberty, which in turn affects the gene CRH. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16510,36691.0,Bevacizumab,breast cancer,disease-protein-drug,indication,"['breast cancer', 'C1QB', 'Bevacizumab']",0.5,"Question: Is breast cancer an indication for Bevacizumab?
Reasoning: The disease breast cancer is associated with the gene C1QB, which is targeted by the drug Bevacizumab. These connections suggest that Bevacizumab may be effective in treating breast cancer.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'AP4S1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene AP4S1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'TNF', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene TNF. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
15424,29637.0,Cabergoline,prolactin producing pituitary gland tumor,disease-protein-drug,indication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Cabergoline']",0.5,"Question: Is prolactin producing pituitary gland tumor an indication for Cabergoline?
Reasoning: The disease prolactin producing pituitary gland tumor is associated with the gene DRD2, which is targeted by the drug Cabergoline. These connections suggest that Cabergoline may be effective in treating prolactin producing pituitary gland tumor.
Answer: YES"
15218,32132.0,Phenylbutyric acid,citrullinemia,disease-phenotype-protein-drug,indication,"['citrullinemia', 'Tremor', 'CYP2D6', 'Phenylbutyric acid']",0.5,"Question: Is citrullinemia an indication for Phenylbutyric acid?
Reasoning: The disease citrullinemia is associated with the phenotype Tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Phenylbutyric acid. These connections suggest that Phenylbutyric acid may be effective in treating citrullinemia.
Answer: YES"
14813,33575.0,Troglitazone,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'PPARA', 'Troglitazone']",0.5,"Question: Is diabetes mellitus (disease) an indication for Troglitazone?
Reasoning: The disease diabetes mellitus (disease) is associated with the gene PPARA, which is targeted by the drug Troglitazone. These connections suggest that Troglitazone may be effective in treating diabetes mellitus (disease).
Answer: YES"
14321,37706.0,Levodopa,parkinsonian disorder,disease-protein-drug,indication,"['parkinsonian disorder', 'DDC', 'Levodopa']",0.5,"Question: Is parkinsonian disorder an indication for Levodopa?
Reasoning: The disease parkinsonian disorder is associated with the gene DDC, which is targeted by the drug Levodopa. These connections suggest that Levodopa may be effective in treating parkinsonian disorder.
Answer: YES"
14793,30826.0,Docetaxel,familial prostate carcinoma,disease-protein-drug,indication,"['familial prostate carcinoma', 'BCL2', 'Docetaxel']",0.5,"Question: Is familial prostate carcinoma an indication for Docetaxel?
Reasoning: The disease familial prostate carcinoma is associated with the gene BCL2, which is targeted by the drug Docetaxel. These connections suggest that Docetaxel may be effective in treating familial prostate carcinoma.
Answer: YES"
14275,84154.0,Doxorubicin,"primary cutaneous diffuse large B-cell lymphoma, Leg type",disease-protein-drug,indication,"['primary cutaneous diffuse large B-cell lymphoma, Leg type', 'ABCB1', 'Doxorubicin']",0.5,"Question: Is primary cutaneous diffuse large B-cell lymphoma, Leg type an indication for Doxorubicin?
Reasoning: The disease primary cutaneous diffuse large B-cell lymphoma, Leg type is associated with the gene ABCB1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating primary cutaneous diffuse large B-cell lymphoma, Leg type.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'PAM', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene PAM. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
16634,28673.0,Coagulation factor VIIa Recombinant Human,congenital factor VII deficiency,disease-protein-drug,indication,"['congenital factor VII deficiency', 'F7', 'Coagulation factor VIIa Recombinant Human']",0.5,"Question: Is congenital factor VII deficiency an indication for Coagulation factor VIIa Recombinant Human?
Reasoning: The disease congenital factor VII deficiency is associated with the gene F7, which is targeted by the drug Coagulation factor VIIa Recombinant Human. These connections suggest that Coagulation factor VIIa Recombinant Human may be effective in treating congenital factor VII deficiency.
Answer: YES"
14054,32629.0,Vitamin E,familial intrahepatic cholestasis,disease-phenotype-protein-drug,indication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'NR1I2', 'Vitamin E']",0.5,"Question: Is familial intrahepatic cholestasis an indication for Vitamin E?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene NR1I2. This gene is targeted by the drug Vitamin E. These connections suggest that Vitamin E may be effective in treating familial intrahepatic cholestasis.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'IGKC', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Hepatomegaly, which in turn affects the gene IGKC. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14310,38242.0,Doxepin,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'SLC6A2', 'Doxepin']",0.5,"Question: Is bipolar disorder an indication for Doxepin?
Reasoning: The disease bipolar disorder is associated with the gene SLC6A2, which is targeted by the drug Doxepin. These connections suggest that Doxepin may be effective in treating bipolar disorder.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Delayed speech and language development', 'FOXP2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Delayed speech and language development, which in turn affects the gene FOXP2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14208,28407.0,Testosterone,hypogonadotropic hypogonadism,disease-protein-drug,indication,"['hypogonadotropic hypogonadism', 'CYP19A1', 'Testosterone']",0.5,"Question: Is hypogonadotropic hypogonadism an indication for Testosterone?
Reasoning: The disease hypogonadotropic hypogonadism is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating hypogonadotropic hypogonadism.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'BSND', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene BSND. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'HIF1A', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene HIF1A. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'IGF2', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene IGF2. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'NTNG2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene NTNG2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'DHPS', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene DHPS. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14385,28208.0,Liraglutide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'GLP1R', 'Liraglutide']",0.5,"Question: Is type 2 diabetes mellitus an indication for Liraglutide?
Reasoning: The disease type 2 diabetes mellitus is associated with the gene GLP1R, which is targeted by the drug Liraglutide. These connections suggest that Liraglutide may be effective in treating type 2 diabetes mellitus.
Answer: YES"
14111,33452.0,Alitretinoin,granulomatous slack skin disease,disease-phenotype-protein-drug,contraindication,"['granulomatous slack skin disease', 'Erythema', 'PTGS1', 'Alitretinoin']",1.0,"Question: Is granulomatous slack skin disease an indication for Alitretinoin?
Reasoning: The disease granulomatous slack skin disease is associated with the phenotype Erythema, which in turn affects the gene PTGS1. This gene is not targeted by the drug Alitretinoin. These connections suggest that Alitretinoin may not be effective in treating granulomatous slack skin disease.
Answer: NO"
15879,30035.0,Nalmefene,substance abuse/dependence,disease-protein-drug,indication,"['substance abuse/dependence', 'OPRM1', 'Nalmefene']",0.5,"Question: Is substance abuse/dependence an indication for Nalmefene?
Reasoning: The disease substance abuse/dependence is associated with the gene OPRM1, which is targeted by the drug Nalmefene. These connections suggest that Nalmefene may be effective in treating substance abuse/dependence.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ACHE', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ACHE. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14544,37703.0,Bupropion,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A2', 'Bupropion']",0.5,"Question: Is neurotic disorder an indication for Bupropion?
Reasoning: The disease neurotic disorder is associated with the gene SLC6A2, which is targeted by the drug Bupropion. These connections suggest that Bupropion may be effective in treating neurotic disorder.
Answer: YES"
15138,31408.0,Selegiline,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'CYP2D6', 'Selegiline']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Selegiline?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the phenotype Resting tremor, which in turn affects the gene CYP2D6. This gene is targeted by the drug Selegiline. These connections suggest that Selegiline may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
15781,28017.0,Acetylsalicylic acid,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Acetylsalicylic acid']",0.5,"Question: Is migraine with or without aura, susceptibility to an indication for Acetylsalicylic acid?
Reasoning: The disease migraine with or without aura, susceptibility to is associated with the phenotype Vomiting, which in turn affects the gene ABCB1. This gene is targeted by the drug Acetylsalicylic acid. These connections suggest that Acetylsalicylic acid may be effective in treating migraine with or without aura, susceptibility to.
Answer: YES"
14435,33575.0,Insulin degludec,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'CYP1A2', 'Insulin degludec']",0.5,"Question: Is diabetes mellitus (disease) an indication for Insulin degludec?
Reasoning: The disease diabetes mellitus (disease) is associated with the gene CYP1A2, which is targeted by the drug Insulin degludec. These connections suggest that Insulin degludec may be effective in treating diabetes mellitus (disease).
Answer: YES"
14152,29113.0,Chlorthalidone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'CD68', 'Chlorthalidone']",1.0,"Question: Is diabetic ketoacidosis an indication for Chlorthalidone?
Reasoning: The disease diabetic ketoacidosis is associated with the phenotype Insulin resistance, which in turn affects the gene CD68. This gene is not targeted by the drug Chlorthalidone. These connections suggest that Chlorthalidone may not be effective in treating diabetic ketoacidosis.
Answer: NO"
14023,33206.0,Triamcinolone,eosinophilic pneumonia,disease-phenotype-protein-drug,indication,"['eosinophilic pneumonia', 'Fever', 'PTGS2', 'Triamcinolone']",0.5,"Question: Is eosinophilic pneumonia an indication for Triamcinolone?
Reasoning: The disease eosinophilic pneumonia is associated with the phenotype Fever, which in turn affects the gene PTGS2. This gene is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating eosinophilic pneumonia.
Answer: YES"
15126,28780.0,Donepezil,Alzheimer disease,disease-phenotype-protein-drug,indication,"['Alzheimer disease', 'Seizure', 'NOS1', 'Donepezil']",0.5,"Question: Is Alzheimer disease an indication for Donepezil?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene NOS1. This gene is targeted by the drug Donepezil. These connections suggest that Donepezil may be effective in treating Alzheimer disease.
Answer: YES"
14478,36453.0,Testosterone undecanoate,hypogonadism,disease-protein-drug,indication,"['hypogonadism', 'CYP19A1', 'Testosterone undecanoate']",0.5,"Question: Is hypogonadism an indication for Testosterone undecanoate?
Reasoning: The disease hypogonadism is associated with the gene CYP19A1, which is targeted by the drug Testosterone undecanoate. These connections suggest that Testosterone undecanoate may be effective in treating hypogonadism.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'PIGP', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene PIGP. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'MECOM', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene MECOM. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GCH1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene GCH1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
15295,33592.0,Triamterene,acidosis disorder,disease-phenotype-protein-drug,contraindication,"['acidosis disorder', 'Increased serum lactate', 'GOT2', 'Triamterene']",1.0,"Question: Is acidosis disorder an indication for Triamterene?
Reasoning: The disease acidosis disorder is associated with the phenotype Increased serum lactate, which in turn affects the gene GOT2. This gene is not targeted by the drug Triamterene. These connections suggest that Triamterene may not be effective in treating acidosis disorder.
Answer: NO"
16180,29854.0,Conestat alfa,hereditary angioedema,disease-protein-drug,indication,"['hereditary angioedema', 'F12', 'Conestat alfa']",0.5,"Question: Is hereditary angioedema an indication for Conestat alfa?
Reasoning: The disease hereditary angioedema is associated with the gene F12, which is targeted by the drug Conestat alfa. These connections suggest that Conestat alfa may be effective in treating hereditary angioedema.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'MED12L', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene MED12L. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'RARS1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene RARS1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Hearing impairment', 'FANCC', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Hearing impairment, which in turn affects the gene FANCC. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'CALCA', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Pulmonary arterial hypertension, which in turn affects the gene CALCA. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'RBFOX1', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene RBFOX1. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'HLA-B', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Allergy, which in turn affects the gene HLA-B. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'IDH2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene IDH2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14158,36209.0,Indomethacin,arthropathy,disease-protein-drug,indication,"['arthropathy', 'PPARG', 'Indomethacin']",0.5,"Question: Is arthropathy an indication for Indomethacin?
Reasoning: The disease arthropathy is associated with the gene PPARG, which is targeted by the drug Indomethacin. These connections suggest that Indomethacin may be effective in treating arthropathy.
Answer: YES"
15012,35651.0,Temsirolimus,B-cell neoplasm,disease-protein-drug,indication,"['B-cell neoplasm', 'MTOR', 'Temsirolimus']",0.5,"Question: Is B-cell neoplasm an indication for Temsirolimus?
Reasoning: The disease B-cell neoplasm is associated with the gene MTOR, which is targeted by the drug Temsirolimus. These connections suggest that Temsirolimus may be effective in treating B-cell neoplasm.
Answer: YES"
15006,28313.0,Iloperidone,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'CYP2E1', 'Iloperidone']",0.5,"Question: Is schizophrenia an indication for Iloperidone?
Reasoning: The disease schizophrenia is associated with the gene CYP2E1, which is targeted by the drug Iloperidone. These connections suggest that Iloperidone may be effective in treating schizophrenia.
Answer: YES"
16634,38622.0,Coagulation factor VIIa Recombinant Human,factor VII deficiency,disease-protein-drug,indication,"['factor VII deficiency', 'F7', 'Coagulation factor VIIa Recombinant Human']",0.5,"Question: Is factor VII deficiency an indication for Coagulation factor VIIa Recombinant Human?
Reasoning: The disease factor VII deficiency is associated with the gene F7, which is targeted by the drug Coagulation factor VIIa Recombinant Human. These connections suggest that Coagulation factor VIIa Recombinant Human may be effective in treating factor VII deficiency.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'FKTN', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene FKTN. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'FOXG1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene FOXG1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'TRH', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene TRH. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'AFF3', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene AFF3. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
17560,39773.0,Orciprenaline,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Orciprenaline']",0.5,"Question: Is allergic asthma an indication for Orciprenaline?
Reasoning: The disease allergic asthma is associated with the gene ADRB2, which is targeted by the drug Orciprenaline. These connections suggest that Orciprenaline may be effective in treating allergic asthma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'FUCA1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene FUCA1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14176,38242.0,Fluoxetine,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'CHRNA2', 'Fluoxetine']",0.5,"Question: Is bipolar disorder an indication for Fluoxetine?
Reasoning: The disease bipolar disorder is associated with the gene CHRNA2, which is targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may be effective in treating bipolar disorder.
Answer: YES"
15193,31408.0,Rotigotine,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'DRD1', 'Rotigotine']",0.5,"Question: Is X-linked parkinsonism-spasticity syndrome an indication for Rotigotine?
Reasoning: The disease X-linked parkinsonism-spasticity syndrome is associated with the gene DRD1, which is targeted by the drug Rotigotine. These connections suggest that Rotigotine may be effective in treating X-linked parkinsonism-spasticity syndrome.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'IFIH1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene IFIH1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14275,31481.0,Doxorubicin,bone osteosarcoma,disease-phenotype-protein-drug,indication,"['bone osteosarcoma', 'Pain', 'ALB', 'Doxorubicin']",0.5,"Question: Is bone osteosarcoma an indication for Doxorubicin?
Reasoning: The disease bone osteosarcoma is associated with the phenotype Pain, which in turn affects the gene ALB. This gene is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating bone osteosarcoma.
Answer: YES"
15218,29034.0,Phenylbutyric acid,hyperammonemia due to N-acetylglutamate synthase deficiency,disease-phenotype-protein-drug,indication,"['hyperammonemia due to N-acetylglutamate synthase deficiency', 'Coma', 'CYP2D6', 'Phenylbutyric acid']",0.5,"Question: Is hyperammonemia due to N-acetylglutamate synthase deficiency an indication for Phenylbutyric acid?
Reasoning: The disease hyperammonemia due to N-acetylglutamate synthase deficiency is associated with the phenotype Coma, which in turn affects the gene CYP2D6. This gene is targeted by the drug Phenylbutyric acid. These connections suggest that Phenylbutyric acid may be effective in treating hyperammonemia due to N-acetylglutamate synthase deficiency.
Answer: YES"
14320,30654.0,Dexamethasone,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Dexamethasone']",0.5,"Question: Is acute lymphoblastic/lymphocytic leukemia an indication for Dexamethasone?
Reasoning: The disease acute lymphoblastic/lymphocytic leukemia is associated with the gene ABCG2, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating acute lymphoblastic/lymphocytic leukemia.
Answer: YES"
15177,28313.0,Zuclopenthixol,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD5', 'Zuclopenthixol']",0.5,"Question: Is schizophrenia an indication for Zuclopenthixol?
Reasoning: The disease schizophrenia is associated with the gene DRD5, which is targeted by the drug Zuclopenthixol. These connections suggest that Zuclopenthixol may be effective in treating schizophrenia.
Answer: YES"
17605,36581.0,Cetuximab,colonic neoplasm,disease-protein-drug,indication,"['colonic neoplasm', 'EGFR', 'Cetuximab']",0.5,"Question: Is colonic neoplasm an indication for Cetuximab?
Reasoning: The disease colonic neoplasm is associated with the gene EGFR, which is targeted by the drug Cetuximab. These connections suggest that Cetuximab may be effective in treating colonic neoplasm.
Answer: YES"
14062,29078.0,Diflunisal,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Diflunisal']",0.5,"Question: Is rheumatoid arthritis an indication for Diflunisal?
Reasoning: The disease rheumatoid arthritis is associated with the gene PTGS1, which is targeted by the drug Diflunisal. These connections suggest that Diflunisal may be effective in treating rheumatoid arthritis.
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SGSH', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene SGSH. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
17584,39524.0,Adalimumab,psoriatic arthritis,disease-protein-drug,indication,"['psoriatic arthritis', 'TNF', 'Adalimumab']",0.5,"Question: Is psoriatic arthritis an indication for Adalimumab?
Reasoning: The disease psoriatic arthritis is associated with the gene TNF, which is targeted by the drug Adalimumab. These connections suggest that Adalimumab may be effective in treating psoriatic arthritis.
Answer: YES"
14955,84155.0,Vincristine,Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly,disease-protein-drug,indication,"['Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly', 'ABCB1', 'Vincristine']",0.5,"Question: Is Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly an indication for Vincristine?
Reasoning: The disease Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly is associated with the gene ABCB1, which is targeted by the drug Vincristine. These connections suggest that Vincristine may be effective in treating Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Answer: YES"
15599,36634.0,Regorafenib,liver cancer,disease-protein-drug,indication,"['liver cancer', 'ABCB1', 'Regorafenib']",0.5,"Question: Is liver cancer an indication for Regorafenib?
Reasoning: The disease liver cancer is associated with the gene ABCB1, which is targeted by the drug Regorafenib. These connections suggest that Regorafenib may be effective in treating liver cancer.
Answer: YES"
16056,32468.0,Procyclidine,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Resting tremor', 'CHRM4', 'Procyclidine']",0.5,"Question: Is postencephalitic Parkinson disease an indication for Procyclidine?
Reasoning: The disease postencephalitic Parkinson disease is associated with the phenotype Resting tremor, which in turn affects the gene CHRM4. This gene is targeted by the drug Procyclidine. These connections suggest that Procyclidine may be effective in treating postencephalitic Parkinson disease.
Answer: YES"
14111,33452.0,Alitretinoin,granulomatous slack skin disease,disease-phenotype-protein-drug,contraindication,"['granulomatous slack skin disease', 'Erythema', 'VIP', 'Alitretinoin']",1.0,"Question: Is granulomatous slack skin disease an indication for Alitretinoin?
Reasoning: The disease granulomatous slack skin disease is associated with the phenotype Erythema, which in turn affects the gene VIP. This gene is not targeted by the drug Alitretinoin. These connections suggest that Alitretinoin may not be effective in treating granulomatous slack skin disease.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'TGFB1', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene TGFB1. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SIGMAR1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SIGMAR1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'KPTN', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene KPTN. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
17568,39773.0,Tulobuterol,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Tulobuterol']",0.5,"Question: Is allergic asthma an indication for Tulobuterol?
Reasoning: The disease allergic asthma is associated with the gene ADRB2, which is targeted by the drug Tulobuterol. These connections suggest that Tulobuterol may be effective in treating allergic asthma.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'EIF3F', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene EIF3F. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14111,33452.0,Alitretinoin,granulomatous slack skin disease,disease-phenotype-protein-drug,contraindication,"['granulomatous slack skin disease', 'Erythema', 'XRCC1', 'Alitretinoin']",1.0,"Question: Is granulomatous slack skin disease an indication for Alitretinoin?
Reasoning: The disease granulomatous slack skin disease is associated with the phenotype Erythema, which in turn affects the gene XRCC1. This gene is not targeted by the drug Alitretinoin. These connections suggest that Alitretinoin may not be effective in treating granulomatous slack skin disease.
Answer: NO"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'SOD2', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene SOD2. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14623,29182.0,Prasterone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,indication,"['systemic lupus erythematosus (disease)', 'Seizure', 'SIGMAR1', 'Prasterone']",0.5,"Question: Is systemic lupus erythematosus (disease) an indication for Prasterone?
Reasoning: The disease systemic lupus erythematosus (disease) is associated with the phenotype Seizure, which in turn affects the gene SIGMAR1. This gene is targeted by the drug Prasterone. These connections suggest that Prasterone may be effective in treating systemic lupus erythematosus (disease).
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'HTR1A', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene HTR1A. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16842,28974.0,Pramipexole,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'HTR1A', 'Pramipexole']",0.5,"Question: Is early-onset parkinsonism-intellectual disability syndrome an indication for Pramipexole?
Reasoning: The disease early-onset parkinsonism-intellectual disability syndrome is associated with the phenotype Resting tremor, which in turn affects the gene HTR1A. This gene is targeted by the drug Pramipexole. These connections suggest that Pramipexole may be effective in treating early-onset parkinsonism-intellectual disability syndrome.
Answer: YES"
17246,37888.0,Clofedanol,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Clofedanol']",0.5,"Question: Is allergic rhinitis an indication for Clofedanol?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Clofedanol. These connections suggest that Clofedanol may be effective in treating allergic rhinitis.
Answer: YES"
15979,27361.0,Coagulation Factor IX Human,hemophilia,disease-protein-drug,indication,"['hemophilia', 'F8', 'Coagulation Factor IX Human']",0.5,"Question: Is hemophilia an indication for Coagulation Factor IX Human?
Reasoning: The disease hemophilia is associated with the gene F8, which is targeted by the drug Coagulation Factor IX Human. These connections suggest that Coagulation Factor IX Human may be effective in treating hemophilia.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'FH', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene FH. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14959,33577.0,Nicardipine,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Nicardipine']",0.5,"Question: Is hypertensive disorder an indication for Nicardipine?
Reasoning: The disease hypertensive disorder is associated with the gene CYP3A5, which is targeted by the drug Nicardipine. These connections suggest that Nicardipine may be effective in treating hypertensive disorder.
Answer: YES"
14320,39245.0,Dexamethasone,panuveitis (disease),disease-protein-drug,indication,"['panuveitis (disease)', 'ALB', 'Dexamethasone']",0.5,"Question: Is panuveitis (disease) an indication for Dexamethasone?
Reasoning: The disease panuveitis (disease) is associated with the gene ALB, which is targeted by the drug Dexamethasone. These connections suggest that Dexamethasone may be effective in treating panuveitis (disease).
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Splenomegaly', 'NFE2L2', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Splenomegaly, which in turn affects the gene NFE2L2. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'MAPK14', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene MAPK14. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
14993,36743.0,Phenobarbital,partial epilepsy,disease-protein-drug,indication,"['partial epilepsy', 'ABCC2', 'Phenobarbital']",0.5,"Question: Is partial epilepsy an indication for Phenobarbital?
Reasoning: The disease partial epilepsy is associated with the gene ABCC2, which is targeted by the drug Phenobarbital. These connections suggest that Phenobarbital may be effective in treating partial epilepsy.
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'LEP', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene LEP. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
15668,35963.0,Apalutamide,prostate carcinoma,disease-protein-drug,indication,"['prostate carcinoma', 'CYP2C19', 'Apalutamide']",0.5,"Question: Is prostate carcinoma an indication for Apalutamide?
Reasoning: The disease prostate carcinoma is associated with the gene CYP2C19, which is targeted by the drug Apalutamide. These connections suggest that Apalutamide may be effective in treating prostate carcinoma.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRK1', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene OPRK1. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14275,37047.0,Doxorubicin,immature ovarian teratoma,disease-protein-drug,indication,"['immature ovarian teratoma', 'CYP1B1', 'Doxorubicin']",0.5,"Question: Is immature ovarian teratoma an indication for Doxorubicin?
Reasoning: The disease immature ovarian teratoma is associated with the gene CYP1B1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating immature ovarian teratoma.
Answer: YES"
14023,29182.0,Triamcinolone,systemic lupus erythematosus (disease),disease-protein-drug,indication,"['systemic lupus erythematosus (disease)', 'PTGS2', 'Triamcinolone']",0.5,"Question: Is systemic lupus erythematosus (disease) an indication for Triamcinolone?
Reasoning: The disease systemic lupus erythematosus (disease) is associated with the gene PTGS2, which is targeted by the drug Triamcinolone. These connections suggest that Triamcinolone may be effective in treating systemic lupus erythematosus (disease).
Answer: YES"
14181,37805.0,Zidovudine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Zidovudine']",0.5,"Question: Is HIV infectious disease an indication for Zidovudine?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Zidovudine. These connections suggest that Zidovudine may be effective in treating HIV infectious disease.
Answer: YES"
14956,83763.0,Carbamazepine,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'SCN2A', 'Carbamazepine']",0.5,"Question: Is manic bipolar affective disorder an indication for Carbamazepine?
Reasoning: The disease manic bipolar affective disorder is associated with the gene SCN2A, which is targeted by the drug Carbamazepine. These connections suggest that Carbamazepine may be effective in treating manic bipolar affective disorder.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PAM', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene PAM. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
15493,28547.0,Bromocriptine,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'ABCB1', 'Bromocriptine']",0.5,"Question: Is Parkinson disease an indication for Bromocriptine?
Reasoning: The disease Parkinson disease is associated with the gene ABCB1, which is targeted by the drug Bromocriptine. These connections suggest that Bromocriptine may be effective in treating Parkinson disease.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'LIF', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Weight loss, which in turn affects the gene LIF. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
14208,33232.0,Testosterone,X-linked intellectual disability with isolated growth hormone deficiency,disease-protein-drug,indication,"['X-linked intellectual disability with isolated growth hormone deficiency', 'CYP19A1', 'Testosterone']",0.5,"Question: Is X-linked intellectual disability with isolated growth hormone deficiency an indication for Testosterone?
Reasoning: The disease X-linked intellectual disability with isolated growth hormone deficiency is associated with the gene CYP19A1, which is targeted by the drug Testosterone. These connections suggest that Testosterone may be effective in treating X-linked intellectual disability with isolated growth hormone deficiency.
Answer: YES"
14280,33575.0,Glyburide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'KCNJ11', 'Glyburide']",0.5,"Question: Is diabetes mellitus (disease) an indication for Glyburide?
Reasoning: The disease diabetes mellitus (disease) is associated with the gene KCNJ11, which is targeted by the drug Glyburide. These connections suggest that Glyburide may be effective in treating diabetes mellitus (disease).
Answer: YES"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Memory impairment', 'MAPT', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Memory impairment, which in turn affects the gene MAPT. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15794,27366.0,Aceclofenac,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Aceclofenac']",0.5,"Question: Is spondyloarthropathy, susceptibility to an indication for Aceclofenac?
Reasoning: The disease spondyloarthropathy, susceptibility to is associated with the phenotype Arrhythmia, which in turn affects the gene PTGS2. This gene is targeted by the drug Aceclofenac. These connections suggest that Aceclofenac may be effective in treating spondyloarthropathy, susceptibility to.
Answer: YES"
14192,32456.0,Lamotrigine,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'DRD1', 'Lamotrigine']",0.5,"Question: Is cutis verticis gyrata an indication for Lamotrigine?
Reasoning: The disease cutis verticis gyrata is associated with the phenotype Seizure, which in turn affects the gene DRD1. This gene is targeted by the drug Lamotrigine. These connections suggest that Lamotrigine may be effective in treating cutis verticis gyrata.
Answer: YES"
20302,32384.0,Potassium Iodide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ZNF142', 'Potassium Iodide']",1.0,"Question: Is adrenal insufficiency an indication for Potassium Iodide?
Reasoning: The disease adrenal insufficiency is associated with the phenotype Seizure, which in turn affects the gene ZNF142. This gene is not targeted by the drug Potassium Iodide. These connections suggest that Potassium Iodide may not be effective in treating adrenal insufficiency.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SLC6A2', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene SLC6A2. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
14275,36794.0,Doxorubicin,ovarian adenocarcinoma,disease-protein-drug,indication,"['ovarian adenocarcinoma', 'CYP1B1', 'Doxorubicin']",0.5,"Question: Is ovarian adenocarcinoma an indication for Doxorubicin?
Reasoning: The disease ovarian adenocarcinoma is associated with the gene CYP1B1, which is targeted by the drug Doxorubicin. These connections suggest that Doxorubicin may be effective in treating ovarian adenocarcinoma.
Answer: YES"
15739,83860.0,Ivosidenib,acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2),disease-protein-drug,indication,"['acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)', 'IDH1', 'Ivosidenib']",0.5,"Question: Is acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) an indication for Ivosidenib?
Reasoning: The disease acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) is associated with the gene IDH1, which is targeted by the drug Ivosidenib. These connections suggest that Ivosidenib may be effective in treating acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2).
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'KLF11', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Hepatomegaly, which in turn affects the gene KLF11. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'COL4A1', 'Chlorprothixene']",1.0,"Question: Is Alzheimer disease an indication for Chlorprothixene?
Reasoning: The disease Alzheimer disease is associated with the phenotype Seizure, which in turn affects the gene COL4A1. This gene is not targeted by the drug Chlorprothixene. These connections suggest that Chlorprothixene may not be effective in treating Alzheimer disease.
Answer: NO"
15018,83859.0,Midostaurin,acute myeloid leukemia with t(9;11)(p22;q23),disease-protein-drug,indication,"['acute myeloid leukemia with t(9;11)(p22;q23)', 'KIT', 'Midostaurin']",0.5,"Question: Is acute myeloid leukemia with t(9;11)(p22;q23) an indication for Midostaurin?
Reasoning: The disease acute myeloid leukemia with t(9;11)(p22;q23) is associated with the gene KIT, which is targeted by the drug Midostaurin. These connections suggest that Midostaurin may be effective in treating acute myeloid leukemia with t(9;11)(p22;q23).
Answer: YES"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Splenomegaly', 'NFE2L2', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Splenomegaly, which in turn affects the gene NFE2L2. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
16510,35741.0,Bevacizumab,cervical adenocarcinoma,disease-protein-drug,indication,"['cervical adenocarcinoma', 'VEGFA', 'Bevacizumab']",0.5,"Question: Is cervical adenocarcinoma an indication for Bevacizumab?
Reasoning: The disease cervical adenocarcinoma is associated with the gene VEGFA, which is targeted by the drug Bevacizumab. These connections suggest that Bevacizumab may be effective in treating cervical adenocarcinoma.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'MLC1', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene MLC1. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'TBCD', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene TBCD. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14113,29361.0,Tamibarotene,acute promyelocytic leukemia,disease-protein-drug,indication,"['acute promyelocytic leukemia', 'RARA', 'Tamibarotene']",0.5,"Question: Is acute promyelocytic leukemia an indication for Tamibarotene?
Reasoning: The disease acute promyelocytic leukemia is associated with the gene RARA, which is targeted by the drug Tamibarotene. These connections suggest that Tamibarotene may be effective in treating acute promyelocytic leukemia.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ATP1A1', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene ATP1A1. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
14264,37805.0,Zalcitabine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Zalcitabine']",0.5,"Question: Is HIV infectious disease an indication for Zalcitabine?
Reasoning: The disease HIV infectious disease is associated with the gene ALB, which is targeted by the drug Zalcitabine. These connections suggest that Zalcitabine may be effective in treating HIV infectious disease.
Answer: YES"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PVALB', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene PVALB. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
15210,37888.0,Mepyramine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Mepyramine']",0.5,"Question: Is allergic rhinitis an indication for Mepyramine?
Reasoning: The disease allergic rhinitis is associated with the gene HRH1, which is targeted by the drug Mepyramine. These connections suggest that Mepyramine may be effective in treating allergic rhinitis.
Answer: YES"
14387,31630.0,Methyltestosterone,androgen insensitivity syndrome,disease-phenotype-protein-drug,indication,"['androgen insensitivity syndrome', 'Male infertility', 'AR', 'Methyltestosterone']",0.5,"Question: Is androgen insensitivity syndrome an indication for Methyltestosterone?
Reasoning: The disease androgen insensitivity syndrome is associated with the phenotype Male infertility, which in turn affects the gene AR. This gene is targeted by the drug Methyltestosterone. These connections suggest that Methyltestosterone may be effective in treating androgen insensitivity syndrome.
Answer: YES"
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'GBA', 'Tolazamide']",1.0,"Question: Is hypogonadotropic hypogonadism with or without anosmia an indication for Tolazamide?
Reasoning: The disease hypogonadotropic hypogonadism with or without anosmia is associated with the phenotype Seizure, which in turn affects the gene GBA. This gene is not targeted by the drug Tolazamide. These connections suggest that Tolazamide may not be effective in treating hypogonadotropic hypogonadism with or without anosmia.
Answer: NO"
16793,32629.0,Chlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Short stature', 'EIF4A3', 'Chlorothiazide']",1.0,"Question: Is familial intrahepatic cholestasis an indication for Chlorothiazide?
Reasoning: The disease familial intrahepatic cholestasis is associated with the phenotype Short stature, which in turn affects the gene EIF4A3. This gene is not targeted by the drug Chlorothiazide. These connections suggest that Chlorothiazide may not be effective in treating familial intrahepatic cholestasis.
Answer: NO"
20394,27286.0,Sulfabenzamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'TSC2', 'Sulfabenzamide']",1.0,"Question: Is galactosemia an indication for Sulfabenzamide?
Reasoning: The disease galactosemia is associated with the phenotype Seizure, which in turn affects the gene TSC2. This gene is not targeted by the drug Sulfabenzamide. These connections suggest that Sulfabenzamide may not be effective in treating galactosemia.
Answer: NO"
14136,31181.0,Enflurane,muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['muscular dystrophy', 'Motor delay', 'MED12L', 'Enflurane']",1.0,"Question: Is muscular dystrophy an indication for Enflurane?
Reasoning: The disease muscular dystrophy is associated with the phenotype Motor delay, which in turn affects the gene MED12L. This gene is not targeted by the drug Enflurane. These connections suggest that Enflurane may not be effective in treating muscular dystrophy.
Answer: NO"
20332,30094.0,Adomiparin,antithrombin III deficiency,disease-phenotype-protein-drug,contraindication,"['antithrombin III deficiency', 'Spontaneous abortion', 'MMP11', 'Adomiparin']",1.0,"Question: Is antithrombin III deficiency an indication for Adomiparin?
Reasoning: The disease antithrombin III deficiency is associated with the phenotype Spontaneous abortion, which in turn affects the gene MMP11. This gene is not targeted by the drug Adomiparin. These connections suggest that Adomiparin may not be effective in treating antithrombin III deficiency.
Answer: NO"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'MIR96', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hearing impairment, which in turn affects the gene MIR96. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
14633,28313.0,Lumateperone,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Lumateperone']",0.5,"Question: Is schizophrenia an indication for Lumateperone?
Reasoning: The disease schizophrenia is associated with the gene DRD2, which is targeted by the drug Lumateperone. These connections suggest that Lumateperone may be effective in treating schizophrenia.
Answer: YES"
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'IGKC', 'Fluoxetine']",1.0,"Question: Is autosomal recessive severe congenital neutropenia due to G6PC3 deficiency an indication for Fluoxetine?
Reasoning: The disease autosomal recessive severe congenital neutropenia due to G6PC3 deficiency is associated with the phenotype Hepatomegaly, which in turn affects the gene IGKC. This gene is not targeted by the drug Fluoxetine. These connections suggest that Fluoxetine may not be effective in treating autosomal recessive severe congenital neutropenia due to G6PC3 deficiency.
Answer: NO"
15767,31072.0,Homatropine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Headache', 'GNRH1', 'Homatropine']",1.0,"Question: Is pseudotumor cerebri an indication for Homatropine?
Reasoning: The disease pseudotumor cerebri is associated with the phenotype Headache, which in turn affects the gene GNRH1. This gene is not targeted by the drug Homatropine. These connections suggest that Homatropine may not be effective in treating pseudotumor cerebri.
Answer: NO"
